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This study’s objectives were to identify, describe, and provide guidelines on using 
indigenous-western antihypertensive therapies in Belize to examine indigenous 
therapies’ efficacy in lowering blood pressure. The researcher utilized an explanatory 
sequential mixed method research design to examine indigenous-western therapies. 
Data were collected quantitatively from the general public (n=422) and qualitatively from 
hypertensive patients (n=24) using indigenous therapies and vendors (n=19) of 
indigenous therapies. The study results identified 47 different medicinal plants used in the 
management of hypertension in Belize, as reported by participants. Besides, leaves were 
the most reported plant part used to manage hypertension, while boiling (decoction) was 
the most common preparation method. The common route of administration was the oral 
route, and ½ to 1 cup 2 to 3 times daily was the dose and frequency of administration, 
respectively. The majority of participants using indigenous therapies did not report side 
effects. Conversely, orally administered hydrochlorothiazide and captopril were the most 
common western therapies reported by most respondents in the study. The majority of 
the respondents did not report concomitant use of indigenous-western therapies to 
manage their hypertension; however, those who used indigenous therapies reported that 
medicinal plants were efficacious in lowering their blood pressure. Some of the claims by 
vi 
 
participants are verified by Western science, thereby authenticating indigenous therapy 
claims. The researcher developed guidelines on the use of indigenous-western therapies 
from the results of the study. Collaboration between indigenous healers and Western 
medical practitioners to provide holistic healthcare approaches was recommended since 
both sciences have identical foundations and can learn from each other. The government 
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ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION AND BACKGROUND OF THE STUDY 
 
Hypertension is a severe medical condition where blood pressure within the arteries is 
elevated above normal values. Hypertensive disorders can be classified as either primary 
or secondary. The majority (95%) of all cases, usually termed primary hypertension, 
defined as continuous rise of resting systolic blood pressure (≥ 140 mm Hg), diastolic 
blood pressure (≥ 90 mm Hg), or both, in which there exists no specific identifiable 
etiology (Bhatt, Kandzari, O'Neill 2014:1393; Bakris 2016:1; Dekker, Amick, Scholcoff, 
and Doobay-Persaud 2017:171). The other 5% of all cases, classified as secondary 
hypertension, are caused by some other conditions that affect the kidney, endocrine 
system, heart, and arteries. Persistent hypertension is among the main risk factors for 
strokes, heart failure, arterial aneurysm, heart attacks, and chronic kidney failure. A 
moderate increase in arterial blood pressure results in shortened life expectancy (Dekker 
et al., 2017:171). Both lifestyle and dietary changes and medicines can help improve 
blood pressure and reduce the risk associated with health complications from 
hypertensive conditions. 
 
Evidence from the epidemiological and family studies described by Alicea-Planas, 
Greiner, and Greiner (2016:43) showed that hypertension occurs from numerous 
interactions between genetic factors and the environment. These studies have also 
reported that there exist more than 50 factors that elevate blood pressure. Most important 
are age, family history of cardiovascular infection, smoking, increased alcohol 
consumption, a diet rich in cholesterol, sedentariness, and coexistence of some other 
diseases like diabetes and obesity (Alicea-Planas, Greiner and Greiner 2016:43; Bakris 
2016:2).To this end, therefore, proper medication and the adoption of an appropriate 
lifestyle are essential in preventing hypertension.   
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The main lifestyle changes that can lower hypertension include reduced body weight in 
obese patients, low salt intake in the diet, increased physical activity, moderate alcohol 
consumption, and ceasing smoking (Kieffer 2015:1191; Bakris 2016:2). Appropriate drug 
treatment is also essential in managing the hypertensive condition. In this case, drug 
treatment relies on the hypertension stage, the diseases associated with existing 
hypertension, and the risk factors present. All the recommendations for western 
hypertensive treatment depend on the classification and definition of hypertension 
adopted by the Joint National Committee (JNC). JNC is responsible for evaluating, 
monitoring, documentation, and treating high blood pressure in America (Bidulescu, 
Francis, Ferguson, Bennett, Hennis, Wilks, Harris, MacLeish, and Sullivan 2015:125). In 
this case, the committee defined high physiological BP as ≥ 140 mm Hg systolic blood 
pressure and ≥ 90 mm Hg for diastolic blood pressure. 
 
A rich base of indigenous practices involving the use of spiritism, medicinal plants, and 
other communal practices has been reported in the Caribbean that is similar to the 
practices in Belize (Mans 2016:1; Mans, Grant, and Pinas, 2017a:1; Mans, Ganga, and 
Kartopawiro, 2017b:111). The practices historically are associated with slaves’ 
immigrants from Africa and the native inhabitants of the region. Indigenous therapies are 
still a common practice by the people of Belize as a holistic approach to managing various 
diseases. The use of indigenous-western therapies in the management of hypertension 
in Belize is the focus of this study. Guidelines on such usage shall serve as a guide to the 
general public on the use of indigenous-western therapies for hypertension and help 
inform the design, development, and implementation of education to build awareness on 
indigenous medicinal plants in managing hypertension.  
 
1.2 BACKGROUND TO THE RESEARCH PROBLEM 
 
Hypertension is a significant disorder affecting close to 30% of adults globally, and it is 
estimated to increase to approximately 60% by 2030. This condition is closely associated 
with numerous severe health conditions and accounts globally for around 13.5% of all 
deaths that are premature, 60% of all cases of strokes, and close to 50% of ischemic 
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heart diseases (Xiong, Yang, Liu, Zhang, Wang, and Wang 2013a: 275279; Xiong, Yang, 
Liu, Zhang, Wang, and Wang 2013b:570). Hypertension causes a severe economic and 
social burden in both developed and developing countries such as Belize.  
 
In Belize, for instance, hypertension is a significant problem causing high morbidity and 
mortality rates among the population (PAHO 2009:1; Danladi, Diomar, Roberta, Innocent, 
and Augustine 2016:357). Developing nations like Belize are experiencing an increase in 
health burden, where overweight and obesity are becoming very common and exist 
together with undernutrition and infectious diseases. It is estimated that cardiovascular 
diseases such as hypertension are some of the leading causes of death in the developing 
nations (Bidulescu, Francis, Ferguson, Bennett, Hennis, Wilks, Harris, MacLeish, and 
Sullivan 2015:125). 
 
Belize, as a developing nation, is progressively joining developed countries in the 
prevalence of non-communicable diseases, especially diabetes and hypertension. As far 
back as 2009, the Pan American Health Organization (PAHO) reported a rise in the 
mortality rates and hospitalizations resulting from hypertension and diabetes (PAHO 
2009:1). Several modifiable risk factors for developing hypertension as described by other 
authors (Biraguma, Mutimura, and Frantz 2019:3181; Mishra, Neupane, Shakya, 
Adhikari, and Kallestrup 2015:863; Shayo 2019:927) are prevalent and on the rise in the 
country of Belize. Modifiable risk factors such as sedentary lifestyle, low diet, and 
excessive alcohol consumption are prevalent in Belize, and the attendant observable 
consequences are already being experienced (PAHO 2009:1; Rosendorff, Lackland, 
Allison, Aronow, Black, Blumenthal, Cannon, De Lemos, Elliott, Findeiss, and Gersh 
2015:1372). 
 
Previously, the incidences of Belize’s infectious diseases have been reported (PAHO 
2009:1) to be high. Still, presently, hypertension and diabetes as non-communicable 
diseases have surpassed infectious diseases, and the number of cases is on the rise. 
Hypertension is associated with different risk factors such as the non-modifiable and 
modifiable risk factors (Rosendorff et al. 2015:1372). The non-modifiable factors, in this 
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case, comprise genetics, gender, and age, while the modifiable risk factors include 
overweight, physical inactivity, and smoking (Schnall, 2016:50). The overall hypertension 
morbidity and mortality in Belize have been reported (PAHO 2009:1) to rise. In supporting 
the existence of a high increase in hypertensive mortality in the country, some studies 
have found increased susceptibility to hypertension (Johnson, Thorpe, Bartels, 
Schumacher, Palta, Pandhi, Sheehy, and Smith, 2014:65). 
 
The global increase in the awareness of indigenous therapies (primarily herbal) perceived 
as safe and efficacious simply because they are natural, coupled with the long ancestral 
history of linkage to African folklore beliefs and practices, has led to people consuming 
indigenous remedies (Bignante and Tecco, 2013:177; Babu and Antony 2017:1; Mans et 
al. 2017a:1; Mphuthi and Pienaar 2017:1; Logan, McNairn, Wiart, Crowshoe, Henderson, 
and Barnabe, 2020). In Belize, for instance, it is a common practice for people to try 
indigenous remedies before coming to the hospital or combining indigenous therapies 
with Western medications. With indigenous–western therapies commonly practiced 
among the Belizean population, hypertensive Belizeans could combine Western 
pharmaceutical products with indigenous remedies. Without standard guidelines for such 
usage, indigenous therapies mostly combined with prescribed Western medications could 
have an unknown beneficial effect or an attendant potential unsafe herb-drug interaction. 
The behavior could also lead to interactions that might lead to beneficial effects in 
lowering hypertension, harmful drug-herb interactions, or toxicities. The lack of guidelines 
from empirical studies on indigenous therapies and documented data on indigenous-
western therapies in Belize’s country makes the practice a significant concern for public 
health and health care providers. 
 
Increasing the general awareness, control, and treatment of hypertension is linked to 
reducing cardiovascular-related infections and total mortality. Using appropriate 
pharmaceutical drugs and the possible inclusion of indigenous remedies have been 
reported to ensure that hypertensive related cases are minimized (Popescu, Scrieciu, 
Mercuţ, Ţuculina, and Dascălu, 2013:1). A major concern for public health might be drug-
herb interactions because of western-indigenous practices and their attendant 
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consequences. Although some literature is available on indigenous therapies of Belize, 
to date, no specific guidelines exist on therapies concerning concomitant consumption 
with Western drugs (Balick and Arvigo, 2015:22; Kate 2009:120; Arvigo, Epstein, and 
Yaquinto 1994:190; Ames, Oakes and Correll, 1985:779). Therefore, the present study 
became very necessary as it seeks to provide detailed information on the use of 
indigenous-western anti-hypertensive therapies among hypertensive patients in Belize. 
The study examined the types of indigenous-western anti-hypertensive therapies used by 
hypertensive patients in Belize, particularly when and how such therapies are used. The 
research also provides guidelines for western-indigenous antihypertensive usage among 
hypertensive patients in Belize with a clear view of generating the required data for 
appropriate interventions designed to curb public health concerns for western-indigenous 
practices.  
 
1.3 INDIGENOUS THERAPIES  
 
The use of indigenous therapies in treating non-communicable related diseases such as 
hypertension has been on the rise within the last few decades, with close to 80% of the 
global population reporting that they had relied on such herbs for their primary healthcare 
(Ekor 2014:177; WHO 2015:1; Al Disi, Anwar, and Eid, 2016:326). While most indigenous 
therapies can treat many diseases, and many drugs were discovered from many plants, 
most such remedies remain untested, with most of their use remained poorly monitored. 
The resulting consequences of this are inadequate knowledge of their possible efficacies, 
adverse reactions, their mode of action, possible contraindications, and potential 
interactions with the already existing Western pharmaceuticals and functional foods that 
can promote the rational and safety of these herbs (Williamson, Liu and Izzo 2020:1227; 
Chan, Li, and Perez, 2016:875). Therefore, it is imperative to investigate the indigenous 
therapies primarily used by hypertensive patients, how they are used, their potential side 
effects related to such remedies, and measures to address side effects. Since medieval 
times, indigenous therapies have been prepared using different methods. Whether the 
treatment is for external or internal use, common preparation methods include decoction, 
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infusions, tinctures, poultices, or salves. In many communities, however, decoctions and 
infusions are usually the most common preparation methods (Ekor 2014:177). 
 
Beneficial effects could also be experienced by the use of indigenous therapies, 
especially among hypertensive patients in Belize and the world over. The current increase 
in indigenous therapies for self-medication by individuals or patients is linked to several 
reasons. Chanda and Kaneria (2011:1251) enumerated some reasons why people 
engage in the use of indigenous medicines. Reasons such as patients feeling very 
uncomfortable talking about their health problems and fear that there will be a lack of 
confidentiality in handling information related to their health. Additionally, fear of 
misdiagnosis and subsequent wrong treatment with Western medications, and a lack of 
enough time for seeing the physician were some of the reasons proffered (Chanda and 
Kaneria, 2011:1251).  
 
Religion and cultural beliefs also inform the patient’s choice to use indigenous therapies, 
the cost of those herbs, and the perceived efficacy of such herbs in treating the patient’s 
condition (Ekor 2014:177). These herbs are readily available and cheap, making them 
the first line of treatment in many communities. Besides, indigenous therapies have 
bioactive phytochemicals used to render health effects. Phytochemical plant constituents 
such as glycosides, terpenoids, tannins, alkaloids, saponins, flavonoids, phenols, and 
cardiac glycosides have been reported to provide many health benefits. Many of these 
phytochemical groups are known individually to have specific health benefits. For 
instance, flavonoids have antioxidant and antibacterial properties and act as enzyme 
inhibitors (Moodley, Krisna, Pillay, Sershen, and Govender, 2018:1; Ng, Koick, and Yong 
2020:1). A common practice with indigenous therapy is concomitant intake with other 
medicinal plants or western medications known as polypharmacy. Polypharmacy is 
described as the concurrent administration of more than one drug or substance for 
therapeutic purposes (Dookeeram, Bidaisee, Paul, Nunes, Robertson, Maharaj, and 
Sammy, 2017:1119; Burt, Elmore, Campbell, Rodgers, Avery, and Payne, 2018:91). The 
practice of polypharmacy is carefully monitored in a clinical setting using carefully 
designed paper-based or computer software. Although it is much easier to monitor the 
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possibilities of drug-drug interactions in the clinical settings, monitoring for indigenous-
western drug interactions is difficult because these interactions have not been 
scientifically proven. The researcher’s view is that it becomes precarious when 
indigenous therapies are combined with other herbal therapies or indigenous 
preparations combined with Western therapies. These drug-herb or herb–herb 
interactions can precipitate toxic effects or, in some instances, render the therapeutic 
effect of a conventional drug or the more promising herbal preparation more effective 
(Mphuthi 2015:212; Mans et al. 2017a:1). Unfortunately, few studies thoroughly 
investigated these interactions between western-indigenous therapies in Latin America 
and the wider Caribbean (Mans et al. 2017b:111). Therefore, the present study identified 
and examined the use of indigenous-western anti-hypertensive therapies to provide 
guidelines on the safe use of indigenous – western therapies in managing hypertension 
in Belize. 
 
Presently, literature exists that document numerous indigenous therapies used to treat 
varying diseases in Belize with proven efficacy (Salvamani, Gunasekaran, Shaharuddin, 
Ahmad, and Shukor 2014:11; Balick and Arvigo, 2015:22; Ames et al., 1985:779; Kate 
2009:120; Arvigo et al., 1994:190). However, other than the much-publicized Western 
drugs for treating hypertension, little is known about Belize’s therapies to treat 
hypertension or indigenous-western combinations in managing hypertension (Mac Arthur, 
Nelson, and Woodye 2014:1).  
 
In recognition of the importance of medicinal plants in managing various diseases, the 
Belizean government in 1993 established the world’s first medicinal plant reserve, called 
Terra Nova Medicinal Plant Reserve (TNMPR) in the Cayo district. TNMPR is a 6,000-
acre reserve of potentially lifesaving indigenous plants in Belize. Seedling plants 
“rescued” from rainforest areas in danger of destruction from development are sent to 
Terra Nova for transplanting. The Belize Association of Traditional Healers manages the 
reserve (Balick and Arvigo, 2015:15). Despite these efforts, currently, no guidelines exist 




1.4 RESEARCH PROBLEM 
 
Based on the literature above, it is clear that indigenous therapy usage has always been 
in existence and known by indigenous community members. The indigenous communities 
still believe and are still practicing the use of indigenous therapies. The practice is well-
accepted and promoted among community members, even though Western medical 
practitioners do not support it. The major non-communicable disease in Belize is 
hypertension. It causes a substantial economic and social burden to the country and 
contributes to mortality and morbidity rate. Since time immemorial, native Belizeans 
depended on the vast rain forest remedies to treat diseases, which is still the practice 
until today. Belizeans are also using Western and indigenous remedies for treating 
hypertension, even in this era of western medicines. The problem is that with all the 
available data on indigenous therapies, presently, there are no guidelines on the use of 
these therapies in Belize for the management of hypertension. This study evaluated the 
practice of indigenous–western antihypertensive therapies use among patients to provide 
guidelines for public safety. 
 
The increase in global usage of indigenous therapies and the rise in the number of people 
with non-communicable diseases such as hypertension have increased remarkably 
(Bakris 2016:1; Ekor 2014:177; Mphuthi 2015:213). Belize also sees an increase in the 
use of indigenous remedies for the treatment of diseases. The use of indigenous 
therapies to manage varying disease conditions is common in Central America and the 
Caribbean and is on the increase. Presently, there are no known written guidelines on 
indigenous-western therapies to manage hypertension in Belize.  
 
Without standard guidelines for such usage, indigenous therapies mostly combined with 
prescribed Western medications, produce an unknown beneficial effect or potentially 
unsafe herb-drug interaction. This study seeks to examine the use of indigenous-western 
anti-hypertensive therapies in Belize to develop guidelines for using these combinations 
of such therapies.  
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1.5 RESEARCH AIM/PURPOSE OF THE STUDY 
 
According to Locke, Spirduso, and Silverman (2013:3), the purpose statement indicates 
why the study should be conducted and what the study intends to accomplish. The 
purpose statement sets the objectives, intent, or the main idea of a proposal or research. 
This study identified common indigenous-western therapies used concomitantly to 
manage hypertension. The study will also provide guidelines on indigenous-western 
therapies used in the management of hypertension in Belize. Finally, the study aims to 
provide a list of the commonly used indigenous therapies used in Belize to manage 
hypertension.  
 
1.6 RESEARCH OBJECTIVES 
 
Based on the aim/purpose of the study above, the following objectives were developed 
for this study as follows: 
1.6.1 Phase 1: Quantitative phase 
 
● To determine the indigenous therapies used by hypertensive patients in Belize to 
treat hypertensive conditions. 
● To identify the common western therapies used in the treatment of hypertension 
in Belize.  
● To identify concomitant use of indigenous-western therapies among hypertensive 
patients in Belize.  
1.6.2 Phase 2 Qualitative phase 
 
● To explore and describe the preparation, storage, and usage of indigenous 
therapies by hypertensive patients in Belize. 
● To understand the concomitant use of indigenous-western therapies by 




1.6.3 Phase 3 Guideline development 
 
● To develop guidelines on the use of indigenous-western therapies for the 




Hypotheses are statements in quantitative research in which the investigator makes a 
prediction or a conjecture about the outcome of a relationship among attributes or 
characteristics (Creswell, 2015:111). The researcher proposed the following hypotheses 
to investigate the use of indigenous-western remedies among hypertensive patients in 
Belize.  
● Hı. The use of indigenous-western anti-hypertensive therapies controls high blood 
pressure compared to single therapy among the Belizean population. 
● H0. The use of indigenous-western anti-hypertensive therapies does not control 
high blood pressure than the single therapy approach among the Belizean 
population. 
 
1.8 RESEARCH QUESTIONS 
 
Creswell (2015:111) defined research questions as questions in quantitative or qualitative 
research that narrow the purpose statement to specific questions that researchers seek 
to answer. Most studies typically develop research questions before identifying the 
methods of the analysis. Based on the above study objectives, this study aims to answer 
the following research questions: 
1.8.1 Phase I 
 
● What are the common indigenous therapies used by patients to treat hypertension 
in Belize? 
● What are the common western therapies used by hypertensive patients in Belize? 
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● Do Belizean hypertensive patients combine indigenous-western therapies in the 
management of their hypertension? 
 
1.8.2 Phase II 
 
● How are indigenous therapies prepared, stored, and used by hypertensive patients 
in Belize? 
● Why do hypertensive patients in Belize use indigenous therapies? 
 
1.8.3 Phase III 
 
What guidelines should hypertensive patients in Belize use in the management of their 
hypertension using indigenous-western therapies?  
 
1.9 SIGNIFICANCE OF THE STUDY 
 
A study on indigenous-western therapies in Belize is significant for many reasons. First, 
identifying the common indigenous-western therapies will help understand the 
relationship between cultural practices and Western medication use in Belize. Second, 
presently, there is a paucity of scientific data on the use of indigenous-western therapies; 
hence, this study’s findings may help the medical personnel better understand and 
approach hypertension management among Belizeans. Third, the study explored 
adherence to western therapies by hypertensive patients in Belize. Suppose patients use 
indigenous therapies more than prescribed Western medications. In that case, there is 
the possibility of wastages of the Western therapies provided to such patients, leading to 
an overall economic waste of public funds since the western therapies are provided free 
of charge.  
 
Therefore, this study’s results may help health professionals adopt methods to educate 
their patients on medication adherence. Fourth, the concomitant use of indigenous-
western therapies has been reported to produce interactions. Suppose the results of this 
study showed hypertensive patients combining indigenous–western therapies to manage 
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their hypertension. In that case, the medical personnel will be guided to enlighten their 
patients on the harms or benefits of such practices. Fifth, many indigenous therapy 
vendors may be ignorant of current scientific discoveries on numerous plants and herbs 
claimed to have medicinal properties. The reviewed literature and the results of this study 
should provide insight into the current scientific efficacies of plants and herbs used by 
vendors in Belize to manage hypertension. This information will guide vendors in using 
indigenous therapies that might be useful or harmful in managing hypertension. 
 
Finally, many Western therapies were originally from indigenous knowledge systems. 
This study’s findings may lead to discovering an indigenous therapy that may be effective 
in managing hypertension not only in Belize but globally. Invariably, this study is 
significant because it will provide much-needed information for patients, health workers, 
policymakers at the Ministry of Health, and researchers on indigenous – western therapy 
practices in Belize.  
 
Summarily this study is critical because: 
● This study is envisioned to understand the health impact of indigenous-western 
anti-hypertensive therapies among the Belizean population. 
● The study may resolve theoretical questions regarding the use of indigenous-
western anti-hypertensive therapies in Belize. 
● The study results will provide guidelines for indigenous-western anti-hypertensive 
therapies, influencing policymakers to formulate indigenous-western anti-
hypertensive therapies for public health. 
● The study will support WHO global traditional medicine strategies and Belize’s 
initiative on alternative medicines. 
● The study will provide an understanding to support the economic impact of 
hypertension management using indigenous-western therapies. 
● The study will provide the basis for further research on indigenous-western 




Proper drug treatment is essential for managing the hypertensive condition. In this 
case, antihypertensive drug treatment depends on the hypertension stage, 
comorbidities, and risk factors present. It is assumed that every community has its 
indigenous drugs for treating conditions such as hypertension. Although hypertension 
is a major problem in Belize, limited guidelines still exist on the type of indigenous-
western anti-hypertensive therapies used among hypertensive patients in Belize. The 
pattern Belize’s hypertensive patients use indigenous therapies to treat their 
hypertensive condition is of great significance in this study. It aims to offer knowledge 
and illustrations on the indigenous therapies used to treat hypertension. This study 
will also attempt to determine how indigenous therapies induce possible drug 
interactions, possible associated adverse effects, and how they are managed. The 
study intends to provide guidelines that will help the public and healthcare providers 
on the use of western-indigenous medications available in Belize. Such guidelines 
shall provide information on the harms and benefits of western-indigenous 
antihypertensive practices in Belize. This study’s results could be further explored for 
molecular studies to provide information regarding indigenous therapies that can be 
synthesized to manage hypertension.  
 




Hypertension is sustained elevation of resting systolic BP (≥140 mm Hg), diastolic BP 
(≥90 mm Hg), or both (Sternlicht & Bakris 2016:139). 
 
1.10.2 Antihypertensive  
 
An antihypertensive agent is a substance that is effective against high blood pressure 




1.10.3 Indigenous therapy 
 
Indigenous therapy is the comprehensive knowledge, skills, and practices based on the 
theories, beliefs, and experiences indigenous to different cultures, whether explicable or 
not, used in the maintenance of health as well as in the prevention, diagnosis, 
improvement, or treatment of physical and mental illness (WHO, 2019). 
 
1.10.4 Western therapies   
 
The use of conventional therapies to help prevent and treat disease. These include 




A vendor is a company or person who sells goods or services (Merriam-Webster 
Dictionary, 2017 Merriam-Webster, Inc.). 
 
1.11 OPERATIONAL DEFINITIONS 
 
Editage insights (2019:1) described operational definitions as a statement of procedures 
used to define the terms of a process needed to determine the nature of an item or 




In this study, hypertension is a condition of high blood pressure. 
 
1.11.2 Anti-hypertensive 
In this study, an antihypertensive is considered a substance, agent, or drug applied by 
patients to lower high blood pressure. 
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1.11.3 Indigenous therapies  
The knowledge, skills, and practices based on the theories, beliefs, and experiences 
indigenous to Belizean culture, used in the maintenance of health and the prevention, 
diagnosis, improvement, or treatment of physical and mental illness. 
1.11.4 Western therapies  
In this study, western therapies are the use of conventional treatments to help prevent 
and treat disease. These include lifestyle changes, counseling, medication, physical 
therapy, or surgery (WHO, 2013). These are drugs or medicines given at hospitals or 
obtained from pharmaceutical shops. 
1.11.5 Vendor/Bush doctor 
 
In this study, a vendor (or Bush doctor) is a person who sells or provides indigenous 
therapies to the public. He is also sometimes called a bush doctor. 
 
1.12 THEORETICAL FRAMEWORK 
 
This study examined indigenous therapies used by traditional healers and hypertensive 
patients to manage hypertension using the Health Belief Model. The Health Belief Model 
(HBM) focuses on individuals’ beliefs, attitudes, and practices (Becker, 1974:409; Jones, 
Jensen, Scherr, Brown, Christy, and Weaver, 2014:566). While the model has traditionally 
been adopted on issues to do with preventive health behaviors, it can be applied to 
different health contexts, including the use of herbal medicines by indigenous 
communities (Albashtawy, Gharaibeh, and Alhalaiqa et al., 2016:708; Gyasi, Asante, 
Abass, Yeboah, Adu-Gyamfi, and Amoah, 2016:1). The model is flexible and suits a 
variety of contexts, such as its use in the interventions and response of individuals and 
communities to treat many health conditions (Becker, 1974:409; Fall, Izaute, and 
Chakroun-Baggioni, 2018:746; Kamran, Sadeghieh, Biria, Malepour, and Heydari, 
2014:922). The HBM offered the ground in which this study was conducted. As a general 
theory, HBM is comprehensive and can be generalized in numerous settings, including 
indigenous therapies to manage diseases (Albashtawy et al., 2016:708; Gyasi et al., 
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2016:1; Kamran et al., 2014:922). When people believe that their medical condition is 
serious, they may use indigenous therapies alone or in combination with Western 
therapies to explore all possible means of healing either by experience or what they 
learned from family, friends, and the community.  
 
The argument from the HBM suggests that communities or individuals will take a health-
related action such as the use of indigenous therapies to treat diseases if such a 
community has access to the therapies. They feel that they can avoid negatively related 
conditions such as side effects or perceived that a more significant benefit occurs in 
partaking in the new behavior or action (Albashtawy et al., 2016:708). Perception and 
attitudes have determined how people behave in certain conditions and the resultant 
practices that ensued. The availability of indigenous therapies within reach of the 
communities, their prices, and perceived effectiveness influence communities’ use of 
such therapies (Albashtawy et al. 2016:708). In addition, from the HBM model’s 
perspective, each community’s uniqueness determines how they respond to different 
diseases. Environmental factors such as culture, religious beliefs, and psychological 
interrelationships make up patients’ dynamic response to some form of illness (Salvamani 
et al. 2014:1). Such responses can either act as perceived barriers or perceived 
promoters of the usage of indigenous remedies. The environment, any external or internal 
factor in the patient’s surroundings, might influence how the patient responds to a given 
health condition.  
 
The HBM applies well to indigenous healers, and hypertensive patients in Belize continue 
to use indigenous therapies to manage hypertension. Generally, as outlined in the HBM, 
people seek therapies depending on the availability of such therapies, perceived 
usefulness, perceived benefits, perceived effectiveness, and the associated cost. In this 
regard, indigenous healers and their clients will continue to use indigenous therapies 
depending on their general knowledge of the therapies, experiences, their perceived 
effectiveness, and the cost the patients are likely to incur in their quest to find relief from 
their illnesses (Albashtawy et al. 2016:708). Therefore, indigenous healers and their 
clients will continue to use indigenous therapies to minimize harmful symptoms from 
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Western medicines because of their use of indigenous therapies and their perceived 
cultural effectiveness. Therefore, this research is grounded in the Health Belief Model as 
it seeks to expound on the use of indigenous anti-hypertensive therapies in Belize. 
 
1.13 RESEARCH METHODOLOGY AND RESEARCH DESIGN  
This study utilized mixed-methodology, where both quantitative and qualitative methods 
were integrated to describe data, while explanatory sequential study design was 
employed (Creswell, 2015:20). Creswell (2015:20) defined the research design as the 
specific procedures involved in the research process. These include data collection, data 
analysis, and report writing. In this study, utilization of indigenous-western therapies was 
evaluated using a non-experimental, quantitative, and qualitative descriptive design. 
Descriptive research describes the present status of an identified variable or phenomenon 
(Creswell 2015:20). This study utilized a mixed-methods explanatory sequential study 
design under which data were collected using quantitative and qualitative methods 
described by Creswell (2015:535). The research was divided into three phases, as 
described below. 
In the first phase of the study, quantitative data were collected from hypertensive patients 
from the entire country of Belize to ensure that the data is an accurate representation of 
the whole population. The first phase of this study was designed to identify indigenous 
therapies use by hypertensive Belizeans and if such therapies are concomitantly used 
with Western medicines.  
This phase examined indigenous-western therapies used by Belizeans in the 
management of hypertension. Data were collected quantitatively utilizing a structured 
questionnaire. In addition, this phase evaluated the indigenous therapies used individually 
or concomitantly with Western medicines by the Belizean population. 
This study utilized a mixed-methods explanatory sequential study design under which 
data were collected using quantitative and qualitative methods. Creswell (2015:535) 
described mixed methods research design as a procedure for collecting, analyzing, and 
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“mixing” through quantitative and qualitative methods in a single study or a series of 
studies to understand a research problem.  
Mixed-methods sequential explanatory design implies collecting and analyzing 
quantitative and then qualitative data in two consecutive phases within one study 
(Creswell 2015:535). Using sequential explanatory design, the designer for the study only 
requires the research investigator to make a general view with regard to some specific 
aspects of investigations (Ary, Jacobs, Sorensen, and Walker 2014:56). In the 
explanatory sequential study design, the researcher collects data during the quantitative 
(numeric) study and analyzes it as a first step to the mixed methods. 
1.13.1 Phase I (Quantitative Method) Research Methods 
 
This phase utilized a quantitative research design to identify indigenous medications used 
by the Belizeans to treat hypertension. Therefore, this study’s first phase identified the 
indigenous therapies used by hypertensive Belizeans and Western medicines 
concomitantly used with indigenous therapies. 
 
1.13.1.1 Research Setting 
 
The cultural, physical, social, and environmental sites for which research is conducted is 
considered the research setting (Creswell 2015:20). The current study on indigenous-
western antihypertensive therapies for hypertension was conducted in the entire country 
of Belize. Belize (formerly British Honduras) is the only commonwealth and English-
speaking country in Central America. Its geographical location, historical background, and 
trade association are Central America and the Caribbean (Figure 3.1). Therefore, the 
country participates in the activities of the Central American Integration System (CAIS) 
and the Caribbean Community (CARICOM). It has a total area of about 8, 867 square 
miles (23,000 km2) and shares borders with Guatemala (266 km) to the south and west 
and Mexico (250 km) to the north. It is bordered by the Caribbean Sea to the east, with 
386 km of coastline (Figure 3.1). The country has a population of 351,600 (Statistical 
Institute of Belize [SIB] 2013:1). The main ethnic groups in the country are Mestizo, 
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Creole, Maya, and Garifuna. The literacy rate was 79.7%, with an unemployment rate of 
14.2%. Belize is a parliamentary democracy, a member of the Commonwealth, divided 
into six administrative districts, Belize, Cayo, Corozal, Orange Walk, Punta Gorda, and 
Stann Creek. The country has a GDP of $1.987 billion (Table 3.1), a GDP growth rate of 
0.7%, and an inflation rate of 0.3% (2018). Belize’s total exports total for 2018 were 
estimated at US$200 million annually. The economy’s principal sectors are agriculture, 
agro-processing, and services, primarily tourism (Martin and Manzano 2010:107; Leslie 
and Heusner 2002:5). The main exports were sugar and molasses (30%), bananas 
(18.5%), citrus (15.7%), marine products (10.7%), and crude petroleum (6.3%) (SIB 
2014:1). 
 
The researcher collected data from major hospitals, clinics, and pharmaceutical outlets in 
Belize. Hypertensive patients attending special clinics or refilling their orders were 
identified and targeted for data collection. Data were collected from all six districts of the 
country. Every confirmed hypertensive patient accessing antihypertensive medications at 
any healthcare facility qualified to participate in the research. 
 
1.13.1.2 Phase I: Population and sample selection 
 
A population is a group of individuals who have the same characteristic. Simultaneously, 
a sample is a subgroup of the target population that the researcher plans to study to 
generalize the target population (Creswell 2015:142). Since the researcher used a non-
probability convenient sampling technique for data collection in this phase of the study, 
the sampling technique allows participants in a given unit to be chosen based on 
convenience and enable generalization. It has been considered as a useful sampling 
method that involves receiving relevant information from a sample population that the 
researcher believes are aware of the matter being investigated. In this case, the study 
participants were selected based on pragmatic considerations such as their availability 
and diagnosis during the research. It is important to note that only patients diagnosed 
with primary hypertension and currently prescribed anti-hypertensive medications were 
recruited to participate in the study.  
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Therefore, this study’s participants comprised all hypertensive adult patients currently 
accessing antihypertensive medications at government-owned hospitals, private clinics, 
or pharmacies. A convenient sampling technique was employed for data collection. An 
estimated sample size of 422 was used for the study with a 95% confidence level and a 
+/- 5% confidence interval.  
 
The researcher explained that the study focuses on learning more about indigenous-
western therapies among hypertensive patients in Belize. During the survey, the 
researcher provided participation information sheets explaining the study in written form 
and an informed consent form with the researcher’s contact number. Participants were 
recruited from the hospitals and pharmacy areas when they refilled their medications or 
when accessing drugs for hypertension.  
 
1.13.1.3 Sample size and sampling procedures – Phase I  
 
OpenEpi, Version 3, an open-source calculator, was used to calculate the sample size 
(Dean, Sullivan, and Soe, 2018:1). OpenEpi is a free and open-source software for 
epidemiologic statistics. It provides statistics for counts and measurements in descriptive 
and analytic studies, stratified analysis with exact confidence limits, matched pair and 
person-time analysis, sample size and power calculations, random numbers, sensitivity, 
specificity and other evaluation statistics, R x C tables, and chi-square for dose-response 
(Dean et al. 2018:1). The study employed a convenient sampling technique to obtain data 





Table 1.1 Phase I sample size calculation using OpenEpi. 
 
Table 1.1 Phase I Sample Size calculation.  
Population size (for Finite Population Correction factor or FPC) (N): 398050 
Hypothesized % frequency of outcome factor in the population (p): 50%+/-5 
Confidence limits as % of 100 (absolute +/- %) (d): 5% 
Design effect (for cluster surveys-DEFF): 1 
Confidence level (%) 95% 
Sample size 422 
Equation: Sample size n = [DEFF*Np(1-p)]/ [(d2/Z21-α/2*(N-1) + p*(1 p)]  
 
1.13.1.4 Phase I: Sample size calculation 
 
OpenEpi, Version 3, an open-source calculator, was used to calculate the sample size 
(Dean et al. 2018:1). OpenEpi is a free and open-source software for epidemiologic 
statistics. It provides statistics for counts and measurements in descriptive and analytic 
studies, stratified analysis with exact confidence limits, matched pair and person-time 
analysis, sample size and power calculations, random numbers, sensitivity, specificity 
and other evaluation statistics, R x C tables, and chi-square for dose-response (Dean et 
al. 2018:1). 
 
The OpenEpi sample size calculator was used to determine the sample size of 384 x 10% 
= 422. The addition of 10% was to take into consideration the non-response factor. The 
final sample size was therefore calculated as 422. The 422 total sample size was further 
stratified to obtain proportionate samples from the six districts in the country (Table 1.1). 
A total of 422 questionnaires were used for data collection in this phase of the study. A 
95% confidence level with a +/- 5% confidence interval was used to determine sample 
size. The sample size was determined using Open Epi, Version 3, open-source (Table 
1.2). Stratified proportionate samples were further calculated based on the district 





Table 1.2 Sample size per population of each district – Phase I  
 
District Population 
   
District Sample size 
Belize 120, 602           128 
Cayo 96,197           102 
Orange Walk 51, 749            55 
Corozal 48, 429        51 
Stann Creek 43, 452        46 
Toledo 37, 614       40     
 
A sample size of 422 with a medium effect size at α = 0.05 confidence-level was 
eventually used for the study’s first phase.  
 
1.13.1.5 Phase I: Data collection 
 
Creswell (2015:9) defines data collection as a “means of identifying and selecting 
individuals for a study, obtaining their permission to study them, and gathering information 
by asking people questions or observing their behaviors.”  
 
In this phase, data were gathered from hypertensive patients in Belize using a structured, 
validated questionnaire. First, the participants were identified, the objectives and 
significance explained to them, and the researcher addressed any queries. Second, their 
consent was then sought, and those who gave their permission were informed that 
participation was voluntary. They were free to withdraw from the research at any point 
without any penalty or repercussions. The questionnaires were then administered to the 
participants by the researcher using paper and pencils. Those who could complete the 
questionnaire without assistance were allowed to do so, while the researcher assisted 
those who could not. The researcher distributed questionnaires at hospitals and 
pharmacy outlets throughout the country. Confidentiality and anonymity were strictly 
applied, and participant identifiers were not required, except if the participants qualified 
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and were willing to participate in Phase II (qualitative) of the study. Finally, the researcher 
kept the completed questionnaires under lock and key during the entire process. 
 
1.13.1.6 Phase I: Data analysis 
 
Analyzing and interpreting the data involves drawing conclusions about it, representing it 
in tables, figures, and pictures to summarize it, and to explain the findings in words to 
provide answers to research questions (Creswell 2015:10). Data coding was done using 
Statistical Package for the Social Sciences (SPSS) version 21.0 software before being 
analyzed. Two other reviewers’ then cross-checked coded data to ensure that they are 
consistent, readable, and complete. Mistakes from respondents were checked or 
corrections made as deemed necessary (Clarke and Braun 2013:120). Descriptive 
statistics were primarily used to describe demographic data and research questions 
based on prevalence, and inferential analyses were used to explore relationships.  
 
The main descriptive statistical procedures used were frequencies and percentages, 
while inferential statistics were used. The responses on indigenous-western therapies 
were analyzed using version 22 of SPSS (Statistical Package for Social Sciences) (IBM 
Corp., Armonk, NY, USA). The data were analyzed for frequency counts, and cross-
tabulation was performed on associations where needed. The z-score test was used to 
identify and report statistically significant associations. Prevalence was calculated and 
reported in terms of 95% confidence interval values. An alpha margin of error (α) was 
identified at 0.05. 
 
1.13.1.7 Phase I: Data validity and reliability 
 
In its simple definition, validity is the ability of a given research instrument to measure 
what is supposed to be measured (Elo, Kääriäinen, Kanste, Pölkki, Utriainen, and Kyngäs 
2014:1).  The validity of this study was assured through some activities. First, the content 
validity of the instruments was determined by expert judgments. The peer reviews and 
research supervisor carefully scrutinized the research questionnaire to judge the 
content’s’ appropriateness and the need for modification to achieve the study’s objectives. 
24 
 
The supervisor determined whether the research instruments’ items adequately 
represented all the areas for investigation. 
 
The well-designed questionnaire was then pretested to ensure coherence and 
comprehensiveness. The pretest was done for the questionnaires to maximize their 
relevancy, preciseness, and clarity in answering the required research questions. All 
ambiguous items not showing were appropriately corrected, replaced, or deleted as 
appropriate. In addition, research experts, including the research supervisor, were 
frequently consulted at each stage of the study for corrections and criticism of the tools 
for data collection (Gysels, Evans, Lewis, Speck, Benalia, Preston, Higginson, 2013:907). 
This approach aimed to ensure that the study results truly represent indigenous-western 
anti-hypertensives usage among hypertensive patients in Belize. Similar findings can be 
obtained even if the study is carried out by another researcher at different times so long 
as all other factors are kept constant. 
 
Finally, the questions were standardized to ensure that they provided desired answers on 
indigenous-western antihypertensive therapies. The researcher also ensured the data’s 
validity by administering the questionnaires to all the participants. The reliability of the 
data was also tested to ensure consistency. Data reliability refers to the extent to which 
a given study is consistent and stable when the same techniques are applied in a 
repeated number of ways or the scores from an instrument are stable and consistent 
(Creswell 2015:159). The primary role of reliability in this study is to minimize biases and 
errors in the research’s conduct. 
 
In this study, the questionnaire was tested for reliability using statistical methods 
(Bolarinwa 2015:195). Reliability testing of the questionnaire showed a Cronbach’s alpha 
value of 0.779. An exploratory factor analysis (EFA) using principle component analysis 
extraction and direct oblimin rotation with Kaiser Normalization was also employed, which 
extracted five components. The Kaiser Mayer Olkin (KMO) measure of sampling 
adequacy and Bartlett’s test for sphericity was also used, which reported a value of 0.6 
and a significant p-value less than 0.001, respectively. 
25 
 
1.13.2 Phase II: Qualitative method 
 
To understand how the Belizeans use indigenous medications and Western therapies to 
treat hypertension, this phase used an exploratory, descriptive research design with 
narration. This phase also explored how indigenous medicines are prepared and stored 
by the community for use as antihypertensive.  
 
1.13.2.1 Phase II: Research design 
 
A qualitative design was carried out to gain more in-depth insight into how and why 
Belizeans use indigenous-western therapies to manage hypertension. A qualitative 
research method was used in the second phase of this study. Creswell (2015:16) 
describes qualitative research as “an inquiry process of understanding based on distinct 
methodological traditions of inquiry that explore a social or human problem. The 
researcher builds a complex, holistic picture, analyzes words, reports detailed views of 
informants, and conducts the study in a natural setting.” Qualitative research comprises 
checking the qualities or characteristics that are not possible to be presented in numerical 
value. It is a kind of study that has focused on the phenomena that occur within natural 
settings and comprises studying such phenomena within all the complexity. Creswell 
(2015:204) further describes qualitative research as comprising doing checks on the 
qualities or characteristics that cannot be presented in numerical value. Within the context 
of this study, literature has offered suggestions that systematic and structured 
approaches are very crucial in tackling the potential causes of undesirable performance 
for the national culture in animation cinemas (Sandelowski, Voils, Crandell, and Leeman 
2013:347). 
 
A qualitative methodology was used in this study to get to know the actual perception of 
the population sampled concerning the use of indigenous-western anti-hypertensives 
amongst hypertensive patients in Belize. Similar to any other qualitative research, the 
study was field focused. Scholarly literatures shows that qualitative studies are usually 
exploratory and might comprise interviews or focus groups (Wilson 2013:275).   
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1.13.2.2 Phase II: Population 
 
All hypertensive patients who participate in phase I of the study, willing to participate in 
the second phase of the study, were invited to participate. Eligible participants were 
purposively selected from the different districts to participate in the second phase of the 
research.  
 
The need to get participants from the entire country became paramount because of the 
diversity in cultural beliefs and usage of indigenous therapies usage. For instance, even 
though every ethnic group can be found in every part of the country, some ethnic groups 
are found in higher numbers in some regions of the country. The Garinagu are 
concentrated in the Stann Creek area, while the Mayans in the far southern part of the 
Toledo district. The northern part of the country has a higher concentration of Hispanics, 
while the Mestizos and Creole are in the country’s western and eastern regions.  
 
Although the information on indigenous therapies is shared freely among the people, 
ethnic groups are known to use specific therapies unique to their culture (Balick and 
Arvigo, 2015:22). The research selected 24 participants from different parts of the country 
and different ethnicities for the study. Recruitment for the study was done from phase I 
respondents who indicated using medicinal plants. In addition, indigenous therapies 
vendors involved in selling indigenous remedies at the market or bush doctors’ homes 
were also used for qualitative data collection. Selection was based on being hypertensive, 
using indigenous therapies, and willingness to participate in the study. 
 
1.13.2.3 Phase II: Sample and sampling technique  
 
Non-probability purposive sampling was used for this phase, as described by Creswell 
(2015:324). Data saturation determined the number of participants in this phase. Data 
saturation is the stage at which no new information is coming during the interview. A total 
of 24 hypertensive patients were interviewed in the entire country to get diverse and rich 
responses to indigenous therapies used to manage hypertension. Nineteen indigenous 
27 
 
therapy vendors were also interviewed from the whole country. In qualitative research, 
the people or sites that can best help understand the central phenomenon are selected 
(Creswell 2015:206). For the second phase of this study, purposeful sampling was used 
to determine participants for data collection. Participants were selected based on their 
involvement as vendors for indigenous therapies or as hypertensive patients who used 
indigenous therapies.  
 
Market places and designated sales points inclusive of the venue for indigenous therapist 
gatherings were targeted for sample collection. Mark (2010:3) reported that qualitative 
research is majorly concerned with meaning and not for making generalized statements. 
Qualitative samples, therefore, must be large enough to ensure that most or all of the 
perceptions that might be important are revealed. Still, at the same time, if the sample is 
too large, data becomes repetitive and, eventually, superfluous. The sample size in most 
qualitative studies should generally follow the saturation concept when the collection of 
new data does not shed any further light on the issue under investigation. As a result of 
the numerous factors that can determine sample sizes in qualitative studies, many 
researchers shy away from suggesting what constitutes a sufficient sample size. Although 
the idea of saturation is helpful at the conceptual level, it provides little practical guidance 
for estimating sample sizes for robust research before data collection" (Mark 2010:3). 
Mark (2010:3) further reported that other researchers have tried to suggest guidelines for 
qualitative sample sizes. Charmaz (2006:114) suggests that "25” participants are 
adequate for smaller projects, while Ritchie, Lewis, and Elam (2003:84), indicated that 
qualitative samples often "lie under 50". Green, Judith, and Thorogood (2004:120) stated 
that "the experience of most qualitative researchers is that in interview studies little that 
is 'new' comes out of transcripts after you have interviewed 20 or so people" (Mark 
2010:3). While some researchers offer qualitative sample guidelines, there is evidence 
that suggests others do not strictly adhere to them. Creswell (2015:128) suggested a 
range of 20 and 30. Therefore, based on the above, this study purposively selected 24 
participants from indigenous therapy users for hypertension and 19 vendors of indigenous 




1.13.2.4 Phase II: Data collection  
 
Creswell (2015:218) defined one-on-one interviews as a data collection process. The 
researcher asked questions and recorded answers from only one participant in the study 
at a time. On the other hand, a focus group interview collects data through interviews with 
a group of people, typically four to six. Information regarding usage and interactions 
should be obtained from the patients using face-to-face interviews. The interviews were 
designed to explore why and how often patients use indigenous remedies to treat their 
hypertension. 
Data were collected from indigenous therapy vendors and hypertensive patients using 
structured face-to-face interview guides in this phase. The research supervisor and other 
researchers critiqued the questions to ensure trustworthiness. Two sets of data were 
collected in this phase. 
 
Data were first collected from hypertensive patients using indigenous therapies. The 
participants were identified during phase I of the study. The patients were contacted at 
their place of residence. Based on the earlier relationship developed and consent 
received during phase I of the study, the participants were included in the phase II study. 
Although consent was sought during the first phase of the study, consent was still sought 
during the qualitative data collection phase. Strict ethical protocols were observed during 
the entire process of data collection. The researcher conducted interviews in a place and 
at a time convenient for the participants, with field notes taken for responses from the 
participants. 
  
The second set of data for this phase were also collected from indigenous therapy 
vendors. Purposively identified in market places and within the communities were 
interviewed after their consent was sought. The researcher conducted interviews based 
on the convenience of indigenous therapy vendors. These sections of the study explored 
and described the sources of indigenous therapies and how they were prepared, used, 




Interviews used for data collection brought salient issues on indigenous-western 
therapies to light. A qualitative interview occurs when researchers ask one or more 
participants general, open-ended questions, and record their answers. The researcher 
then transcribed and typed the data into a computer file for analysis (Creswell 2015:217). 
Available information regarding indigenous remedies used to treat hypertension and their 
efficacy were obtained from indigenous vendors using one-on-one interviews.  
1.13.2.5 Phase II: Data analysis 
 
Responses from structured and unstructured qualitative interviews were entered into a 
computer coded, counted, and analyzed. Creswell (2015:245) describes a computer 
analysis of qualitative data as a means that researchers use a qualitative computer 
program to facilitate the process of storing, analyzing, sorting, and representing or 
visualizing the data. Data collected during in-depth interviews with hypertensive patients 
were transcribed, read several times, and their themes were coded in line with the study 
objectives.  
 
In transcribing the information, performing categories of the critical dimensions of 
summaries and associations were also strategic for data analysis. Additionally, a thematic 
analysis is aided and presented in a thematic network form that provided a general outline 
of the key themes generated from a given dataset (Elo et al., 2014:1). As quoted in the 
literature, the thematic analysis helped enhance understanding of some given 
phenomenon. It promoted accurate interpretation of the data collected during fieldwork, 
leading to more in-depth explorations and more explanations. Themes with similar codes 
aggregated together to form a central idea in the database (Creswell 2015:245).  
 
This researcher’s primary study focus was to explore indigenous-western anti-
hypertensive therapies among hypertensive patients in Belize. Therefore, a combination 
of both categorical and holistic strategies was essential for this research.  The researcher 
first made the analysis quantitatively by collecting data on indigenous-western therapies 
using questionnaires. Then, qualitatively analyzed data on indigenous-western therapies 
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from vendors and patients interviews were determined using categorical strategies. The 
kind of categories initiated in this case acted as a guide for analysis.  
 
For the purpose of revealing the general perception of the patients and vendors regarding 
the concomitant usage of indigenous-western therapies, a holistic analysis is more 
appropriate, especially after developing categories since the researcher can narrate the 
perception of individual respondents and compare it with the observed behaviors in that 
respect as outlined by Clarke and Braun (2013:120). They reported that the two analysis 
strategies are not by any chance exclusive of one another. 
 
1.14 PHASE III: DEVELOPMENT OF THE GUIDELINES 
 
Guidelines on the use of indigenous-western anti-hypertensive therapies were developed 
at the end of phase 2 of the study. In developing these guidelines, this study adapted the 
principles of triangulation to combine the quantitative data with the qualitative data to 
produce the guidelines used of indigenous-western antihypertensive therapies among 
Belizeans. Such guidelines included part of the plants used for hypertensive management 
and how to process the indigenous remedy. In addition, Western medications commonly 
prescribed for hypertensive therapy were documented, including concomitant use with 
indigenous therapies. 
 
Guidelines for the use of indigenous-western hypertensive therapies were established 
based on the explanatory sequential mixed-methods design. Creswell and Plano-Clark 
(2018:54) described an explanatory sequential mixed-methods design consisting of 
collecting quantitative data and then collecting qualitative data to explain or elaborate on 
the quantitative results. This approach’s rationale was that the quantitative data and 
results provide a general picture of the research problem; more analyses, specifically 
qualitative data collection, helped refine, extend, or explain the general concept. In this 
method, Creswell (2015:542) further classified three ways to mix the data from an 
explanatory sequential method. First, the priority of quantitative data (QUAN) collection 
and analysis are given by introducing it early in the study and having it represent a 
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significant aspect of data collection. A small qualitative (qual) component typically follows 
in the second phase of the research. Second, quantitative data were first collected in the 
sequence, followed by secondary qualitative data collection, presented in two stages, with 
each phase identified in headings on the report. Third, the qualitative data are used to 
refine the results from the quantitative data. Refinement of the results leads to exploring 
a few typical cases, probing a key result in more detail, or following up with an outline.  
 
The merging or mixing of the data shall be done by triangulation. Creswell (2015:542) 
described triangulation “as a means that investigators could improve their inquiries by 
collecting and integrating different kinds of data bearing on the same phenomenon.” The 
three points to the triangle are the two sources of the data and the phenomenon. This 
improvement in inquiries would come from blending one type of method’s strengths and 
neutralizing the other’s weaknesses. This study adapted the principles of triangulation to 
combine the quantitative data with the qualitative data to produce the guidelines used of 
indigenous-western antihypertensive therapies in Belize. Such guidelines included part 
of the plants used for hypertensive management, how to process the indigenous remedy, 
the recommended dosage, how the therapies should be taken, and reported adverse 
effects or interactions when used with Western medicines. 
 
This phase of the study provided the guidelines for public safety and health care 
professionals. The phase also offered useful suggestions for future investigations into the 
use of indigenous-western therapies in Belize. 
 
1.15 SCOPE AND LIMITATIONS OF THE STUDY 
 
This research was delimited to hypertensive patients in Belize only. Moreover, only 
patients found during the time of the study were involved as study participants. All ethnic 
groups in the country of Belize were eligible and were included in the study. Some 
participants from the local communities did not speak fluent English, which created a sort 
of barrier in data collection during both phases of the study. However, this limitation was 
overcome by the help of other health professionals who provided excellent interpretation. 
32 
 
The researcher visited some homes more than once to interview participants, which 
increased the research cost.  
 
1.16 STRUCTURE OF THE DISSERTATION 
 
The research study shall be organized according to the following pattern: 
Chapter 1: Orientation to the study  
Chapter 2: Literature review 
Chapter 3: Research design and method  
Chapter 4: Analysis, presentation description of the research findings  
Chapter 5: Integration of research findings and the development of guidelines. 
Chapter 6: Conclusions and recommendations  
 
1.17 SUMMARY  
 
Currently, hypertension is one of the leading causes of morbidity and mortality in Belize. 
A chunk of the government’s budget is spent purchasing medications and losing the 
workforce with huge economic burdens to the nation. The other non-communicable 
disease is diabetes. This chapter presented a general outline for research on indigenous-
western antihypertensive usage among Belizean people. The purpose, objectives, and 
broad background of the study are presented in this chapter. 
 
Hypertension is a significant disorder affecting close to 30% of adults globally, and it is 
estimated to increase to around 60% by 2030. Being a major problem in Belize, the 
condition is associated with numerous other health problems in the communities.  
 
In addition to lifestyle modifications, different Western medicines exist in the treatment 
and management of hypertension. However, currently, no guidelines exist regarding the 
indigenous-western remedies for use among Belizeans.  
 
Belize, as a country, is blessed with rich rain forest and the locals, with great success, 
have used indigenous therapies to cure many diseases. To date, the rich availability of 
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indigenous therapies in the country of Belize has not been fully explored, even though the 
indications of such successes are very evident in many communities.  
 
The results generated from this study intend to validate claims by vendor’s hypertensive 
patients on indigenous therapies used by locals to lower blood pressure. Evidence exists 
on many indigenous remedies used for the management of several diseases. Further 
research could lead to discovering an antihypertensive drug from Belizean indigenous 
herbs that could be patented. Therefore the study shall provide the Ministry of Health with 
guidelines for public use of indigenous-western therapies among hypertensive patients. 
 
The study’s primary focus was to identify and provide guidelines on popular indigenous 
remedies used concomitantly and non-concomitantly in hypertension therapy in Belize. 
The study, therefore, investigated the use of indigenous-western antihypertensive 




























2.0 INTRODUCTION  
 
The previous chapter highlighted the general study overview of indigenous-western 
antihypertensive therapies usage in Belize. This chapter focuses on the literature review 
described in the following paragraph. Creswell (2015:80) described the literature review 
as a written summary of journal articles, books, and other documents that describe the 
past and current state of information on the topic being researched. It also organizes the 
literature into subtopics and documents the need for a proposed study. In the most 
rigorous research form, researchers base this review mainly on research reported in 
journal articles. However, a good review might also contain other information drawn from 
conference papers, books, and government documents (Creswell, 2015:80). In reviewing 
the literature for this study, reported journal articles, books, online blogs, dissertations, 
magazines, and newspapers were extensively consulted and reviewed for useful 
information on hypertension, western antihypertensive medications, and indigenous 
remedies used in the management of hypertension.  
 
2.1 HYPERTENSION  
 
According to Bakris (2016:1), hypertension, defined or described as a sustained elevation 
of resting systolic blood pressure (≥140 mm Hg), diastolic BP (≥90 mm Hg), or both. The 
World Health Organization (WHO) reported that cardiovascular diseases (CVD) are the 
leading cause of morbidity and mortality globally, and by extension, a significant public 
health problem in many countries (WHO 2013a:1, 2013b:1). The risk factors for CVD are 
sedentary lifestyle, smoking, diabetes, hyperlipidemia, and hypertension. In 2013, the 
WHO reported that hypertension was implicated as the most common factor that triggers       
CVD and becomes even more debilitating when comorbid with other CVD risk factors 
(WHO 2013a:317). In the same document, hypertension has also been reported to be 




A study conducted in 2010 by Kizhakekuttu and Widlansky (2010:20) reported 
hypertension as the leading cause of morbidity and mortality related to cardiovascular 
diseases. Worldwide annual death toll from hypertension has been estimated to rise to a 
staggering 23.5 million people by 2030 (WHO 2013a:317). In addition to all these, 
hypertension can lead to other debilitating diseases such as dementia, damage to the 
kidneys, or blindness. Furthermore, the onset of diseases such as coronary heart 
disease, heart failure, atherosclerosis, peripheral artery disease, and stroke has also 
been attributed to hypertension as a significant liable player (Freedman and Cohen 
2016:1607). Currently, Bakris (2016:1) reported that about 75 million people have 
hypertension in the United States of America alone, of which 81% are cognizant that they 
have hypertension. Of this percentage, 73% are undertaking therapy, with only 51% 
having adequate control of their blood pressure. The morbidity and mortality rates of 
hypertension have been reported to be greater in blacks who have higher rates of 
diagnosed hypertension with 41% than whites and Mexican Americans, who have 28% 
each.  
 
Hypertension, therefore, has been defined as a sustained elevation of resting systolic 
blood pressure (≥140 mm Hg), diastolic BP (≥90 mm Hg), or both (Bakris, 2016:1; Weber, 
Schiffrin, White, Mann, Lindholm, Kenerson, Flack, Carter, Materson, Ram, Cohen, 
Cadet, Jean-Charles, Taler, Kountz, Townsend, Chalmers, Ramirez, Bakris, Wang, 
Schutte, Bisognano, Touyz, Sica, and Harrap, 2014:3). Primary hypertension (formerly 
called essential hypertension) is the most common and has no known singular cause. 
Secondary hypertension (hypertension with an identified cause) is usually a result of 
chronic kidney disease or primary aldosteronism. 
 
2.1.1 Types of hypertension 
 
Primary and secondary hypertension is the most commonly described types of 
hypertension (Bakris 2016:1). Although primary hypertension is the focus of this research, 




2.1.1.1 Primary hypertension 
 
Although other types of hypertension have been identified and described, 85-95% of 
people with clinically reported hypertension cases are primary. Physiologic and 
hemodynamic factors vary, indicating that a single cause is unlikely in primary 
hypertension’s etiology (Bakris, 2016:1). Even if a single etiological factor is initially 
identified as responsible for developing primary hypertension, multiple factors are always 
involved and work together to sustain high blood pressure. Age, diet, obesity, stress, 
malfunction of ion pumps, lifestyle, neuro-humoral activity, and hereditary have all been 
implicated as predisposing factors that can lead to primary hypertension development. 
Difficulty in ascertaining or establishing the etiological factors for primary hypertension 
makes it more challenging to manage (WHO 2013a:1; Bakris, 2016:1; Singh, Shankar, 
and Singh, 2017). 
 
2.1.1.2 Secondary hypertension 
 
On the other hand, secondary hypertension affects 5 – 10% of hypertensive individuals 
globally, and the causes are identifiable with relatively higher chances of therapeutic 
success than primary hypertension. The most common cause of secondary hypertension 
is primary aldosteronism. Other identifiable causes of primary hypertension are diabetes, 
renovascular diseases, renal parenchymal disease, pheochromocytoma tumor, 
hyperthyroidism, coarctation of the aorta, Cushing syndrome, myxedema, and adrenal 
hyperplasia. Common causes of curable secondary hypertension are the use of oral 
contraceptives and excessive use of alcohol. Drugs such as cocaine, sympathomimetics, 
corticosteroids, and NSAIDs have been reported to commonly contribute or worsen 
control of high blood pressure (WHO 2013a:1; Bakris, 2016:1). A higher risk stage of 
hypertension is indicated with every increase of 20/10 Systolic blood pressure (SBP) 
/diastolic blood pressure (DBP) (SBP/DBP) mmHg; a reading of 140-159/90-99mmHg is 
considered stage I, while stage II is ≥160/≥100mmHg, which usually requires immediate 
medical attention (Weber et al., 2014:3). 
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Presently, the American Society of Hypertension (ASH) and International Society of 
Hypertension (ISH) (Weber et al., 2014:3) consider individuals with a blood pressure of 
120– 139/80–89mmHg pre-hypertensive. Pre-hypertensive individuals are usually three 
times more likely to become hypertensive later in life than normotensive individuals, and 
this needs to be taken into consideration when considering targeted therapeutic 
measures. For the general population, the Eighth Joint National Committee (JNC 8) on 
hypertension recommended pharmacological treatment be initiated at an SBP of 
150mmHg or DBP of 90mmHg. Treatment is usually initiated when blood pressure values 
of SBP and DBP reach 140 or 90mmHg or higher in patients diagnosed with chronic 
kidney disease (CKD) (James, Oparil, Carter, Cushman, Dennison-Himmelfarb, Handler, 
Lackland, LeFevre, MacKenzie, Ogedegbe, Smith, Svetkey, Taler, Townsend, Wright, 
Narva, and Ortiz, 2014:507; Al Disi et al., 2016:326). 
 
Additionally, age is considered a severe predisposing factor in the development of 
hypertension because the increase in age increases blood pressure, and two-thirds of 
individuals greater than 65 years have been diagnosed with hypertension. A 90% lifetime 
risk of developing hypertension exists in people aged 55 with normal blood pressure, such 
that age-related increases in blood pressure have become common and mostly appearing 
harmless. Overall, higher increases in blood pressure in the elderly increase the chances 
of higher morbidity and mortality. Pregnancy-induced hypertension has also been 
reported (Bakris, 2016:1).  
 
2.2 PATHOPHYSIOLOGY OF HYPERTENSION 
 
Several factors that characterize the pathogenesis of hypertension are discussed below. 
Derangement of the arteries in the vascular tree affects the conduit of large arteries such 
as the aorta, small resistance arteries of sizes between 150 and 400µm, and arterioles 
and capillaries that make up the micro-circulation conduit. Increased peripheral resistance 
resulting from vascular smooth muscle cells’ proliferation, for instance, decreases arterial 
diameter, leading to hypertension. Many plants and herbs tend to modify blood pressure 
by favorably modulating vascular smooth muscles (Al Disi et al., 2016:326).   
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Furthermore, increased sensitivity and potency of the arteries result from enhanced basal 
and activated calcium levels due to overactive transmembrane calcium permeability via 
calcium channels, dysregulation of endothelial pro-oxidant enzymes, nitric oxide 
synthase, inclusive of the coexistence of cellular vascular smooth muscle hypertrophy 
and hyperplasia. Individually and collectively, these factors work to bring about increased 
vasoconstriction. Additionally, an increased ratio of vessel wall thickness can result from 
these pathological events. Compared to the arterial lumen dimension, the increased ratio 
of arterial vessel wall thickness plays a significant role in precipitating hypertension (Al 
Disi et al., 2016:326).  
 
2.2.1 Vascular smooth muscle cell (VSMC) proliferation  
 
A decrease in the diameters of arteries leads to increased peripheral resistance. 
Increased resistance in the periphery reduces vascular smooth muscle cells’ 
multiplication and contributes to hypertension’s pathogenesis. Growth factors such as 
visfatin, fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) 
stimulate or inhibit vascular smooth muscle cell growth. Cyclic guanosine monophosphate 
(cGMP) and nitric oxide (NO) have been reported to be vascular smooth muscle relaxants 
(Al Disi et al., 2016:326). To a large extent, the determinants of vascular smooth muscle 
cell phenotypes are usually a balance between anti-proliferating signals and proliferative 
signals, and several herbs and plants studied favorably modulate vascular smooth muscle 
cells to ameliorate the increase in blood pressure (Lacolley, Regnault, Nicoletti, Li, and 
Michel,  2012:194; Miao and Li, 2012:643; Al Disi et al. 2016:326). 
 
2.2.2 Endothelial Cells  
 
The endothelial cell layer plays an essential role in many homeostatic regulations of the 
cardiovascular system. The regulation of smooth muscle cell proliferation and vascular 
tone is brought to the release of vasoactive substances. In addition, the vascular 
endothelium is stimulated by circulating cells to release vasodilators such as prostacyclin 
and nitric oxide and vasoconstrictors such as thromboxane and endothelin, leading to 
increased production of reactive oxygen from an imbalance between vasoactive agents, 
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which can lead to dysfunction of the endothelium resulting in hypertension. Finally, 
modification therapy with indigenous herbal remedies could reverse the endothelia’s 
derangement (Virdis and Taddei 2011:167; Montezano and Touyz 2012:87; Silva, 
Pernomian, and Bendhack, 2012:441).  
 
2.2.3 Signaling Molecules  
 
Several studies have reported that many plants and extracts of herbs and their 
metabolites modulate a cascade of signals implicated in cardiovascular system 
physiology. These plants and herbs with their metabolites have the potential to reverse a 
diverse range of hypertensive pathophysiologies in addition to their ability to protect the 
vasculature, especially when early diagnoses indicate a lack of decompensated state in 
hypertensive patients (Montezano, Dulak-Lis, Tsiropoulou, Harvey, Briones, and 
Touyz,  2015:631; Niture, Khatri, and Jaiswal, 2014:36). 
 
2.2.4 Reactive oxygen species (ROS) 
 
Reactive chemical species such as peroxides and hydroxyl radical superoxides 
comprising oxygen referred to as reactive oxygen species (ROS) (Hayyan, Hashim, and 
AlNashef, 2016). Pathological states such as hypertension, atherosclerosis, and other 
vascular diseases arise when the balance between antioxidants and pro-oxidants is 
disturbed. In the pathogenesis of hypertension, ROS play an essential role in creating an 
environment of oxidative stress. Hydroxyl ions (OH -) and superoxide anions and (O•− 2), 
for instance, are major reactive oxygen species that are involved in the pathogenesis of 
hypertension (Montezano et al. 2015:631). The reactivity of nicotinamide-adenine 
dinucleotide phosphate (NADPH) oxidase inclusive of numerous enzymatic reactions, 
especially reactions related to the electron transport chain inside the mitochondria, adds 
to cellular environmental oxidative stress. An increase in reactive oxygen species 
concentration reduces intracellular endothelial antioxidant levels, indicating oxidative 
stress. In contrast, vascular smooth muscle remodeling and endothelial cell dysfunction 
from oxidative stress lead to decreased nitric oxide bioavailability. Furthermore, enhanced 
proliferation and inflammation have been reported to significantly activate plaque 
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development, which results in increased blood pressure (Montezano et al. 2015:631). 
Hence, a reduction in blood rodents’ pressure due to the blockage of reactive oxygen 
species exposed to antioxidants. By up-regulating antioxidant enzymes through the 
Keap1-Nrf2 pathway, numerous phytochemicals suppress oxidative stress (Tao, Zheng, 
Lau, Jaramillo, Chau, Lantz, Wong, Wondrak, and Zhang, 2013:631; Niture et al. 2014:36; 
Hayyan et al. 2016) 
 
2.2.5 Nitric oxide  
 
Among key vascular health indicators, nitric oxide has often been accepted as the most 
important. Due to its ability to dilate vessels, nitric oxide plays a crucial role in inhibiting 
aggregation of platelets, multiplication of vascular smooth muscle cells, and physiological 
regulation of blood pressure (Zeng, Villar, Yu, Zhou, and Jose, 2009:157; Francis, Busch, 
Corbin, and Sibley,  2010:525). Nitric oxide is synthesized from l-arginine by nitric oxide 
synthases (Francis et al. 2010:525); its release and subsequent translocation into the 
vascular smooth muscle cells bring about the activation of soluble guanylate cyclase, 
leading to the catalytic conversation and cyclization of guanosine triphosphate to cGMP 
(Francis et al. 2010:525). With nitric oxide, the modulation of calcium levels and the 
resultant contraction of vascular smooth muscle cells are brought into cGMP binding to 
the cGMP-dependent protein kinase. The production of peroxynitrite due to nitric oxide 
reacts with superoxide anions occurs within seconds of nitric oxide production, 
precipitating oxidative stress while reducing the vasodilation effect of nitric oxide 
(Drummond, Selemidis, Griendling, Sobey, 2011:453). Therefore, nitric oxide’s 
bioavailabilityNADPH oxidase levels depend on the concentration of reactive oxygen 
species; hence, vascular tone and endothelial dysfunction result from the interplay 
between nitric oxide and its bioavailability (Montezano and Touyz, 2012:87).  
 
2.2.6 Hydrogen Sulfide  
 
In a few animal studies, a positive correlation has been reported between hydrogen 
sulfide deficiency and the pathogenesis of hypertension (Benavides, Squadrito, Mills, 
Patel, Isbell, Patel, Darley-Usmar, Doeller, and Kraus, 2007:17977; Liu, Lu, Hu, Wong, 
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Webb, and Bian, 2012:141). Endothelial cells and vascular smooth muscles potentially 
produce hydrogen sulfide by the enzyme cystathionine γ-lyase through the catalysis of l-
cysteine (Calvert, Coetzee, and Lefer, 2010:1203; Pan, Liu, Gong, Yang, and Zhu, 
2012:106). Opening ATP-dependent potassium channels, increasing intracellular levels 
of cGMP leading to vasorelaxant effects on vascular smooth muscle cells at the cellular 
and molecular levels has been reported to be with hydrogen sulfide (Bucci, 
Papapetropoulos, Vellecco, Zhou, Zaid, Giannogonas, Cantalupo, Dhayade, Karalis, 
Wang, Feil, and Cirino, 2012:e53319) and opening ATP-dependent potassium channels 
(Banerjee, Maulik, Mancahanda, Dinda, Gupta, and Maulik, 2002:1509; Calvert et al. 
2010:1203; Bucci et al. 2012:e53319; Pan et al. 2012:106). Hydrogen sulfide has also 
been reported to diminish vascular smooth muscle cell proliferation, depress angiotensin 
II and angiotensin-converting enzyme levels, reduce reactive oxygen species, induce 
nitric oxide synthesis, prevent vascular inflammation, and potentiating antioxidant 
mechanisms (Calvert et al. 2010:1203; Pan et al. 2012:106; Benavides et al. 
2007:17977). 
 
2.2.7 Rennin angiotensin mechanism  
 
The renin-angiotensin-aldosterone system plays a crucial role in regulating blood 
pressure (RAAS) (Nguyen and Touyz, 2011:2141; Hall, do Carmo, and da Silva, 2019:2; 
Santos, Oudit, Verano-Braga, Canta, Steckelings, and Bader, 2019:H959). The secretion 
of renin in response to a decrease in cardiac output activates the renin-angiotensin-
aldosterone system. Renin, in turn, catalyzes the conversion of angiotensinogen to 
angiotensin I, which is cleaved to form angiotensin II by the angiotensin-converting 
enzyme. Vasoconstriction and the promotion of sodium and water retention leading to 
angiotensin II-mediated hypertension are enhanced by binding to the angiotensin I type 
receptor. Angiotensin II also enhances aldosterone production and stimulation of NADPH 





Additionally, the elevation of cardiac output and increase in peripheral vascular resistance 
brought about by the stimulation of the sympathetic nervous system activity through 
angiotensin II precipitates the pathogenesis of hypertension (Bernstein, Ong, Blackwell, 
Shah, Giani, Gonzalez-Villalobos, Shen, Fuchs, Touyz, 2013:1; Santos et al. 2019:H959). 
Other elements such as inflammation, hydrogen sulfide, and reactive oxygen species 
contribute to hypertension’s pathogenesis (Al Disi et al., 2016:326; Hall et al. 2019:2; Kitt, 
Fox, Tucker, and McManus, 2019:44).  
 
2.2.8 Nuclear Factor Kappa B (NF-KB) 
 
Vascular remodeling and consequent hypertension development due to inflammation 
have been reported (Vazquez-Prieto, Rodriguez, Lembo, Galmarini, and Miatello, 
2011:475216; Petrie, Guzik, and Touyz, 2018:575; Grillo, Salvi, Coruzzi, Salvi, and Parati, 
2019:1970). Transcription factors such as nuclear factor B (NF-κB), is active in the 
pathogenesis of hypertension. Through the release of pro-inflammatory cytokines such 
as interleukin-6 and tumor necrosis factor-alpha, NF-κB has been reported to induce 
oxidative stress, endothelial cell dysfunction, and inflammation (Li and Zhuo 2008:37; 
Kang, Ma, Zheng, Elks, Sriramula, Yang, and Francis, 2009:503; Petrie et al. 2018:575; 
Grillo et al. 2019:1970). Increased renal injury and hypertension have been reported as 
a result of increased expression and activation of nuclear factor kappa B (Elks, 
Mariappan, Haque, Guggilam, Majid, and Francis, 2009: F298). Several factors can 
induce the activation of NF-κB. Reactive oxygen species, tumor necrosis factor-alpha, 
and angiotensin II can activate NF-κB (Petrie et al., 2018:575). Angiotensin II-induced 
pressor response is attenuated by NF-κB, and angiotensin I receptor regulation 
(Vazquez-Prieto et al. 2011:475216; Bhatt, Lokhandwala, and Banday, 2014:367; Luo, 
Wang, Wang, Chen, Wang, Xu, Chen, and Zeng, 2015:76; Petrie et al. 2018:575). 
Additionally, stimulation of the expression of vascular cell adhesion molecule-1 (VCAM-
1) decreased apoptosis of endothelial cells as well, and increased proliferation has all 
been reported as a function of NF-κB (Vazquez-Prieto et al. 2011:475216; Jiang, Qi, 
Zhang, Gu, Yan, Shen, Yao, Kong, Chien, and Jiang, 2013b:e56076; Petrie et al. 
2018:575; Grillo et al. 2019:1970). 
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2.3 PHARMACOLOGICAL MANAGEMENT OF HYPERTENSION 
 
Many drugs are now available for the management of hypertension, and depending on 
the stage of hypertension or race of the individual, some cocktails are at the physician’s 
disposal to choose. Diuretics such as hydrochlorothiazide are usually the first line of 
treatment for most patients at the beginning of hypertension. Other classes of drugs are 
β-adrenergic blockers (atenolol), renin inhibitor (Aliskiren), Calcium Channel Blockers 
(Verapamil, Nifedipine), Angiotensin Receptors Blockers (Losartan), α-adrenergic 
blockers (Prazosin), angiotensin-converting enzymes inhibitors (ACEI) (enalapril); 
sympathoplegic agents (clonidine, reserpine), and direct-acting vasodilators (minoxidil, 
nitroprusside sodium). Newer and more specific drugs are being designed to manage 
hypertension, and therapy is now majorly evidence-based (James et al. 2014:507; Al Disi 
et al. 2016:326). 
With the availability of numerous drugs for managing hypertension, as shown in Table 
2.1, many patients diagnosed with hypertension do not have their blood pressure under 
control. In the US, for instance, out of the 73% undertaking therapy, only 51% have 
adequate control of their blood pressure (Bakris 2016:1). Lack of blood pressure control 
in many patients has been attributed to a number of factors ranging from reduced patient 
compliance, higher cost of treatment, availability, accessibility of drugs, the undesirable 
adverse effects of the medications, and perception by patients about antihypertensive 
drugs. Considering all these factors, therefore, patients diagnosed with hypertension in 
the third world countries, especially from rural communities, will not hesitate to seek 
unconventional approaches, such as indigenous medicinal therapies, to manage their 





Table 2.1 Oral antihypertensive drugs  
 
Drug Class and Trade 
Name 






Thiazide diuretics exert their diuretic effect via blockage of the sodium-chloride (Na/Cl) 
channel in the distal convoluted tubule’s proximal segment, leading to increased Na/Cl 
and water excretion. 
chlorothiazide (Diuril)  125–500 1–2 




 12.5–50 1 
polythiazide (Renese)  2–4 1 
indapamide (Lozol†)  1.25–2.5 1 
metolazone (Mykrox)  0.5–1.0 1 
metolazone (Zaroxolyn)  2.5–5 1 
Loop diuretics 
Loop diuretics induce its effect by competing with chloride to bind to the Na-K-2Cl 
(NKCC2) cotransporter at the apical membrane of the thick ascending limb of the loop 
of Henle and blocking the cotransporter, which inhibits the reabsorption of sodium and 
chloride 
bumetanide (Bumex†)  0.5–2 2 
furosemide (Lasix†)  20–80 2 
torsemide (Demadex†)  2.5–10 1 
Potassium-sparing diuretics 
Prevent sodium reabsorption in the collecting tubule by binding ENaCs 
amiloride (Midamor†)  5–10 1–2 
triamterene (Dyrenium)  50–100 1–2 
Aldosterone receptor blockers 
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Interferes with sodium reabsorption by competitively inhibiting the action of aldosterone 
in the distal tubule, thus promoting sodium and water excretion and 
increasing potassium retention 
eplerenone (Inspra)  50–100 1 
spironolactone 
(Aldactone†) 
 25–50 1 
Beta-Blockers 
Block beta receptors in the heart leading to negative chronotropic and inotropic  
atenolol (Tenormin†)  25–100 1 
betaxolol (Kerlone†)  5–20 1 
bisoprolol (Zebeta†)  2.5–10 1 
metoprolol (Lopressor†)  50–100 1–2 
metoprolol extended-
release (Toprol XL) 
 50–100 1 
nadolol (Corgard†)  40–120 1 
propranolol (Inderal†)  40–160 2 
propranolol long-acting 
(Inderal LA†) 
 60–180 1 





Block beta receptors in the 
heart leading to negative 
chronotropic and inotropic  
  
acebutolol (Sectral†)  200–800 2 
penbutolol (Levatol)  10–40 1 
pindolol (generic)  10–40 2 
Combined alpha- and 
Beta Blockers 
Block beta receptors in the 
heart leading to negative 
chronotropic and 




carvedilol (Coreg)  12.5–50 2 
labetalol (Normodyne, 
Trandate†) 
 200–800 2 
Angiotensin-Converting Enzyme Inhibitors (ACEI) 
ACE inhibitors produce vasodilation by inhibiting the formation of angiotensin II. 
benazepril (Lotensin†)  10–40 1 
captopril (Capoten†)  25–100 2 
enalapril (Vasotec†)  5–40 1–2 
fosinopril (Monopril)  10–40 1 
lisinopril (Prinivil, Zestril†)  10–40 1 
moexipril (Univasc)  7.5–30 1 
perindopril (Aceon)  4–8 1 
quinapril (Accupril)  10–80 1 
ramipril (Altace)  2.5–20 1 
trandolapril (Mavik)  1–4 1 
candesartan (Atacand)  8–32 1 
eprosartan (Teveten)  400–800 1–2 
irbesartan (Avapro)  150–300 1 
losartan (Cozaar)  25–100 1–2 
olmesartan (Benicar)  20–40 1 
telmisartan (Micardis)  20–80 1 
valsartan (Diovan)  80–320 1–2 
Calcium Channel Blockers (CCBs)—non dihydropyridines 
Decrease systemic vascular resistance by relaxing smooth muscles, which lowers 
arterial blood pressure 
diltiazem extended-
release (Cardizem CD, 
Dilacor XR, Tiazac†) 
 180–420 1 
diltiazem extended-
release (Cardizem LA) 




release (Calan, Isoptin†) 
 80–320 2 
verapamil (Coer, Covera 
HS, Verelan PM) 
 120–360 1 
Calcium Channel Blockers (CCBs) —dihydropyridines 
Decrease systemic vascular resistance by relaxing smooth muscles, which lowers 
arterial blood pressure 
amlodipine (Norvasc)  2.5–10 1 
felodipine (Plendil)  2.5–20 1 
isradipine (Dynacirc CR)  2.5–10 2 
nicardipine sustained-
release (Cardene SR) 
 60–120 2 
nifedipine long-acting 
(Adalat CC, Procardia 
XL) 
 30–60 1 
nisoldipine (Sular)  10–40 1 
Alpha-1 blockers 
Block alpha one receptors leading to vascular smooth muscle  
doxazosin (Cardura)  1–16 1 
prazosin (Minipress†)  2–20 2–3 
terazosin (Hytrin)  1–20 1–2 
Central alpha-2 agonists and other centrally acting drugs 
Stimulate central alpha 2 receptors leading peripheral vascular smooth muscles 
relaxation 
clonidine (Catapres†)  0.1–0.8 2 
clonidine patch 
(Catapres-TTS) 
 0.1–0.3 1 weekly 
methyldopa (Aldomet†)  250–1,000 2 
reserpine (generic)  0.1–0.25 1 
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guanfacine (Tenex†)  0.5–2 1 
Direct vasodilators 
Directly cause smooth muscle relaxation by relaxing the capillaries.  
 
hydralazine (Apresoline†)  25–100 2 
minoxidil (Loniten†)  2.5–80 1–2 
                                                                           Source: JNC 7, 2004:1 
 
2.4 MEDICINAL PLANT MODULATION OF BLOOD PRESSURE  
 
Medicinal plants contain bioactive substances, especially antioxidants capable of 
modulating blood pressure (Anwar, Al Disi, and Eid, 2016:50). The ability of medicinal 




With the global increase in diagnosed individuals suffering from cardiovascular diseases, 
the need and demand for cost-effective therapeutic products that are safe, efficacious, 
readily available, and accessible are also rising. With the availability of clinically-oriented 
research providing shreds of evidence of proven records of numerous phytochemicals 
that provide prevention and treatment of diverse diseases and ailments, many patients 
with cardiovascular diseases are gradually turning to medicinal plants and herbs to find 
effective means of managing their diseases. Besides, conventional medicines are not 
affordable for some patients, not easily accessible, or do not adequately respond to the 
medications. Alongside this trend, the search for affordable indigenous remedies with 
fewer adverse effects that are easily accessible and available is gaining slow but sure 
grounds as many herbal remedies are presently incorporated into evidence-based 







2.4.2 Medicinal plants used for hypertension 
 
Ever before the emergence of modern medicines, people used indigenous therapies to 
treat their diseases. Presently, over a hundred active compounds have been scientifically 
identified as drugs from plants alone (Helmenstine, 2019:1). An increasing amount of 
literature exists on medicinal plants and herbs used for the management of hypertension. 
Some of the herbal therapies have gone through extensive studies with many reported 
discoveries about their bioactive metabolites. Other plants are still being investigated, and 
new information on their pharmacology and toxicities has been revealed. Below is a list 
of some of the reported medicinal plants and herbs documented for use in hypertension. 
 
Numerous factors have led to a substantial global increase in medicinal herb usage. 
Foremost among them is that herbal remedies are inexpensive compared to conventional 
drugs and have fewer adverse effects. The World Health Organization (2014:4) reported 
that this increase in patronizing herbal remedies is not necessarily dependent on the 
country, region, or economic status of the individuals, since complementary and 
alternative medicines are now used by over 70% of people in developed countries for the 
prevention or treatment of various ailments and diseases. The trend is not any less in 
developing countries where a more pronounced usage of alternative medicines is being 
recorded (WHO 2014:4; Onyebode, Kandala, Chilton, and Lilford, 2016:984). 
 
Throughout human history, medicinal plants and herbs have been used to prevent and 
treat many ailments and diseases; hence, their importance must in medicine (Table 2.2). 
The Chinese Unani Tibb medicine and Ayurvedic medical practices, for instance, have 
most of their origins from plants or herbal-based extractions. Today, many such 
formulations are still used in the management of various diseases. Summarily, the history 
of use of diverse medicinal plants with successes and the clinically proven efficacy of 
several plant extracts explains in part the continued global interest and increased 
utilization of these products for therapeutic purposes (Pan, Zhou, Gao, Yu, Zhang, and 
Tang, 2013:627375; Weber et al. 2014:3). Herbal therapies are presently in high demand 
in many countries because of their perceived safety, fewer adverse effects, effectiveness, 
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and low cost. These remedies are readily available, easily accessible, and natural, 
perceived to have no harm are growing with increasing popularity the world over (Oga, 
Sekine, Shitara, Toshiharu-Horie, 2015:0296).  
 
The use of plant and herb extracts for medicinal purposes is termed herbal medicine or 
indigenous therapies. For the most part, herbal therapies are unlike pharmaceutical 
products because they are made up of mixtures of highly complex chemical components 
that are yet to be characterized but whose bioactive constituents are efficacious 
medicinally (Oga et al. 2015:0296). Due to their perceived safety, fewer adverse effects, 
effectiveness, and low cost, herbal therapies are presently in high demand in many 
countries. These remedies are readily available, easily accessible, and natural, perceived 
to have no harm are growing with increasing popularity the world over.  
 
Consequently, indigenous therapies from medicinal herbs have a long history of use even 
before discovering conventional therapies. With advances in clinical studies, these herbal 
therapies are becoming increasingly valuable in preventing and treating various diseases, 
making them more established, especially with overall improvements in quality control 
and analytical advancements (Calixto, 2000:179). For instance, it has been reported that 
dependence on indigenous and medicinal plants has increased significantly by about 80% 
in many developing countries. In many developing nations, indigenous medicines and 
herbal therapies are mainly a substantial source of primary health care. Herbal therapies 
are currently not only utilized by developing countries; instead, the trend has shown a 
global increase in awareness and usage of the products (Mahady, 2001:1120S; WHO 
2008:1). According to reports, there is presently an active reliance on natural and 
complementary therapies to prevent or manage many ailments in Germany, where over 
75% of the population use the products (Tuffs, 2002:325). The report further indicated 
that as many as 70% of the country’s physicians prescribe indigenous herbal medicines 
to their patients for diverse ailments (Tuffs, 2002:990). 
 
Furthermore, even in countries with a highly developed healthcare system like the United 
States of America, the population is slowly reverting to organic and natural therapies due 
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to discontentment with prescribed conventional drugs, which are becoming costlier by the 
day. This trend has led to increased research into natural products, emphasizing delivery, 
safety, and efficacy (Tachjian, Tachjian, Maria, and Jahangir, 2010:515). On the other 
hand, countries like Japan have made significant progress in traditional and herbal 
medicine research and usage with over 148 different medicinal plants listed on the 
Japanese National Health Insurance Drug Tariff alone. Among those listed, Japanese 
medical practitioners prescribe medicinal therapies to over 78% of their patients to 
prevent and treat various diseases (Komiya, Watanabe, and Fuse, 2011:15; Moschik, 
Mercado, Yoshino, Matsuura, and Watanabe, 2012:139818). Compared to conventional 
therapies, increased utilization of medicinal plants has been attributed to increased 
perceived safety because they are obtained from natural sources. They are cheaper and, 
for the most part, with reported efficacy and low incidence of side effects than Western 
drugs (Zhang 1998:45). 
Table 2.2 List of drugs derived from plants. 
Drug/Chemical Action Plant Source 
Acetyldigoxin Cardiotonic Digitalis lanata (Grecian foxglove, 
woolly foxglove) 
Adoniside Cardiotonic Adonis vernalis (pheasant's eye, red 
chamomile) 
Ajmalicine Treatment for circulatory 
disorders 
Rauvolfia sepentina 




Deslanoside Cardiotonic Digitalis lanata (Grecian foxglove, 
woolly foxglove) 
Digitalin Cardiotonic Digitalis purpurea (purple foxglove) 
Digitoxin Cardiotonic Digitalis purpurea (purple foxglove) 
52 
 




Ephedra sinica (ephedra, ma huang) 
Gitalin Cardiotonic Digitalis purpurea (purple or common 
foxglove) 
Lanatosides A, B, C Cardiotonic Digitalis lanata (Grecian foxglove, 
woolly foxglove) 
Ouabain Cardiotonic Strophanthus gratus (ouabain tree) 
Protoveratrines A, B Antihypertensives Veratrum album (white false hellebore) 
Pseudoephredrine Sympathomimetic Ephedra sinica (ephedra, ma huang) 
nor-
pseudoephedrine 









Rhododendron molle (rhododendron) 
Scillarin A Cardiotonic Urginea maritima (squill) 
Tetrandrine Antihypertensive Stephania tetrandra 
Theobromine Diuretic, vasodilator Theobroma cacao (cocoa) 
Theophylline Diuretic, bronchodilator Theobroma cacao and others (cocoa, 
tea) 
                                                                      Source: Taylor, Rabe, McGaw, (2001:1) 
 
Although herbal therapies use is grossly rising in many countries, and approval for their 
usage is gaining wide acceptance, the story is different in other countries where rigorous 
regulative obligations make it challenging and sometimes difficult for herbal medications 
to be registered. Therefore, the stringent regulatory requirements in such countries limit 
the opportunity for the use of medicinal herbs. For instance, herbal medicines in the 
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United Kingdom have been viewed with reservation and seen suspiciously as therapies 
that are likely to cause peculiar health challenges to the public. Because of this 
perception, many consultations between indigenous medicine practitioners and 
physicians are being conducted to ensure public safety while being careful not to deny 
the benefits derived from such products (Walker, 2015:1; Boyle, Doolan, Andrews, and 
Reid, 2011:951). 
 
Furthermore, about 50% of synthesized pharmaceutical products evolved from medicinal 
plants and other natural products, and the discovery of conventional drugs from plants 
and herbs is still ongoing, with great success being recorded (Table 2.2). It is a fact that 
drugs like ephedrine (Ephedra sinica), reserpine (Rauwolfia serpentina), atropine (Atropa 
belladonna), lovastatin (Monascus purpureus), digitoxin/digoxin (Digitalis purpurea), 
aspirin (Salix alba), vincristine (Catharanthus roseus), etoposide (Podophyllum peltatum), 
emetine (Cephaelis ipecacuanha), artemisinin (Artemisia annua) and quinine (Cinchona) 
were derived from indigenous therapies (Pan et al. 2013: 627375). One effective drug in 
treating hypertension is reserpine, obtained from a medicinal plant; reserpine produces 
its action by depleting adrenergic neurotransmitters in the central nervous system (Weber 
et al. 2014:3). Throughout human history, medicinal plants and herbs have been used to 
prevent and treat many ailments and diseases; hence, their importance in medicine 
(Newman and Cragg 2012:311; Lahlou 2013:17; Katiyar, Gupta, Kanjilal, Katiyar, 
2012:10). 
 
Table (2.3) below illustrates some of the medicinal plants tested for their effects on blood 





































Leaves  Methanol, 
Water  














Bulb  Powder 
Water 
extract 













































































Stem Water and 
ethanol 
extraction 































                      Source: Al Disi et al., 2016:326 
 
Based on table 2.3 above, most medicinal plants are mainly prepared by boiling or alcohol 
extraction. The commonly used parts are roots and leave either green or dry. Most of the 
experiments were done on rats and mice. Many of the reported medicinal plants did not 
present significant side effects. The common side effects reported were mild hypotension, 
heartburn, acid reflux, abdominal swelling, and flatulence. Table 2.3 presents a summary 
of the various studies conducted and the mechanism of blood pressure-lowering effect by 
medicinal plants (Al Disi et al. 2016:326). 
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2.4.2.1 Coriandrum sativum (Cilantro or Coriander) 
 
Cilantro has been established and used the world over both as a culinary ingredient 
(Anilakumar, Khanum, and Bawa 2010:9; Wu, Tsai, Yao, Lii, Chen, and Wu, 2010:1846) 
and for the indigenous management of both gastrointestinal and cardiovascular disorders 
(Jabeen, Bashir, Lyoussi, and Gilani, 2009:123). Presently, no clinical trials have been 
reported that considered the effects of cilantro on blood pressure (Al Disi et al. 2016:326). 
However, cilantro has been shown to have antioxidant properties (Cioanca, Hritcu, 
Mihasan, and Hancianu, 2013:193; Ramkissoon, Mahomoodally, and Ahmed, Subratty 
2013:561). Increased antioxidant enzymes from cilantro’s leaves and seed powder have 
been reported to have a potent effect on the antioxidant GPX (Anilakumar et al. 2010:9). 
Inactivation of β-adrenoceptor-induced ROS production and the prevention of myocardial 
infarction by inhibiting myofibrillar damage was also reported in an isoproterenol-induced 
myocardial infarction (MI) model of cardiotoxicity using cilantro’s extracts (Patel, Desai, 
Gandhi, Devkar, and Ramachandran, 2012:3120). Other researchers have reported 
similar effects of cilantro’s antioxidant activities and its vasodilatory effects (Cioanca et al. 
2013:193; Ramkissoon et al. 2013:561). For instance, in normotensive Sprague-Dawley 
rats, a dose-dependent fall in SBP, DBP, and mean arterial blood pressure (MABP) was 
reported after intravenous application of an aqueous methanolic extract of dried, ground 
coriander seeds (1–30mg/ml) (Jabeen et al. 2009:123). Dose-dependent relaxation of 
pre-constricted (phenylephrine and potassium chloride) rabbit aortas was also described 
with cilantro’s fruit extracts in the same study (Jabeen et al., 2009:123). The described 
response in those studies was atropine - and calcium-channel-dependent. In addition to 
this, the diuretic effects of cilantro’s extracts were further reported to act in synergy with 
cilantro’s vasoactive constituents to complement the treatment and management of high 
blood pressure (Jabeen et al. 2009:123). Furthermore, Wu et al. (2010) reported the 
inhibitory effects of cilantro in reducing the activities of NF-κB and iNOS. Additionally, the 
same extracts showed diuretic effects as well, depicting the active component that acts 
synergistically with the vasoactive constituent to complement the treatment and 
management of hypertension (Jabeen et al., 2009). Finally, coriander acts as an inhibitory 
agent to reduce the activities of NF-κB and iNOS (Wu et al. 2010:1846). 
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2.4.2.2 Bidens pilosa L. (Beggar’s Tick, Black Jack)  
 
Bidens pilosa has been reported to have both anti-cancer, anti-malarial, and anti-obesity 
properties, in addition to exhibiting antihypertensive effects (Bartolome, Villaseñor, and 
Yang, 2013:340215). Although extracts of B.pilosa leaves were shown to prevent and 
attenuate high blood pressure in different rat models and normotensive Wistar rats, no 
clinical trials have been conducted to determine the potential effect of B.pilosa on 
hypertension (Bartolome et al. 2013:340215; Al Disi et al. 2016:323). The methanol leaf 
extracts of B.pilosa showed a reduction in systolic blood pressure by 17 and 21% in 
fructose-fed rats after 6h treatment with 75 and 150mg/kg.respectively. Furthermore, 
B.pilosa leaf extracts showed preventive effect on SBP by 9 and 11% at 75 and 150mg/kg, 
respectively (Bartolome et al. 2013:340215; Dimo, Rakotonirina, Tan, Azay, Dongo, and 
Cros, 2002:183; Al Disi et al. 2016:323). 
 
Interestingly, reports on insulin sensitivity in B.pilosa have been shown to conflict. 
Whereas Bartolome et al. (2013:340215) reported improved insulin sensitivity, Dimo et 
al. (2002:183), reported no effect observed on plasma insulin sensitivity. Although to date, 
the mechanism of vasodilation with B.pilosa has not been completely deciphered, studies 
on its vasorelaxant effects showed a general agreement among researchers (Bartolome 
et al. 2013:340215; Dimo et al. 2002:183; Al Disi et al. 2016:323). B.pilosa’s scavenging 
abilities have also been reported with crude extracts which are isolated phytochemicals 
and fractions (Bartolome et al. 2013:340215). Potent anti-inflammatory effects via 
inhibition of the pro-inflammatory transcription factor, NF-κB was reported with luteolin (a 
flavonoid) and ethyl caffeate (ester of hydroxycinnamic acid), both phytochemicals of 
B.pilosa (Xagorari, Papapetropoulos, Mauromatis, Economou, Fotsis, and Roussos 
2001:181). 
 
2.4.2.3 Zingiber officinale (Ginger)  
 
Ginger is a common ingredient used to season food or for general culinary purposes in 
many homes. Ginger has been reported to reduce blood pressure mainly from its 
bioactive constituents, namely (6)-gingerol and (6)-shogoal (Mao, Xu, Cao, Gan, Corke, 
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Beta, and Li, 2019:185). Triphasic blood pressure profiles (initial rapid fall, intermediate 
rise, and finally a delayed decrease in BP) as a result of administration of oral (70-
140mg/kg) or intravenous (1.75-3.5mg/kg) of two bioactive constituents of ginger, namely 
(6)-gingerol and (6)-shogoal was demonstrated in a clinical study (Suekawa, Ishige, 
Yuasa, Sudo, Aburada, and Hosoya, 1984:836; Mao et al. 2019:185). Castro, Lorenzo, 
González, and Cruzado (2010:781) reported (6)-gingerol as a potent angiotensin II type 
1 receptor blocker. Inhibition of angiotensin-converting enzyme (ACE) and lipid 
peroxidation in rat hearts has been demonstrated (Akinyemi, Ademiluyi, and Oboh, 
2013:641). Potent scavenging of oxidant molecules like peroxynitrite has been reported 
with zingerone, another active compound found in ginger (Shin, Kim, Chung, and Jeong 
2005:7617). Akinyemi, Ademiluyi, and Oboh (2014:317) recently reported ginger extracts 
to inhibit ACE-1 activity while reducing levels of LDL, total cholesterol, vLDL, and 
triglycerides. Ginger will continue to be used as an ingredient for most culinary purposes 
(Mao et al., 2019:185). 
 
2.4.2.4 Allium sativum (Garlic)  
 
Garlic has been reported to have anti-inflammatory, hypocholesterolemic, anti-cancer, 
antibacterial, hypotensive, and antioxidant properties, and its healing abilities have been 
reported in various cultures over a thousand years (Chan, Mclachlan, Luca, and Harnett, 
2020:100292). In many developed and developing countries, physicians and clinical 
researchers are continuing in their efforts to investigate the numerous claims made 
regarding the multi-fold healing powers of garlic (Qidwai and Ashfaq, 2013:125649; Chan 
et al. 2020:100292).  
 
Ried, Frank, and Stocks (2013:64) reported that individuals using garlic for medicinal 
purposes or spices consume either the extract, powder, oil, or raw form. The pungent 
smell of garlic limits raw consumption in some individuals; hence, many enteric-coated 
supplements that dissolve quickly in the gastrointestinal tract are available for ease of 
consumption (Chan et al., 2020:100292). Reports by Qidwai and Ashfaq (2013:125649) 
and Chan et al. (2020:100292) indicated that the number of people treating their 
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hypertension with garlic is high, and interest in its use on the rise. The major bioactive 
organo-sulfur substances reported in garlic are diallyl disulfides (DADS), methyl 
thiosulfonate, Sallylcysteine (SAC), diallyl trisulfides (DATS) and Allicin (Qidwai and 
Ashfaq 2013:125649), which produce its unique mechanisms of action. Although garlic is 
presented to be potentially effective in many health situations, and its use has found 
global acceptance, numerous pharmacologic mechanisms of action for hypotension have 
been reported based on the constituents identified (Shouk, Abdou, Shetty, Sarkar, and 
Eid, 2014:106). For instance, reduction in systolic blood pressure or diastolic blood 
pressure only has been reported in some studies, while no change in blood pressure or 
significant lowering of blood pressure was reported in other studies (Augusti, Jose, 
Sajitha, and Augustine, 2012:6; Oga et al. 2015:24; Chan et al. 2020:100292). Despite 
the irregular reported effects of garlic and its constituents, the induction of its hypotensive 
abilities has been confirmed in many studies (Chan et al. 2020:100292). Various garlic 
types have been reported to lower systolic, diastolic, or both blood pressure in an 
extensive review (Barnerjee et al. 2002:1509). In the same vein, garlic was reported 
(Qidwai and Ashfaq 2013:125649; Chan et al. 2020:100292) to have an efficacy of almost 
80% anti-hypertensive herb.  
 
Consistency in reducing high blood pressure by aged extract of garlic as compared to 
other forms of garlic was evident, as reported in a few meta-analyses studies. More 
recently, for instance, a significant lowering of systolic (by 3.75mmHg) and diastolic (by 
3.39mmHg) blood pressures was reported in a randomized, controlled trial with garlic 
supplement (Wang, Yang, Qin, Yang, 2015:223). When compared to placebo, a 
significant (4.6 ± 2.8mmHg) lowering of systolic blood pressure was observed in another 
meta-analysis on randomized, controlled trials (Ried et al. 2013:64). Similarly, a 12-week 
treatment with 960mg/day aged garlic extract given to persons with uncontrolled high 
blood pressure (≥140mmHg) in a double-blind, parallel randomized placebo study 
showed a systolic blood pressure of up to an average of 10.2 ± 4.3mmHg (Ried et al. 
2013:64). Ried et al. (2013:64) further reported that the more stable S-allylcysteine 




Furthermore, Ashraf, Khan, Ashraf, and Qureshi (2013:859) reported a significant 
lowering of systolic (9.2mmHg) and diastolic (6.27mmHg) blood pressures in another 
randomized, parallel, placebo-controlled trial where stage 1 hypertensive patients were 
administered 300–1500 mg/day tablets of garlic for 24 weeks. Greater antioxidant 
potency was reported in aged extracts of garlic compared to other garlic derivatives 
(Mathew and Biju, 2008:65; Chan et al. 2020:100292). An increase in cellular antioxidants 
was seen when aged extracts of garlic lead to potent scavenging of reactive oxygen 
species (Drobiova, Thomson, Al-Qattan, Peltonen-Shalaby, Al-Amin, and Ali 
2011:703049; Morihara, Hayama, and Fujii 2011:17). In addition, a 50% reduction in 
systolic blood pressure raised the levels of antioxidants by over 60% when 500mg/ml 
garlic aqueous extracts were used to treat two-kidney, one-clip hypertensive rats for three 
weeks in a comparable study (Drobiova et al. 2011:703049). 
 
The ability of aged garlic extracts to scavenge superoxides was not only demonstrated in 
rats but equally reported in human neutrophils (Morihara et al., 2011:71). Vazquez-Prieto 
et al. (2011:475216) reported a reduction in NADPH oxidase levels in fructose-fed rats’ 
aorta after daily administration of 150 or 400mg/kg garlic extracts. Furthermore, garlic’s 
antihypertensive properties have been reported to be mediated by endogenous signaling 
gases such as nitric oxide and hydrogen sulfide (Banerjee et al. 2002:1509; Mousa and 
Mousa 2007:119; Ried et al. 2013:64; Chan et al. 2020:100292), where a significant 
decrease of 17mmHg in SBP was reported in stage I hypertensive patients administered 
2600mg of garlic for ten days (Mousa and Mousa 2007:119). Interestingly, garlic extracts 
have also been shown to increase the bioavailability of nitric oxide by 200% (Mousa and 
Mousa 2007:119), increased hydrogen sulfide production and induces its synthesis for 
vasorelaxant activity (Benavides et al. 2007:17977); increased expression of Connexin-
43 (Cx43), a gap junction protein correlated with a reduced VSMC proliferation and DNA 
synthesis (Joshi, Martin, Shaver, Madamanchi, Muller-Borer, and Tulis, 2012:220), and 
inhibition of ACE (Sendl, Elbl, Steinke, Redl, Breu, and Wagner, 1992:1). Inhibition of 
vascular smooth muscle cell proliferation, reduction in angiotensin II-induced 
vasoconstrictor responses, abrogation of the activation of NF-κB, and inhibition of 
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endothelin-1 induced vasoconstriction have all been reported with garlic (Banerjee et al. 
2002:1509; Castro et al. 2010:781; Pan, Liu, Gong, Yang, and Zhu, 2012:106). 
 
Few side effects have been reported with garlic, regardless of the diverse therapeutic 
effects on hypertension. Heartburn, acid reflux, abdominal swelling, and flatulence have 
been reported with garlic (Yang, Chan, Hu, Walden, Tomlinson, 2011: 397136; Ried et 
al. 2013:64; Chan et al. 2020:100292). 
 
2.4.2.5 Camellia sinensis (green tea) 
 
Deka and Vita (2011:136) reported that camellia sinensis has anti-cancer, antibacterial, 
antidiabetic, anti-inflammatory, and antihypertensive effects (Al Disi et al. 2016:323). 
Camellia tea was also reported to be the most frequently consumed beverage worldwide 
(Faria, Papadimitriou, Silva, Lopes de Faria, and Lopes de Faria, 2012:1838; Peng, Zhou, 
Wang, Yu, Yang, and Liu, 2014:6251). Different researchers have presented conflicting 
reports on the antihypertensive effect of C. sinensis. For instance, earlier reported data 
(Hodgson, Puddey, Burke, Beilin, and Jordan, 1999:457; Hodgson, Puddey, Burke, 
Watts, and Beilin, 2002:195; Peng et al. 2014:6251) showed an increase in blood 
pressure after 30 min of C. sinensis consumption with a return to baseline readings after 
60 min. Nagao, Hase, and Tokimitsu (2007) reported decreased systolic blood pressure 
in patients with 140mmHg or higher values. Meta-analysis studies also showed varying 
blood pressure effects among participants given C.sinensis (Peng et al. 2014:6251). 
Taubert, Roesen, and Schömig (2007:626) reported no change in blood after drinking C. 
sinensis in a meta-analysis of five trials. However, Peng et al. (2014:6251) demonstrated 
a reduction in both systolic (1.98mmHg) and diastolic (1.92mmHg) blood pressure in a 
meta-analysis study of randomized controlled trials. Other studies tend to agree with 
reducing both systolic and reduce blood pressure due to C.sinensis consumption 
(Bogdanski, Suliburska, Szulinska, Stepien, Pupek-Musialik, and Jablecka, 2012:421; 
Hodgson, Puddey, Woodman, Mulder, Fuchs, and Scott 2012:186). Compared with black 
tea, green tea induced a more potent antihypertensive effect, especially with long-term 
consumption (Al Disi et al. 2016:323). Different catechins have been described as the 
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major flavonoids found in green tea. Deka and Vita (2011:136) reported epicatechin (EC), 
epicatechin-3-gallate (ECG), epigallocatechin (EGC), and epigallocatechin-3-gallate 
(EGCG) as the major catechins found in green tea. The primary catechins predominant 
in green tea were reported to be EGCG (Babu and Liu 2008:1840; Faria et al. 2012:1838; 
Slevin, Ahmed, Wang, McDowell, and Badimon 2012:1186; Thomson, Al-Qattan, 
Mansour, and Ali 2012: 409047).  
 
Vasorelaxant effects have long been reported as responses to flavonoids. Ras, Zock, and 
Draijer (2011:e16974) reported flow-mediated dilation, while Oyama, Maeda, Kouzuma, 
Ochiai, Tokimitsu, and Higuchi (2010:578) reported endothelial-dependent dilation. 
Catechins are converted by an enzymatic (polyphenol oxidase and peroxidase) oxidative 
polymerization reaction to tannins: the aflavins (benztropine ring) and arubigins, both of 
which are orange-red colored polyphenolic pigments that are also potent vasodilators 
(Yang et al. 2011:397136).  
 
The risks of hypertension are significantly reduced by green tea by attenuating oxidative 
stress through a few mechanisms such as inhibition of eNOS uncoupling (Faria et al. 
2012:1838); increase of CAT antioxidant enzymes while simultaneously blocking AT1 
receptors in streptozotocin-treated rats (Thomson et al. 2012: 409047); upregulate the 
expression of antioxidant genes such as SOD1 and GST in C57BL/6 mice (Newsome, 
Petriello, Han, Murphy, Eske, and Sunkara 2014:126); scavenging superoxides in vitro 
(Nakagawa and Yokozawa, 2002:1745), and attenuate NAPDH oxidase production in 
people with diabetes (Ribaldo, Souza, Biswas, Block, Lopes de Faria, and Lopes de Faria 
2009:96).  
 
The bioactive tea components have been reported to express anti-inflammatory 
properties, reflected by the mitigated expression and release of different cytokines 
(Bogdanski et al. 2012:421). Green tea extract (379 mg/day for three months) also caused 
a decrease in BP as well as TNF-α levels (Bogdanski et al., 2012:421). In addition, EGCG 
was able to inhibit NFκB activation in human endothelial cells (Hong, Kim, Chang, Kim, 
Shin, and Ahn 2007:1957) and elicited a concentration-dependent inhibition of 
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proliferation in human aortic VSMCs by increasing HO-1 enzyme expression (Liu, Liu, 
Kuo, Chong, and Hsieh 2014: 523684), while the aflavin derived from green tea have 
been reported to reduce VCAM-1 levels (Lü, Hua, Yu, Jiang, and Leng 2005:304). 
 
2.4.2.6 Hibiscus sabdariffa (Roselle)  
 
One of the most extensively studied plants for hypertension is Hibiscus, widely known as 
Roselle (Islam 2019:1003). Roselle is a popular beverage in Africa, Europe, the 
Caribbean, Central, and South America. Fresh or dried, the different parts of the plant are 
used for food, health purposes, lotions, and refreshing beverages (Al Disi et al., 2016: 
326; Islam 2019:1003). Roselle is consumed as a tea or a refreshing beverage. The blood 
pressure-lowering activities of Roselle have been extensively studied and reported both 
in humans (Onyenekwe, Ajani, Ameh, and Gamaniel 1999:199; Herrera-Arellano, Flores-
Romero, Chávez-Soto, and Tortoriello 2004:375; Mojiminiyi, Dikko, Muhammad, Ojobor, 
Ajagbonna, and Okolo 2007:292; Mozaffari-Khosravi, Jalali-Khanabadi, Afkhami-
Ardekani, Fatehi, and Noori-Shadkam 2009:48; Inuwa, Al-Lawati, Beegam, Ziada, and 
Blunden 2012:563; Hopkins, Lamm, Funk, and Ritenbaugh 2013:84; Islam 2019:1003) 
and in animal studies (Odigie, Ettarh, and Adigun 2003:181; Ali, Al Wabel, and Blunden 
2005:369; Ajay, Chai, Mustafa, Gilani, and Mustafa 2007:388; Mojiminiyi et al. 2007:292; 
McKay, Chen, Saltzman, and Blumberg 2010:298; Ojeda, Jiménez-Ferrer, Zamilpa, 
Herrera-Arellano, Tortoriello, and Alvarez 2010:7; Inuwa et al. 2012:563; Hopkins et al. 
2013:84; Islam 2019:1003). Additionally, all clinical trials with Roselle extracts reviewed 
showed a significant reduction in high blood pressure in patients who consumed varying 
concentrations of Roselle (Herrera-Arellano et al. 2004:375; Herrera-Arellano, Miranda-
Sanchez, Avila-Castro, Herrera-Alvarez, Jimenez-Ferrer, and Zamilpa 2007:6; McKay et 
al. 2010:298; Jalalyazdi, Ramezani, Izadi-Moud, Madani-Sani, Shahlaei, and Ghiasi 
2019:107). 
 
Consequently, different mechanisms for Roselle’s antihypertensive effect have been 
reported (Islam 2019:1003). The vasorelaxant pathways of both VSMCs (Ali et al. 
2005:369; Ajay, Chai, Mustafa, Gilani, Mustafa 2007:388) and endothelial cells (Ajay et 
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al. 2007:388; Herrera-Arellano et al. 2007:6) are primed by Roselle. Inhibition of Ca2+ 
channels (Ajay et al. 2007:388), the opening of KATP channels (Sarr, Ngom, Kane, Wele, 
Diop, and Sarr 2009:45), and increased production of NO (Ajay et al. 2007:388; Alarcón-
Alonso, Zamilpa, Aguilar, Herrera-Ruiz, Tortoriello, and Jimenez-Ferrer 2012:751) are 
various mediated pathways of Roselle’s relaxant effect. Roselle has also been reported 
to decrease heart rates in rats (Odigie et al., 2003:181) and inhibit cardiac hypertrophy 
(Odigie et al. 2003:181; Inuwa et al. 2012:563). Additionally, Roselle’s diuretic abilities 
(Onyenekwe et al. 1999:199; Ali et al. 2005:369; Herrera-Arellano et al. 2007:6; Alarcón-
Alonso et al., 2012:751; Jalalyazdi et al., 2019:107), its ability to lower uric acid 
concentration (Ali et al., 2005:365), and decrease in the blood sodium content of stage 1 
and 2 hypertensive humans (Herrera-Arellano et al. 2007:6) have all been described. This 
diuretic activity is related to the vasorelaxant effect, as NO elevation is positively 
correlated with increases in renal filtration rates (Alarcón-Alonso et al. 2012:751).  
 
Furthermore, potent antioxidant function (Ali et al. 2005:369; McKay et al. 2010:298), 
reduction of oxidative stress; potential scavenging of free radicals in the livers of CCl4-
treated rats (Ajiboye, Salawu, Yakubu, Oladiji, Akanji, and Okogun 2011:109), and 
enhancement of the concentration of cellular antioxidants in healthy humans (Frank, 
Netzel, Kammerer, Carle, Kler, and Kriesl 2012:2207) have all been reported as Roselle’s 
activities. Lin, Chen, and Wang (2011:1245) also reported Roselle’s anti-atherogenic 
properties as well as its ability to proliferate in VSMCs. Inhibition of Roselle’s ACE activity 
was confirmed as part of its anti-inflammatory properties (Herrera-Arellano et al. 2007:6; 
Ojeda et al. 2010:7; Jalalyazdi et al. 2019:107). 
 
2.4.2.7 Crataegus spp. (Hawthorns or thorn apple)  
 
Asher, Viera, Weaver, Dominik, Caughey, and Hinderliter (2012:26) disclosed hawthorns’ 
use in managing cardiovascular disorders since the seventeenth century. The plant has 
been described as shrubs comprised of over 300 species (Tassell, Kingston, Gilroy, 
Lehane, and Furey 2010:32; Csupor, Viczián, Lantos, Kiss, Hegyi, Tenk, and Tóth 
2019:152984), which are widely used in most parts of the world. Walker, Marakis, Morris, 
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and Robinson (2002:48) and Tassell et al. (2010:32), at different times, demonstrated 
that hawthorns produced a modest reduction in blood pressure in humans. Other clinical 
trials and human studies with Hawthorn extracts showed a marked reduction in blood 
pressure among hypertensive patients treated with Hawthorn (Asgary, Naderi G, 
Sadeghi, Kelishadi, and Amiri 2004:221; Bone and Mills, 2013:667). The antihypertensive 
actions of hawthorns are attributed to several compounds in the plant. Compounds such 
as epicatechin, procyanidin B-2, oligomeric proanthocyanidins (OPCs,), flavonoids 
(hyperoside, quercetin, rutin, and vitexin), and quercetin (a major polyphenolic flavonoid 
in hawthorn shrubs), have been reported (Valli and Giardina 2002:1083; Houston 
2005:396; Asher et al. 2012:26; Yang and Liu 2012:1578). Quercetin has been reported 
(Larson, Symons, and Jalili 2012:39; Csupor et al., 2019:152984) to produce several 
bioactive functions including antioxidant, anti-inflammatory, and vasorelaxant effects, 
demonstrating a reduction in blood pressure properties (Larson et al., 2012:39). An effect 
on both endothelial cells and VSMCs has been reported with Hawthorn extracts, possibly 
due to enhanced phosphorylation of eNOS at serine 1177 and hence, NO release 
(Brixius, Willms, Napp, Tossios, Ladage, and Bloch 2006:177; Anselm, Socorro, Dal-Ros, 
Schott, Bronner, and Schini-Kerth 2009:253).  
 
Reducing the thickness of the vascular medial layer, decreasing body weight, improving 
kidney function, improving hyperlipidemia, and resolving hyperplasia are all mechanistic 
actions reported on hawthorn that contribute to the improvement of hypertensive outcome 
(Koçyildiz, Birman, Olgaç, Akgün-Dar, Melikoǧlu, and Meriçli 2006:66; Csupor et al. 
2019:152984). These effects of Hawthorn appear to be mediated by expression of NOS 
enzyme, efflux of water and sodium, as well as an increase in diuretic activity. The 
capacity to augment the concentration of the reducing glutathione, scavenge ROS, and 
upregulate antioxidant enzymes (SOD, CAT) has been reported by Tassell et al. 
(2010:32) and Cheng, Wang, Gao, Yuan, Feng, and Cao (2013:709) as part of the 
integrated cardiovascular beneficial bioprocesses of hawthorn. Additionally, the decline 
in the concentrations of iNOS, IL-6, NF-κB, TNF-α (Topal, Koç, Karaca, Altuǧ, Ergin, and 
Demirci 2013:330), and VCAM-1 (Shin, Lee, Lim, Ha, Seo, and Kim 2012:e45734) are 
mirrored as express anti-inflammatory activity with extracts of hawthorn.  
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2.4.2.8 Cymbopogon citratus (Lemongrass)  
 
Lemongrass has been reported to exhibit antihypertensive properties attributed to its 
active phytochemicals, especially citral (Devi, Sim, and Ismail 2011:143; Unuigbe, 
Enahoro, Erharuyi, and Okeri 2019:1; Devi, Sim, and Ismail 2012:539475). Lemongrass 
has been used as an indigenous therapy in Asia, Brazil, China, and other parts of the 
world (Devi et al. 2012:539475; Unuigbe et al., 2019:1). Even though presently no clinical 
trials have been reported on lemongrass’s antihypertensive effects, its relaxant properties 
and effects in rats have been described (Devi et al. 2011:143, 2012:539475; Bastos et 
al., 2010:331). Devi et al. (2012: 539475) described a dose-dependent vasorelaxation in 
phenylephrine pre-constricted aortic rings from male WKRs or SHRs when treated with 
crude extracts (leaves, stems, or roots) of lemongrass (citral). Based on their findings, 
activation of NO and the inhibition of calcium channels were identified and described as 
the underlying mechanism for this relaxation (Devi et al. 2012:539475). Similarly, an 
acyclic mono-terpenoid isolated from lemongrass (citronellol) produced a hypotensive 
response when administered in an intravenous bolus. Before the findings of Devi et al. 
(2012:539475), Bastos, Moreira, Ribeiro, Medeiros, Antoniolli, and De Sousa (2010:331) 
reported that hexamethonium, L-NAME, atropine, and indomethacin did not affect the 
hypotensive effect produced by citronella.  
 
Besides, citronella induced relaxation of rat superior mesenteric artery via an 
endothelium-independent mechanism; inhibited Ca2+-influx through voltage-operated 
calcium channels (VOCCs) as well as regulating IP3- and caffeine-gated intracellular Ca2+ 
stores (Bastos et al. 2010:331). Moderate antioxidant activity has been reported with 
lemongrass by some authors. For instance, Rahim, Taha, Mubark, Aziz, Simon, and 
Mazlan (2013:329) reported a reduction of oxidative stress and increased GSH 
expression in rat testes; increase in antioxidant enzymes and molecules such as SOD 
and GSH in murine lungs after administering 5 and 10µg of lemongrass’ extract (Tiwari 
et al. 2010:2913) and suppress ROS molecular activity (Tiwari, Dwivedi, and Kakkar 
2010:2913; Koh, Mokhtar, and Iqbal 2012:81). In addition, citral contributes to the anti-
inflammatory pathways by inhibiting iNOS activity and NF-κB (Lee, Jeong, Kim, Noh, Yuk, 
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and Hong 2008:342; Figueirinha, Cruz, Francisco, Lopes, and Batista 2010:681; 
Francisco, Costa, Figueirinha, Marques, Pereira, and Miguel-Neves 2013:126; Unuigbe 
et al. 2019:1). 
 
2.4.2.9 Andrographis paniculata (King of Bitter) 
 
Antioxidant effects, anti-bacterial properties, anti-inflammatory and remedies for cold, 
fever, and cardiovascular diseases have been reported with Andrographis paniculata 
(Awang, Abdullah, Hadi, and Fong 2012: 876458; Kunwar, Shrestha, and Bussmann 
2010:35; Nyeem, Mannan, Nuruzzaman, Kamrujjaman, and Das. 2017:318). Although no 
clinical trial has been conducted to test the antihypertensive properties of Andrographis 
paniculata, some hypotensive compounds have been identified from the plant. The active 
hypotensive ingredients identified from the plant are andrographolide, 14-deoxy11, 12-
didehydroandrographolide, and 14-deoxyandrographolide (Awang et al. 2012:876458). A 
decrease in blood pressure in spontaneously hypertensive rats has been shown by A. 
paniculata extracts, where angiotensin-converting enzymes and reactive oxygen 
superoxides have been decreased (Zhang and Tan 1996:1). Additionally, in isolated rat 
hearts, both 14-deoxy-11,12-didehydroandrographolide and 14 deoxyandrographolide 
reduced vascular resistance reflected by decreased coronary perfusion pressure (Awang 
et al. 2012:876458; Nyeem et al. 2017:318). A dramatic hypotensive effect was also 
reported with crude extracts with a high content of 14-deoxy-11,12-
didehydroandrographolide (Awang et al. 2012:876458). Increased release of nitric oxide, 
on the other hand, was attributed to the induced vasodilation seen (Awang et al. 
2012:876458). Awang et al. (2012:876458) further reported that additional inhibition of 
intracellular Ca2+ via receptor- and voltage-gated Ca2+ channels with 14-deoxy-11, 12 
didehydroandrographolide. A. paniculata can potently inhibit the activation of NFκB, and 
daily administration of andrographolide 4mg/kg caused a significant reduction in the 
production of NF-κB (Das, Periyasamy, and Pandey 2012:430). Furthermore, reports also 
indicated A. paniculata exhibits antiinflammatory activities in natriuretic peptide receptor-




2.4.2.10 Apium graveolens (Celery)  
 
Moghadam, Imenshahidi, and Mohajeri (2013:558) reported the hypotensive effects of 
seed extracts of celery reducing blood pressure in deoxycorticosterone acetate-induced 
hypertensive rats after the administration of 300mg/kg aqueous ethanolic (20/80, v/v), 
hexanic and methanolic extracts of Apium graveolens. Compared to other solvents, 
extracts of Apium graveolens, the hexanic extracts are more potent in lowering blood 
pressure. N-butylphthalide gives celery its aromatic odor and flavor and has been 
reported to lower blood pressure in animal models (Tsi and Tan 1997:576; Dianat, Veisi, 
Ahangarpour, and Moghaddam 2015:203; Tashakori-Sabzevar, Razavi, Imenshahidi, 
Daneshmandi, Fatehi, Sarkarizi, and Mohajeri, 2016:619). Aortic ring contractions caused 
by cumulative calcium increases in high potassium (60mM); thus, blocking of Ca2+ influx 
via calcium channels, has also been shown to be a property of apigenin flavone isolate 
of A. graveolens (Ko et al., 1991:69). Notably, extracts and celery constituents have been 
reported to reduce arterial pressure in humans (Weber et al. 2014:3; Al Disi et al. 2016:5; 
Dianat et al. 2015:203; Tashakori-Sabzevar et al. 2016:619), possibly by lowering levels 
of circulating catecholamines and decreasing vascular resistance (Houston 2005:396). 
Conversely, this herb can reduce oxidative stress by its flavonoid content that potentiates 
antioxidant mechanisms (Popovic, Kaurinovic, Trivic, Mimica-Dukic, and Bursac 
2006:531; Dianat et al. 2015:203; Tashakori-Sabzevar et al. 2016:619). 
 
2.4.2.11 Coptis chinensis (Chinese Goldthread)  
 
The ability of Chinese goldthread’s main compound Berberine (BBR) to lower blood 
pressure has been indicated since Coptis chinensis has been used widely in Chinese 
traditional medicine (Affuso, Mercurio, Fazio, and Fazio 2010:71; Xiong, Yang, Liu, 
Zhang, Wang, and Wang 2013b:275279; Liu and Huang 2016:469). Significant 
hypotensive effects have been reported in clinical trials and meta-analyses (Lan, Zhao, 
Dong, Yan, Zheng, and Fan 2015:68). The increased antioxidant enzyme, SOD in rats 
with an atherosclerotic renovascular disease, amelioration of oxidative stress (Zhang, 
Song, Liu, Li, Zhao, and Zhang 2011:450; Wan, Chen, Liu, Zhao, Huang, and Zhang 
2013:e59794), scavenging ROS, via inhibition of NADPH oxidase (Wan et al. 
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2013:e59794), and relaxing arterial tissues through endothelial-dependent and 
independent routes (Affuso et al. 2010:71) have all been proposed as goldthread’s 
antihypertensive effects. A concomitant increase in NO release that leads to enhanced 
flow-mediated vasodilation due to elevation in the expression of eNOS by BBR has also 
been indicated (Affuso et al. 2010:71; Zhang et al. 2011:450; Liu and Huang 2016:469). 
The opening of KATP channels, blockage of Ca2+ influx, and the vasodilator PGI2 are the 
likely reported mediated vasodilation effects caused by BBR (Zhang et al., 2011:450). 
Additionally, VSMC proliferation modulates inflammatory pathways through suppression 
of transcription factor NF-κB, VCAM-1 expression (Affuso et al. 2010:71; Wan et al. 
2013:e59794; Liu and Huang 2016:469), and inhibiting endothelial injury (Wang, Huang, 
Lam, Li, Wong, and Ye 2009:484) have been described with an isolate of BBR. BBR also 
improves cardiac muscle hypertrophy and lipid profile by reducing total and LDL 
cholesterol (Zhang et al., 2011:450; Liu and Huang 2016:469). 
 
2.4.2.12 Panax (Ginseng)  
 
The principal active components of ginseng are heterogeneous triterpenoid saponins and 
steroid glycosides or ginsenosides (or panaxosides). In contrast, the four most common 
species of ginseng are P. notoginseng (Chinese ginseng, P. ginseng (Asian or Korean 
ginseng), P. japonicas (Japanese ginseng), and P. quinquefolius (American ginseng) 
(Valli and Giardina 2002:1083; Kim 2012:16; Liu and Huang 2016:469; Komishon et al. 
2016:619). Ginseng is prepared and administered in various forms, either as a solid 
(tablets, capsules, dried roots), or as a liquid (oil, extracts, or tea) (Valli and Giardina, 
2002:1083), and used for centuries as folk medicine in Asia (Jang et al. 2011:176; Kim 
2012:16; Komishon, Shishtar, Ha, Sievenpiper, de Souza, Jovanovski, Ho, Duvnjak, and 
Vuksan  2016:619). 
 
Several authors have reported both the antihypertensive effect of ginseng and its ability 
to elevate blood pressure (Jeon, Kim, Park, Lee, Park, and Kim 2000:135; Valli and 
Giardina, 2002:1083; Jang, Lim, and Lim 2011:176; Kim, 2012:16; Mucalo, Jovanovski, 
Rahelic, Božikov, Romic, and Vuksan 2013:148; Liu and Huang 2016:469). Higher 
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ginseng concentrations showed hypotensive effects, while low doses were contextually 
shown to raise blood pressure (Jang et al. 2011:176). Varied action of different 
ginsenosides could be a probable explanation for this phenomenon (Valli and Giardina, 
2002:1083). Although the primary mechanism associated with the ginseng-induced 
hypotensive effect is attributed to an improved arterial function, regulating the arterial 
baroreflex, tuning vascular function, or modulating the autonomic nervous system are 
possible suggestions on the ginsengs blood pressure mechanism (Kim 2012:16).  
 
Ultimately, activation of eNOS (Valli and Giardina 2002:1083; Jang et al. 2011:176; Liu 
and Huang 2016:469; Komishon et al. 2016:619), a dramatic increase in eNOS 
expression and NO production (Valli and Giardina 2002:1083; Jang et al. 2011:176, 
2012:463; Hong, Kim, Ahn, Shin, and Kwon 2012:3086; Pan et al., 2012:106), increase 
NO and cGMP levels, as well as activation of Ca2+-gated potassium channels (Kim, Kang, 
Park, and Schini-Kerth 1999b:41), have all been documented with ginseng. Ginseng also 
elicits an anti-proliferative effect on VSMCs. Hence, it can be expected to possess 
antihypertensive and anti-atherosclerotic capacities (Jovanovski, Bateman, Bhardwaj, 
Fairgrieve, Mucalo, and Jenkins 2014:537). In addition to antihypertensive effects, Choi, 
Kim, Choi, and Lee (2013: e59978) documented ginseng’s role as anti-carcinogenic and 
antidiabetic effects. 
 
2.5 INTERACTIONS BETWEEN INDIGENOUS AND WESTERN THERAPIES  
 
With wide acceptance and use of herbal remedies in different cultures, there is a growing 
habit of concurrent herb-drug use, which raises the concern for pharmacokinetic 
interactions (Parvez and Rishi, 2019:275). In many communities, administering herbal 
remedies in combination with therapeutic drugs is a common practice, raising the 
potential for herb-drug interactions. Furthermore, the rising interest in natural products for 
disease management has reawakened natural product research in drug discovery, 
necessitating pharmacokinetic studies of phytochemicals, including their potential for 
drug interactions. Therapies involving these agents have shown promising potential with 
significant efficacy. However, many of these indigenous products are yet to be 
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scientifically tested, and a large portion of them are either not monitored or poorly 
monitored scientifically. The result of a lack of adequate knowledge of indigenous 
products, especially their pharmacokinetic and pharmacodynamics with existing Western 
medications and other food products, calls for caution and a more rational approach in 
their usage (Ekor 2014:177). Accordingly, the availability of Western medicines in the 
market follows rigorous laboratory and clinical investigations and goes through stringent 
regulatory scrutiny; the same cannot be said of indigenous therapies. A wide variety of 
acclaimed herbal products currently lack sufficient scientific data to provide information 
on such products’ safety or efficacy (Parvez and Rishi, 2019:275). The concomitant use 
of Western medications and indigenous therapies could result in drug-herb interactions 
that could result in clinical outcomes that are unwanted or toxic. To make matters worse, 
most individuals consuming both western and indigenous therapies do not provide vital 
documentation of such usage, thereby making clinical decisions on interactions difficult 
(Parvez and Rishi, 2019:275). 
 
In any case, not many studies have been reported on the dynamics that occur during a 
concomitant administration of a medicinal herbal product and conventional Western 
drugs. In terms of pharmacokinetics and pharmacodynamics influence, studies into 
indigenous herbal products’ influence on drug pharmacokinetics are necessary, as noted 
by Fasinu, Bouic, and Rosenkranz (2012). Fasinu et al. (2012) reported further that the 
non-specificity of metabolic enzymes and drug transporters makes them susceptible to 
interactions with phytochemicals, where the latter can be substrates, inhibitors, or 
inducers. The inhibition and induction of metabolic enzymes or transport proteins are not 
desirable, especially in the events of concomitant herb-drug consumption or multiple uses 
of medicinal products. Such effects as the failure attributed to induced metabolism by St. 
John’s wort (SJW) have been widely reported. Previous reports implicated SJW in 
numerous herb-drug interactions that may have clinical importance (Fugh-Berman, 2000; 
Fasinu et al., 2012; Borse, Singh, and Nivsarkar, 2019). For instance, breakthrough 
menstrual bleeding has been reported in women taking oral contraceptives in combination 
with SJW. The common herbal products that interact with western medications have been 
reported to include Panax ginseng (ginseng), Ginkgo biloba (ginkgo), Hypericum 
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perforatum (St John's wort), Allium sativum (garlic), and Zingiber officinale (ginger). 
Furthermore, St. John's wort has been reported to significantly reduce the blood 
concentrations of Theochron (theophylline), Gengraf (cyclosporine), Prograf (tacrolimus), 
Lanoxin (digoxin), Crixivan (indinavir), Versed (midazolam), Elavil (amitriptyline), 
Coumadin (warfarin) and Marcoumar (phenprocoumon). St. John’s wort also reduced the 
area under the plasma concentration-time curve (AUC). Common drugs that interact with 
herbal medicines include Crixivan (indinavir), Coumadin (warfarin), Gengraf 
(cyclosporine), Prograf (tacrolimus), Lanoxin (digoxin), Elavil (amitriptyline), Versed 
(midazolam), and Camptosar (irinotecan). Indigenous herbal therapies may interact with 
drugs in the kidneys, intestines, liver, and at the receptor site of action on the target organ. 
Most of these Western medications have been reported to have significant, narrow 
therapeutic indices; as such, they may be prone to toxic adverse reactions (Parvez and 
Rishi 2019:275).  
 
Despite the multi-beneficial effects of consuming herbs in managing and treating several 
diseases, including hypertension, herbal medicine is not without many limitations. The 
World Health Organization presented the under-listed limitations of using complementary 
and alternative therapies (WHO, 2019). 
a. Lack of sufficient quality control due to the absence of governmental or other 
health-related bodies overseeing the production and other relevant issues on 
herbal medicine, practice, and products. 
b. Undesired side effects, which may not always be very obvious or immediate. 
c. Allergy to some components of the herb (or herbal product). 
d. Seasonal variations in the herbal plant parts (both aerial: bark, leaves, flowers, fruit 
seeds or stems, and underground: rhizomes or roots) and the potential quantitative 
changes in composition and ratios of bioactive ingredients. 
e. Drug interactions with other medicines. 
f. Adulteration of medications, where herbal prescriptions can be mixed with 
synthetic drugs like pain-killers or anti-inflammatory corticosteroids. 
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g. The long time needed for an effect to be observed in some cases, which 
consequently precludes the use of the herb/herbal compound when an immediate 
resolution to the medical problem is needed. 
h. Limitations in certain diseases, since herbal medicine cannot heal a concussion, 
broken bone, or a heart attack. 
i. Misclassification of the herb/plant, which may sometimes lead to misidentification. 
j. The lack of enough information on labels of bottles of herbal products, such as 
expiry dates (and how this affects the function; related to point “a” above). 
k. The lack of awareness among patients, physicians, and the average public about 
the use or abuse of herbs and herb-related products. 
l. Self-medication due to over-the-counter availability of many herbal products. 
m. The large numbers of similar herbs in respective pharmacopeias. 
 
2.6 SUMMARY OF THE CHAPTER  
 
This chapter presented an extensive review of the literature on indigenous-western 
antihypertensive therapies. A review of the literature on the pathophysiology of 
hypertension and the factors that contribute to hypertension development was presented. 
The chapter also reviewed all the medications used in managing hypertension and 
interactions that are likely to occur when such medications are used concurrently with 
indigenous therapies. The use of plants and herbs in the management of hypertension 
was also extensively reviewed. Western medications that were discovered from medicinal 
plants and different plants and herbs that have been tested for the management of 
hypertension are presented. The following chapter will present the research design and 









RESEARCH DESIGN AND METHODOLOGY 
 
3.0 INTRODUCTION  
 
The previous chapter focused on the literature review for both indigenous and western 
therapies. This chapter describes the research design and methodologies involved in 
indigenous-western therapies used in managing hypertension in Belize. Creswell 
(2015:535) described research design as a broad framework that provided guidelines, in 
this case, on indigenous-western therapies used in the management of hypertension in 
Belize. Both quantitative and qualitative research designs were used in this study, as this 
chapter explained the need for such integration. The chapter also presented sample and 
sampling techniques used for data collection. The data analysis methods were also 
presented and related to the collected data’s reliability, validity, and trustworthiness.  
 
3.1 RESEARCH DESIGN 
Yousaf (2019:1) described the research design as the systemic approach used to conduct 
scientific research and its overall organization of all identified constituents and data that 
resulted in credible outcomes. A strategic methodology is employed to provide plausible, 
accurate, and authentic outcomes in line with the type of research chosen. This study on 
indigenous-western antihypertensive therapies in Belize utilized the mixed-methods 
explanatory sequential design via which data were collected using quantitative and 
qualitative techniques. Creswell and Creswell (2018:35) described mixed methods 
research design as a procedure for collecting, analyzing, and “mixing” quantitative and 
qualitative methods in a single study or a series of studies to understand a research 
problem. Data collected in this study, therefore, utilized both quantitative (Phase I) and 
qualitative (Phase II) research designs. The study’s 2 phases were integrated to provide 
a comprehensive understanding of indigenous-western antihypertensive therapy 
practices among hypertensive patients in Belize.   
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The research was designed to collect quantitative data, followed by qualitative data, and 
integrate the two after that.  
3.2 QUANTITATIVE RESEARCH DESIGN  
 
A quantitative research design examines relationships among variables as a means of 
testing theories (Creswell and Creswell, 2018:37). A quantitative research design is 
considered a rational process for verifying, refuting, or lending credibility to theories that 
have existed (Leavy 2017:300). The research design involves identifying correlations and 
patterns in variable relationships by examining and testing such variables. In this phase 
of the study, the primary purpose was to assess the utilization of indigenous-western 
antihypertensive among Belizeans diagnosed with hypertension; therefore, acquiring 
knowledge, neutrality, and objectivity shall characterize the study results. 
 
3.3 QUALITATIVE RESEARCH DESIGN  
 
Quantitative research has been defined as a technique for examining and better-
comprehending individuals or groups attributed to a social or peculiar problem (Creswell 
and Creswell, 2018:37). With qualitative research, data is typically obtained from the 
participant’s setting using questions and procedures that will generally lead to an 
inductive analysis from thematic interpretations. A full depth of comprehension of the 
phenomenon being investigated is presented at the end of the qualitative study. In the 
current study, the qualitative research designed was utilized to explore and understand 
the practices of indigenous-western antihypertensive therapies in Belize. The qualitative 
component of gathering data provided a focused engagement with indigenous therapy 
users and indigenous therapy vendors to help unravel the practices of indigenous 
therapies in managing hypertension in Belize. The participants’ experiences in utilizing 






3.4 MIXED-METHODS  
 
In mixed methods research, the analyzed quantitative and qualitative data are integrated 
into a single dataset to understand the studied phenomenon (Leavy 2017:300). In this 
study on indigenous-western antihypertensive therapies, both data collected during the 
quantitative and qualitative phases were integrated to provide a depth of comprehension. 
Mixed-methods sequential explanatory design implies collecting and analyzing 
quantitative and then qualitative data in two consecutive phases within one study 
(Creswell and Creswell, 2018:37). Using the sequential explanatory design only requires 
the research investigator to generalize some specific aspects of investigations (Ary, 
Jacobs, Sorensen, and Walker 2014:56). Furthermore, with an explanatory sequential 
study design, the researcher collects data during the quantitative (numeric) study and 
analyzes it as a first step to the mixed methods. To help explain or elaborate on the 
quantitative results obtained in the first stage of the study, the researcher further collects 
and analyzes more data in the qualitative phase, which builds on the first stage of the 
research. Second, the qualitative stage expands on the prior quantitative understanding 
of the phenomenon investigated. This approach reasons that the quantitative information 
and subsequent results give a general comprehension of the studied phenomenon. The 
qualitative data and their analysis refined and explained the statistical results by exploring 
participants’ views in more depth (Creswell 2015:535; Alvarez and Woodhead-Lyons 
2013:697). 
 
Consequently, scholars argued that explanatory research aimed at exploring the research 
questions to provide a definitive and final solution to the problems which are already 
existing (Wisdom, Cavaleri, Onwuegbuzie, and Green 2012:721). Therefore, explanatory 
sequential study designs are conducted to determine the nature of the problem while 
offering conclusive evidence and understanding the nature of the problem better.  
 
It is always maintained that when the researcher is conducting an explanatory sequential 
study design, he or she must be flexible enough to change the direction of the study due 
to new insights and data revelation (Bazeley and Jackson 2013:170). However, in some 
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cases, explanatory research always intends to handle new problems in which minimal 
studies have been done previously. Moreover, it is essential to appreciate that an 
explanatory sequential study is usually the initial research of its kind, which forms a more 
conclusive study (Saunders, Lewis, and Thornhill 2009). Other studies have shown that 
explanatory research can provide new research design, data collection methods, and 
sampling techniques (Creswell and Plano-Clark 2018:54). 
 
Therefore, with this background, the main advantage of why explanatory sequential study 
design was opted for in examining the indigenous-western antihypertensive therapies in 
Belize was that such a study had not been conducted before in Belize. Hence, the study 
design enabled the researcher to explore all the relevant data that was needful for the 
study, improving the study’s general reliability and validity (Bazeley and Jackson 
2013:170). The design also provided the researcher with a chance to know how cultural 
influence affects the usability of indigenous-western anti-hypertensive therapies among 
hypertensive patients in Belize. Bowling (2014:215) pointed out that explanatory study 
design is a descriptive study that involves describing a given population in the society, 
their behavior, or the process of undertaking such types of research.  
 
Accordingly, in this study, explanatory sequential research methodology, therefore, 
played a very prominent part in the development of the process and the procedures that 
are to be followed in order to attain the results that have been desired in examining 
indigenous-western therapies in the management of hypertension in Belize (Alvarez and 
Woodhead-Lyons 2013:697).  
 
Thus, the explanatory sequential research methodology is marked as highly evident 
norms that must be designed to improvise or produce the result to ensure that the study 
has successfully come up with the exact outputs to be achieved during the investigation. 
Therefore, this section describes the general design applied when collecting data and 
how the data was analyzed. Furthermore, the section also incorporated the sampling 
technique applied, data collection procedure, data analysis technique, reliability, validity, 
and trustworthiness. Lastly, the general ethical considerations were also presented in this 
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chapter. Overall, the entire section will provide the exact procedures to be followed by 
this current study to derive the results.  
 
Finally, because a mixed-methods explanatory sequential study design was used for this 
study, it implied that both quantitative and qualitative data collection methods were 
employed. The mixed-methods sequential explanatory design consists of two distinct 
phases: quantitative and qualitative (Creswell and Creswell, 2018:37). First, quantitative 
data were collected, analyzed, and the results set up the second qualitative phase stage. 
The qualitative data were collected and analyzed second in the sequence, help explained, 
or elaborated on, the quantitative results obtained in the first phase, and the two phases 
are integrated with the intermediate stage in the study. This approach’s rationale is that 
the quantitative data and subsequent analysis provided a general understanding of the 
research problem. The qualitative data and their analysis refined and explained the 
statistical results by exploring participants’ views in more depth (Creswell and Creswell, 
2018:37). The author further described the advantages of this approach to include 
straightforwardness and opportunities to explore the quantitative results in more detail. 
This design can be advantageous when unexpected results arise from a quantitative 
study. The current study on indigenous-western antihypertensive therapies was divided 
into two phases based on the data collected. 
 
3.5 PHASE I: RESEARCH METHOD 
 
A cross-sectional quantitative survey was conducted among hypertensive patients in 
Belize. Research participants included adult hypertensive patients residing in the country 
of Belize. The quantitative research designed ensured data on indigenous-western 
therapies to be collected utilizing a well-structured questionnaire containing 38 items. 
Some of the questions were adapted and modified to use in this study. This study 
employed a mixed-methods explanatory sequential design under which data were 
collected using quantitative and qualitative techniques. Creswell (2015:535) described 
mixed methods research design as a procedure for collecting, analyzing, and “mixing” 
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quantitative and qualitative methods in a single study or a series of studies to understand 
a research problem. 
 
3.5.1 Phase I: Sampling 
 
Sampling is a process utilized in statistical analysis during which a predetermined number 
of observations are taken from a more significant population. A sample is usually taken 
from a larger population using a sampling technique (Creswell 2015:20). 
 
3.5.1.1 Study Setting and population  
 
The cultural, physical, social, and environmental sites for which research is conducted is 
considered the research setting (Creswell 2015:20). The current study on the use of 
indigenous-western antihypertensive therapies was conducted in the entire country of 
Belize. Belize (formerly British Honduras) is the only commonwealth and English-
speaking country in Central America, and by its geographical location and historical 
background, it is part of both Central America and the Caribbean (Figure 3.1). Therefore, 
the country participates in the programs of the Central American Integration System 
(SICA) and the Caribbean Community (CARICOM). It has a total area of about 8, 867 
square miles (23,000 km2) and shares borders with Guatemala (266 km) to the south and 
west and Mexico (250 km) to the north. It is bordered by the Caribbean Sea to the east, 
with 386 km of coastline (Figure 3.1).  
 
According to the 2010 last census report, the country had 351,600 (Statistical Institute of 
Belize [SIB] 2013:1). The current 2019 population was estimated at 408,487 (SIB 2019:1). 
The main ethnic groups in the country are Mestizo, Creole, Maya, and Garifuna. The 
literacy rate is 79.7%, with an unemployment rate of 14.2%. Belize is a parliamentary 
democracy, a member of the Commonwealth, divided into six administrative districts (Fig. 
3.1). The country has a GDP of USD 1.987 billion, a GDP growth rate of 0.7%, and an 
inflation rate of 0.3% (2018). Belize’s total exports for 2018 were estimated at US$200 
million annually. The economy’s principal sectors are agriculture, agro-processing, and 
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service, primarily tourism (Martin and Manzano 2010:107; Leslie and Heusner 2002:5). 
The main exports were sugar and molasses (30%), bananas (18.5%), citrus (15.7%), 
marine products (10.7%), and crude petroleum (6.3%) (SIB 2019:1). 
 
Figure 3.1 Map of Belize, Central America 
 
    
 




3.5.1.2 Phase I: Methodology 
 
A cross-sectional quantitative survey was conducted among hypertensive patients in 
Belize, where data was collected using a well-structured questionnaire, as described 
below. 
 
3.5.1.3 Phase I: Population 
 
A population is a group of individuals who have the same characteristic, while a sample 
is a subgroup of the target population that the researcher plans to study for generalizing 
about the target population (Creswell 2015:142). The participants in this study comprised 
all hypertensive adult patients currently accessing antihypertensive medications from any 
government-owned hospitals, private clinics, or pharmacies in the entire country of Belize.  
The participants’ eligibility in this phase of the research comprised all hypertensive adult 
patients currently attending government hospitals, private clinics, or community 
pharmacies. All hypertensive adult patients currently accessing antihypertensive 
medications at any government-owned hospitals, private clinics, or pharmacies were 
eligible and participated in the research. Participants who were duly diagnosed with 
hypertension volunteered to participate in the research after giving their consent to 
partake in the survey. Participants who did not give consent to participate in the study 
were excluded from the study. 
 
3.5.1.4 Phase I: Sampling 
 
Leavy (2017:76) defined sampling as the process whereby a subset of the population is 
selected to represent the study population and make possible statistical inferences. In 
this study, a non-probability convenient sampling technique was used to collect data on 
the use of indigenous-western antihypertensive therapies in Belize in this first phase of 
the research. The purpose of the convenient sampling technique was to identify patients 
diagnosed with hypertension specifically. Patients refilling antihypertensive medications 
at government-owned or private hospitals inclusive of pharmaceutical shops were 
identified and asked to participate in the study. Therefore, with a convenient sampling 
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technique, participants in a given unit are chosen based on a specific purpose. It has 
been considered as a useful sampling method that involves receiving relevant information 
from a sample population that the researcher believes is aware of the phenomenon 
investigated (Leavy 2017:76).  
 
3.5.1.5 Phase I: Sample  
 
The sample size was used to draw and generate data from the number of individual cases 
in the study population (Leavy 2017:76). This study employed a convenient sampling 
technique to obtain data from diagnosed hypertensive patients in Belize. A sample size 
of 422 was used for the study with a 95% confidence level and a +/- 5% confidence 
interval to determine sample size. The sample size was determined using the online 
software Open Epi (Epi Info™), Version 3, open-source.  
 
3.5.1.6 Phase I: Sample size calculation  
 
OpenEpi (Epi Info™), Version 3, open-source calculator (Dean et al. 2018:1) was used 
to calculate sample size (Table 3.1). OpenEpi (Epi Info™) is a free and open-
source software for epidemiologic statistics. It provides statistics for counts and 
measurements in descriptive and analytic studies, stratified analysis with exact 
confidence limits, matched pair and person-time analysis, sample size and power 
calculations, random numbers, sensitivity, specificity and other evaluation statistics, R x 
C tables, and chi-square for dose-response (Dean et al. 2018:1). 
 
Using the OpenEpi (Epi Info™) open-source sample size calculator, therefore, the country 
size was calculated to be 384 x 10% = 422. The addition of 10% was to take into account 
the non-response factor. The final sample size, therefore, arrived at 422. In order to obtain 
proportionate samples from the six districts in the country, the 422 total sample size was 
further stratified proportionately to obtain representative behaviors from each district 
(Table 3.1). A total of 422 questionnaires were used for data collection in this phase of 
the study. Stratified proportionate samples were further calculated based on the district 
population, as shown in Table 3.1. 
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Table 3. 1 Sample size calculation (OpenEpi open-source calculator). 
 
Population size (for Finite Population Correction factor or FPC) (N): 398050 
Hypothesized % frequency of outcome factor in the population (p): 50%+/-5 
Confidence limits as % of 100(absolute +/- %) (d): 5% 
Sample Size(n) for Various Confidence Levels 1 
Confidence Level (%) 95% 
Sample Size 384 
Equation: Sample size n = [DEFF*Np(1-p)]/ [(d2/Z21-α/2*(N-1) + p*(1 p)]  
 
The phase I total sample size was calculated to be 384 x 10% = 422. The addition of 10% 
was made to consider the non-response bias (Suresh and Chandrashekara 2012:7). The 
final sample size was estimated to be 422. In order to obtain proportionate samples from 
the six districts in the country of Belize, the 422 total sample size was further stratified 
proportionately. The total sample size computed was further proportionately stratified to 
calculate sample sizes for each district, as shown in Table 3.2. The strategy to stratify the 
sample size was to provide a proportionate selection of participants from each district 
based on the districts’ population behaviors. 
 
Table 3.2. Districts population and sample size. 
 
District  Population  Sample size 
Belize 120, 602 128 
Cayo 96,197 102 
Orange Walk 51, 749 55 
Corozal 48, 429 51 
Stann Creek 43, 452 46 





3.5.1.7 Phase I: Data collection  
 
A questionnaire was used for data collection in this first phase of the research. Creswell 
(2015:9) defines data collection as a “means of identifying and selecting individuals for a 
study, obtaining their permission to study them, and gathering information by asking 
people questions or observing their behaviours.” In this phase of the study, data were 
collected from hypertensive patients in Belize’s entire country using a carefully designed, 
well-structured questionnaire. The data collection approach was first to pretest 
questionnaire, and then a validated questionnaire was used to gather data from patients 
diagnosed with hypertension.  
 
3.5.1.8 Phase I: Development of the questionnaire 
 
The questionnaire was first presented to the research supervisor, expert professors in 
questionnaire design, health practitioners, and pharmacists for review. Their 
recommendations led to the inclusion of questions on medication adherence to explain 
indigenous therapy usage. Furthermore, the item on herbal teas usage was added for 
respondents who may not be directly consuming indigenous therapies but are taking 
prepared teas to manage their hypertension. The questionnaire was then piloted in 35 
hypertensive patients in Belmopan to check for errors. Some spelling and grammatical 
errors have been corrected. The skip option was further added to individuals who 
indicated that they did not use indigenous therapies to manage their hypertension. 
 
3.5.1.9 Characteristics of the questionnaire 
 
The questionnaire was the tool used for data collection in this phase of the study. A 
questionnaire is defined as a predetermined set of questions used to collect data 
(Bolarinwa 2015:196). For this phase, therefore, a carefully designed questionnaire was 
developed after reviewing relevant available literature. Some questions were adapted and 
modified from previously developed research instruments (TRAMIL 2010:1; Picking, 
Younger, Mitchell, and Delgoda 2011:305), which align with current research. The 
questionnaire was divided into three sections and consisted of 38 items. 
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The questionnaire had an introductory part in which the research focus and summary of 
objectives were outlined for the participants. After that, the questionnaire was divided into 
three sections that consisted of 38 items. The first section of the questionnaire obtained 
general information from the respondents. Questions addressing demographics formed 
the first section of the questionnaire.  
 
The second part of the questionnaire focused on collecting information on hypertension 
diagnosis, medication use, and medication adherence. Simultaneously, the final set of 
questions explored indigenous therapies usage and concomitant indigenous-western 
therapies utilization among hypertensive patients in Belize. The three sections that made 
up the questionnaire were as follows: 
Section A. Demographic data: 9 items were included in the demographic data. 
These are age, gender, marital status, religious affiliation, educational status, 
employment status, district, ethnicity, and monthly income. 
Section B: Western medication usage: 10 items were included in this section. 
The items explored hypertension diagnosis, Western antihypertensive medication 
use, and adherence. 
Section C: Indigenous therapy usage: In total, 19 items examined indigenous 
therapy usage in managing hypertension in Belize.  
 
In this case, the study participants were selected based on pragmatic considerations such 
as being diagnosed with hypertension, willingness to consent to participate in the study, 
and their availability during the study. It is important to note that only patients suffering 
from primary hypertension were conveniently recruited to participate in the study. 
Belizean residents diagnosed with hypertension by a medical person and are currently 
on antihypertensive medications were included in the survey. 
 
3.5.1.10 Phase I: Piloting and validation of the questionnaire  
 
The questionnaire was first presented to the research supervisor for a critical review. Input 
from the research supervisor and other professional colleagues, health practitioners, and 
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pharmacists was also sought for further review and feedback. Their recommendations 
led to the inclusion of questions on medication adherence to explain indigenous therapy 
usage. Furthermore, the item on herbal teas usage was added for respondents who may 
not be directly consuming indigenous therapies but are taking prepared teas to manage 
their hypertension. The questionnaire was then piloted in 35 hypertensive patients in 
Belmopan to check for errors. Some spelling and grammatical errors have been 
corrected. The skip option was further added to individuals who indicated that they did 
not use indigenous therapies to manage their hypertension.  
 
The questionnaire was further validated using statistical methods. Reliability testing of the 
questionnaire showed a Cronbach’s alpha value of 0.779. An exploratory factor analysis 
(EFA) using principle component analysis extraction and direct oblimin rotation with 
Kaiser Normalization was also employed, which extracted five components. The Kaiser 
Mayer Olkin (KMO) measure of sampling adequacy and Bartlett’s test for sphericity was 
also employed, which reported a value of 0.6 and a significant p-value less than 0.001, 
respectively. Therefore, based on the statistical validation, the questionnaire was divided 
into three sections: demographic information, hypertension, and medication usage, and 
indigenous-western therapies usage. In this regard, the questionnaire was considered 
validated and used for data collection in the first phase.  
 
3.5.1.11 Data collection process  
 
Creswell (2015:9) defines data collection as a “means of identifying and selecting 
individuals for a study, obtaining their permission to study them, and gathering information 
by asking people questions or observing their behaviors.” Participants were recruited from 
government hospitals and pharmacies, private hospitals, and pharmaceutical stores. 
Consent was first sought from participants before the questionnaire was administered, 
and the researcher assisted those who could not read or write. Participation was voluntary 




Data were gathered from hypertensive patients in Belize using a structured, validated 
questionnaire. The study’s objectives and significance were explained to the respondents, 
and any queries they had addressed. Their consent was then sought, and they were 
informed that participation was voluntary and free to withdraw from the research without 
any penalty or repercussions from the researcher. The questionnaires were then 
administered to the participants by the researcher using paper and pencils. Those who 
could complete the questionnaire without assistance were allowed to do so, while the 
researcher assisted those who could not. The self-administered questionnaires were 
distributed at hospitals and pharmacy outlets throughout the country. Confidentiality and 
anonymity were strictly applied, and participant identifiers were not required, except if the 
participants met the requirement for phase II (qualitative) of the study and were willing to 
participate. Completed questionnaires were retrieved and stored in a secure cabinet for 
safety. The confidentiality of respondents’ information was maintained at all times. A total 
of 422 questionnaires were completed from October 2018 to April 2019. 
 
3.5.1.12 Phase I: Ethical considerations related to data collection 
 
The research proposal and instrument was duly reviewed and approved by the research 
supervisor. Ethical Clarence for the study was obtained from UNISA’s review board 
(approval # HSHDC/761/2017) and Faculty of Health Sciences, Univerisity of Belize. 
Participants were approached, and consent was sought and obtained before the 
administration of the questionnaire. Participants were informed that their participation was 
voluntary, and at any point in the study, they were free to withdraw without any 
consequences. Identifiers were not used on the questionnaire, and participant’s personal 
information was not requested as part of the study, except for those who indicated they 
were interested in participating in the second phase of the study. The researcher secured 
collected data in a locked drawer at the University of Belize.   
 
3.5.1.13 Phase: Data analysis  
 
Analyzing and interpreting the data involves representing it in tables, figures, and pictures 
to summarize it, concluding, while explaining the conclusions in words to provide answers 
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to research questions (Creswell: 2015:10). Collected data were analyzed using 
descriptive and inferential statistics. Data coding was done using Statistical Package for 
the Social Sciences (SPSS) version 21.0 software before being analyzed. Two other 
reviewers’ then cross-checked coded data to ensure that they are consistent, readable, 
and complete. Mistakes from respondents were checked or corrections made as deemed 
necessary (Clarke and Braun 2017:120). Descriptive statistics were primarily used to 
describe demographic data and research questions based on frequency, and inferential 
analyses were used to explore relationships. The main descriptive statistical procedures 
used were frequencies and percentages, and the main inferential statistics were z-score 
tests.  
 




In its simple definition, validity is the ability of a given research instrument to measure 
what is supposed to be measured (Elo, Kääriäinen, Kanste, Pölkki, Utriainen, and Kyngäs 
2014:1). The validity of this study was assured through the following procedures. First, 
the content validity of the instrument was determined by expert judgments. The peer 
reviews and research supervisor carefully scrutinized the instrument/items’ to judge the 
items on their appropriateness of the content and or need modification to achieve the 
study’s objectives. The supervisor determined whether the research instruments’ items 
adequately represented all the areas needing investigation. 
 
The well-designed questionnaire was then pretested to ensure coherence and 
comprehensiveness. The pretest was done for the questionnaires to maximize their 
relevancy, preciseness, and clarity in answering the required research questions. All 
ambiguous questions were modified, deleted, or appropriately replaced. In addition, 
research experts, including the research supervisor, were frequently consulted at each 
stage of the study for corrections and criticism of data collection tools (Gysels et al., 
2013:907). This approach aimed to ensure that the study results truly represent 
indigenous-western anti-hypertensives usage among hypertensive patients in Belize. 
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Similar findings can be obtained even if the study is carried out by another researcher at 
different times so long as all other factors are kept constant. Finally, the questions were 
standardized to ensure that they provided desired answers on indigenous-western 
antihypertensive therapies. The researcher also ensured the data’s validity by personally 
administering the questionnaires to all the participants.  
 
3.6.2 Reliability  
 
Reliability refers to the extent to which a given study is consistent and stable when the 
same techniques are applied in a repeated number of ways or the scores from an 
instrument are stable and consistent (Creswell 2015:159). The primary role of reliability 
in this research is to minimize biases and errors encountered in the study. The 
questionnaire was tested for reliability using statistical methods (Bolarinwa 2015:198). 
Reliability testing of the questionnaire showed a Cronbach’s alpha value of 0.779. An 
exploratory factor analysis (EFA) using principle component analysis extraction and direct 
oblimin rotation with Kaiser Normalization was also employed, which extracted five 
components. The Kaiser Mayer Olkin (KMO) measure of sampling adequacy and 
Bartlett’s test for sphericity was also employed, which reported a value of 0.6 and a 
significant p-value less than 0.001, respectively. Therefore, based on the statistical 
reliability testing, the questionnaire was deemed validated for indigenous-western 
antihypertensive therapy use in Belize. In this regard, the questionnaire was considered 
validated and used for data collection for this study phase.  
 
3.7 PHASE II: QUALITATIVE SECTION 
 
To understand how Belizean hypertensive patients use indigenous-western therapies to 
manage hypertension, this study phase used an exploratory, descriptive design with 
narration. This phase also explored and described how the indigenous medicines were 





3.7.1 Phase II: Research design 
 
Yousaf (2019:1) described the research design as the systemic approach used to conduct 
scientific research and its overall organization of all identified constituents and data that 
resulted in credible outcomes. A strategic methodology is employed to provide plausible, 
accurate, and authentic outcomes in line with the type of research chosen. In order to 
understand how and why Belizeans use indigenous-western therapies to manage 
hypertension, a qualitative design was carried out. A qualitative research method was 
used in this second phase of this study. Creswell (2015:16) describes qualitative research 
as “an inquiry process of understanding based on distinct methodological traditions of 
inquiry that explore a social or human problem. The researcher, in this case, builds a 
complex, holistic picture, analyzes words, reports detailed views of informants, and 
conducts the study in a natural setting.” Qualitative research comprises checking the 
qualities or characteristics that are not possible to be presented in numerical value. It is 
a study that focuses on the phenomena that occur within natural settings and comprises 
studying such phenomena within complexities. Creswell (2015:204) further describes 
qualitative research as comprising checks on the qualities or characteristics that cannot 
be presented in numerical value. It is a study that focuses on the phenomena that occur 
within natural settings and comprises studying such phenomena within all complexities. 
Within the context of this study, literature has offered suggestions that systematic and 
structured approaches are very crucial in tackling the potential causes of undesirable 
performance for the national culture in animation cinemas (Sandelowski et al. 2014:347). 
 
Therefore, the qualitative methodology was used in this study to get to know the actual 
perception of the population sampled for the use of indigenous-western anti-
hypertensives among hypertensive patients in Belize. Similar to any other qualitative 
research, the study was field focused. Scholarly literature shows that qualitative studies 
are usually exploratory in their natures and might comprise interviews or focus groups 
(Wilson 2013:275).   
Furthermore, as earlier indicated, this research utilized a mixed methods explanatory 
sequential design via which data collected using both quantitative and qualitative 
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techniques integrated. Creswell (2015:535) described mixed methods research design as 
a procedure for collecting, analyzing, and “mixing” quantitative and qualitative methods in 
a single study or a series of studies to understand a research problem. Data collected in 
this segment of the study and the second segment of phase II were integrated to provide 
a comprehensive understanding of indigenous-western antihypertensive therapies usage 
among hypertensive patients in Belize. This research phase was designed to collect data 
using a qualitative design.  
 
3.7.2 Phase II: Research methodology 
 
A qualitative research method was used in the second phase of this study. Creswell 
(2015:16) describes qualitative research as “an inquiry process of understanding based 
on distinct methodological traditions of inquiry that explore a social or human problem. 
The researcher builds a complex, holistic picture, analyzes words, reports detailed views 
of informants, and conducts the study in a natural setting.” In order to holistically 
understand indigenous-western antihypertensive therapies usage, the qualitative 
methodology was adopted for this study where participants were interviewed on the “how” 
and “why” the use of such therapies or the management of hypertension. Qualitative 
research comprises checking the qualities or characteristics that are not possible to be 
presented in numerical value. It is a kind of study that has focused on the phenomena 
that occur within natural settings and comprise studying of such phenomena within all the 
complexity (Creswell 2015:16).  
 
A qualitative methodology was used in this study to get to know the actual perception of 
the population sampled for the use of indigenous-western anti-hypertensives among 
hypertensive patients in Belize. Similar to any other qualitative research, the study was 
field focused. Scholarly literature shows that qualitative studies are usually exploratory in 
their natures and might comprise interviews or focus groups (Wilson 2013:275).   
Qualitative data were collected from two different sources in this phase. Data were 
collected from hypertensive patients and herbal remedies vendors using semi-structured 
interview questions. Face-to-face interviews were used to collect data from selected 
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vendors of indigenous therapies. Phase II data collection was done qualitatively by 
majorly using interviews from standardized semi-structured pretested questions. The 
phase explores questions such as why, how, and how often hypertensive patients use 
indigenous-western therapies and whether hypertensive patients use them as 
combinations or not. The design also allowed the researcher to know how cultural 
influence affects indigenous-western antihypertensives’ usability among hypertensive 
patients in Belize.  
 
The study’s qualitative section was designed to gather data from antihypertensive 
patients and vendors involved in selling indigenous remedies. A qualitative interview 
occurs when researchers ask one or more participants general, open-ended questions, 
and record their answers. The researcher then transcribed and typed the data into a 
computer file for analysis (Creswell 2015:217). General information regarding indigenous 
remedies used to treat hypertension and their efficacy shall be obtained from indigenous 
vendors using one-on-one interviews. Creswell (2015:218) defined one-on-one interviews 
as a data collection process in which the researcher asked questions to and recorded 
answers from only one participant in the study at a time. Information regarding usage and 
interactions was obtained from the patients using one-on-one interviews. The interview 
was designed to explore why, how, and how often participants use indigenous remedies 
to treat their hypertension. 
 
3.7.2.1 Phase II: Sample and sampling technique 
 
A non-probability purposive sampling technique was used for this phase, as described by 
Creswell (2015:324). Data saturation determined the number of participants in this phase. 
Data saturation is the stage at which no new information is coming during the interview. 
A total of 24 hypertensive patients who indicated that they were using indigenous 
therapies to manage their hypertension were purposively selected from the phase I study. 
In addition, a total of 19 indigenous therapy vendors were purposively selected and 
interviewed from the entire country. The information of the vendors was obtained from the 
traditional healers association of Belize. In qualitative research, the people or sites that 
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can best help understand the central phenomenon are selected (Creswell 2015:206). For 
the second phase of this study, purposeful sampling was used to select participants for 
data collection. Participants were selected based on their involvement as vendors for 
indigenous therapies or as hypertensive patients who use indigenous therapies. Market 
places and designated sales points were targeted for sample collection. Mark (2010:3) 
reported that qualitative research is majorly concerned with meaning and not for 
generalized statements. Qualitative samples, therefore, must be large enough to assure 
that most or all of the perceptions that might be important are revealed, but at the same 
time, if the sample is too large, data becomes repetitive and eventually superfluous. The 
sample size in most qualitative studies should generally follow the saturation concept 
when the collection of new data does not shed any further light on the issue under 
investigation. As a result of the numerous factors that can determine sample sizes in 
qualitative studies, many researchers shy away from suggesting what constitutes a 
sufficient sample size. Although the idea of saturation is helpful at the conceptual level, it 
provides little practical guidance for estimating sample sizes for robust research before 
data collection" (Mark 2010:3). Mark (2010:3) further reported that other researchers had 
suggested guidelines for qualitative sample sizes. Charmaz (2006:114) suggests that 
"25” participants are adequate for smaller projects while according to Ritchie et al. 
(2003:84), qualitative samples often "lie under 50"; while Green and Thorogood 
(2004:120) stated that "the experience of most qualitative researchers is that in interview 
studies little that is 'new' comes out of transcripts after you have interviewed 20 or so 
people" (Mark 2010:3). While some researchers offer qualitative sample guidelines, there 
is evidence that suggests others do not strictly adhere to them. Creswell’s (2015:128) 
suggested a range of 20 and 30. Therefore, based on the above, this study purposively 
selected 24 and 19 participants from both hypertensive patients and indigenous therapy 
vendors in Belize, respectively. 
 
3.7.2.2 Phase II: Population 
 
All hypertensive patients in Belize willing to participate in the study had the opportunity to 
participate in this phase. Eligible participants were purposively drawn from each district 
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to participate in the study. The need to get participants from the entire country became 
paramount because of the diversity in cultural beliefs and usage of indigenous therapies 
usage. For instance, even though every ethnic group is represented in the entire country, 
some ethnic groups are predominantly in some regions. The Garinagu are concentrated 
in the Stann Creek area, while the Mayans in the far southern part of the Toledo district. 
The northern part of the country has a higher concentration of Hispanics, while the 
Mestizos and Creole are in the country’s western and eastern parts.  
 
Although the information on indigenous therapies is shared among the people, some 
ethnic groups are known to use specific therapies unique to their culture (Ballick and 
Arvigo 2015:14). A group of 24 hypertensive patients from different parts of the country 
and different ethnicities were purposely selected from phase I to participate in the second 
phase of the study. In addition, 19 vendors of indigenous therapies were purposefully 
selected in collaboration with Belize’s traditional association.  
 
3.7.2.3 Phase II: Sampling  
 
A non-probability purposive sampling technique was used for the selection of research 
participants in this phase. Purposive sampling is defined as a technique of selecting a 
sample based on specific purposes to answer the study’s questions (Teddlie and Yu 
2007:77). With a purposive sampling technique, participants in a given unit were chosen 
based on a specific purpose. It has been considered as a useful sampling method that 
involves receiving relevant information from a sample population that the researcher 
believes are aware of the matter being investigated (Li 2004: 305). In this case, the study 
participants were selected based on pragmatic considerations, such as their availability 
and willingness to participate in the research. Since non-probability purposive sampling 
was used for this phase as described by Creswell (2015:324), data saturation determined 
the number of participants in this phase. Data saturation is the stage at which no new 
information is coming during the interview. A total of 24 hypertensive patients purposely 
selected from phase I were interviewed to get diverse and rich responses to indigenous 
therapies used in managing hypertension. A total of 19 indigenous therapy vendors were 
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also interviewed from the entire country. In qualitative research, the people or sites that 
can best help understand the central phenomenon are selected (Creswell 2015:206). For 
the second phase of this study, purposeful sampling was used to select participants for 
data collection. Participants were selected based on their involvement as vendors for 
indigenous therapies or as hypertensive patients who use indigenous therapies. Market 
places and designated sales points were targeted for sample collection. Mark (2010:3) 
reported that qualitative research is majorly concerned with meaning and not making 
generalized statements. Qualitative samples, therefore, must be large enough to assure 
that most or all of the perceptions that might be important are uncovered, but at the same 
time, if the sample is too large, data becomes repetitive and, eventually, superfluous. The 
sample size in most qualitative studies should generally follow the saturation concept 
when the collection of new data does not shed any further light on the issue under 
investigation. As a result of the numerous factors that can determine sample sizes in 
qualitative studies, many researchers shy away from suggesting what constitutes a 
sufficient sample size. Although the idea of saturation is helpful at the conceptual level, it 
provides little practical guidance for estimating sample sizes for robust research before 
data collection" (Mark 2010:3). 
 
In the same vein, Mark (2010:3) further reported that other researchers had suggested 
some kind of guidelines for qualitative sample sizes. Charmaz (2006:114) suggests that 
"25” participants are adequate for smaller projects while according to Ritchie et al. 
(2003:84), qualitative samples often "lie under 50"; while Green et al. (2004:120) stated 
that "the experience of most qualitative researchers is that in interview studies little that 
is 'new' comes out of transcripts after you have interviewed 20 or so people" (Mark 
2010:3). While some researchers offer qualitative sample guidelines, there is evidence 
that suggests others do not strictly adhere to them. Creswell (2015:128) suggested a 
range of 20 and 30. Therefore, based on the above, this study purposively selected 24 
and 19 participants from indigenous therapy users for hypertension and indigenous 
therapy vendors in Belize, respectively. The sample for this phase of the study was 




First, the hypertensive patients who participated in phase one of this study were 
purposively selected for the qualitative phase. Participants who indicated that they use 
indigenous therapies to manage their hypertension, willing to participate in phase II of the 
study, and voluntarily gave their informed consent were selected for the qualitative phase. 
Second, vendors of indigenous therapies were purposively selected from all over the 
country, and data on indigenous therapies were obtained. All the registered vendors were 
included in the study. Data were collected from those who gave their informed consent 
and when data saturation was reached. Because of the diversity in Belize’s culture and 
the fact that not many vendors of indigenous therapies are found in the country, most 
indigenous therapy vendors identified were interviewed. Data were collected on 
indigenous therapies to used to manage hypertension.  
 
3.7.2.4 Phase II: Data collection 
 
Data were collected via interviews using well-structured questions as an interview guide. 
Creswell (2015:218) defined one-on-one interviews as a data collection process in which 
the researcher asked questions to and recorded answers from only one participant in the 
study at a time. On the other hand, a focus group interview collects data through 
interviews with a group of people, typically four to six. Information regarding usage and 
interactions was obtained from the patients using face-to-face interviews. The interviews 
were designed to explore why and how often patients use indigenous remedies to treat 
their hypertension, methods of preparation, dosing, shelf-life, and side effects. 
 
3.7.2.5 Phase II: Data collection approach  
 
The researcher collected data through an interview. Creswell (2015:204) describes 
qualitative research as involving checking on the qualities or characteristics that are not 
possible to be presented in numerical value. It is a study that focuses on the phenomena 
that occur within natural settings and comprises studying such phenomena within 
complexities. Within the context of this study, literature has offered suggestions that 
systematic and structured approaches are very crucial in tackling the potential causes of 
undesirable performance for the national culture in animation cinemas (Sandelowski et 
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al. 2014:347). Information regarding usage and interactions was obtained from the 
patients using face-to-face interviews. The interviews were designed to explore why and 
how often patients use indigenous remedies to treat their hypertension. 
Data were collected from indigenous therapy vendors and hypertensive patients using a 
structured face-to-face interview guide in this phase. The research supervisor and other 
researchers critiqued the questions to ensure trustworthiness. Two sets of data were 
collected in this phase of the study. 
 
Data were first collected from hypertensive patients using indigenous therapies. The 
participants who used indigenous therapies for their hypertension were identified during 
phase I of the study. Although consent was sought during the first phase of the study, 
consent was still sought during the qualitative data collection, while strict ethical protocols 
were observed during the entire data collection process. Interviews were done in a place 
and at a time convenient for the participants, with field notes taken. The second set of 
data for this phase was also collected from indigenous therapy vendors. Interviews were 
conducted based on the convenience of indigenous therapy vendors. These sections of 
the study explored and described the sources of indigenous therapies and how they were 
prepared, used, and stored by the vendors for use as antihypertensive therapies.  
 
Interviews used for data collection brought salient issues on indigenous-western 
therapies to light. A qualitative interview occurs when researchers ask one or more 
participants general, open-ended questions, and record their answers. The researcher 
then transcribed and typed the data into a computer file for analysis (Creswell 2015:217). 
General information regarding indigenous remedies used to treat hypertension and their 
efficacy were obtained from indigenous vendors using one-on-one interviews.  
 
3.7.2.6 Phase III: Development of the interview guide 
 
Two different instruments were used for this phase of the study because two different 
data sets were collected. An interview guideline was used to collect data from 
hypertensive patients using indigenous-western therapies. Another interview guideline 
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that collected data from indigenous therapy vendors was employed. Interview guides 
were developed to address salient issues on indigenous-western antihypertensive usage 
in Belize. The interview guides were scrutinized by the research supervisor and other 
research experts before used for the study.  
 
3.7.2.7 Characteristics of the data collection instrument  
 
The interview guidelines for both interviews with hypertensive patients involved in 
indigenous therapies and indigenous therapy vendors had an introductory part and an 
interview section where the main research question and the probing questions were. The 
introductory part welcomed the participants and informed them of the study’s focus and 
confidentiality and informed consent issues. The interview section had questions on the 
main research objective as well as eight probing questions. The final section of the 
questionnaire had a conclusion where participants were thanked for their voluntary 
contributions. Both interviews took 20 to 40 minutes per participant.  
 
3.7.2.8 Phase II: Data collection process  
 
In this phase, data were collected from hypertensive patients and indigenous therapy 
vendors using structured face-to-face interview guides. Data were collected via interviews 
using well-structured questions as an interview guide, while notes were taken to capture 
the participants’ responses. 
 
3.7.2.8.1 Phase II: Hypertensive patients 
 
Identified hypertensive patients from phase I of the study were followed up and 
interviewed using the structured guidelines for data collection. A total of 24 hypertensive 
patients were interviewed on the use of indigenous-western therapies in Belize. 
Interviews were done in a place and at a time convenient for the participants. Participants’ 
informed consent was still reiterated, and participants were free to either withdraw from 
the interview at any time without any consequences. Participants also had the right to 
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refuse to respond to any uncomfortable question. Responses were noted and later 
transcribed electronically. 
 
3.7.2.8.2 Indigenous Therapy vendors 
 
Data were also collected from 19 indigenous therapies vendors at market places and 
other identified outlets where vendors sell their indigenous products. The vendors were 
purposively identified, and their consent was sought and received before the interviews. 
All the indigenous therapy vendors contacted agreed to participate in the study. In 
addition, the vendors consented that their names or businesses be mentioned as a form 
of advertisement to aid in selling indigenous therapies. They cooperated and provided all 
the information required willingly. The vendors were also willing to give us samples of 
their products to try, but that was not part of the study’s focus. Interview responses were 
noted and later transcribed electronically.  
 
3.7.2.9 Data analysis  
 
Responses from structured and unstructured qualitative interviews were entered into a 
computer in order for them to be coded, counted, and analyzed. Creswell (2015:245) 
describes a computer analysis of qualitative data as a means that researchers use a 
qualitative computer program to facilitate the process of storing, analyzing, sorting, and 
representing or visualizing the data. Data collected during in-depth interviews with 
hypertensive patients were first transcribed, read several times, and coded themes 
revealed concerning the study objectives.  
 
Transcribing the information, performing categories of summaries, and associations’ 
critical to present data analysis is critical to the research’s success. Additionally, a 
thematic analysis was employed to present a thematic network that provided the general 
summary of the key themes generated from a given dataset (Elo et al. 2014:1).  
 
As quoted in the literature, thematic analysis helps enhance understanding of some given 
phenomenon and promotes the aspect of accurate interpretation of the data collected 
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during fieldwork, leading to more in-depth explorations and more explanations. Themes 
(also called categories) are similar codes aggregated together to form the database’s 
main ideas (Creswell 2015:245). 
 
This research’s primary study focus was to explore indigenous-western antihypertensive 
therapies among hypertensive patients in Belize. Therefore, a combination of both 
categorical and holistic strategies was essential based on the fact that the researcher first 
made a quantitative analysis based on the type of indigenous western anti-hypertensives 
used and then made the analysis of qualitative data from observations and interviews 
using categorical strategies for patients using indigenous-western antihypertensive 
therapies in Belize. The kind of categories initiated in this case acted as a guide for 
analysis. A holistic analysis was employed to reveal the general patients’ perception 
regarding the concomitant use of indigenous-western medications in this study. This 
approach is more appropriate, especially after developing categories since the researcher 
can narrate individual respondents’ perception and compare it with the observed 
behaviors in that respect. Clarke and Braun (2017:120) outlined that the two analysis 
strategies are not by any chance exclusive to one another. Summarily, the following steps 
were used for data collection as described by Creswell (2015:245): 
● The interviews from both herbal remedies hypertensive patients and 
indigenous therapy vendors were organized, prepared, and arranged 
meaningfully according to sources and types. A thorough study of the 
interviews revealed the participant’s general impressions and connotations.  
● The information was then categorized, labeled, and organized into smaller 
components with clearly defined coded themes identified and described.  
● Information was analyzed using the software QDA Miner Lite version 2.6 for 
thematic analysis. Miner Lite is a free software for analyzing qualitative data. 
It is utilized to tag texts that are related to specific codes in each question. 
Coding aids in unifying data into groups (nodes) or themes so that data from 
diverse sources can be ordered and integrated. With significant themes 
coded in this manner, the researcher can later scrutinize and extract 




● Finally, meanings were attached to the theme and commonly used words 
chronologically described by the participants to provide more precise 
meanings of themes resulting in data interpretation.  
Data on indigenous-western remedies usage among the Belizean population was 
then integrated to incorporate findings from phases one and two (Creswell, 
2015:245). Detailed integrated findings from all phases are presented in chapter 
five. 
 
3.8 PHASE II: RIGOR OF THE STUDY 
 
3.8.1 Data trustworthiness 
 
The process to ensure dependability, credibility, transferability, and confirmability in 
qualitative research is referred to as trustworthiness (Lincoln and Guba 1985:308). In this 
study, the qualitative section’s trustworthiness was ensured through credibility, 
transferability, dependability, and confirmability strategies. The Lincoln and Guba 
(1985:308) model was applied for this research, and some of the issues considered to 




The confidence that can be placed in the truth of a qualitative research finding is defined 
as its credibility (Anney 2014:276). To ascertain whether or not the research finding 
corresponds to the information obtained from research participants’ original data and is 
an accurate representation of participants, the credibility of the data needs to be ensured 
(Graneheim and Lundman 2004:105). In this study, triangulation, peer briefing, and 






3.8.1.2 Triangulation:  
 
Using multiple data sources to provide a better understanding is referred to as 
triangulation (Creswell and Miller 2000:124; Creswell 2015:259). Triangulation is the 
process of corroborating evidence from different individuals, types of data, or data 
collection methods in descriptions and themes in qualitative research. In order to facilitate 
a deeper understanding of research outcomes, multiple methods are adapted because a 
single method usually does not shed adequate light on the phenomenon (Angen 
2000:378; Mays and Pope 2000:50). Triangulation methods, where the consistency of 
findings generated by different data collection methodologies defined as methods 
triangulation, are utilized in this study (Patton 1999:1189). Methods triangulation in this 
study involved having quantitative and qualitative data elucidated complementary aspects 
of the study where the diverged data provided deeper insights than a single data collection 
method.  
 
3.8.1.3 Peer briefing  
 
Lincoln and Guba (1985:308) defined peer briefing as a process of exposing the research 
outcome to a disinterested peer in a way comparable to an analytical session and for the 
intention of exploring aspects of the study that might otherwise only implicit within the 
inquirer’s mind. Peer briefing was done to ensure the credibility of the study.  
 
3.8.1.4 Member Checks 
 
Member checking was defined as a process in which the researcher asked one or more 
participants in the study to check the accuracy of the information. This check involves 
taking the findings back to participants and asking them about the report’s accuracy 
(Creswell 2015:259). To assess the adequacy of the data and preliminary research 
results and confirm particular aspects of the research data, member checks shall be done 
to provide such opportunities to respondents. Member checks, therefore, was used to 






Bitsch (2005:75) defines transferability as the degree to which qualitative research results 
can be transferred to other contexts with other respondents. The interpretive equivalent 
of generalizability is transferability (Tobin and Begley 2004:388). In transferability, Bitsch 
(2005:85) and Anney (2014:278) reported that “the researcher facilitates the 
transferability judgment by a potential user through ‘thick description and purposeful 
sampling.” 
 
3.8.1.6 Thick Description 
 
The judgments of how well the research context fits other contexts are defined as a thick 
description (Li 2004:305). A detailed account of methodology, experiences, relationships, 
patterns, and context about the research needs to be reported by the researcher (Anney 
2014:278). The entire research process from data collection, the study’s context, and the 
final report are elucidated with thick descriptions. Providing thick descriptions helps other 
researchers replicate the study using related premises and different settings (Shenton 
2004:63). Therefore, to ensure this study’s trustworthiness through transferability, a 




The stability of research findings over time has been defined as dependability (Bitsch 
2005:86). Participants were allowed to evaluate the findings, interpretation, and 
recommendations of the research to ensure consistency and agreement from the 
respondents of the study (Anney 2014:278; Creswell 2015:259). The goal of dependability 
is to ensure that research findings are consistent with informants’ information and that 
data can be replicated. In order to ensure the dependability of the current study’s inquiry, 






The data collected for the study were coded twice and given space in between the first 
and second coding. The results of the coding were compared for consistency or lack of 
it. When the coding results agree, it enhanced the inquiry’s quality’s dependability while 
helping the researcher gain a better understanding of data presentations and patterns 
(Anney 2014:278). This process provided an evaluation of whether or not findings, 
interpretations, and conclusions were accurate and supported by the data (Creswell 
2015:259). 
 
3.8.1.8 Peer examination 
 
The entire process of the research process, data collection, results, interpretation, and 
conclusions, was discussed with peers. The discussion was honest to allow critique and 
contribute to a more in-depth reflexive analysis of the entire research process (Bitsch 
2005:86). Research experts, including the research supervisor, were frequently consulted 
at each stage of the study for corrections and criticism of the overall research process at 
different stages (Gysels et al. 2013:107). Peer examination of the current study also 
provided feedback on aspects of research categories and questions not covered by the 




The degree of neutrality and the extent to which other researchers could corroborate 
research findings is referred to as confirmability (Anney 2014:279). The goal of 
confirmability is to ensure that the data and interpretation of findings were not influenced 
by the researcher’s bias, interests or motivation, but were obtained purely from the data 
(Tobin and Begley 2004:392). This study’s research process was checked for 





3.8.1.10 Reflexive Journal  
 
The reflexive document is a diary kept by the researcher, where regular entries are made 
to reflect on, interpret, and for a data collection plan (Wallendorf and Belk 1989:218). The 
journal usually includes records of methodological decisions, the study’s logistics, and the 
reasons for decisions taken and reflected on their background, beliefs, perceptions, 
values, and interests (Anney 2014:279). In order to avoid personal bias and improve the 
integrity of the research inquiry, an honest assessment of the researcher’s values, 
preconceptions, beliefs, position, and assumptions during the research process was 
documented. In this study, a reflexive journal was kept to ensure that the researcher’s 
preconceptions do not come into play with the research process. 
 
3.9 DEVELOPMENT OF THE GUIDELINES 
 
Guidelines on the use of indigenous-western antihypertensive remedies were developed 
at the end of phase 2 of the study. The guidelines utilized information obtained from all 
the results in both phases I and phase II studies. In developing these guidelines, the study 
adopted triangulation principles to combine quantitative data with qualitative data to 
produce guidelines for the use of indigenous-western antihypertensive therapies in 
Belize. The guidelines included part of the plants used for hypertension management and 
methods of processing indigenous therapy. Also, Western medications commonly 
prescribed for hypertensive therapy were documented, including concomitant use with 
indigenous therapies and reported interactions from other literature.  
 
Guidelines for the use of indigenous-western hypertensives were established based on 
the explanatory sequential mixed-methods design. Creswell and Clark (2017:54) 
described an explanatory sequential mixed methods design consisting of first collecting 
quantitative data and then collecting qualitative data to explain or elaborate on the 
quantitative results. This approach’s rationale is that the quantitative data and results 
provide a general picture of the research problem; more analysis, specifically through 
qualitative data collection, is needed to refine, extend, or explain the general picture. In 
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this method, Creswell (2015:542) further classified three ways to mix the data from an 
explanatory sequential method. 
 
First, the priority of quantitative data (QUAN) collection and analysis are considered by 
introducing it first in the study and having it represent a significant aspect of data 
collection. A small qualitative (qual) component typically follows in the second phase of 
the research. Second, quantitative data were first collected in the sequence. This is 
followed by secondary qualitative data collection. This was presented in two phases, with 
each phase identified in headings on the report. Third, the qualitative data are used to 
refine the results from the quantitative data. This refinement results in exploring a few 
typical cases, probing a fundamental result in more detail, or following up with an outline.  
 
The merging or mixing of the data was done by triangulation. Creswell (2013:542) 
described triangulation “as a means that investigators could improve their inquiries by 
collecting and integrating different kinds of data bearing on the same phenomenon.” The 
three points to the triangle are the two sources of the data and the phenomenon. This 
improvement in inquiries came from blending the strengths of one type of method and 
neutralizing the weaknesses of the other. This study adapted the triangulation principles 
to combine quantitative data with qualitative data to produce the guidelines used for 
indigenous-western antihypertensive therapies in Belize. The guidelines also included 
part of the plants used for hypertensive management, how to process the indigenous 
therapies, the recommended dosage, how the therapies should be taken, and reported 
adverse effects or interactions when used with Western medicines. This section of the 
study, therefore, provided the much-needed guidelines for public safety and healthcare 
professionals. The section also provided useful suggestions for future investigations into 
the use of western- indigenous medicines in Belize. 
 
3.10 Ethical considerations for this study 
 
Ethical research aims at providing safe and secure protection of the research participants 
and the subsequent publication of the gathered information (Creswell 2015:22). In the 
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general process of planning and doing research, and in reporting the research findings, 
the researcher fulfilled the following responsibilities for the study as such considered as 
having met the required ethical standards set forth by the international bodies of research 
(Wilson 2013:275).  
3.10.1 Planning 
 
The first and initial thing was planning for the whole research project, minimizing the 
chances of getting results, which are misleading (Salkind 2010). The second step was all 
about having an ethical plan so that the research met the ethical acceptability. At this 
point, an extensive literature search on indigenous therapies and Western medications 
was conducted to remove any doubts that the researcher may have concerning 
questionable ethical methods or procedures. Peer review and consultation with the 
appropriate parties, like in this case, the supervisor and university of South Africa 
institutional review committee, was done.  
3.10.2 Ethical Permission 
 
Ethical permission was sought and obtained from relevant authorities before carrying out 
the scientific study as it is obtainable with best research practices (Wisdom et al. 
2012:275). In this study, ethical permission was sought and obtained from the UNISA 
ethical review committee and the University of Belize. Upon getting permission, the study 
participants’ general welfare and dignity were respected during the study’s conduct. 
Additionally, the dignity of many other people who can be affected by the research project 
results was considered and respected. Mulvey (2015:477) summarized the three main 
ethical principles that should always be applied in any research to ensure that all human 
participants are respected and protected. The principles in this case comprised of respect 
for persons, justice, and beneficence. Ethical Conduct for Research involving human 
participants provided by the UNISA institutional board review (IRB) was duly followed, 




3.10.3 Informed consent 
 
The primary ethical consideration in conducting research is informed consent. Informed 
consent seeks to provide adequate information to the participants regarding the purpose, 
objectives, and significance of the research to intelligently, knowingly, and voluntarily 
consent to their participation. With informed consent, the subjects’ rights, autonomy, and 
personal liberty to partake in the research with clarity and veracity are provided. Consents 
were obtained from each participant before the administration of the questionnaire. Active 
(or passive) consent was necessary depending on the disposition of the participant.  
 
During data collection, each participant was informed about confidentiality, anonymity, 
volunteer, the freedom to withdraw from the study at any point without any consequence, 
and the fact that no incentives are associated with participation other than the service 
they offer to help make Belize public healthcare system better. The study, however, had 
the advantage that it has no known risk. 
 
Participants were duly informed about their rights to participate and withdraw from the 
study at any time. The study’s purpose and significance were explained to the 
participants, and consent was sought and received before the study’s commencement. 
Participants were told about the fact that participating in the study comes with no risk. 
Names or identifiers were not used except for those volunteering to participate in the 
qualitative study. Researcher’s contact details were given, and the participants duly 
signed consent forms or provided oral consent. The primary reason for consent 
agreements is to provide evidence that the participant agreed to participate in the study 
(Creswell, 2015:247). 
3.10.4 Security of data 
 
Finally, the collected questionnaires and consent forms were immediately secured, and 
same transported for analysis. Collected questionnaires and consent forms were kept 
under key and lock, and data entered into the computers were password-secured. All 
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information regarding the research was filed and kept for a period specified by the 
institutional research ethics board.  
 
The principal ethical requirements during this kind of study were strictly upheld without 
any intrusions. Since the study also involved reviewing secondary data, especially from 
books, government records, policy statements, academic journals, and articles, the 
literature’s authors were also acknowledged through text citation and referencing for 
conformity to plagiarism policy. The gathering of information from such documents was 
conducted using a systematic review designed with the utmost integrity and responsibility 
and at the same time avoiding any form of related misconduct. The analysis and synthesis 
of other people’s ideas were done to respect the copyright-related regulations on the 
primary sources of data. Presenting a work that has been plagiarized and has redundant 
duplications, contravening general guidelines and ethics, and borrowing data from reports 
that have insufficient ethical standards was avoided (Mulvey 2015:477). To avoid these, 
all resources that contributed to the development of this dissertation were recognized 
through in-text citation and by being included in the reference list.   
 
3.11 Summary  
 
This chapter presents the research design, methodologies, and analytical approaches 
used for gathering both phases of the data. This study employed a mixed-methods 
explanatory sequential design through which data were collected using quantitative and 
qualitative procedures. For phase I research, a descriptive quantitative research design 
was used. A well-structured validated questionnaire was used for data collection. The 
results were analyzed using SPSS v.21, and data presented using frequency tables, 
charts, and graphs. For phase II of the research, on the other hand, an exploratory 
qualitative research design was employed, and interviews using semi-structured 
questions as guidelines were used for data collection. Thematic analysis was used to 
analyze the data and results presented based on themes. Finally, the chapter presents 





ANALYSIS, PRESENTATION, AND DESCRIPTION OF THE RESEARCH 
FINDINGS 
 
Quantitative data collection and results (Phase I) 
4.1 INTRODUCTION  
 
The previous chapter focused on the different methodologies used for data collection and 
analysis. This chapter presents the data collection, analysis, and results from 422 
questionnaires completed by hypertensive patients in Belize in the first phase of the study. 
The purpose of the phase was to examine indigenous-western antihypertensive therapies 
use among Belizeans.  
The objectives of this phase were: 
4.1.1 Phase 1: Quantitative phase 
 
● To determine the indigenous-western therapies used to manage hypertension by 
patients in Belize. 
● To identify the common western therapies used in the treatment of hypertension 
in Belize.  
● To identify concomitant usage of indigenous–western therapies among 
hypertensive patients in Belize.  
 
Based on the above study objectives, the study answered the following research 
questions: 
Phase I 
● What were the common indigenous therapies used by patients to manage 
hypertension in Belize? 
● What were the common western therapies used by hypertensive patients in 
Belize? 
● Do Belizean hypertensive patients combine indigenous – western therapies in the 





The researcher used a cross-sectional quantitative survey to collect data from 
hypertensive patients in Belize, employing convenient sampling. Data were collected 
using a well-structured questionnaire.  
 
4.2.1 Participants for the study and eligibility criteria 
 
The participants’ eligibility in this phase of the research comprised all hypertensive adult 
patients currently attending government hospitals, private clinics, or community 
pharmacies. Hypertensive adult patients currently accessing antihypertensive 
medications at any government-owned hospitals, private clinics, or pharmacies were 
eligible to participate in the research. Those who consent were included in the study, 
while others were considered ineligible because they did not consent. Participants were 
recruited from government hospitals and private hospitals, and pharmaceutical stores 
across Belize. Consent was first sought from participants before the questionnaire was 
administered, and the researcher assisted those who could not read or write. Participation 
was voluntary, without any incentive or pressure from the researcher. Finally, completed 
questionnaires were retrieved and stored in a secure cabinet for safety. Data collection 
was divided into two stages: pretesting and administration of the instrument. The 
confidentiality of respondents’ information was maintained at all times. A total of 422 
questionnaires were completed from October 2018 to April 2019. 
 
4.2.2 Sample size and sampling procedures 
 
The study employed a convenient sampling technique to obtain data from diagnosed 
hypertensive patients in Belize. A sample size of 422 was used for the study (Table 4.1). 
A 95% confidence level with a +/- 5% confidence interval was used to determine sample 
size. The sample size was determined using the online software Open Epi (Epi Info™), 




Table 1.1 Phase I Sample Size calculation.  
Population size (for Finite Population Correction factor or FPC) (N): 398050 
Hypothesized % frequency of outcome factor in the population (p): 50%+/-5 
Confidence limits as % of 100 (absolute +/- %) (d): 5% 
Design effect (for cluster surveys-DEFF): 1 
Confidence level (%) 95% 
Sample size 384 
Equation: Sample size n = [DEFF*Np(1-p)]/ [(d2/Z21-α/2*(N-1) + p*(1 p)]  
 
Table 4.1 Phase I sample size calculation using OpenEpi (Epi Info™) 
 
4.2.2.1 Sample size calculation: Phase I  
OpenEpi (Epi Info™) open-source calculator was used to calculate sample size (Dean et 
al., 2018:1). OpenEpi (Epi Info™) is a free and open-source software for epidemiologic 
statistics. It provides statistics for counts and measurements in descriptive and analytic 
studies, stratified analysis with exact confidence limits, matched pair and person-time 
analysis, sample size and power calculations, random numbers, sensitivity, specificity 
and other evaluation statistics, R x C tables, and chi-square for dose-response (Dean et 
al. 2018:1). 
 
Using the OpenEpi, the country’s sample size was calculated and found to be 384 x 10% 
= 422. The addition of 10% was to take into consideration the non-response factor. 
Therefore, the final sample size was determined to be 422, with a medium effect size at 
α = 0.05 level was used.  
 
In order to obtain proportionate samples from the six districts in Belize, the 422 total 
sample size was further stratified proportionately to get representative samples from each 
district (Table 4.2).   
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A total of 422 questionnaires were used for data collection in this phase of the study. A 
95% confidence level with a +/- 5% confidence interval was used to determine sample 
size. The sample size was determined using the online software Open Epi (Epi Info™), 
Version 3, open-source (Table 4.2). Stratified proportionate samples were further 
calculated based on the district population, as shown in Table 4.2. 
 
Table 4.2 Sample size based on district – Phase I 
District Population 
   
District Sample size 
Belize 120, 602 128 
Cayo 96,197 102 
Orange Walk 51, 749 55 
Corozal 48, 429 51 
Stann Creek 43, 452 46 
Toledo 37, 614 40     
 
4.2.2.2 Research instrument  
 
After reviewing the literature, the researcher developed a carefully designed 
questionnaire for the study. Some questions were adapted and modified from previously 
developed research instruments (TRAMIL 2010:1; Picking et al. 2011:305). The 
questionnaire was divided into three sections and consisted of 32 items. The first section 
of the questionnaire dealt with general information from the respondents. Questions 
addressing age, gender, education level, marital status, income, and religion formed the 
questionnaire’s first section. The second part of the questionnaire focused on collecting 
information on hypertension diagnosis, medication use, and medication adherence, while 
the final set of questions explored herbal usage and indigenous-western therapies 
practice among hypertensive patients in Belize. 
● Section A: Demographic data. 
● Section B: Western medication usage. 
● Section C: Indigenous therapy usage.  
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4.2.2.3 Piloting and validation of the questionnaire 
 
The questionnaire was first presented to the research supervisor, college professors, 
health practitioners, and pharmacists for review. Their recommendations led to the 
inclusion of questions on medication adherence to explain indigenous therapy usage. 
Furthermore, the item on herbal teas usage was added for respondents who may not be 
directly consuming indigenous therapies but are taking prepared teas to manage their 
hypertension. The questionnaire was then piloted in 35 hypertensive patients in 
Belmopan to check for errors. Some spelling and grammatical errors have been 
corrected. The skip option was further added to individuals who indicated they did not use 
indigenous therapies for their hypertension.  
 
The questionnaire was also validated using a statistical method. Reliability testing of the 
questionnaire showed a Cronbach’s alpha value of 0.779. An exploratory factor analysis 
(EFA) using principle component analysis extraction and direct oblimin rotation with 
Kaiser Normalization was also employed, which extracted five components. The Kaiser 
Mayer Olkin (KMO) measure of sampling adequacy and Bartlett’s test for sphericity was 
also employed, which reported a value of 0.6 and a significant p-value less than 0.001, 
respectively. Therefore, based on the statistical validation, the questionnaire was divided 
into three sections: demographic information, hypertension, and medication usage, and 
indigenous-western therapies usage. In this regard, the questionnaire was considered 
validated and used for data collection for this study phase.  
 
4.2.2.4 Data analysis 
 
Coding of data was done before being analyzed in a computer package Statistical 
Package for the Social Sciences (SPSS) version 21.0 software. The researcher reviewed 
all collected data to ensure consistency, readability, and completeness. Mistakes from 





Descriptive statistics was primarily used to describe demographic data and research 
questions based on prevalence, while inferential analyses were used to explore 
relationships. The main descriptive statistical procedures used were frequencies and 
percentages, and the main inferential statistics were χ2
 
and t-test. The responses on 
indigenous-western therapies were analyzed using version 22 of SPSS (Statistical 
Package for Social Sciences) (IBM Corp., Armonk, NY, USA). The data were analyzed 
for frequency counts, and cross-tabulation was performed on associations. The chi-
square (X2) test was used to identify and report statistically significant associations. 
Prevalence was calculated and reported in terms of 95% confidence interval values. An 
alpha margin of error (α) was identified at 0.05. 
 
4.2.2.5 Response rate 
 
Harrison, Henderson, Alderdice, and Quigley (2019) reported a general decrease in 
survey response rates. The current study’s response rate was not in agreement with 
Harrison et al. (2019) since a 100% response rate was achieved. All 422 questionnaires 
distributed were received, giving a cumulative response rate (RR) of 100% for this study 
phase. The 100% RR could be attributed to the culture of the people who always wanted 
to offer help, and the majority of the respondents did not take the questionnaire home but 
completed the questionnaire immediately. The research’s objective was clearly explained 
to the respondents, and support was given to those who could neither read nor write.  
 
4.2.2.6 Demographic data  
 
This section of the questionnaire covered demographic data such as age, gender, marital 
status, religious affiliation, ethnicities, districts, education, employment, and income of the 
patients. The demographic data helped to contextualize the overall result in making useful 
recommendations for the use of western-indigenous therapies among hypertensive 






Fig. 4.1 Age of participants  
 
The age range of patients with hypertension in this study was between 18 and 61 years 
and above, with the age category 41 and 50 years having the highest number of 
respondents (n=116; 27.5%). The risk of developing hypertension increases with an 
increase in age. Age-related increases in blood pressure are widely reported and 
accepted features of aging. In the western, systolic blood pressure has been reported to 
increase by approximately 7mmHg from 40 years and above. Epidemiological studies 
have shown an increase in age-related systolic blood pressure that is progressive, 
reaching an average of approximately 140 mmHg in the 80th year (Gurven, Blackwell, 
Rodriguez, Stieglitz, and Kaplan 2012:25).  
 
Age-related hypertension reported cases in this survey are in agreement with previous 
studies on age-related hypertension in Belize. For instance, PAHO (2009:22) reported a 
national survey on the prevalence of hypertension distribution on age to be 40-64 (42.8%) 
and 65 years and older (35.1%) was 2 to 3 times higher than among persons 20-39 years. 
Respondents of White (42.0%), mixed (37.2%), East Asian (37.1%), Garifuna (36.2%), 
and Creole ethnicity (32.4%) had a higher prevalence (Fig. 4.1). 
 












Fig. 4.2 Gender distribution of participants  
 
422 (53.8%) of respondents in this study were female, representing a frequency of 227 
(Fig. 4.2). Currently, Belize’s 2019 mid-term estimated population puts the male to female 
data at 247 to 204 (SIB 2019:1). Although population-wise, the females in Belize were not 
more than the males; there seem to be higher reported cases of hypertension in females 
than in males in this study. 
The general perception of gender-based hypertension is that it is the most prevalent 
disease in men. Contrary to this belief, most cardiovascular diseases, including 
hypertension, are higher in women than men. Menopausal women have been reported to 
have a higher incidence of hypertension compared to other women. Furthermore, women 
have been reported to have uncontrolled hypertension and experience higher incidences 
of cardiovascular diseases later in life. The higher prevalence of hypertension in females 
has been attributed mostly to hormonal changes and longevity seen in women than in 
men (Rahman, Williams, and Al Mamun 2017:23; Abramson and Melvin 2014:553; 
Doumas, Papademetriou, Faselis, and Kokkinos 2013:321). The present study results 
corroborated the report indicating that females have a higher prevalence of hypertension 
than men. In 2009, PAHO published national survey data on diabetes, hypertension, and 










The report indicated the highest prevalence of hypertension among women in Stann 
Creek (35.3%), Belize (34.6%), and Orange Walk (33.1%), with the prevalence among 
women notably high in all six districts as compared to their male counterparts. Even 
though in the current study, the sample size was much smaller than that of PAHO, the 




Fig. 4.3 Marital status of respondents  
 
The majority (n= 131; 31.0%) of the respondents were married, while 16.8% (n=71) were 
in a common law relationship (Fig. 4.3). 
 
A significant predictor of a wide range of health outcomes is the marital status of the 
individual. It is a vital social factor that has also been associated with cardiovascular 
diseases, including hypertension. However, several studies have presented conflicting 
evidence regarding the role of marital status in hypertension. For instance, a study in 
Ghana (Tuoyire and Ayetey, 2018:313) reported significantly higher odds of hypertension 
for married (OR=2.14, 95% CI=1.30-3.53), cohabiting (OR=1.94, 95% CI=1.16-3.23) and 
























Manfredini, De Giorgi, Tiseo, Boari, Cappadona, Salmi, Gallerani, Signani, Manfredini, 
Mikhailidis, and Fabbian (2017:624), however, reviewed 13 studies on the subject matter 
(accounting for 1,245,967 subjects) and concluded that “most studies showed better 
outcomes for married persons, and generally, men who were single had the poorest 
results.” They further reported, “being married was associated with lower risk factors and 
better health status, even in the presence of many confounding effects.” 
 
Therefore, the current study results are predictive of the possibility that culture, 
environmental factors, and religious beliefs play a significant role in the relationship 
between hypertension and marital status. Further studies need to be conducted in Belize 
to examine the relationship between marital status and hypertension.  
 
 
Fig. 4.4 Religious affiliation of participants  
 
In some studies, religion has been reported to have a protective role against 






















exercise, smoking abstinence, nut consumption, and social support were mediators 
indicated to help protect against hypertension (Meng, Xu, Shi, Zhang, Wang, Liu, and 
Chen 2018:8203; Meng, Zhang, Shi, Liao, and Chen 2019:209; Sherma and Jerry 
2016:709). Although the current study did not examine the correlation between religion 
and hypertension, the results (Fig.4.4) indicated that the highest number of hypertensive 
participants was Catholics (n=151; 35.8%), followed by the evangelicals (n=116; 27.5%). 
The high frequency of hypertension seen among the religious organizations in this study 
could be attributed to factors beyond the scope of this study. Genetic factors, improper 
nutritional, dietary practices, and lack of adherence to strict religious meditation may 
contribute to higher levels of hypertension seen among religious participants in this study. 
The results suggest a need to further explore religion as it affects hypertension in Belize. 
 
 


















According to their districts, the respondents were proportionately stratified based on the 
population data obtained from the Statistical Institute of Belize (SIB). Based on the SIB’s 
data, Belize and Cayo districts had the highest number of people; therefore, sample sizes 
from these districts were higher than other districts.  
 
Previous studies (PAHO 2009:22) on hypertension distribution in the districts showed a 
statistically significant relationship between the district of residence and hypertension. 
The PAHO study reported high (≥ 20.0%) hypertension prevalence in all districts of Belize. 
The prevalence of hypertension was highest in Stann Creek (35.1%), Belize district 
(34.1%), and Orange Walk (30.7%), respectively (Fig. 4.5). 
 
Furthermore, the report indicated the highest prevalence of hypertension among women 
in Stann Creek (35.3%), Belize (34.6%), and Orange Walk (33.1%), although the 
prevalence among women was notably high in all six districts as compared to their male 
counterparts. The current study showed that the Belize district had the highest number of 
participants with hypertension only due to the sample size. 
 
 
Fig. 4.6 Ethnicity distribution of respondents 


























Data on ethnicity (Fig.4.6) showed that Mestizo had the highest participants (n=98; 
23.2%), followed by Creole (n=97; 23%). The least ethnic group that participated in the 
study was the Europeans and North Americans (n=3; 0.7%). It should be noted that the 
number of Westerners living in Belize is in the minority. Conversely, Europeans and North 
Americans may not have been observed due to other reasons, such as obtaining 
medications from alternative sources unknown to the researcher.  
 
Ethnicity and ethnic variations have been reported among hypertensive patients, leading 
to errors in hypertensive management and control (Thomas and Allison 2019:43; 
Thomas, Pannier, Danchin, and Safar 2019:555). For instance, it is a well-established 
fact that the black race is especially susceptible to hypertension and its associated organ 
damage than the white race (James et al. 2014:507). A report on hypertension by PAHO 
(2009:22) indicated the highest prevalence of hypertension among women to be 40-64 
(42.3%) and 65 years and older (64.2%), East Asian women (39.4%), Garifuna (42.3%), 
mixed (36.5%), white (39.8%) and Creole (34.0%) ethnicity, obese (36.0%) and women 
who were overweight (29.5%), women with elevated cholesterol levels, and women with 
waist circumference ≥ 88 cm (35.2%) had a higher prevalence than women without these 
characteristics. Therefore, the current study results are a confirmation of variations that 




Fig. 4.7 Educational status of respondents  
 
The majority (n= 148; 35.1%) of the respondents attended secondary school, while those 
without formal education (n=54; 12.8%) had the least participants (Fig. 4.7). Educational 
attainment has been reported to be associated with risk for cardiovascular disease (CVD), 
presumably as a marker or mediator of other traditional risk factors (Kubota, 2017:1877; 
Adler and Glymour 2017:1892). For instance, lower educational status has been reported 
to be associated with a high prevalence of hypertension (Sarki, Nduka, Stranges, 
Kandala, and Uthman 2015: e1959). 
 
In this study, primary educational status was associated with higher hypertension levels 
than participants with no formal education. From the results of this study, the association 
between hypertension and education level is likely to be mediated by other nonclinical or 
clinical factors. Nevertheless, awareness of a patient’s education status could improve 















Fig. 4.8 Employment status of respondents  
 
Figure 4.8 shows analyzed data based on the employment status of participants showed 
the majority (n=119; 28.2%) to be from the private sector; this was followed by self-
employed participants (n=109; 25.8%), with the least participants being students (n=2; 
0.5%). Most research on employment status with hypertension has been on salaried 
populations, and the results were conflicting on how employment affects hypertension. 
Be that as it may, an inverse relationship between workplace and morbidity has been 
reported. Hypertension and reduced heart disease risks have been shown with higher job 
status (Amano, Shirakawa, and Hashimoto 2019:10936). In this study, employment status 
was associated with higher hypertension levels compared to participants with no 
employment. From the results of this study, the association between hypertension and 
employment status is likely to be mediated by other nonclinical or clinical factors. 
Nevertheless, awareness of a patient’s employment status could improve overall clinical 
management, especially regarding purchasing power for pharmaceutical products and 
other lifestyle changes.  
 



























Fig. 4.9 Monthly income distribution of participants  
 
From the current study, results on monthly income indicated that the majority (n=144; 
34.1%) of the participants earn between $1001 and $2000 Belize dollars monthly income 
(Fig. 4.9). The result of this research corresponds with Belize statistical data (SIB, 
2019:1), where the median income was reported to be 1,244 Belizean dollars. Information 
on patients’ incomes is essential for effective targeting of health care professionals’ 
interventions and monitoring progress in improving hypertension care. Hypertension 
rates have been reported to be likely higher in upper-middle-income countries than in 
lower-middle-income countries, and the latter is more likely to be higher than low-income 
countries (Sarki et al. 2015: e1959). In this study, the participants’ seemingly average 
income could be directly attributed to their educational attainment and subsequent 
employment status, as shown in figures 4.7 and 4.8. 
 
  















4.3 HYPERTENSION DIAGNOSIS AND MEDICATION USE 
 
This section explored the use of antihypertensive medications by respondents. Questions 
explored the frequency and duration of medication use, medication adherence, and types 
of medications used by respondents.  
 
 
Fig. 4.10 Number of years diagnosed with hypertension 
 
Figure 4.10 above showed the distribution of respondents’ years diagnosed with 
hypertension. The majority of the respondents were diagnosed with hypertension within 
the last ten years, with those diagnosed within 1 – 5 years having the highest number 
(n=167; 39.6%) of reported cases, followed by those diagnosed within 6 – 10 years 
(n=116; 27.5%).  
 
The risk of developing cardiovascular complications in either young or older age patients 
is substantially conferred by hypertension. More significant risks of adverse outcomes 
and heritable risk factors can be developed either with early or late onset of hypertension, 

























Henglin, Lakdawala, Vasan, and Cheng 2017:1949). This figure’s results correlate with 
the participants’ age, where the highest age category of participants with hypertension 
fell within the age category of 41 and 50 years (Fig. 4.1). Given that hypertension is 
multifaceted and heterogeneous, it is likely that the less common type of hypertension 
that develops earlier in life is genetically determined. On the other hand, the 
environmentally determined type of hypertension could develop later in life. Individuals 
presenting with high blood pressure in the clinical setting should be screened for heritable 
factors or, at the onset, be administered, pharmacological agents.  
 
 
Fig. 4.11 Duration of western antihypertensive therapies  
 
The majority (n=173; 41.0%) of the participants reported being on westerns medications 
for 1-5 years, while 25.5% (n=107) reported using western medications for 6 – 10years 
(Fig. 4.11). This result aligns with the data presented in figure 4.10, where most of the 
respondents were diagnosed with hypertension within 1 – 5 years and 6 – 10 years, 
respectively. To prevent organ damage in patients diagnosed with hypertension, effective 













nonpharmacological and pharmacologic interventions (Rivera, Martin, and Landry 
2019:97).  
 
Fig. 4.12 Western medication frequency 
 
The majority (n=353; 83.6%) of the participants took their medications once daily (Fig. 
4.12). Reduction in medication consumption has been reported to increase adherence, 
especially in patients on life-long therapies such as hypertension (Burnier and Egan, 
2019:1124). Hypertensive patients who will reach therapeutic goals with their medications 
were usually those with once-daily single-dose combinations and experienced minimal 
adverse effects. Being a long-term cardiovascular disease, adherence to hypertensive 
treatment declined over the years. Adherence to hypertensive medication regimen has 
been shown to remarkably improve with single-pill once-daily medications or fewer 
medications (Burnier and Egan 2019:1124). Furthermore, refill frequency consolidation, 
where a large number of pills are given with each prescription to reduce the number of 
visits for a refill, aided in compliance with medication utilization among hypertensive 
patients (Burnier and Egan 2019:1124). The results of this study indicate that most 















Fig. 4.13. Use of western medications when hypertension is under control.  
 
Participants were asked if they stopped taking their western antihypertensive medications 
when their blood pressure was under control. The majority (n=166; 39.3%) of the 
participants reported that they did not stop taking their medications when they felt their 
blood pressure was under control (Fig. 4.13). The higher rate of adherence seen in this 
study could be due to the participants’ daily single-pill dosing reported in figure 4.12. 
Effective patient counseling by pharmacists and minimal adverse effects have been 
reported to improve Western medication adherence (Burnier and Egan, 2019:1124). 
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Fig. 4:14 How often respondents stopped taking their antihypertensive 
medications.  
 
To further establish western medication adherence, participants were asked if they 
stopped taking their western medications in the last 30 days. The majority (n=163; 38.6%) 
of the respondents reported near-strict adherence to their western antihypertensive 
medications, while 35.3% (n=149) reported stopping their western antihypertensive 
medications more than once and less than five times in 30 days (Fig. 4.14). The key to 
successful hypertension therapy is the patient’s medication adherence. In this study, the 
majority of participants reported adhering to western medication therapy. Poor adherence 
to antihypertensive medications has been reported to worsen hypertension with increased 
hospital admissions and higher risks for cardiovascular emergencies such as stroke 
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Table 4.3. Utilization of Western medication 
 
 Frequency Percent (%) 
Forgot to take western medication   
No 173 41.0 
Yes 227 53.8 
I do not take western therapies 22 5.2 
Total 422 100.0 
   
Forgetting medications when leaving or during travel. Frequency Percent (%) 
No 184 43.6 
Yes 217 51.5 
I do not take western therapies 21 5.0 
Total 422 100.0 
   
Reduction or stoppage of Western medications without 
informing doctors. 
Frequency Percent (%) 
No 225 53.3 
Yes 74 17.5 
Sometimes 102 24.2 
I do not take western therapies 21 5.0 
Total 422 100.0 
   
Stressed by adhering to antihypertensive treatment  Frequency Percent (%) 
No 146 34.6 
Yes 159 37.7 
Sometimes 96 22.7 
I do not take western therapies 21 5.0 
Total 422 100.0 
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The majority (n=227; 53.8) of the participants reported that they forgot to take their 
western antihypertensive medications. Participants were also asked, “if they sometimes 
forget to take along their western antihypertensive medications when they travel or leave 
home.” The majority (n=217; 51.5%) of the respondents reported that at one time or the 
other, they forgot to take along their medications when they leave home or travel, while 
43.6% (n=184), however, reported otherwise (Table 4.3). Furthermore, participants were 
asked, “if they are stressed by their adhering to their western antihypertensive 
medications.” The majority (n=159; 37.7%) admitted that they do, while 22.7% (n=96) 
reported that they “sometimes” felt stressed by adhering to their western antihypertensive 
medication regime (Table 4.3).  
 
The results seen in this study are in agreement with similar studies on adherence to 
Western antihypertensive medications. For instance, the cost of medication, medication 
side effects, physician-patient relationship, cultural beliefs and lack of social support, low 
literacy, patient motivation, and failure to remember to take medications are all examples 
of barriers to medication adherence (Tong, Chu, Fang, Wall, and Ayala 2016:892). 
Patients missing doses for any reason, being unable to purchase antihypertensive 
medications because of finances, skipping doses deliberately, and not taking medications 
as prescribed are some of the reasons why hypertensive patients do not adhere to their 
medication regimen (Tong et al. 2016:892). Tong et al. (2016:892) further reported that 
people of low-income, Hispanics, and younger adults were more likely not to adhere to 
antihypertensive medications than others.  
 
Moreover, data presented in Table 4.3 on forgetting to take Western antihypertensive 
medications was one of the commonly reported barriers to hypertension therapy (Tong et 
al. 2016:892). Improving awareness and knowledge of western antihypertensive therapy 
is, therefore, essential in achieving optimal treatment goals. Strategies to improve patient 
adherence to Western antihypertensive medications should include selecting an 
appropriate schedule and time for medication administration. Efforts to improve 
knowledge should also help patients understand antihypertensive medication’s adverse 
effects (Tong et al., 2016:892).   
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Although cardiovascular complications may arise due to hypertension complications, 
hypertensive patients usually do not present with obvious symptoms. Most patients, 
therefore, are not knowledgeable about the adverse effects of antihypertensive 
medications tend to be reluctant to adhere to their regime to avoid adverse effects. The 
adverse effects and the fact that hypertension does not usually present with symptoms is 
a sufficient discouraging factor to hamper adherence.  
 
Intervention strategies to improve adherence among patients must, therefore, be adopted 
based on patient disposition. Simplifying dosing such as one dose per day; face-to-face 
patient counseling; 90-day prescriptions; special dosing devices; home visits; telephone 
reminders; a designated family member support system, and home visits have all been 
reported to be effective strategies that could improve patient’s adherence to Western 
antihypertensive medications (Gebreyohannes, Bhagavathula, Abebe, Tefera, and 
Abegaz 2019:25; Tong et al. 2016:892). 
 
 
Fig. 4.15 Western therapies used by respondents 
 
Participants were asked to indicate the different types of western antihypertensive 
medications they are currently taking (Fig. 4.15). The option to select as many 
medications the participant was taking was made available.  
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The majority (n=335; 33.7%) of the respondents reported being on hydrochlorothiazide, 
while 12.3% (n=122) were on captopril. Respondents in this study indicated single, dual, 
or triple medication usage (Fig. 4.15). There is a universal agreement among clinicians, 
and some studies have supported combinational antihypertensive therapies to produce 
better hypertension goals than single therapies (Silva, de Figueiredo, and Rios 
2019:3458; Guerrero-García and Rubio-Guerra 2018:212531; Oparil, Acelajado, Bakris, 
Berlowitz, Cífková, Dominiczak, Grassi, Jordan, Poulter, Rodgers, and Whelton 
2018:18014). Typical combinations of antihypertensive medications that are safe and 
effective in the management of hypertension include a calcium antagonist with a renin-
angiotensin system inhibitor (RASI), whether an angiotensin-converting enzyme inhibitor 
(ACEI) or angiotensin receptor blocker (ARB). 
 
Regardless of whether a free combination or fixed doses type of antihypertensive 
medications are prescribed to patients, most combinations will include a diuretic. Some 
studies (Silva et al. 2019:3458; Guerrero-García and Rubio-Guerra (2018: 212531; Oparil 
et al. 2018:18014) reported universal agreement among clinicians regarding 
combinational therapies. Greater blood pressure control has always been reported with 
combinational therapies as compared to monotherapies. Guerrero-García and Rubio-
Guerra (2018: 212531) reported that for most antihypertensive patients to reach the 
recommended goal, a combination of at least two antihypertensive medications should 
be given. Combination therapies are recommended for patients with a systolic blood 
pressure reading of about 20mmHg above the target or diastolic pressure 10mmHg above 
the recommended goal. Aside from providing greater hypertensive control, multiple 
medications are also recommended in hypertensive patients with risks for cardiovascular 
complications. Finally, combined therapies reduce the potential for adverse effects while 
providing superior protection to target organs compared with monotherapy (Guerrero-
García and Rubio-Guerra, 2018: 212531). Patients who do not respond to dual therapies 
within 6-8 weeks will usually require triple therapy with renin-angiotensin system 
inhibitors, a natriuretic, and a calcium antagonist (Guerrero-García and Rubio-Guerra, 




4.4 USE OF INDIGENOUS THERAPIES 
 
This section explored the use of indigenous therapies among Belizeans. Respondents 
were asked about indigenous therapy usage in treating hypertension (HTN) or other 
diseases, parts of plants used for therapies, sources of therapies, and methods used to 
prepare indigenous therapies.  
 
Table 4.4 knowledge and usage of indigenous therapies. 
 
Knew about indigenous therapies for HTN Frequency Percent (%) 
No 61 14.5 
Yes 361 85.5 
Total 422 100.0 




No 95 22.5 
Yes 197 46.7 
Sometimes 130 30.8 
Total 422 100.0 




No 86 20.4 
Yes 336 79.6 
Total 422 100.0 
Use of indigenous therapies to treat HTN Frequency Percentage 
(%) 
No 190 45.0 
Yes 161 38.2 
Sometimes 71 16.8 
Total 422 100.0 
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Table 4.4 above presents respondents’ knowledge and use of indigenous therapies. 
85.5% (n=361) of participants reported that they are knowledgeable of indigenous 
therapies for HTN, 46.7% (n=197) reported they use indigenous therapies to treat other 
diseases, while 30.8% (n=130) “sometimes” use indigenous therapies to treat other 
diseases apart from hypertension. Whereas 79.6% (n=336) reported that they knew about 
indigenous therapies for hypertension, about 45% (n=190) did not use indigenous 
therapies to manage their hypertension. About 38.2% (n=38.2) reported using indigenous 
therapies for HTN, while 16.8% (n=71) used indigenous therapies sometimes.  
 
Ever before the emergence of modern medicines, people have used indigenous therapies 
to treat their diseases. Presently, over a hundred active compounds have been 
scientifically identified as drugs from plants alone (Helmenstine 2019:1). An increasing 
amount of literature exists on medicinal plants and herbs used for the management of 
hypertension. Some of the herbal therapies have gone through extensive studies with 
many reported discoveries about their bioactive metabolites, while others are still being 
studied, and new information on their pharmacology and toxicities has been revealed 
(Helmenstine 2019:1). This study is in agreement with globally presented research on the 




Fig. 4.16 Indigenous therapies used by Belizeans for hypertension management 
 
Respondents were asked the indigenous therapies they knew about the management of 
hypertension in Belize. Over 30 different plants were mentioned as indigenous therapies 
used for the management of hypertension in Belize. Beetroot (n=56; 13.3%), garlic (n=45; 
10.7%), and aloe vera (n=27; 6.4%) were among the highest reported indigenous 
therapies used for the management of hypertension (Fig. 4.16). 
 
Beetroot juice was reported to be the most indigenous antihypertensive therapy 
consumed by hypertensive clients in this study. Nitrate-dietary supplementation with 
beetroot juice has been advanced as a nutritional approach for controlling arterial blood 
pressure in healthy clients, pre-hypertensive subjects, and already diagnosed patients 
managed with Western antihypertensive medications (Bonilla et al. 2018:134). Secondary 
metabolites found in Beta vulgaris juice probably utilizes the nitrate/nitrite/nitric oxide 
(NO₃-/NO₂-/NO) pathway has been reported to be a cost-effective approach to reducing 
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Reduction in morbidity and mortality from hypertension complications could be 
significantly reduced by using beetroot juice as a cheap and easily accessible diet to 
manage cardiovascular complications. The use of beetroot juice in populations at risk of 
developing hypertension and those already diagnosed with hypertension should practice 
a healthy nutritional lifestyle to control hypertension. In order to have sustained and 
significant blood reduction with beetroot, it is recommended that a minimum of 2 weeks 
of administration be adopted (Bonilla, Paipilla, Marín, Vargas-Molina, Petro, and Pérez-
Idárraga 2018:134). Therefore, this study’s results need to be further explored in the use 





Table 4.5 Rational for indigenous therapies usage for hypertension. 
Rationale for taking indigenous therapies 
for hypertension. 
Frequency Percent (%) 
Safe 27 6.4 
Cheap 30 7.1 
Available 35 8.3 
Religion 16 3.8 
Natural 173 41.0 
Effective 43 10.2 
Chose all options 18 4.3 
Combination of 2 or more 23 5.5 
I do not know 57 13.5 
Total 422 100.0 
   
Rationale for not taking indigenous 
therapies to treat hypertension. 
Frequency Percent (%) 
Not safe 51 12.1 
Interactions 53 12.6 
Doctors/health professional advice 13 3.1 
No reason 114 27.0 
Herbs and medications do not work together 48 11.4 
No response 115 27.3 
Other 26 6.2 
I do not take indigenous therapies for HTN 2 .5 
Total 422 100.0 
 
Respondents were asked reasons “why they take or do not take indigenous therapies to 
treat their hypertension.” The majority (n=173; 41%) of respondents attributed using 
indigenous therapies to the simple reason that they were natural (Table 4.5). The “no 
response” (n=115; 27.3%) and “no reason” (n=114; 27%) formed the highest reported 
rationales for not consuming indigenous therapies for hypertension, respectively.   
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The high figures seen as a rationale for not taking indigenous antihypertensive therapies 
could probably be attributed to respondents who did not use indigenous therapies to 
manage hypertension.  
 
Numerous factors have led to a substantial global increase in medicinal plant usage. 
Foremost among them is that indigenous therapies are inexpensive compared to 
conventional drugs and have fewer adverse effects. The World Health Organization 
(2014:8) reported that this increase in patronizing herbal remedies is not necessarily 
dependent on the country, region or economic status or the individuals since 
complementary and alternative medicines are now used by over 70% of people in 
developed countries for the prevention or treatment of various ailments and diseases. 
The trend is not any less in developing countries where a more pronounced usage of 
alternative medicines is being recorded (WHO 2014:8; Ekor 2014:177). 
 
 
Figure 4.17 Herbal tea consumption 
 
The majority of the respondents reported using herbal teas regularly (n=106; 25.1%) or 
sometimes (n=115; 27.3%) for the management of their hypertension (Fig. 4.17). 47.2% 













The use of teas, especially Camellia sinensis (green tea), has been reported by many 
scientists in many disease conditions. Green tea has been reported to be the most 
frequently consumed beverage worldwide (Faria et al. 2012:1838; Peng et al. 2014:6251). 
Different researchers have presented conflicting reports on the antihypertensive effect of 
C. sinensis. For instance, earlier reported data (Hodgson et al. 1999:457; Hodgson et al. 
2002:195; Peng et al. 2014:6251) showed an increase in blood pressure after 30 min of 
C. sinensis consumption with a return to baseline readings after 60 minutes. Nagao et al. 
(2007:1473), however, reported a decrease in systolic blood pressure in patients with 
140mmHg or higher values. Meta-analysis studies also showed varying levels of blood 
pressure effects among participants given C.sinensis (Peng et al. 2014:6251). Taubert et 
al. (2007:626) reported no change in blood after drinking C. sinensis in a meta-analysis 
of five trials. However, Peng et al. (2014:6251) demonstrated a reduction in both systolic 
(1.98mmHg) and diastolic (1.92mmHg) blood pressure in a meta-analysis study of 
randomized controlled trials. Other studies tend to agree with a reduction in both systolic 
and reduce blood pressure due to C.sinensis consumption (Bogdanski et al. 2012:421; 
Hodgson et al. 2012:186). Compared with black tea, green tea induced a more potent 
antihypertensive effect, especially with long-term consumption (Al Disi et al. 2016:323).  
 
Furthermore, different catechins have been described as the major flavonoids found in 
green tea. Deka and Vita (2011:136) reported epicatechin (EC), epicatechin-3-gallate 
(ECG), epigallocatechin (EGC), and epigallocatechin-3-gallate (EGCG) as the significant 
catechins found in green tea. The primary catechins predominant in green tea were 
EGCG (Babu and Liu, 2008:1840; Faria et al. 2012:1838; Slevin et al. 2012:1186; 
Thomson et al. 2012: 409047). In addition, vasorelaxant effects have long been reported 
as responses to flavonoids. Ras et al. (2011: e16974) reported flow-mediated dilation, 
while Oyama et al. (2010:578) reported endothelial-dependent dilation.  
 
Catechins are converted by an enzymatic (polyphenol oxidase and peroxidase) oxidative 
polymerization reaction to tannins: the aflavins (benztropolone ring) and arubigins, both 
of which are orange-red colored polyphenolic pigments that are also potent vasodilators 
(Yang et al. 2011: 397136).  
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The risks of hypertension are significantly reduced by green tea via attenuating oxidative 
stress. Through some mechanisms such as inhibition of eNOS uncoupling (Faria et al. 
2012:1838), an increase of CAT antioxidant enzymes while simultaneously blocking AT1 
receptors in streptozotocin-treated rats (Thomson et al. 2012: 409047), upregulate the 
expression of antioxidant genes such as SOD1 and GST in C57BL/6 mice (Newsome et 
al. 2014:126), and scavenging superoxides (Nakagawa and Yokozawa, 2002:1745) in 
vitro as well as to attenuate NAPDH oxidase production (Ribaldo et al. 2009:96) in people 
with diabetes.  
 
With over 50% of participants reporting using herbal teas to manage their hypertension, 
this figure calls for further investigation to identify the type of teas being used, frequency, 
duration, and concomitant use with western antihypertensive therapies. There is a need 
to investigate the efficacy of herbal teas for the management of hypertension in Belize.  
 
Table 4.6 Indigenous therapies used by respondents to manage their hypertension 
 
Indigenous therapies used by 








Garlic (Allium Sativum) 227 19.4 70.9 
Lime (Citrus aurantiifolia) 105 9.0 32.8 
Aloe Vera (Aloe barbadensis miller) 78 6.7 24.4 
Soursop (Annona muricata Linnaeus) 72 6.2 22.5 
Celery (Apium graveolens) 72 6.2 22.5 
Beetroots (Beta vulgaris) 71 6.1 22.2 
Lettuce (Lactuca sativa) 51 4.4 15.9 
Sorrel (Hibiscus sabdariffa) 45 3.9 14.1 
Eggplant (Solanum Molongena) 45 3.9 14.1 
Trumpet Tree (Cecropia peltata) 43 3.7 13.4 
Moringa (Moringa oleifera) 40 3.4 12.5 
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Cerocee (Momondica charantia) 30 2.6 9.4 
Jackass Bitter (Neurolaena lobata) 27 2.3 8.4 
Almond/hammon (Termialia catapp) 27 2.3 8.4 
Choko (Sechium edule) 25 2.1 7.8 
Lemongrass (Cymbopogon citratus) 24 2.1 7.5 
Avocado leaves (Persea americana) 23 2.0 7.2 
Susumba (Solanum Turvum) 15 1.3 4.7 
Noni (Morinda citrifolia) 15 1.3 4.7 
Bay Leaves (Laurus nobilis) 14 1.2 4.4 
Calabash Tree (Crescentia cujeta) 14 1.2 4.4 
Neem (Azadirachta indica) 13 1.1 4.1 
Wild Tamarind/Jumbie plant (Tamarindus 
Indica) 
11 0.9 3.4 
Periwinkle/ Ram goat (Catharanthus 
roseus) 
11 0.9 3.4 
Cat's claw (Uncaria tomentosa/ U. 
guianensis) 
11 0.9 3.4 
Cascarilla (Croton eluteria) 9 0.8 2.8 
Scoggineal (Opuntia cochenillifera) 9 0.8 2.8 
Pine bark (Pinus) 9 0.8 2.8 
Mango (Mangifera indica) 8 0.7 2.5 
Guava (Psidium guajava) 8 0.7 2.5 
Papaya (Carica papaya) 7 0.6 2.2 
Breadfruit (Artocarpus Altillis) 7 0.6 2.2 
Chestnut (Pachina aquatica) 2 0.2 0.6 
 
Respondents were asked to choose single or multiple/combinational indigenous 
therapies they used to manage their hypertension. Over 30 indigenous therapies used to 
manage hypertension were reported by the respondents (Table 4.6). Respondents also 
reported Garlic (Allium sativum) 70.9% of cases (n=225); Lime (Citrus aurantiifolia) 32.8% 
of cases (n=105), while aloe vera (Aloe barbadensis miller), 24.4% of cases representing 
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a frequency of 78 as the most common indigenous therapies used for the management 
of hypertension. 
 
The high response seen with garlic in this study is in line with many reported health 
benefits of garlic, especially its use in managing hypertension. For instance, garlic has 
been reported for its anti-inflammatory, hypocholesterolemic, anti-cancer, antibacterial, 
hypotensive, and antioxidant properties, and its healing abilities have been reported in 
various cultures and societies for over a thousand years (Chan et al. 2020:1). 
Furthermore, in many developed and developing countries, physicians and clinical 
researchers are continuing in their efforts to investigate the numerous claims made 
regarding the multi-fold healing powers of garlic (Qidwai and Ashfaq, 2013:12; Chan et 
al. 2020:1). In line with some of these claims, Ried et al. (2013:16) reported that 
individuals using garlic for medicinal purposes or spices consume either the extract, 
powder, oil, or raw form. The pungent smell of garlic limits raw consumption in some 
individuals; hence, many enteric-coated supplements that dissolve easily in the 
gastrointestinal tract are available for ease of consumption (Chan et al. 2020:1). Reports 
by, Qidwai and Ashfaq (2013:12) and Chan et al. 2020:1) indicated that the number of 
people treating their hypertension with garlic is much, and interest in its use is rising. The 
main bioactive organo-sulfur substances reported in garlic are diallyl disulfides (DADS), 
methyl thiosulfonate, S-allyl cysteine (SAC), diallyl trisulfides (DATS) and Allicin (Qidwai 
and Ashfaq, 2013:12), produce unique mechanisms of action. Although garlic is 
presented to be potentially useful in many health situations, and its use has found global 
acceptance, numerous pharmacologic mechanisms of action for hypotension have been 




For instance, the reduction in systolic blood pressure or diastolic blood pressure only has 
been reported in some studies, while no change in blood pressure or significant lowering 
of blood pressure was reported in other studies (Augusti et al. 2012:7; Oga et al. 2015:24; 
Chan et al. 2020:1). Despite the irregular reported effects of garlic and its constituents, 
the induction of its hypotensive abilities has been confirmed in many studies (Chan et al. 
2020:1). Various garlic types have been reported to lower systolic, diastolic, or both blood 
pressure in an extensive review (Barnerjee et al. 2002:1509). In the same vein, garlic was 
reported (Qidwai and Ashfaq 2013:12; Chan et al. 2020:1) to have an efficacy of almost 
80% as an antihypertensive herb.  
 
Finally, garlic’s antihypertensive properties have been reported to be mediated by 
endogenous signaling gases such as nitric oxide and hydrogen sulfide (Banerjee et al. 
2002:1509; Mousa and Mousa 2007:119; Ried et al. 2013:4; Chan et al. 2020:1), where 
a significant decrease of 17mmHg in SBP was reported in stage I hypertensive patients 
administered 2600mg of garlic for ten days (Mousa and Mousa 2007:119). Interestingly, 
Garlic extracts have also been shown to increase the bioavailability of nitric oxide by 
200% (Mousa and Mousa 2007:119), increased hydrogen sulfide production and induces 
its synthesis for vasorelaxant activity (Benavides et al. 2007:3), increased expression of 
Connexin-43 (Cx43), a gap junction protein correlated with a reduced VSMC proliferation 
and DNA synthesis (Joshi et al. 2012:220), and inhibition of ACE (Sendl et al. 1992:3). 
Inhibition of vascular smooth muscle cell proliferation, reduction in angiotensin II-induced 
vasoconstrictor responses, abrogation of the activation of NF-κB, and inhibition of 
endothelin-1 induced vasoconstriction have all been reported with garlic (Banerjee et al. 
2002:1509; Castro et al. 2010:552; Pan et al. 2012: 627375). Therefore, the current study 





Figure 4.18 Frequency of indigenous therapy usage for hypertension  
 
Survey respondents were asked how often in the last 12 months, they used indigenous 
therapies to manage their hypertension. Approximately 20.1% (n=85) reported having 
consumed indigenous therapy for their hypertension more than five times in 12 months. 
13.5% (n=57) reported consuming the therapies more than five times in a week, while 
10.2% (n=43) reported taking indigenous therapies for their hypertension every day in the 
past 12months (Fig. 4.18). These results suggest that participants are involved in the 
active consumption of indigenous therapies to manage their hypertension, even though 
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Table 4.7 Combined indigenous and western therapies for hypertension 
 
Combined indigenous therapy with western medicines for 
hypertension 
Frequency Percent (%) 
Indigenous therapies alone 83 19.7 
Indigenous therapies and western medications together 26 6.2 
Sometimes indigenous therapies alone and sometimes in 
combination with western therapies. 
98 23.2 
Western therapies alone 13 3.1 
I do not take indigenous therapies for HTN 202 47.9 
Total 422 100.0 
   
Rationale for combining indigenous therapies with western 
medicines  
Frequency  Percent (%) 
Combination of the 2 is effective 119 28.3 
Medicines alone not effective 17 4.0 
Medicines are expensive 9 2.1 
Medications have many side effects 7 1.7 
No harm in taking both together 44 10.4 
Combination of 2 or more responses 22 5.2 
I do not take indigenous therapies for HTN 204 48.3 
Total 422 100.0 
   
Combining indigenous and western therapies help lower blood 
pressure 
Frequency Percent (%) 
No response 9 2.1 
No 62 14.7 
Yes 71 16.8 
Sometimes 93 22.0 
I do not know 74 17.5 
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I do not take indigenous therapies for HTN 113 26.8 
Total 422 100.0 
   
Awareness of probable interactions  Frequency  Percentage 
No response 33 7.8 
No 106 25.1 
Yes 153 36.3 
I do not know 38 9.0 
I do not take indigenous therapies for HTN 92 21.8 
Total 422 100.0 
 
Respondents were asked if they consumed indigenous therapies combined with Western 
medicines, and if the combination was effective in lowering elevated blood pressure. Only 
6.2% (n=26) reported consuming indigenous therapies with western medications (Table 
4.7). However, 23.2% (n=98) reported that they sometimes take indigenous therapies 
alone and sometimes in combination with Western therapies. The majority (n=119; 
28.3%) of the respondents also reported that the combination of indigenous-western 
medications used to manage hypertension is effective. 10.4% (n=44) opined that there is 
no harm in combining indigenous therapies with Western medications, while 22% (n=93) 
and 16.8% (n=71) reported “sometimes and “yes” respectively, to how effective 
combining indigenous and Western therapies lower blood pressure. Conversely, 36.3% 
(n=153) reported being aware of probable interactions when indigenous and western 
therapies were taken together. 25.1% (n=106) were unaware of possible interactions 
when indigenous and Western therapies were consumed together (Table 4.7). 
 
A common practice with indigenous therapy is polypharmacy. Polypharmacy is the use 
of more than one drug or substance for therapy (Dookeeram et al. 2017:1119; Burt et al. 
2018:2). This practice is monitored in the clinical setting using carefully designed paper-




Although it is much easier to monitor the possibilities of drug-drug interactions in the 
clinical setting, monitoring for indigenous-western drug interactions is difficult because 
these interactions have not been scientifically extensively studied. There are many 
uncharacterized compounds in medicinal plants that present many opportunities for drug-
herb or herb-herb interactions. These drug-herb or herb–herb interactions can precipitate 
toxic effects or, in some instances, render the therapeutic effect of a conventional drug or 
the more promising herbal preparation (Mphuthi 2015:203; Kahraman, Arituluk, and 
Cankaya 2020). The concomitant use of indigenous therapies with Western 
antihypertensive medications seen in this study calls for further investigation and 
monitoring. 
 
It has been reported that dependence on indigenous medicines and medicinal plants has 
increased significantly by about 80% in many developing countries. In many developing 
nations, indigenous medicines and herbal therapies are mainly a substantial primary 
health care source. Herbal therapies are currently not only utilized by developing 
countries; instead, the trend has shown a global increase in awareness and usage of the 
products (Mahady 2011:120S; WHO 2019:1). For instance, according to reports, there is 
presently an active reliance on natural and complementary therapies to prevent or 
manage many ailments in Germany, where over 75% of the population use natural 
products (Tuffs 2002:990). The report further indicated that 70% of the country’s 
physicians prescribe traditional herbal medicines to their patients for diverse ailments 
(Tuffs 2002:990). 
 
In many communities where indigenous therapies are used, the general belief is that they 
are safer than Western medications because they are obtained from natural sources and 
have fewer side effects. However, several studies have debunked this perception and 
showed that interactions do occur between herbs and western medications and that such 
interactions could be harmful, ranging from mere side effects to more serious adverse 
reactions. For instance, St. John's wort (H. perforatum L.) has been reported to 
increase warfarin metabolism, initiating a reduction in warfarin’s anticoagulant effect at 
the same time leading to an increases digoxin renal excretion (Kahraman et al. 2020).   
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Ginkgo (Ginkgo biloba L.) has been reported to potentiate the aspirin’s antiplatelet effect, 
while garlic (Allium sativum L.) has a blood-thinning effect when taken concurrently with 
warfarin. Green tea (Camellia sinensis L.), on the other hand, antagonizes the 
anticoagulant effect of warfarin, while reduction of digoxin absorption has been reported 
when concomitantly taken with guar gum (Cyamopsis tetragonoloba Taub.).Therefore, 
these available scientific reports provide evidence that interactions exist between 
indigenous therapies and Western therapies, especially those used to manage 
cardiovascular events (Bonilla et al., 2018:134; Kahraman et al., 2020). 
 
Table 4.8 informed doctor/medical practitioner of indigenous therapy use for 
hypertension. 
 
Doctor informed of indigenous therapy usage Frequency Percent (%) 
No response 65 15.4 
No 149 35.3 
Yes 50 11.8 
I do not take indigenous therapies for HTN 158 37.4 
Total 422 100.0 
   
Rationale for not informing doctor of 
indigenous therapy usage 
Frequency  Percent (%) 
No response 96 22.7 
Did not think it was important 18 4.3 
I was not asked 18 4.3 
Was not aware that I should inform him/her 7 1.7 
Doctors do not like indigenous therapies 4 .9 
Did not want doctor to stop me 3 .7 
No reason 90 21.3 
I do not take indigenous therapies for HTN 186 44.1 




The majority (n=149; 35.3%) of respondents reported not informing their medical 
practitioners about using indigenous therapy to manage their hypertension, and 21.3% 
(n=90) did not give a reason for not informing their medical practitioners about indigenous 
therapy consumption for the management of their hypertension. 4.3% (n=18) reported 
that they did not think it was necessary to report indigenous therapy usage to their medical 
practitioners. At the same time, the same percentage of respondents also reported that 
their medical practitioners did not ask them about their use of indigenous therapies for 
the management of their hypertension (Table 4.8).  
 
Although the use of herbal therapies is rising in many countries and approval for their 
usage is gaining wide acceptance, the story is different in other countries where rigorous 
regulative obligations make it challenging and difficult for herbal medications to be 
registered. Therefore, the stringent regulatory requirements in such countries limit the 
opportunity for the use of medicinal herbs. For instance, herbal medicines in the United 
Kingdom have been viewed with reservation and seen suspiciously as therapies that are 
likely to cause peculiar health challenges to the public’s general health. Because of this 
perception, many consultations between indigenous medicine practitioners and 
physicians are being conducted to ensure public safety while being careful not to deny 
the benefits derived from such products (Walker 2015:1; Boyle et al. 2011:951). 
 
The concurrent use of conventional and indigenous therapies for treating high blood 
pressure, including other non-communicable diseases such as diabetes, is a global 
phenomenon. For example, earlier research reports among diagnosed hypertensive 
clients in Palestine (Ali-shtayeh and Jamous 2013:256) showed that 85.7% of 4575 had 
concomitantly been taking western prescription antihypertensive medicines alongside 
herbal therapies. In a similar study in India, Shafiq, Gupta, Kumari, and Pandhi (2003:294) 
reported that both herbal remedies and western prescribed medications were 
concurrently consumed by approximately 63.9% of hypertensive study participants. In 
both studies, the study participants did not reveal to their health practitioners the use of 
indigenous therapies to manage their hypertension. Additionally, the respondents did not 
believe that the indigenous therapies they consumed were relevant to their hypertensive 
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management since they were not asked by their healthcare providers (Bonilla et al., 
2018:134). The responses seen in this study agree with those of previous studies. 
 
Table 4.9 Sources and parts of indigenous therapies 
 
Sources of indigenous therapies Frequency Percent (%) 
Grocery store 13 3.1 
Bush doctor/vendor/market 69 16.3 
Herbal store 11 2.6 
Yard/Family/friends/ 94 22.3 
Combination of 2 or more responses 49 11.6 
I do not take indigenous therapies for HTN 186 44.1 
Total 422 100.0 
   
Parts of indigenous therapies used for 
hypertension management  
Frequency  Percent (%) 
Leaves 64 15.2 
Roots 3 .7 
Seeds 1 .2 
Fruit 3 .7 
Combination of leaves, roots, seeds, or bark.) 161 38.2 
I do not take indigenous therapies for HTN 190 45.0 





The primary sources of indigenous therapies reported by respondents were 
yard/family/friends (n=94; 22.3%) and indigenous therapy vendors/markets (n=69; 
16.3%). Leaves (n=64; 15.2%), or a combination of leaves, roots, seeds, or bark (n=161; 
38.2%), were majorly reported as the parts used for hypertension therapy (Table 4.9). 
 
The search for new drugs, especially from indigenous sources, has continued to heighten 
in recent years, and global interest is daily developing, with research being conducted to 
unravel the active ingredients and efficacy of indigenous therapies. Belize has a rich rain 
forest that is important for searching for new medicines for cardiovascular management. 
Especially for the management of cardiovascular diseases. So far, not much has been 
studied to discover the vast potential of medicinal plants in Belize. Plants from rain forests 
can be sources of new drugs that have the potential for fewer side effects and may have 
greater bioavailability for the management of hypertension and other non-communicable 
diseases. As it were, Belize is a considerable source of indigenous therapies that is yet 
untapped.  
 
Table 4.10 preparation and consumption of indigenous therapies 
 
Indigenous therapies preparations  Frequency Percent 
No response 3 .7 
Infusions (hot teas) 72 17.1 
Decoctions (boiled teas) 11 2.6 
Tinctures (alcohol and water extracts) 9 2.1 
Macerations (cold-soaking) 4 .9 
Blend with water 11 2.6 
Soaking 12 2.8 
Eat/chew raw 5 1.2 
Combination 98 23.2 
Prepared: Capsules/teas/powders etc. 6 1.4 
I do not take indigenous therapies for HTN 191 45.3 
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Total 422 100.0 
   
How indigenous therapies are taken Frequency Percent 
(%) 
Drinking 122 28.9 
Combination of 2 or more 84 19.9 
With food (add to food) 25 5.9 
I do not take indigenous therapies for HTN 191 45.3 
Total 422 100.0 
   
Single or combined indigenous therapies  Frequency Percent 
(%) 
No response 12 2.8 
Single 40 9.5 
Combination 66 15.6 
Sometimes single and sometimes a 
combination 
113 26.8 
I do not take indigenous therapies for HTN 191 45.3 
Total 422 100.0 
 
Infusions or hot teas (n=72; 17.1%) and a combination of preparations (n=98; 23.2) are 
the most commonly used methods for preparing indigenous therapies, as reported by 
respondents. Drinking (n=122; 28.9%) indigenous therapy was the commonest route of 
administration in addition to the reported combination (n=84; 19.9%) of one or more 
routes (Table 4.10). Respondents also reported that they consume indigenous therapies 
“sometimes single and other times in combination” (n=113; 26.8%), in combination (n=66; 




The clinical efficacy of indigenous therapies is affected by some factors. These include 
extraction methods such as water decoction, accurate diagnosis of the disease condition 
by untrained personal, accurate prescriptions, and the dosage of the indigenous therapy 
inclusive of the administration method are few such factors. However, the most restricting 
factor in the use of indigenous therapies is the dosage. The dosage of indigenous 
therapies has, for the most part, been challenging to study because it can be influenced 
by extraction methods, the production area, the effective fraction of the indigenous 
therapy, and the formulation of the preparation. Additionally, this becomes more 
complicated if more than one formulation is required to prepare the therapy (Wet, 
Ramulondi, and Ngcobo 2016:78).  
 
The results of this study indicated that more than 42% (n=179) of the participants were 
involved in combining one or more herbs in the formulation of indigenous therapies to 
manage hypertension. With the difficulty of ascertaining the dosages of indigenous 
therapies, the lack of adequate knowledge of active ingredients by those involved in 
indigenous therapies, and the lack of knowledge on disease conditions, using multiple 
ingredients to formulate indigenous therapies for hypertension may complicate 
hypertension management among participants. 
 
Table 4.11 Indigenous therapies use and rationale for the use. 
 
Indigenous therapies better than western medicines Frequency Percent 
No response 2 .5 
No 19 4.5 
Yes 44 10.4 
Both are effective 56 13.3 
Sometimes western medicine is better 30 7.1 
Sometimes herbs are better 55 13.0 
I do not know 24 5.7 
I do not take indigenous therapies for HTN 190 45.0 
Other 2 .5 
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Total 422 100.0 
   
Rationale for preferring indigenous therapies to 
western medicines  
Frequency Percent 
(%) 
No response 11 2.6 
Western therapies are expensive 7 1.7 
Hospitals waste too much time 18 4.3 
Indigenous therapies are natural 76 18.0 
Indigenous therapies are available 23 5.5 
Indigenous therapies are safe 35 8.3 
I do not like doctors/nurses. 3 .7 
Combination of 2 or more responses 23 5.5 
I do not prefer indigenous to western therapies 16 3.8 
Indigenous therapies are effective 60 14.2 
Other 10 2.4 
I do not take indigenous therapies for my HTN 140 33.2 
Total 422 100.0 
 
Participants were asked if they considered indigenous therapies better than Western 
therapies in the management of hypertension. Varying responses were obtained from 
respondents (Table 4.11). For instance, 13% (n=56) of the respondents reported 
“sometimes herbs are better,” while 10.4% (n=44) indicated that they considered 
indigenous therapies better than Western therapies (Table 4.11). On the other hand, 
13.3% (n=56) reported that indigenous and Western therapies effectively manage 
hypertension. Furthermore, respondents were asked why they preferred indigenous 
therapies better than Western therapies in managing hypertension. Approximately 18% 
(n=76) of the respondents reported that they use indigenous therapies because they are 





The global increase in the awareness of indigenous therapies, especially herbs, is 
perceived to be safe and efficacious simply because they are from natural sources 
coupled with the long ancestral history of linkage to African folklore beliefs and practices 
(Mphuthi 2015:212; Mans et al. 2017b:1), has led to people consuming indigenous 
remedies. In Belize, for instance, it is a common practice for people to try indigenous 
remedies before coming to the hospital or combining indigenous remedies with Western 
medications. 
 
Beneficial effects could also be experienced by the use of indigenous therapies, 
especially among hypertensive patients in Belize and globally. The current increase in the 
use of indigenous remedies for doing self-medication by individuals or patients is attached 
to many reasons. Chanda and Kaneria (2011:1251) enumerated the following as reasons 
why people engage in the use of indigenous medicines, as follows: patients feeling very 
uncomfortable talking about their health problems and fear that there will be a lack of 
confidentiality in handling information related to their health. Additionally, the patient’s fear 
of misdiagnosis, wrong treatment with western medications, and lack of time by the 
physician to see the patients were reasons for increased patronage of indigenous 
therapies.  
 
Religion and cultural beliefs inform the patient’s choice to use indigenous medicines, the 
cost of those herbs, and the perceived efficacy of such herbs in treating the patient’s 
condition (Ekor 2014:177). These herbs are readily available and cheap, making them 
the first line of treatment in many communities. 
 
4.3 SUMMARY OF QUANTITATIVE PHASE  
 
This chapter presents the results obtained in the first phase of the research on 
indigenous-western therapies usage among hypertensive patients in Belize. A total of 422 





Information collected from participants was grouped into demographic, western 
medication, and indigenous therapy usage. Collected data were was analyzed using 
SPSS version 21.0 software. Results are presented in frequency tables, graphs, and 
charts. 
 
Female participants were more than male participants in the study. The majority of the 
respondents were diagnosed with hypertension within the last ten years, with those 
diagnosed within 1 – 5 years having the highest number (n=167; 39.6%) of reported 
cases, followed by those diagnosed within 6 – 10 years (n=116; 27.5%). The majority 
(n=335; 33.7%) of the respondents reported being on hydrochlorothiazide, while 12.3% 
(n=122) were on captopril. Over 30 different plants were mentioned as indigenous 
therapies used for the management of hypertension in Belize. Beetroot (n=56; 13.3%), 
garlic (n=45; 10.7%), and aloe vera (n=27; 6.4%) were among the most reported 
indigenous therapies used for the management of hypertension. Respondents also 
reported garlic (Allium sativum) 70.9% of cases (n=225), lime (Citrus aurantiifolia) 32.8% 
of cases (n=105), while aloe vera (Aloe barbadensis miller), 24.4% of cases representing 
a frequency of 78 as the most common indigenous therapies used for the management 
of hypertension. The main sources of indigenous therapies reported by respondents were 
yard/family/friends (n=94; 22.3%) and indigenous therapy vendors/markets (n=69; 
16.3%). Leaves (n=64; 15.2%), or a combination of leaves, roots, seeds, or bark (n=161; 
38.2%), were majorly reported as the parts used for hypertension therapy. 
 
Participants used indigenous therapies for the management of their hypertension. A few 
of the participants combined indigenous-western therapies for the management of their 
hypertension. The major reason given by participants for using indigenous therapies was 












In the last section (Phase 1), a detailed quantitative analysis is described for the study. In 
this phase of the study, two data sets were collected on indigenous-western therapies for 
treating hypertension. The first set of data was collected from patients diagnosed with 
hypertension who used either or both indigenous and Western therapies to manage 
hypertension, while the second set of data were collected from vendors of indigenous 
therapies. In this section, data collected qualitatively from hypertensive patients and 
vendors of hypertensive therapies were presented to have a deeper understanding of the 
use of indigenous therapies among Belize’s population. This section presents a brief 
description of the data collection process, data analysis and discusses the second 
phase’s findings. The essential themes and sub-themes categories that emerged from 
the analysis of interviews are discussed in the following section. The description is in 
regards to the research objectives and the reviewed literature. The first part of the 
discussion focused on hypertensive patients, while the second part of the discussion 
describes and discussed the analysis of interviews from the vendors of indigenous 
therapies.  
 
4.4.2 Part 1: Patients using medicinal therapies for the treatment of hypertension. 
 
This part of the study presented the data collected from patients suffering from 
hypertension, commonly known as high blood. Data were collected from patients who 
had been diagnosed with hypertension. 
 
4.5 BIOGRAPHICAL PROFILE OF PARTICIPANTS (HYPERTENSIVE PATIENTS). 
 
The participants in this phase of the study were 24 diagnosed hypertensive patients who 
currently use indigenous therapies to manage their hypertension.   
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The interviews from the 24 participants were analyzed and discussed in this section. The 
participants comprised 14 (58%) females and 10 (42%) males. The average age of the 
participants was 56.  
 
4.6 DATA COLLECTION PROCEDURE  
 
Appointments were made with participants through the phone to meet at a place 
convenient to them. Most meetings for the interviews were conducted at the homes of the 
participants. A few were conducted at the workplace of the participants. During the 
quantitative phase, the participants were identified and consent to participate in the 
study’s qualitative phase. The study’s purpose and interviews were explained to the 
participants, and consent was sought and accepted before the interview sessions. Each 
interview session lasted about 20-45 minutes. Fieldwork notes were taken and recorded, 
as well as observing non-verbal cues. The researcher gave written notes on respondents’ 
information unique codes to maintain participants’ privacy, anonymity, and confidentiality.  
 
4.6.1 Data analysis and management  
 
As described by Vaismoradi and Snelgrove (2019:1), thematic analysis was used for data 
management and analysis of interviews conducted for this phase. A theme was described 
as a thread of underlying meanings within similar data pieces that can be combined to 
give the researcher answers to the study phenomenon (Vaismoradi and Snelgrove 
2019:1). The results of the 24 interviews were transcribed using Microsoft Excel and 
loaded into qualitative data analysis (QDA) Miner Lite version 2.0.6 online software for 
coding. QDA Miner Lite is free software that is easy to use, generates basic themes, and 
has capabilities for exporting tables to Microsoft Word or Excel for further analysis. The 
QDA Miner Lite® has a limitation in that it cannot generate smart charts as done by other 
applications such as Microsoft Word and Excel. The tables were exported to Microsoft 




The integrated themes and sub-themes generated were presented in narrative passages 
and used to summarize study findings on indigenous therapies used to manage 
hypertension in Belize.  
 
4.7 PURPOSE OF THE QUALITATIVE PHASE  
 
As described in chapter one, this study’s main purpose was to investigate the use of 
indigenous-western anti-hypertensive therapies in Belize to develop guidelines for using 
these therapies. This section of the study was carried out to understand the different 
indigenous therapies used to manage hypertension and why people use indigenous 
therapies to manage their hypertension. The objectives of this section are presented 
below, as earlier described in chapter one. 
 
4.8 OBJECTIVES OF QUALITATIVE PHASE (PHASE 2 – HTN PATIENTS) 
 
The qualitative phase of this study has a few sets of objectives. In order to achieve the 
aim of this phase, the following objectives were developed: 
● To identify indigenous remedies used by hypertensive patients in the management 
of hypertension.  
● To describe the preparations, storage, and usage of indigenous therapies by 
hypertensive patients in Belize. 
● To assess the concomitant use of indigenous-western therapies by hypertensive 
patients in Belize. 
The data were collected and analyzed as stated above, and the following themes and 
sub-themes emerged from the analysis. These themes and sub-themes are illustrated in 





4.9 EMERGING THEMES AND SUB-THEMES 
 
Based on the received data that was analyzed, the following themes and sub-themes 
developed are presented in Table 4.12 and discussed below: 
 
Table 4.12 Themes and sub-themes revealed during data analysis of hypertensive 
patients. 
 Themes  Sub-themes  
1.  Indigenous medicinal 
plants for hypertension 
 
1.1 Medicinal plants used for hypertension 
1.2 Knowledge and source of indigenous therapies  
1.3 Duration of use for medicinal plants in 
hypertension  
2.  Preparation of medicinal 
plants for hypertension  
2.1 Plant parts used for therapy  
2.2 Preparation of medicinal plants  
2.3 Administration of medicinal plants for 
hypertension therapy  
3.  Efficacy of medicinal 
plants for hypertension  
3.1 Beliefs on the effectiveness of medicinal plants 
and the duration of use 
3.2 Safety and adverse effects of medicinal plants  
3.3 Concomitant usage of medicinal plants with 
western medications  
3.4 Availability and cost of medicinal plants 
 
4.9.1 Theme 1: Indigenous medicinal plants for hypertension 
 
The World Health Organization (WHO) defines indigenous medicines as plants or plant 
products that possess medicinal properties utilized for therapy (WHO, 2019:1). Currently, 
many countries are widely embracing medicinal plants for the treatment of various 
diseases and conditions (Ekor 2014:117; Mphuthi 2015:223; Shaikh, Thomas, and 




Additionally, medicinal plants for the management of hypertension have been surveyed 
in many countries like Pakistan, Iran, Brazil and reported in some publications (Al Dasi et 
al. 2016:1; Baharvand-Ahmadi, Bahmani, Tajeddini, Rafieian-Kopaei, and Naghdi 
2016:1; Meresa, Fekadu, Degu, Tadele, and Geleta 2017:1; Malik, Ahmad, Bussmann, 
Tariq, Ullah, Alqahtani, Shahat, Rashid, Zafar, Sultana, and Shah 2018:789). In Belize, 
few studies have been conducted on indigenous therapies to treat and manage 
hypertension, even though the practice exists. The participants interviewed revealed the 
medicinal plant they use to manage hypertension, the sources of their knowledge, and 
the duration they had taken indigenous therapies for the treatment and management of 
hypertension. The sub-themes were generated during the analysis, and participants 
indicated that they used medicinal plants as indigenous therapies for the management of 
their hypertension as quoted below by participants:  
 
“To treat my blood pressure, I have been doing several things because 
I really intend to cure it. I have been having a lot of teas and eat plenty 
garlic and drink garlic capsules as well. I have been drinking green tea 
and moringa tea. I have also been eating moringa leaves in my salad 
for lunch. You see there is cure in nature I only need to find it.” P1 
“Many people use many things for their hypertension. Sometimes I use 
a combination of some herbs sometimes for my hypertension, but 
majorly, I use the fruit Annatto.” P5 
“I am 57-years-old, and I suffered from arthritic joints due to my youthful 
days of football am now hypertensive. I take soursop leaves for my 
hypertension.” P19 
 
The three sub-themes that emerged from participants under these themes are described 







4.9.1.1 Sub-Theme 1.1: Medicinal plants used for hypertension 
 
According to the WHO (2019:8), herbal or medicinal plants are preparations obtained 
from plants or herbs that contain active ingredients used for the treatment or management 
of diseases, usually by indigenous people. The hypertensive participants from this study 
reported various medicinal plants used to manage their hypertension. The different 
therapies used included but not limited to soursop, breadfruit, and trumpet tree leaves, 
pineapple, lemongrass, green teas, cat’s claw seed, garlic, annatto fruit, moringa, serosi, 
and bukut leaves. Medicinal plants have been reported to be used either as a single plant 
or as a mixture of plants.  
 
The following quotations evidence some of the medicinal plants mentioned for the 
management of hypertension:  
“I take the pineapple tea for my pressure.” P2 
“I take a combination of bukut leaf and serosi for my pressure.” P7 
 “I use soursop leaf and moringa for my pressure.” P8 
“I take garlic and moringa in tea to treat my blood pressure.” P10  
   “I use cat’s claw seed to treat my hypertension.” P16 
“I use Breadfruit leaves for my pressure.” P22 
 
Based on the participants’ quotations above, various medicinal plants have been used to 
manage hypertension. As noted earlier and as shown by the quotations, some used single 
medicinal plants to manage hypertension, while others used a combination of plants. 
Many medicinal plants have been reported to manage hypertension (Ekor 2014:117; 
Landazuri, Chamorro, and Cortes 2017:1; Rawat, Jugran, Bahukhandi, Bahuguna, Bhatt, 
Rawal, and Dhar, 2016:154). Although some of the reported medicinal plants have 
verifiable scientific evidence in terms of their pharmacological activity, many are still being 
studied, and information obtained from indigenous users provides useful understanding 
for scientific research into such medicinal therapies. The results obtained in this phase of 
the study showed that hypertensive patients use various indigenous therapies to manage 
hypertension. These plants play a vital role in managing hypertension in Belize and have 
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significant health implications for public health. The results of this phase of the study 
corroborated the quantitative phase of the study. 
 
 4.9.1.2 Sub-theme 1.2: Knowledge and source of indigenous therapies  
 
The Oxford online dictionary describes knowledge as the facts, information, and skills 
acquired by a person through education or experience. This knowledge could be in terms 
of the theory or practical understanding of a subject matter. Similarly, the WHO (2019:8) 
describes indigenous medicine and the comprehensive knowledge and practices of 
indigenous people to diagnose, prevent, treat, or manage diseases. Hypertensive 
participants were asked how they acquired their knowledge of indigenous therapies. Most 
of the participants indicated that the knowledge of indigenous therapies was passed down 
from generation to generation. The current results resonate similar study by Mphuthi 
(2015:215). The participants reported their sources of knowledge about medicinal plants 
to come from family members, community, practitioners, or other sources, as evidenced 
by some of the participant’s quotations below and summarized in Figure 4.19 below. 
 
“My mom, grandma, great grandmom, and everyone always use herbs. 
We are from the village, and the village people use herbs for everything 
until Whiteman came with their propaganda. There is always something 
around to cure you. We live off the land.” P4 
“You need to understand that in the villages, these remedies have been 
passed down from generation to generation. So, I grew up knowing herbs 
and what they do.” P5 
“I learned from my grandmother. From I was a little girl, she always boils 
bush for us to drink. We live on bush, and it helps with many things.” P9 
“I grew up watching my grandmother and other relatives use a lot of herbs 
that we grow in our yard for many different things. It seems to work for 
them, and I have seen it working for me…….” P23 
“I learn that from the Internet, the Bush Medicines of Belize.” P22 
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As shown by the quotations from participants, most of the information is from the 
community. Indigenous vendors’ also gave some advice to the patients regarding the use 
of medicinal plants, as shown in Figure 4.19 below: 
 
Figure 4.19. Knowledge and sources of indigenous therapies 
 
Most hypertensive participants reported knowledge of medicinal plants being handed 
down to them from generations before them. According to the World Health Organization 
(WHO 2019:12), many countries embrace indigenous therapies handed over to them by 
their forefathers. The WHO’s submission is also the Belize case, where many people rely 
on indigenous therapies to manage various diseases. This reliance on indigenous 
therapies is mostly seen in older people who inherited their ancestors’ knowledge, as 
seen in this study phase. Even though indigenous therapies have been used for 
generations and mostly the knowledge is passed from one generation to the other, as 
seen in this study, many times the challenge is that such information is not adequately 
documented and hence some vital ingredients is likely to be lost along the line over the 
years (Baharvand-Ahmadi et al. 2016:1; Meresa et al. 2017:1; Malik et al. 2018:789.). 
The dynamics of migration from rural to urban communities by the younger generation, 
the advent of education, and Western therapies play vital roles in indigenous therapies 
knowledge being lost (Malik et al. 2018:789). In addition, with some younger generations, 
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indigenous therapies knowledge from older folks. For instance, Malik et al. (2018:789) 
reported that in Northern Pakistan, young people lack interest in indigenous medicines, 
as such transmission of such knowledge from older people is becoming difficult, 
especially because younger people have ease of access to readily available Western 
medications. Even though the purpose of this phase of the study is to identify and gain 
insight into indigenous therapies used in the management of hypertension in Belize, the 
study results will also serve as useful documentation of indigenous therapies, especially 
those used in the management of hypertension in Belize. 
 
4.9.1.3 Sub-Theme 1.3: Duration of use of medicinal plants in hypertension 
 
In an attempt to appraise the length of time hypertensive participants have been using 
indigenous therapies for the management of hypertension, the researcher asked the 
following question: “how long have you been using medicinal plants for the management 
of hypertension?” It was noticeable that the participants used medicinal plants not only 
for the management of hypertension but also for other diseases. Most participants 
claimed that medicinal plant use for managing hypertension was majorly dependent on 
the number of years diagnosed with hypertension. Whereas some of the participants did 
not specify the duration of usage, most participants reported short-term, medium-term, 
and long-term use of medicinal plants to manage hypertension. The evidence is shown 
by the participant’s quotation below and the summary in Figure 4.20 
“I do not remember, but I know it is for a very long time.” P13 
“All my life, I drink herbs for everything. I believe in herbs. They are very 
effective in treating many diseases.” P4 
“I have been doing these herbal remedies for the last three months. I 
have just been diagnosed with hypertension, and I am looking for a cure.” 
P1 
“Oh men, I have been taking herbs for a long time, but since I was 




“I started taking herbs when I found out I had high blood pressure, so 
that's about ten years ago, and since then, I have been taking herbs for 
my pressure.” P7 
“I have been using my bush on and off for over ten years.” P11 
 
 
Figure 4.20. Length of time patients have been using indigenous therapies for 
hypertension 
 
The desire to use medicinal plants for the management of a variety of diseases has 
significantly increased, and although many factors are responsible for this, the main 
reasons are the perceived safety of medicinal plants and their cheapness when compared 
to western medications (Ekor, 2014:117; Shaikh et al. 2020:1008). In Belize, for instance, 
the provision of Western medications from government-owned hospitals is free to all 
hypertensive patients. However, because medicinal plants in Belize are profoundly rooted 
culture in almost all ethnic groups, especially among the Maya, Kechi, Garinagu, and East 
Indians, the habit is difficult to let go of even with the freely accessible Western 
medications. The desire to maintain the originality of cultural and ethnobotanical practices 
among natives has been reported as a means to strengthen cultural and ethnic identities 
from the colonial era (Mans 2016:1; Mans 2017:1; Mans et al. 2017a:1). In addition, the 
vast rainforest of Belize and biodiversity provides the right environment and atmosphere 
for the use of many medicinal plants for the treatment of hypertension and other diseases. 
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The hypertensive participants in this study have reported using medicinal plants for less 
than a year to as much as ten years and beyond to manage their hypertension, possibly 
because of generational use, availability, and culture.  
 
4.9.1.4 Theme 2: Preparation of medicinal plants for hypertension 
 
Preparation is described as the different methods employed to extract the active 
ingredients from parts of a plant, plant material, or a combination thereof from a medicinal 
plant (WHO 2019:8; Malik et al., 2018:789). Different medicinal plants’ preparation 
methods have been described to include extracts, powder, boiled teas, scorched, 
steamed, poultice, infusions, and decoctions (Malik et al., 2018:789; Baharvand-Ahmadi 
et al. 2016:1; Boadu and Asase, 2017:1). In this phase of the study, the researcher aimed 
to identify the medicinal plants for managing hypertension in Belize and document their 
preparations. Documentation of preparation methods is essential if indigenous therapy 
knowledge is to be preserved. Due to acculturation and biodiversity, indigenous 
knowledge of medicinal plants has been reported to be on the decline and, in some 
cultures, outrightly lost (Boadu and Asase, 2017:1). The authors further stated that to 
ensure that indigenous therapies’ rare heritage is passed on to future generations, the 
need to describe and document such knowledge becomes paramount. To support 
indigenous therapies’ importance, the World Health Organization (WHO) partners with 
several member countries to document and share information on indigenous medicines 
(WHO, 2019:10). Such information is regularly updated to provide current information on 
indigenous therapies available for the public in member nations. The document was also 
designed to provide some guidelines on medicinal plants to manage various diseases.  
 
From the sub-themes generated during the analysis, most participants reported the plants 
part used to manage hypertension, how the plants are prepared for use in hypertension, 
and how they are administered. Additionally, the shelf-life of medicinal plant preparations 





4.9.1.5 Subtheme 2.1: Plant parts used for therapy 
 
Participants were asked the part or parts of the medicinal plant they used to manage their 
hypertension. Most participants reported leaves as the common part of the medicinal 
plant used to manage their hypertension. In addition to leaves, fruits, roots, seeds, stems, 
and whole herbs have been reported by a few participants as parts of plants used to 
manage their hypertension. The participants’ responses are supported by their quotes 
below: 
“I use cat’s claw seed…” P16 
“I use soursop leaves….” P6 
“I use the leaves from the moringa tree…” P9  
 “I use breadfruit leaves…” P22 
“I have been using Trumpet tree leaves…” P23 
“I take the soursop leaves, and sometimes I take the moringa 
leaves.” P12 
“I use a mixture of herbs to make juice. P4 
“I use the ginger, garlic, lime, cinnamon stick.” P18 
  “I take lime and garlic….” P13 
 
Reports by hypertensive participants on the medicinal plant part used to treat 
hypertension showed that a single part of a medicinal plant such as leaves (P6) could be 
used for hypertension or a combination of leaves (P9). Seeds (P16), roots, stem sticks, 
and pods (P18) have also been reported to manage hypertension in Belize. Most 
participants in this phase of the study reported using the leaves of a medicinal plant to 
manage their hypertension.  
 
The results noted in the current phase of this study support Malik et al. (2018:789), who 
conducted a study on ethnobotanical anti-hypertensive plants used in Northern Pakistan. 
The study reported that stem, root, flower, bark, leaves, seed, aerial parts, fruit, and whole 
herbal plant were used by indigenous Pakistani people to manage hypertension. Their 
report further indicated that most respondents (55.1%) reported using leaves to manage 
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their hypertension. Similar studies have shown that leaves are the highest plant part used 
than other medicinal plants, with 57% and 36% reported by Boadu & Asase (2017:1) and 
Baharvand-Ahmadi et al. (2016:1), respectively.  
 
4.9.1.6 Subtheme 2.2: Preparation of medicinal plants  
 
In order to ensure the quality and consistency of medicinal plants, methods of preparation, 
quality control, and standardization of medicinal plants are fundamental (Nafiu, Hamid, 
Muritala, and Adeyemi 2017:171). Different medicinal plants’ preparation methods have 
been described to include infusions, decoctions, boiling, teas, syrups, concoctions, 
powders, and chemical extractions (Ekor, 2014:117; Nafiu et al. 2017:171; WHO, 2019:1; 
Shaikh et al., 2020:1008). Variations in the medicinal plants, the plants’ identity, and 
adulteration have been reported to be factors that affect medicinal plant preparation 
(Nafiu et al. 2017:171). When a plant part is boiled in water until the water volume is 
reduced, usually to approximately half, the extract is considered a decoction. Similarly, 
soaking a plant part in the water at room temperature for more than an hour is called 
infusion. The juice is made from medicinal plants by blending the fresh part of the 
medicinal plant with water (Malik et al., 2018:789).  
 
In the current study phase, the researcher attempted to get details of preparation methods 
for medicinal plants used by hypertensive patients to manage their hypertension. 
Although no standardized method was reported by participants, boiling of medicinal plant 
part was the commonly reported method of preparation, as evidenced by the quotations 
below: 
 
“I take the pineapple tea……. I wash a large pineapple, then I peeled the skin 
and boil it in about a 1 liter of water for like 20 minutes, then I leave to cool 
for another 20 min more. Then I left to soak for one hour, then I strain.” P2   
 
“I use soursop leaves and moringa leaves. I have a soursop tree right in my 
back yard. I pick the leaves when they are big and put them to boil for about 
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15 minutes to about half an hour. When that is cooled, I put it in the fridge….” 
P8 
 
“I take garlic and moringa in tea... I normally boil the garlic in the water and 
add a tablespoon of the moringa powder to the garlic water. The moringa 
powder I get from my mom, she prepares it right here because we have the 
tree. Garlic is better boiled because you no smell it all day like when you eat 
it.” P10 
 
“I use soursop leaves…I boil the leaves in water and drink; however, I also 
boil the green leaves. I just wash the leaves and put them in hot water for 
about half an hour; then I strain it.” P6 
 
“I take a combination of bukut leaf and serosi……. I boiled water and added 
the leaves. After I add the leaves, I boil for about 5 minutes more; then I take 
it off the stove.” P7 
 
“I use the leaves from the moringa tree to cure my blood pressure. I soak it 
in water and keep it in the refrigerator…….” P9 
 
“I take soursop leaves. I make tea by boiling about ten leaves in 2-3 cups of water.” 
P14 
 
“I drink lemongrass tea. I prepare it by boiling a handful of the grass blades 
in 1-2 cups of water.” P15 
“I use a mixture of herbs to make juice. I blend the moringa leaves along with 
garlic, ginger and lime to make the juice……” P4 
 
“I use the ginger, garlic, lime, cinnamon stick. Boil slowly for 10 min. Leave it 
covered to keep the steam in the pot. Left it to rest and then serve, add honey 
for a nice taste.” P18 
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“I take breadfruit leaves for my pressure. I get the leaves from my farm and 
dry them first for about a week in a special container, out in the sun. I then 
weigh about one pound of it and boil it in a stainless steel pot. I will use like 
ten leaves for about a liter of water.” P3 
 
“To use lemongrass for high blood pressure, I simply steep dried or fresh 
lemongrass in a cup of hot water for five to 10 minutes, then strain and add 
a sweetener. I also used ready-to-use lemongrass tea bags. I Pour 1 cup 
boiling water over 1 to 3 teaspoons of fresh or dried lemongrass. I then steep 
for at least five minutes. I will strain the tea and enjoy hot or add ice cubes 
for iced lemongrass tea. It is very nice.” P17 
 
Most hypertensive respondents reported decoctions as the means of medicinal plant 
preparation for the management of hypertension. Washed pineapple skin is boiled for 
about 20 min in a liter of water (P2), big leaves of moringa are boiled in water for about 
15 minutes (P8), moringa powder is added to boiled garlic (P10), ten leaves of soursop 
are boiled in 2-3 cups of water (P14), and a handful of lemongrass blades are boiled in 
2-3 cups of water. As noted in this phase of the study, hot water extractions of leaves 
resonate with previously reported studies where participants indicated hot water 
extraction as the most used method of preparation, while the oral route is the common 
route (Malik et al. 2018:789). Participants also reported that they prepare their indigenous 
remedies by boiling them in a pot filled with water for an average of 5 to 30 minutes. After 
it was boiled, they would leave the drink to cool and be strained before drinking.  
 
The lack of standardization in the preparation of medicinal plants was observed in this 
phase of the study. For instance, only a few respondents indicated the number of leaves 
they used to make preparations. Some indicated mature or large-sized leaves, while 
others did not. The sizes of leaves of different medicinal plants vary according to the 
developmental stage of the tree. In addition, only a few indicated the amount of water 
used to boil the medicinal plant part. Finally, the time it took to boil the medicinal plant 
part was not stated by many despite the researcher’s effort to extract such information. 
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The duration of boiling of the medicinal plant mentioned by a few respondents’ ranged 
from 15 to 20 minutes of boiling. Despite the lack of standardized reporting on preparation 
methods for medicinal plants observed in this phase of the study, medicinal plants’ 
decoctions for hypertension are common practices reported globally (Mphuthi 2015:259; 
Malik et al. 2018:789; Baharvand-Ahmadi et al. 2016:1; Boadu and Asase 2017:1). The 
current results seen in this phase of the study support these findings.  
 
4.9.1.7 Subtheme 2.3: Administration of medicinal plants for hypertension 
therapy 
 
Boadu and Asase (2017:1), in a study of herbal medicines used in the treatment of human 
diseases in Ghana, reported oral administration as the common route for herbal 
administration. Other medicinal plant administration routes have been described to 
include topical, rectal, inhalational, and drops. The active ingredient in a medicinal plant 
and the disease being treated usually determines the administration route (Busia 
2016:20; Boadu and Asase 2017:1). Boadu and Asase (2017:1) further reported that 
absorption of medicinal plants containing alkaloids is readily absorbed from the 
gastrointestinal tract system, while the best routes for administering essential oils of 
terpenoids are nasal and dermal routes. Even though infusions can be administered 
rectally and nasally, most infusions and decoctions have been reported to be best 
administered orally (Busia 2016:20; Boadu and Asase 2017:1).   
 
Interview analysis of hypertensive patients in this phase of the study showed that the main 
route for administering medicinal plants in managing hypertension was the oral route. The 
dosage of the medicinal plant taken by the participant seems conflicting among 
participants but helpful. The frequency of intake of the medicinal plant for hypertension 
was also reported based on the interview analysis. The quotations below show evidence 
of routes, dosage, and duration of intake as reported by participants: 
 
“I blend the moringa leaves along with garlic, ginger, and lime to make the 
juice that I drink two times a day, in the morning and at night, I have a glass 
full.” “Usually, I just take as much as will make a glass of juice.” P4 
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“I pick the fresh leaves of Trumpet tree and put in boiling hot water like a tea 
and drink one cup of tea two times a day.” P23 
“I drink lemongrass tea. ……….I can drink the tea anytime, but I usually drink 
it in the morning and at night.” P15 
“I use the leaves from the moringa tree…….. I soak it in water and keep it in 
the refrigerator, and I drink it all day long instead of regular water.” P9 
“I take a combination of bukut leaf and serosi…... I boil …………when it is 
cool, I drink a glass every morning and night.” P7 
“I use the soursop leaf and moringa…………when that is cooled, I put it in 
the fridge and drink a glass every day.” P8 
“I use the fruit Annato. I always boil the fruit and drink the juice throughout 
the day. I take like half a glass.” P5 
 
Most respondents in this survey reported the oral route as the main route for medicinal 
plant intake. Respondents take medicinal preparations as decoctions, teas, juices, 
mixtures of boiled plant parts, or herbs to manage their hypertension. Half a glass to full 
glass of medicinal plant therapies is taken either once or twice per day, as reported by 
most participants. Some participants reported taking the therapy anytime and for the 
entire day. Apart from participant 8, who reported refrigerating the therapy, most 
participants were silent about the preparation’s shelf-life, while others seemed to prepare 
fresh teas or decoctions each day. The respondents indicating varying dosages for 
medicinal plants in this study corroborated similar research reports conducted in other 
places (Ahmed, Mahmood, Ashraf, Bano, Tahir, and Mahmood 2015:109; Malik et al. 
2017:789).  
 
The major issue with the dosing of indigenous therapies, especially those obtained from 
medicinal plants, is knowing the correct concentration to use. The time when herbs or 
plants are harvested presents a unique challenge in the concentration of active 
ingredients found in medicinal plants. For instance, during the rainy season, the active 
ingredients found in plants and herbs are diluted due to the availability of rain, whereas 
in the dry seasons, plants seem to conserve water as such has a high concentration of 
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active ingredients compared to the rainy season (Lawson and Rand 2019:561; 
Nascimento, Luiz, Vega, Villela, and Nascimento 2019:18293). Depending on the season, 
therefore, the plant or herb is harvested for medicinal usage, the concentration of what is 
extracted and used varies. Additionally, the extraction method, the amount of water used 
for the extraction, and the leaves’ size or weight could play a role in the dosage and 
potency that was eventually consumed by the participant. In this study, participants 
reported drinking “half or full glass,” and that they drink the extracted therapy “every day, 
all day or when they feel the pressure.” The results observed in this study resonate with 
previously published studies where the season and time when medicinal plants are 
harvested affect their concentration (Lawson and Rand 2019:561; Nascimento et al. 
2019:18293; Nare, Pienaar, and Mphuthi 2018:1) 
 
4.9.1.8 Theme 3: Efficacy of medicinal plants for hypertension 
 
The importance and usefulness of indigenous therapies cannot be overemphasized. The 
practice has been recognized, approved, and encouraged by the World Health 
Organization (WHO 2019:11). In its 2019 global report on traditional and complementary 
medicine, a General Program of Work (GPW13) on traditional and complementary 
medicines came into effect by the World Health Organization (WHO 2019:11). The 
GPW13 is a priority strategy where traditional and complementary therapies are promoted 
for universal health coverage, health emergencies, and promoting healthier living globally 
(WHO 2019:11). The WHO’s recognition of indigenous medicine could only span from the 
therapy’s effectiveness, and historically, long before the WHO’s declarations, many 
indigenous populations have used indigenous therapies to treat their ailments. 
Participants in this study gave examples of how their health condition improved because 
of indigenous therapy usage. In this phase of the study, the beliefs about medicinal plants’ 
efficacy, safety, concomitant use with Western medications, and medicinal plants’ 
availability reported by participants and revealed by emerged sub-themes are discussed. 
No doubt, participants are confident about the efficacy of medicinal plants in the 
management of hypertension, as evidenced by the quotes below:  
“You see, there is cure in nature I only need to find it.” P1 
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“Very, very effective even the doctors are surprised that my blood pressure 
is under control, and I told them I was not taking their medicines.” P12 
 
“Anytime I monitor my hypertension, it is under control. My daughter bought 
me a pressure measuring instrument that I use, and my pressure is under 
control. My friend Mr._____ uses hospital medication, but my pressure is 
more under control than his own. So, I know that mine is more effective than 
hospital drugs.” P20 
 
“Look, man! These herbs are very effective—nothing like them. I have been 
using them to manage my hypertension well with only the herbs I monitor it, 
and it's not high. It works, man! Hehe.” P24 
 
4.9.1.9 Subtheme 3.1: Beliefs on the effectiveness of medicinal plants and 
duration of use 
 
Many medicinal plants have traditionally shown great potential in managing various 
diseases, and historically, many Western medications have been discovered in medicinal 
plants (Al Dasi et al. 2016:1). However, with the growing use of medicinal plants in both 
developed and developing nations, there is still insufficient knowledge about how they 
produce their mechanism of action in treating or preventing disease progression (Ekor 
2014:117; Shaikh et al. 2020:1008). In Belize, traditional and cultural beliefs on 
indigenous therapies are robust and have been preserved from the pre-colonial era; 
thereby, ethnic heritage is passed on to generations as a means of strengthening 
communities. These beliefs and cultures as also been reported in similar studies in South 
Africa (Mphuthi 2015:220; Nare et al. 2018:1) and Suriname (Mans et al. 2017b:1). 
Participants in this phase of the study reported that medicinal plants used for the 
management of hypertension are effective in lowering blood pressure, as evidenced by 
the quotations below:  
Herbal medicines come from nature, and they are the best. Every time I go 
to the doctor, my blood the pressure is normal. It has to be the herbs that I 
take because I do not take the other medicines at all. However, I still go to 
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the doctor and check mi pressure, and they give me the hospital medications, 
but I don't take them. I only use mi herbs. P6 
The herbs work very good. Most times, I don't take my other medicines that 
the doctor gave me. P8 
I think it helps me a lot because I keep my weight down. I had a big belly, but 
now it's gone down a lot, and my feet no swell up again. P2 
Drinking a glass of lemongrass juice in the morning helps lower high blood 
pressure and boost blood circulation in the body. It also helps to get rid of 
uric acid, harmful toxins, and fats, as it works as a diuretic to cleanse and 
detoxify the body. It increases the frequency and quantity of urination, which 
helps to flush out bad cholesterol and other toxins. P17 
 
Presently, the medicinal plants available in Belize have not been extensively studied and 
described, even though the practice of using medicinal plants has existed from time 
immemorial. Although many of the participants were not able to provide insight into the 
biological activity of the medicinal plant they are using for their hypertension, most of them 
reported a lowering of their blood pressure, as evidenced by the fact that some of the 
participants did not take their medications but went to the hospital regularly to check their 
blood pressure (P6, P8). The participants indicated that Western practitioners always 
verified their claims of indigenous therapies’ effectiveness to lower their blood pressure. 
The effect of medicinal plants was described by most participants and not necessarily the 
mechanism of the action of the various medicinal plants they are using for their 
hypertension. Participant P17 described the effect of lemongrass as having antioxidant 
and diuretic effects. 
 
Although very little scientific evidence is currently available in Belize regarding medicinal 
plants for hypertension, the revelations from hypertensive patients give insight and raise 
the need for extensive scientific evaluations of medicinal plants used in Belize. A 
comprehensive pharmacological evaluation of these medicinal plants will provide further 




When hypertensive participants were asked the expected time it would take the 
indigenous therapy to bring relief to their hypertension, participants reported various 
durations of use and indicated that they had been drinking the treatment for different 
lengths of time. Some participants mentioned that they had been drinking the herbs for 
about three months, while others for more than ten years. The quotes from the 
participants expressed some of their beliefs, as shown in the quotes below:  
“I don't know if it cures it, but I take it almost every day.” P13 
“There is no cure, but if I feel good, then I don't take both my bush and 
medications.” P8 
“The herbs make you feel good fast. I don't think it will cure the pressure, but 
they work fast.” P6 
“I can't say how long because that would depend on the person and how they 
take care of themselves. For me, I will take the herbs as long as it keeps me 
feeling good, and it does.” P4 
“Once you take it daily as a tea, your pressure will never go high no matter 
what. But you also need to watch what you eat and take care of yourself.” P5 
“The way I know it is that you can't cure hypertension. So, all my life, I will 
take soursop to make sure I stay well and healthy. It is possible there may be 
another herb somewhere that I can use to cure it, but until then, I will use 
soursop. Also, it is possible the Whiteman told us that there is no cure, so we 
can continue to use his medicines, but one day we will find a cure. I am sure 
of that.” P24 
“The herbs are to be taken for the rest of your life.” P15 
“Well, my elders tell me that I cannot stop taking the trumpet tree leaves, or 
else my pressure will go up again.” P23 
 
One common consensus among participants is that the indigenous therapies do not cure 
hypertension, even though many confessed that they effectively control high blood 
pressure. Although a wide range of antihypertensive medications is available for 
managing hypertension to date, no cure has been found for this cardiovascular disorder 
(Esler, Lambert, Schlaich, and Schlaich 2016:1996). The choice of medicinal plants as a 
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substitute for the management of hypertension may have its value, especially since it is 
related to cultural perceptions, yet to date, no cure has been reported in the use of 
medicinal plants or any medication for the cure of hypertension (Esler et al. 2016:1996). 
Lifestyle modification, prescribed medications, and indigenous therapies are used to 
manage hypertension (Bakris 2016:1). The medicinal plants’ inability to cure hypertension 
as reported by participants’ supports previously reviewed studies (Malik et al. 2018:789; 
Baharvand-Ahmadi et al. 2016:1; Boadu and Asase 2017:1). 
 
4.9.1.10 Subtheme 3.2: Safety and adverse effects of medicinal plants  
 
The global increase in the awareness of indigenous therapies, mostly medicinal plants, 
is perceived to be safe and efficacious simply because they are found naturally coupled 
with the long ancestral history of linkage to African folklore beliefs and practice has led to 
people consuming indigenous therapies (Mphuthi et al. 2015:135; Mphuthi and Pienaar 
2017:1; Mans et al. 2017a:1). For instance, generally, it is common for people to try 
indigenous remedies before coming to the hospital (Mphuthi 2015:30); this is also a 
common practice in Belize. Some participants combined indigenous remedies with 
Western medications for the treatment of ailments. While therapies using medicinal plants 
have always reported the potential efficacy of most indigenous products, the majority of 
such remedies remain untested, with their use remaining poorly monitored (Ekor 
2014:117; Shaikh et al. 2020:1008).  
 
The resulting consequences of this are inadequate knowledge of their possible adverse 
reactions, their mode of action, possible contraindications, and possible interactions with 
the already existing Western pharmaceuticals and functional foods that can promote the 
rational and safety of medicinal plants (Chanda and Kaneria 2011:1251). When 
participants in this study were asked if they experienced side effects of medicinal plants 
for managing hypertension, most of them reported not experiencing any side effects. 
However, a few participants reported dizziness, stomach upset and burns, bad feeling, 
drops of pressure, and sugar, and a few participants were not sure. Some of the quotes 
are shown below and summarized in Figure 4.21 below. 
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“None that's the good part about taking natural remedies; they cause you 
no harm at all.” P10 
“No, man! No side effects at all. These are natural herbs given to us by 
nature. They do not harm you if you take the right amount.” P24 
“Nope, I don't experience any side effects.” P22 
“Sometimes, my stomach would get a little upset.” P2 
“Yes, I have. Sometimes the herbs will take my pressure and sugar too low.” P7 
“If I drink it in the morning, my stomach would burn, so most times I take it 
at night after I eat.” P13 
 
 
Figure 4.21 Reported side effects in the use of medicinal plants for hypertension 
 
The utilization of indigenous therapies and supplements has expanded tremendously in 
recent years, with over 80% of individuals depending on them as part of primary 
healthcare (Ekor 2014:117; Al Disi et al. 2016: 326; Shaikh et al. 2020:1008). Even though 
indigenous therapies have demonstrated promising potential, the efficacies of a decent 
number of such therapies remain untested, and their utilization is either inadequately 
checked or not observed by any means (Ekor 2o14:117; Shaikh et al. 2020:1008). This, 
therefore, results in insufficient information on indigenous therapies’ method of activity, 
potential adverse responses, contraindications, and interactions with existing 
pharmaceutical products. A significant issue in the use of indigenous therapies is that of 
safety, which makes it essential for studies into their activities and for regulatory bodies 
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to put in place measures for the safety of public health (Ekor 2014:1; Shaikh et al. 
2020:1008). Additionally, concerns with indigenous therapies’ adverse effects and 
interactions are because medicinal plants have not been refined and process for toxicity; 
therefore, the likelihood of drug-herb or herb-herb interactions and adverse effects are 
likely to occur (Ekor 2014:117; Shaikh et al. 2020:1008). Although some of the 
participants reported not experiencing side effects with medicinal plants, a few mentioned 
that they experienced side effects ranging from stomach upset, dizziness, bad feeling, 
and the dropping of both blood glucose and pressure. The general perception that 
medicinal plants are safe because they are natural has been reported in other studies 
(Ekor 2014:117; Malik et al. 2018:789; Baharvand-Ahmadi et al. 2016:1; Boadu and 
Asase 2017:1; Shaikh et al. 2020:1008). The results of this study support these previous 
studies.  
 
4.9.1.11 Subtheme 3.3: Availability and cost of medicinal plants 
 
The patient’s choice to use indigenous medicines is also informed by religion, cultural 
beliefs, the cost of those herbs, and the perceived efficacy of such herbs in treating the 
condition (Ekor 2014:117; Al Disi et al. 2016:326). Medicinal plants are affordable and 
readily available, making them the first line of treatment in many communities (Ekor 
2014:117; Shaikh et al. 2020:1008).  
 
Hypertensive participants in this phase of the study reported that most of the medicinal 
plants they used to manage their hypertension are found within the community, while a 
few will buy some of the ingredients in the market. The claim on availability and cost of 
medicinal plants among participants is evidenced in Figure 4.22 and the quotes below: 
I spend nothing. Soursop leaves were free. I have a soursop tree and my 
neighbors too.” P14 
I make my own soursop leaves tea because I have soursop trees in my yard, 
so I do not spend money to purchase it.” P21 
I do not spend any money since it grows in the wild and readily available.” P5 
183 
 
I do not spend anything on the moringa leaf. My friend in Ladyville has a tree, 
and she sends for me.” P9 
The tea does not cost any money, but the pills from the hospital cost money 
when the hospital runs out, I have to buy the pills. The bush to make the tea 
is available and free.” P15 
I spend about $20 - $25 per month (1 big pineapple for the week costs $5). 
It's not cheap. One pineapple gives you tea for 2-3 days.” P2 
The only thing I buy is garlic. I have everything else available. The garlic cost 
about $6 or $8 for the month.” P4 
Honestly, every month I buy like $15.00 worth of cats claw. Sometimes I use 
all, but most times I don't.” P16 
 
Figure 4.22 below summarizes the responses of the participants. Most participants 
reported that they did not spend any funds to purchase the therapies because they either 
grew them at home or were found within the community. Friends and family members 
also supply medicinal plants to their relatives at no cost. Some participants reported that 
when they do not have a supply, they buy from the market, and the cost is reported to be 
less than 50 Belizean dollars in a month.  
 
 
Figure 4.22 Availability and cost of medicinal plants for hypertensive therapy 
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High morbidity and mortality rates with most diseases have always been associated with 
high hospitalization rates and an increase in the cost of therapy (McPhail 2016:143). 
Besides, long-term management of diseases such as hypertension and other 
comorbidities has been reported to be the greatest challenge for patients and healthcare-
givers (McPhail 2016:143). Hypertension and related diseases it has been reported to 
have a high cost of management, especially that prescribed Western medications are 
expected to be taken for life since cure cannot be attained (Kastor and Mohanty 
2018:1995). In addition, the cost of western medications, cultural beliefs (WHO 2019:11), 
and the perception that indigenous therapies are harmless because they are natural (Ekor 
2014:1; Shaikh et al. 2020:1008) are excellent incentives to make people with 
hypertension to explore alternative methods for hypertension management. Most of the 
participants in this phase of the study did not have to pay for the indigenous therapies 
they used for their hypertension because they are found in abundance in nature, within 
their homes, communities, or readily available in the market. The report by hypertensive 
patients on indigenous therapy costs confirms its ease of availability, accessibility, 
affordability, and perhaps effectiveness as a drive for usage. This study resonates with 
previously published studies on the availability and affordability of medicinal plant 
therapies to manage hypertension and other diseases (Ekor 2014:117; Malik et al. 
2018:789; Baharvand-Ahmadi et al. 2016:1; Boadu and Asase 2017:1). 
 
4.9.1.12 Subtheme 3.4: Concomitant use of medicinal plants with western 
medications  
 
Most of the participants expressed that medicinal plants were the only therapy they used 
to manage their hypertension, while few others acknowledged that they combined the 
medicinal plants with prescribed Western therapies. Some of the participants who used 
only medicinal plants still visited their doctors to check their blood pressure. The same 
participants felt that combining medicinal plants and prescribed Western medications will 
better manage their blood pressure. Furthermore, as a precautionary measure, a few 
participants reported taking medicinal plants and western medications just if the medicinal 
plant does not work to lower their blood pressure. The following quotes by the participants 
are evidence of the statements above: 
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“No, I don't do that because it’s either one or the other. Can't do two because 
you will end up in problem. I prefer bush medicine, though.” P4 
 
“I only take herbs. I do not take the medicines from the doctor at all. The 
herbs are natural, so they are much better. Once you take those, you don't 
need the other medications.” P6 
 
“Not only that, I drink the sour sap leave drink because that works for me. I 
don't drink my medicines from the doctor because they make me feel bad.” 
P11 
 
“No, I don't combine the herbs with western medicines. I have no need to. 
When I make my cat's claw in my liter bottle, it helps greatly, so I don't bother 
with western medicines.” P16 
 
“No, I do not do that because I don't like natural with chemicals.” P18 
 
“No, I don't use hospital drugs. One time I went, and they gave me the drugs, 
but I felt worse when I tried them, so I stopped. I only use herbs, and I am 
good. My body doesn't like hospital medications.” P20 
 
“No, I do not take any other medication with the herbs because once you are 
taking herbs and take tablets, the herbs won't work the way it should, so I 
don't take any tablets.” P23 
 
“I only take my Aspirin 81mg to help the blood circulate better. As for 
hypertension, I only use my soursop.” P24 
 
“Yes, I do because that's what the doctor prescribed for me, and I didn't want 
to be non-compliant and have my blood pressure go high. I do not intend to 
stay on the medication; this is why I started the teas along with healthy eating 
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and exercise. I have dropped 25 pounds already, and my doctor says if I 
continue, I can be taken off the medication.” P1 
 
“I still take my prescribed medication because I had a brother who had a 
severe stroke due to high blood pressure, and he had to be in a wheelchair 
for years before he died. I don't want the same to happen to me. It was 
sudden. I try to exercise, keep my weight down, take my medicines as 
prescribed, and also drink natural medicine - one that is safe to take with my 
medication.” P3 
 
“I take both the herbs and the other medicines. I only took the other medicines 
for the diabetes, and I still got high blood pressure. So now I take both so that 
they will work better.” P7 
 
“I still take my soursop leaf tea with my high blood pressure medicines. I find 
out that I do not need to take the same dose after my herbal treatment, even 
if the dose needs to be reduced. Even though I am still taking my herb and 
blood pressure medicines, I do not take them at the same hours. I still follow 
my doctor's instruction because I am just trying to see the effect of soursop.” 
P21 
 
“Yes. I take the pills every day, but when I feel bad because my pressure is 
high, I drink the soursop tea too.” P14 
 
A few participants in this phase of the study reported the concomitant use of indigenous 
and Western therapies. The wide acceptance and usage of indigenous remedies in 
different cultures provide a growing habit of concurrent herb-drug use, which raises the 
concern of pharmacokinetic interactions (Parvez and Rishi 2019:275). In many 
communities, administering medicinal plant extracts in combination with therapeutic 
drugs is common, raising the potential for herb-drug interactions. Furthermore, the rising 
interest in natural products for disease management has reawakened natural product 
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research in drug discovery, necessitating pharmacokinetic studies of phytochemicals, 
including their potential for drug interactions (Parvez and Rishi 2019:275). Many 
indigenous therapies have shown promising potential, thereby establishing clear 
therapeutic use potentials. However, many of these indigenous products are yet to be 
scientifically tested, and a large portion of them are either not monitored or poorly 
monitored scientifically (Ekor 2014:117; Shaikh et al. 2020:1008). The lack of adequate 
knowledge of indigenous therapies, especially their pharmacokinetics and 
pharmacodynamics with existing Western medications and other food products, calls for 
caution and a more rational approach in their usage (Ekor 2014:117; Mphuthi 2015:212). 
Accordingly, the availability of Western medicines in the market follows rigorous 
laboratory and clinical investigations and goes through stringent regulatory scrutiny; the 
same cannot be said of indigenous therapies. A wide variety of acclaimed herbal 
therapies currently lack sufficient scientific data and information on such products’ safety 
or efficacy (Parvez and Rishi, 2019:275). The concomitant use of Western medications 
and indigenous therapies reported in this phase of the study could result in drug-herb 
interactions that could result in clinical outcomes that are unwanted or toxic.  
 
To make matters worse, most individuals consuming both Western and indigenous 
therapies do not provide vital documentation of such usage, thereby making clinical 




The hypertensive patients who participated in this phase of the study primarily reported 
medicinal plants as the indigenous therapies used to manage their hypertension. The 
plants reported were soursop (n=9), moringa (n=6), garlic (n=5), lime (n=3), ginger (n=2), 
lemongrass (n=2), breadfruit (n=2), cat’s claw seed (n=1), pineapple (n=1), annatto (n=1), 
bukut (n=1), serosi (n=1), trumpet leaves (n=1), and cinnamon (n=1). Some of the 
participants reported a single medicinal plant, while others reported a combination of 




Most of the participants indicated that the knowledge of indigenous therapies was passed 
down from generation to generation. Similarly, the participants reported their sources 
about medicinal plants’ knowledge to come from family members, community, 
practitioners, or other sources. In addition, for most of the participants, the duration of 
medicinal plant use for the management of hypertension was mostly dependent on the 
number of years diagnosed with hypertension. Whereas some of the participants did not 
specify the duration of usage, most participants reported short-term, medium-term, and 
long-term use of medicinal plants to manage hypertension.  
 
Most participants reported leaves as the common part of the medicinal plant used to 
manage their hypertension. In addition to leaves, fruits, roots, seeds, stems, and whole 
herbs have been reported by a few participants as parts of plants used to manage their 
hypertension. Although no standardized method was reported by respondents, boiling 
medicinal plant parts was the commonly reported preparation method reported by 
hypertensive participants. In addition, most respondents in this survey reported the oral 
route as the primary route for medicinal plant intake. 
 
Respondents took the medicinal preparations as decoctions, teas, juices, mixtures of 
boiled plant parts, or herbs to manage their hypertension. Half a glass to full glass of 
medicinal plant therapies is taken either once or twice per day, as reported by most 
participants. Some participants reported taking the therapy anytime and for the entire day. 
 
Although many of the participants could not provide insight into the medicinal plant’s 
biological activity for their hypertension, most of them reported lowering their blood 
pressure. Respondents go to the hospital to regularly check their blood pressure even 
though they were not taking their prescribed medications. Additionally, participants 
reported various durations of use and indicated that they had been drinking the treatment 
for different time lengths. Some participants mentioned that they had been drinking the 




Although a few participants reported dizziness, stomach upset and burns, bad feeling, 
drop in blood pressure and sugar, most participants reported not experiencing side effects 
with the medicinal plants they were taking for their hypertension.  
 
Finally, hypertensive participants in this phase of the study reported that most of the 
medicinal plants they used to manage their hypertension are found within the community, 
while a few will buy some of the ingredients in the market. Most participants reported that 
they did not spend any funds to purchase the therapies because they either grew them 
at home or were found within the community. Friends and family members also supply 
medicinal plants to their relatives at no cost. Some participants reported that when they 
do not have a supply, they buy from the market, and the cost is reported to be less than 
50 Belizean dollars in a month. A few participants in this phase of the study reported the 
concomitant use of indigenous and Western therapies. The participants reported that 
combining both medicinal plants and prescribed Western medications will better manage 
their blood pressure.  
 
The concomitant use of western medications and indigenous therapies reported in this 
phase of the study could result in drug-herb interactions resulting in beneficial clinical 
outcomes or unwanted toxic responses.  
 
4.11 PART 2: VENDORS OF INDIGENOUS HYPERTENSIVE THERAPIES 
 
This part of the study presents data collected and analyzed from the vendors/suppliers of 
indigenous therapies in Belize.  
4.11.1 Introduction 
 
Previously, in chapter three and earlier in this phase of the study, it was mentioned that 
two sets of data were qualitatively collected using interviews. One data set was collected 
from hypertensive patients who are users of indigenous therapies, and another set of data 
from indigenous therapies vendors. This second part of the qualitative study presents an 
analysis of interviews from vendors of indigenous therapies to gain a more in-depth 
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insight into the different therapies, preparation methods, and possible 
ethnopharmacology of medicinal plants used to manage hypertension in Belize. The 
critical themes and sub-themes categories that emerged from the analysis of interviews 
are discussed in this section. The description is in regards to the research objectives and 
the reviewed literature.  
4.12 DATA COLLECTION 
 
Vendors for this phase of the study were identified using three methods. Vendors were 
identified from the indigenous vendor association, hypertensive patients using indigenous 
therapies, and finally, using the snowball effect from previously identified vendors. 
Appointments were made with vendors through phone calls to meet at a place convenient 
to them. Most meetings for the interviews were conducted at the vendor’s homes or 
business place, with a few at the market place where they sell medicinal plants to their 
clients. One-on-one, face-to-face interviews were conducted with the vendors by first 
explaining the study’s purpose and obtaining their consent before the interview sessions. 
Each interview session lasted approximately 15-40 minutes.  
Field notes were taken, and records of observed non-verbal clues were also taken. 
Written notes on the information provided by the vendors' were given unique codes known 
only to the researcher to protect the participant’s privacy, anonymity, and confidentiality.  
4.12.1 Data analysis and management  
 
Data analysis for vendors was conducted in the same manner as in the previous section. 
As described earlier, the thematic analysis described by Vaismoradi and Snelgrove 
(2019:2) was used for data management and analysis of interviews conducted for part II 
of this phase. A theme was described as a thread of underlying meanings within similar 
pieces of data that can be combined to give the researcher answers to the study 
phenomenon (Vaismoradi and Snelgrove 2019:2). The results of 19 interviews conducted 
with vendors were transcribed using Microsoft Excel and loaded into QDA Miner Lite 
version 2.0.6 online software for coding. Miner Lite is free software that is easy to use, 
generates basic themes, and has capabilities for exporting tables to Microsoft Word or 
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Excel for further analysis. Miner Lite® has a limitation because it cannot generate smart 
charts, as done by other Microsoft Word and Excel applications. The tables were exported 
to word, and the Microsoft Word smart art was used to design the figures. The integrated 
themes and sub-themes generated were presented in narrative passages and used to 
summarize study findings on indigenous therapies used to manage hypertension in 
Belize. The input from the research supervisor was received, which allowed for fine-tuning 
of themes and sub-themes. Since the emphasis for this phase of the study was to explore 
a deeper understanding of how indigenous therapies are prepared, dosage, 
administration, and perceived efficacy, only the themes, and sub-themes that address 
these issues were presented. Other useful information from the themes and sub-themes 
are summarized and presented in Table 4.13 below.  
 
4.13 PART 2: OBJECTIVES 
 
● To identify indigenous remedies used by vendors in the management of 
hypertension.  
● To describe the preparations, treatments, storage, and efficacy of indigenous 
therapies used by vendors in managing hypertension in Belize. 
4.14 VENDORS’ BIOGRAPHICAL PROFILE AND SUMMARIES OF 
RECOMMENDED THERAPIES FOR HYPERTENSION 
 
The vendors for this phase of the study comprised 19 licensed vendors of indigenous 
therapies in Belize. Part of the emerged themes and subthemes analyzed from the 
interviews with 19 vendors are summarized and presented in Table 4.13. The main 
themes and sub-themes that addressed this phase of the study’s significant objectives 
are also discussed and described below. Nine of the vendors were males, and 10 were 
females. The average age of practice as an indigenous therapist was approximately 30 
years, with 66 years being the maximum age, while the minimum age was nine years. 
Most of the vendors learned about indigenous therapies from their ancestors, such as 
grandparents, parents, or older people in the community. Few vendors learned therapies 
from other indigenous healers and herbal books, while one vendor took college courses 
on indigenous medicines. A vast majority of the vendors either cultivate medicinal plants, 
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obtain them from the forest, or purchase from the local market. The plant parts reported 
by the vendors for use in the preparation of therapy for hypertension were leaves, fruits, 
seeds, bark, and the calyx of flowers. Leaves were the most commonly used plant parts 
by most vendors, as shown in Table 4.13 below.  
Furthermore, $100Bzd was reported by vendors as the highest cost of indigenous 
antihypertensive therapies. Some vendors only accepted donations for their services, 
while a few vendors reported charging a minimal fee to cover the therapy’s cost of 
ingredients. In contrast, some vendors do not charge their clients for the services offered. 
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Based on the table above, some of the medicinal plants used for the treatment and management of hypertension were 
soursop, lemongrass, moringa, turmeric, garlic, ginger, Almonds, Serosi, Lime leaves, Sage, Boldo, Annatto, Bukut, and 
Dandelion.  Leaves of the medicinal plants were the most part reported by the vendors. 
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4.15 EMERGING THEMES AND SUB-THEMES 
 
Based on the data analyzed from interviews conducted with indigenous therapy vendors, 
the following themes and sub-themes developed are presented in Table 4.14 and 
discussed below: 
 
Table 4.14 Themes and sub-themes that emerged during the analysis of interviews 
with vendors 
  
 Themes  Sub-themes  
1. Indigenous therapies for 
hypertension 
 
1.1 Recommended antihypertensive therapies  
1.2 Preparation of therapies for hypertension 
1.3 Treatment of hypertension 
2. Perceived efficacy of 
indigenous therapies  
2.1 Proposed mechanism of action of indigenous 
therapies for hypertension 
 
The above themes and sub-themes are discussed in the paragraphs that follow. 
 
4.15.1 Theme 1: Indigenous therapies for hypertension 
 
Since time immemorial, indigenous therapies have been used to treat many illnesses in 
many communities (Ekor 2014:117; Mphuthi 2015:214; Shaikh et al. 2020:1008). Despite 
this global popularity, indigenous therapies have not developed in the same way as 
Western medicines due to the lack of policies and procedures for testing their 
effectiveness (WHO 2019:83). Often, those trained in Western medicine have taken this 
to mean that indigenous therapies are not effective in treating diseases. However, the 
apparent absence of techniques for testing its effectiveness should not be seen as 
evidence of its ineffectiveness (WHO 2019:84). In many countries, society determines the 




While some healing aspects of indigenous medicine are not yet fully understood, many 
communities have faith in the efficacy of their therapeutic benefits because they are 
attuned to their culture and their beliefs (Ekor 2014:117). The analyzed results of 
interviews on vendors of indigenous therapies showed that the vendors are confident of 
their therapy to effectively lower, control, or even cure hypertension. The identified 
therapies, preparation methods, and how the therapies are used in managing 
hypertension are discussed and described below.  
 
4.1.1.1 Subtheme 1.1: Recommended antihypertensive therapies  
 
A summary of medicinal plants recommended by vendors for hypertension management 
is presented in Table 4.13 above. The therapies used by the vendors for hypertension 
included roots (carrots, turmeric, garlic, and Talawala), seeds (cats claw, flaxseed, and 
sesame seeds), fruits (lime, grape, pineapple, and noni), and leaves (bukut, John Elema, 
Hammonds, soursop, lemongrass, moringa, breadfruit tree leaves, celery, orange tree 
leaves, annatto, boldo, samento, serosi, rosemary, neem, lime tree leaves, sage, 
dandelion, and Senna), and flowers (sorrel calyx). In addition, honey was mentioned as 
a sweetener by one vendor, and coconut water as a cooling agent. Seven vendors 
mentioned soursop leaves as a remedy for hypertension, making soursop leaves the most 
common therapy reported by the vendors. Additionally, therapies mentioned more than 
once by the vendors included garlic (4), serosi (3), ginger (3), boldo (2), annatto (2), 
Hammonds (2), bukut (2), and turmeric (2). All other therapies were mentioned just once 
by the vendors, as summarized in Table 4.13 above. Some of the mentioned therapies 
are evident by the quotes of the vendors below:  
 
“I recommend fresh soursop leaves and garlic.” P7 
“I treat hypertension with soursop leaves, and it works.” P12 
“I use soursop to treat my patients that have pressure.” P18 
“I give people with pressure moringa leaves.” P14 
“I will give my clients Hammonds leaves for their pressure.” P17 
“I treat hypertension with turmeric and garlic.” P11 
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“………..for hypertension, I recommend the skin of the pineapple.” P5 
“I recommend carrots, celery, and honey to my patients for their pressure.” P10 
“I always recommend a mixture/combination of Samento, Boldo, and 
Annato for hypertension.” P4 
“I used serosi, lime tree leaves, sage, boldo, soursop, annatto, and 
bukut, but the main plant I use for hypertension is dandelion.” P1 
 
A single medicinal plant or a combination of two or more plants in managing hypertension 
has been reported. The variety of medicinal plants recommended by the vendors has 
been reported in similar studies elsewhere, hence confirming the results of the study’s 
current phase (Malik et al., 2018:789; Mans et al., 2017a:1; Baharvand-Ahmadi et al. 
2016:1; Boadu and Asase 2017:1). Although some of the reported medicinal plants have 
verifiable scientific evidence in terms of their pharmacological activity, many are still being 
studied, and information obtained from native users provides useful information for 
scientific research into such medicinal therapies. For instance, soursop (Annona muricata 
L.) leaves, which were mostly mentioned by vendors in this phase of the study, belong to 
the family Annonaceae and reported in some studies to be useful in managing a few 
ailments, including hypertension (Mans et al. 2017b:1). The medicinal plant contains 
bioactive ingredients such as alkaloids and essential oils. The fruit also contains vitamin 
B2, vitamin B1, and vitamin C (Moghadamtousi, Fadaeinasab, Nikzad, Mohan, Ali, and 
Kadir 2015:15625). Although no evidence has been shown for its anticancer activity, 
indigenous people consider the fruit an alternative to managing cancer (Tundis and 
Loizzo, 2017:30).  
 
4.15.1.2 Subtheme 1.2: Preparation of indigenous therapies for hypertension 
 
The vendors of indigenous therapies were asked how they prepare their therapies for the 




At least two vendors indicated that they would first “prepare or clean out the patients” 
before the hypertensive therapy, while other vendors simply give the therapy without 
patient preparation. The vendor’s quotes on how they prepare their patients and therapies 
are shown below: 
 
Vendor 2, for instance, will first prepare his hypertensive patients as evidenced by the 
quote below: 
“The treatment is given in three different stages and dosages. First, I prepare 
the patient by beginning with the ‘cooling’ given on week one, the ‘purge’ given 
on week two (2), and then treatment named ‘Spanish 9’ given after that. The 
cooling and purge are given as a single dose within a week interval. The 
Spanish nine is prepared by me the same day it will be taken by the patient. I 
prepare a fresh batch of the remedy in the morning time.” P2 
 
Vendor 14, on the other hand, recommends a “clean out” before the commencement of 
therapy, as evidenced by his quotes below: 
“Before taking this treatment, one must have a “clean out.” For cleanout, I 
use Senna and salt in the morning. The patient must be active after a dose 
of Senna and salt, so the treatment can be effective, and drink plenty of 
water. Clean out must be done on a full moon for best results.” P14 
 
Other vendors, however did not describe patient preparation; instead, they described the 
preparation of the therapy for hypertension as evidenced by their quotes below:  
You take a pinch full of the grinded John Elama and put it in one liter of water, 
and leave to soak for 5 to 10 minutes. After being prepared, you take one cup 
full every morning.” P15 
I prepared the soursop therapy by putting some dried soursop leaves into a 
cup containing boiled water. I allowed soaking for 10-15 min, strain, and ready 




The Talawala herb has no bitter taste. It was removed from the stem. The root 
must be cleaned of all orange Hair-like covering. A 6-inch piece must be boiled 
only with purified water and 1L of purified water. Allowed to stand for an 
overnight (10h). Strain water from the residue of the root. Collect water and 
place in a glass container, placed in a refrigerator. P13 
A few branches of moringa would be boiled in purified water with no sugar. 
One medium lime will be added after boiling if the person wants a bit of flavor. 
The boiled mixtures would let sit overnight (10h). The mixture would then be 
strained, and pure boiled water was collected. The pure boiled water was 
placed in a glass container and refrigerated while drinking. The number of 
leaves needed to prepare a treatment. P14 
A handful of fresh lemongrass was prepared every day. All fresh. You can get 
the grass from me, but only one week of supply at a time, or you can grow 
your own at home, even better. The lemongrass is boiled with 2-3 cups of 
water and drank as tea. P19 
Well, turmeric can be prepared using different methods. One of the ways is by 
using the root that I usually recommend. The root can be boiled until the color 
of turmeric is gone, then allowed to cool, and you can strain it and use drink 
the boiled water. However, you can also buy the turmeric powder form and 
boil it. Garlic can be sprinkled on food, eaten raw, or swallowed.  P11 
 
Two vendors who recommended Hammonds leaves differ in their preparation methods. 
One vendor recommended that fresh leaves of Hammonds be soaked in water for about 
10 min, while the other vendor recommended that the leaves be boiled for approximately 
20-30 minutes, as evidenced by their direct quotes below:  
About three fresh leaves of Hammonds are soaked in 1L of water for about 10 min 
transferred into a mug, and drink a cupful every morning. P16 
Boil five leaves of Hammonds in a small pot of water on a low heat for about 20 -




The vendors reported a variety of methods for preparing therapies for hypertension. Most 
of the vendors prepare their antihypertensive therapies by decoction or infusion of the 
medicinal plant part. Boiling (decoction) and infusion have been reported as a common 
medicinal plant preparation (Busia 2016:14). The result seen in this study resonates with 
similar studies that reported decoction and infusion as the common method of medicinal 
plant preparation (Busia 2016:14; Malik et al. 2018:789; Baharvand-Ahmadi et al. 2016:1; 
Boadu and Asase 2017:1). Differences in preparation methods were also observed 
among vendors. Moreover, reports from indigenous therapy vendors showed diversity in 
water quantity and the length of time to boil the therapy. The lack of standard preparation 
methods for medicinal therapies for hypertension seen in this phase of the study is a 
general problem that has been reported in other studies (Evans-Anfom, 1986:13; Boadu 
and Asase 2017:1). The lack of standardization methods, sometimes even from the same 
healer, is a major source of concern with indigenous therapies (Boadu and Asase, 
2017:1). The implication of a lack of standardization in preparing medicinal therapies 
means variations in dosage, potency, and efficacy could be experienced by clients even 
from the same vendor (Baharvand-Ahmadi et al. 2016:1; Boadu and Asase, 2017:1). 
 
In addition to the lack of standardization in preparation methods, vendors reported 
differences in the shelf-life of the prepared therapies for use in hypertension, as 
evidenced by the quotes below: 
“The lemongrass is to be prepared fresh every day.” P19 
“I usually recommend that it is freshly prepared, or a small amount prepared, 
and you keep it refrigerated for about three days.” P16 
“The shelf life is twelve hours because I do not add any preservatives to my 
therapies.” P2 
“I add citric acid as a preservative. So it can last for about a year.” P4 
“It is good for about five days if you keep it cool in the refrigerator; otherwise, three 
days.” P17 
“Shelf life of the product after soaking is maximum of seven (7) days. All 
products should be kept in a cool place and away from direct sunlight.” P1 
“I usually recommend like about six months when refrigerated.” P15 
220 
 
“It can be stored up to one year if you store it in a fresh condition and keep it 
refrigerated.” P12 
 
The vendors of indigenous therapies reported that therapies could be prepared fresh each 
day and last for between 12 hours and up a year if properly refrigerated. Differences in 
the shelf-life observed in this phase of the research are an additional challenge for 
indigenous therapies globally (Ekor 2014:117; WHO 2019:16; Shaikh et al. 2020:1008). 
The differences in standard methods of preparing indigenous therapies compromise their 
safety, especially that there is a general lack of standard quality control, information for 
patients, and appropriate labeling of the active ingredients found in the indigenous 
therapies (Ekor 2014:117; Shaikh et al. 2020:1008). Recognizing these concerns inspired 
the World Health Organization to partner with different countries and researchers to 
provide the traditional medicine manual as a guide to practitioners and patients in the use 
of medicinal plants (WHO, 2019:12). As a country, Belize is yet to sign up partnerships 
with WHO, especially that not many studies have been conducted in the country to 
support the partnership. This study’s final report will provide baseline data for future 
studies on medicinal plants and other indigenous remedies found in Belize.  
 
4.15.1.3 Subtheme 1.3: Treatment of hypertension 
 
The use of indigenous therapies for the management of various diseases is a deep-rooted 
tradition in many cultures, and Belize is not an exception (Ekor 2014:117; WHO 2019:1; 
Shaikh et al. 2020:1008). In Belize, medications given at government hospitals, inclusive 
of antihypertensive medications, are usually free. Patients are only asked to purchase 
drugs from pharmaceutical stores when they are not available in a government facility. 
Despite the free and easily accessible medications at government facilities, the deep-
rooted culture of indigenous therapies was noted in this study since the practice has not 
extinct. The indigenous therapies vendors reported various medicinal plants they used in 





Vendor two gave a detailed treatment recipe as follows: 
 
“First, I give them bukut, serosi, garlic, and coconut water for cooling. After a 
week, I give Senna (piss-a-bed) for the purge. Finally, I treat hypertension with 
Spanish 9. Spanish 9 is a special remedy that I prepare. It is a combination of 
flaxseed, Rose Mary, Sesame seed, Senna, and neem leaves.” P2 
 
Other vendors are quoted as evidenced below: 
“I mix the breadfruit leaves and serosi in bottles already for people to drink. 
The bottles are 1L and the person drinks like ¼- ½ cup about two to three 
times daily.” P3 
“Well, I have a remedy that I prepare and is in this bottle. It is a 
mixture/combination of samento, boldo, and annatto leaves. I give my clients 
to use for their hypertension.” P4 
“I give my patients boiled soursop leaves to drink 1 cup 3 times a day before 
meals and at bedtime.” P7 
“One cup of boiled moringa and soursop leaves can be taken every night.” P8 
“My product is already prepared, and customers are given 1L bottle, and they 
are to take ½ glass three times a day.” P10 
“Four teaspoonfuls of the boiled soursop leaves were mixed with one cup of 
boiling water three times a day.” P12 
“With Talawala, the hypertensive patient will drink 4 ounces after meals twice 
daily. Mild hypertensive patients and stressed hypertensive patients: drink 4 
ounces once daily.” P13 
“The patient will consume 4 ounces of moringa tea once daily. Then, the dose 
is reduced as per the patient’s response. Before bedtime, one glass of water 
at room temperature.” P14 
“Drink one cup full of the Hammonds tea every morning.” P17 
“The freshly prepared lemongrass is to be taken - one cup of hot tea two times 
a day.” P19 
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Most of the vendors have a ready-made packaged therapy for hypertension to sell or 
provide to their clients. The therapy is either a single medicinal plant or a combination of 
plants. The treatment is made up of either a single or a combination of medicinal plants. 
Most vendors indicated ¼ cup to full cup of the treatment once, twice, or three times per 
day. A few recommended the treatment to be taken before bedtime. Specifically, vendors 
gave quantifiable indications of the amount of treatment to be taken by the clients. As 
observed earlier, the vendors reported no standardized therapy regimen in this phase of 
the study, even though vendors seem to be confident of the therapy’s ability to lower and 
control hypertension. Many widely used medicinal therapies have great potential and 
abilities in treating or managing some diseases; however, many are yet to be tested and 
their use standardized for public consumption (Ekor 2014:117; Shaikh et al. 2020:1008). 
The promising possibilities of plants as a continual source for new drugs discovery is still 
being documented (Sharifi-Rad, Salehi, Stojanović-Radić, Fokou, Sharifi-Rad, Mahady, 
Sharifi-Rad, Masjedi, Lawal, Ayatollahi, Masjedi, Sharifi-Rad, Setzer, Sharifi-Rad, 
Kobarfard, Rahman, Choudhary, Ata, and Iriti 2017:1), and current studies are showing 
increased in demand and use of indigenous therapies in the treatment and management 
of various diseases (Ekor 2014:117; Malik et al. 2018:789; Baharvand-Ahmadi et al. 
2016:1; Boadu and Asase, 2017:1). This increased demand for indigenous therapies is 
not unrelated to their perceived safety, availability, and affordability (Ekor 2014:117; 
Shaikh et al. 2020:1008). The World Health Organization recently reported that 
approximately 80% of people in both developing and developed countries rely on 
alternative herbal therapies to treat various ailments (WHO 2019:23). Despite their 
promising potentials, many challenges have been reported with indigenous therapies. For 
instance, their rational use is hampered by inadequate knowledge of their safety and 
adverse effects (WHO 2019:14; Shaikh et al. 2020:1008). Also, the lack of standard 
methods of indigenous therapies for the treatment of diseases as seen in this phase of 
the study is a general problem that has been reported in the literature (Evans-Anfom 
1986:12; Boadu and Asase, 2017:1). The full potentials of indigenous therapies can only 
be fully maximized when standard methods of preparation, therapy, and adverse effects 




Another challenge noted with the vendors is the combinational therapies with medicinal 
plants. It is a common practice for two or more medications to be prescribed to patients 
with western medicines, especially in the management of infections such as tuberculosis, 
Acquired Immune Deficiency Syndrome (AIDS), and chronic diseases like hypertension 
and diabetes mellitus type-2 (Dookeeram et al. 2017:1119). The combinational therapies 
with Western medications are deliberately designed to achieve additional therapeutic 
benefits (Dookeeram et al. 2017:1119). The combinational therapy with medicinal plants 
however is not without concerns. For instance, various interactions can occur between 
medicinal plants’ components leading to complications (Che, Wang, Chow, and Lam 
2013:5125). The often complicated and unpredictable herb-herb interactions can lead to 
severe detrimental consequences even though combinational therapy’s intended desire 
was to enhance the therapeutic effect (Kahraman et al. 2020:1). The herb-herb 
interactions are usually due to the lack of understanding of active ingredients found in 
these herbs and the molecular mechanisms behind their bioactive properties (Che et al. 
2013:5125). Furthermore, the lack of preclinical and clinical studies on medicinal plants’ 
safety and efficacy makes their combination another major concern. However, because 
indigenous therapies evolved over the years have shown many combinatorial therapies 
(Che et al. 2013:5125), the practice reported by the vendors in this phase of the study 
was not without credibility given the historic combinational use of indigenous therapies. 
 
4.15.1.4 Theme 2: Perceived efficacy of indigenous therapies 
 
The perceived efficacy, safety, availability, and affordability of indigenous therapies have 
been reported to be the main reasons for their continual patronage (Ekor 2014:117; WHO 
2019:12; Shaikh et al. 2020:1008). In this phase of the study, most indigenous therapy 
vendors reported alleged efficacies in their antihypertensive therapies to lower, control, 
or even out-rightly cure hypertension. This claim is evidenced by their comments as 
quoted and summarized in Figure 4.23 below: 
Some vendors who indicated control or lowering of hypertension with their therapies 
No, but it controls the pressure but cannot say it cures. P10 
Turmeric and garlic usually control blood pressure. P11 
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No, my therapy does not cure hypertension, but it keeps it under control. P14 
This lowers the pressure, so it no high again. P17 
The herb helps to lower the pressure. P18 
I am sure that my remedy controls the patient's hypertension. P2 
The herb does not cure hypertension; it only regulates it and lowers it along 
with management and lifestyle changes. P3 
 
A few of the vendors, however, lay claim that their therapies cures hypertension, as shown 
by the quotes below:  
It will cure hypertension once you take it as long as possible and follow the 
instructions. P12 
It will cure hypertension, especially if you take it every day, and you also need 
to do other things like do not put on weight and eat more green vegetables like 
chaya, callaloo, chib, and others. P20 
This remedy will cure high blood pressure, and you will see the results in about 
2 weeks’ time. P15 
It will cure hypertension once it is taken according to instruction and as long as 
possible. P7 
 
Few vendors claimed if the therapies are taken, it will eliminate the need for prescribed 
Western medications, as evidenced by the quotes below: 
It lowers the pressure. Since it is taken every day, there is no need to continue 
taking pills for high blood pressure. P5 
As far as I know, turmeric and garlic only control blood pressure, but they 
eliminate the need for medications. P6 






One vendor confessed that the therapies could control blood pressure, but he had no 
documentation to prove as evidenced by the quote below:  
 
My blood pressure therapy controls hypertension only, however, there is no 
documentation to prove the success of the remedy. I am sure that the patients 
have their blood pressure under control. P10 
 
               
Figure 4.23 Reported efficacy of medicinal plants in the management of 
hypertension 
 
The lowering of blood pressure abilities of many medicinal plants has been well described 
and documented (Al Disi et al. 2016:1; Malik et al. 2018:789; Baharvand-Ahmadi et al. 
2016:1; Boadu and Asase 2017:1; WHO, 2019:16; Maresa et al. 2017:1). In this phase of 
the study, most indigenous therapy vendors reported a lowering or control of blood 
pressure with their therapies. These results resonate with previous studies and reports 
on medicinal plants’ therapeutic benefits to lower or reduce blood pressure (Malik et al., 
2018:789; Baharvand-Ahmadi et al. 2016:1; Boadu and Asase 2017:1; Mans et al. 
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2017a:1). Some vendors claim that their therapies can cure hypertension calls for further 
investigation because, presently, there is no known scientific report on medicinal or 
western medication that cures primary hypertension. Involvement of genetic, dietary, 
nonspecific lifestyle, stress, and family history are usually associated with primary 
hypertension’s etiology (Bakris 2016:1). Presently, the management of primary 
hypertension involves lifestyle modification, the Dietary Approaches to Stop Hypertension 
(DASH), and the use of prescribed Western medications (Bakris 2016:1). The claim by 
some of the vendors to cure hypertension is presently contrary to available scientific 
evidence and medical practice, as such needs additional research and exploration. 
 
The lack of standardization reported with indigenous therapies is common in many 
communities. Although there is a lack of sufficient knowledge of these therapies, they 
have always served as useful guides for identifying and discovering new drugs (Ekor 
2014:117; Shaikh et al. 2020:1008). This study is a judicious approach in documenting 
baseline information for future research in Belize.  
 
Concerning the concomitant use of indigenous therapies with western medications, 
vendors were asked if their clients could combine them with prescribed western 
medications. The analyzed responses of vendors are evidenced by the quotes below:  
“No, they cannot take with it other medicines because the herb will not work 
how it’s supposed to.” P15 
“The mixture helps the patient to get well and does not interfere with western 
medications because I ask my patients to stop taking White man medicine 
when they are on my therapy.” P5 
“Yes, they can take with it other medicines.” P14, P16 
“Yes, yes, they can take with their medications. It is safe.” P17, P19. 
 
Not many vendors responded to the question on the concomitant use of medicinal plants 
with prescribed Western antihypertensive medications. The few vendors that responded 
had conflicting recommendations to their clients. Some vendors believe that the remedies 
should not be combined with Western medications, while a few vendors indicated that the 
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therapies could be combined. The natives have used these therapies for an extended 
period and may imply a certain level of perceived safety by the vendors. This is a common 
belief in many cultures that use indigenous therapies. For instance, in countries like Brazil 
and the European Union (EU), traditional medicines are generally acceptable, and 
because they have a recognized efficacy are considered a special category of drugs 
called traditional herbal medicine products (THMP). These special categories of drugs 
have less rigorous requirements in terms of non-clinical and clinical studies (Moreira, 
Moreira, Teixeira, Monteiro, De-Oliveira, Ana, and Paumgartten 2014:248). The THMP’s 
are considered generally acceptable when they have reported long-standing use as 
herbal therapies and if there is evidence of their safety (Moreira et al. 2014:248). The use 
of medicinal plants reported for the management of hypertension should still be done with 
caution since, historically, herbal therapies have been shown to have mild to grave 
adverse effects (Ekor 2014:117; Shaikh et al. 2020:1008; Kahraman et al. 2020:1). 
 
4.15.1.5 Subtheme 2.1: Proposed mechanism of action of indigenous therapies 
for hypertension 
 
Vendors of indigenous therapies were asked how their therapies work to lower or control 
blood pressure, and the quotes below evidenced some of their responses: 
“Hammonds tree leaves clean out the kidney and make you urine out a lot just 
like the high blood pressure medicine pills.” P17 
“It cleans the body out, especially the kidneys that make blood pressure high.” P16 
“Lemongrass cleans the liver and takes out the fat and purifies the blood that's 
why the person urinates a lot.” P19 
“The samento builds up the immune system, the annatto lowers pressure, 
makes you urine a lot, so it's good for enlarged prostate too, and the boldo is 
a detoxicant of the liver and blood. So these jungle medicines work by treating 
the liver that makes the cholesterol.” P4 
“The pineapple skin tea cleans the kidneys. By keeping the kidney clean, all 
the toxins are removed from the body, and therefore the blood is clean, so the 
blood pressure does not go up. It also cleans the body of the bad fat. It also 
makes the patient pee very often.” P5 
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“John Elama leaves cleans all the toxins and impurities from the body, 
especially from the blood, which flows through the body. If the blood is sick, 
then the person will be sick too. Once the person is ok, then everything will be 
ok. It is just a balance.” P15 
The summary of the vendor’s responses is also captured in Figure 4.24 below: 
Figure 4.24. How indigenous antihypertensive therapies work 
 
The vendors proposed a few mechanisms of action for recommended medicinal plants. 
The mechanism of action included antioxidant activity, antidiuretics, hypolipidemic, and 
immunomodulatory activity. The general mechanisms of action attributed to many 
medicinal plants used in managing hypertension have been reported and are briefly 
discussed here for some of the medicinal plants mentioned by the vendors.  
 
4.15.1.6 Soursop (Annona muricata) [Linnaeus] 
 
Soursop was the major mentioned medicinal plant for hypertension management by the 
vendors. Their claims are not without significant support from scientific studies. For 
instance, in a controlled randomized trial with 143 human subjects, Alatas, Sja'bani, 
Mustofa, Mukti, Bawazier, Irijanto, Zulaela, and Tomino (2017:223) investigated the 
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reduction in both hypertension and serum uric acid among the study subjects. 
Additionally, antagonism of Ca2+ leading to vasodilation and a reduction in blood pressure 
have been reported with leaf extract of soursop (Nwokocha, Owu, Gordon, Thaxter, 
McCalla, and Ozolua 2012:1436). These studies gave preclinical indications of the 
efficacy of soursop in the management of hypertension. Similar studies have indicated 
the indigenous use of soursop to reduce hypertension (Nwokocha et al. 2012:1436; Mans 
et al. 2017a:1). Inconclusive reports of atypical Parkinsonism have been linked to soursop 
when large quantities of the extracts are taken (Lannuzel and Ruberg 2008:2122). The 
adverse effects associated with soursop are directly connected to inhibition of 
mitochondrial complex I of annonamine and annonacin, which are potent neurotoxins 
found in soursop (Lannuzel and Ruberg 2008:2122). 
 
4.15.1.7 Tumeric (Curcuma longa) [Zingiberaceae] 
 
Tumeric is a spice used for cosmetics, cooking, medicines, and dyes. As a food additive, 
it gives color and flavor to food. More than 100 compounds have been identified in 
turmeric, including curcuminoids, polysaccharides, volatile oils, and turmerone, 
arturmerone, and zingiberene responsible for the aroma in turmeric (Prasad and 
Aggarwal 2011:13). The active component found in turmeric is curcumin (Qin, Huang, 
and Gong 2017:68). Curcumin has further been reported to lower serum lipids and 
decreases oxidative stress in the process, acting as a cardioprotective agent (Li, Ding, Li, 
Xu, Yang, Bi, and Wang 2015:1; Maithilikarpagaselvi, Sridhar, Swaminathan, Sripradha, 
and Badhe 2016:1; Pulido-Moran, Moreno-Fernandez, Ramirez-Tortosa, and Ramirez-
Tortosa 2016:1). The mention of turmeric by the vendors; therefore, as an indigenous 
therapy for hypertension, is not without scientific backing. Turmeric and its compounds 
have no known toxicity to humans and animals. The United States Food and Drug 
Administration (USFDA) has been conducted clinical trials on turmeric and reported that 





4.15.1.8 Moringa (Moringa oleifera) [Moringaceae] 
 
A few vendors mentioned moringa as a medicinal plant that they recommend to their 
clients for hypertension. The anticancer, lipid-lowering, antioxidant, and antidiabetic 
effects of moringa extracts have been reported (Gonzalez-Trujano, Martinez-Gonzalez, 
FloresCarrillo, Luna-Nophal, Contreras-Murillo, and MagdalenoMadrigal 2018:1; 
Vergara-Jimenez et al. 2019:2). In addition, extracts of moringa leaves have been shown 
to produce anti-inflammatory, diuretic, and antihypertensive activities (Chatterjee, 
Anantharaya, Singhal, Chatterjee, Shiva, and Mallya 2016:119). Furthermore, moringa 
contains vitamins, phytochemicals such as carotene, and minerals (Haseeb, Sarkhil, 
Fayazuddin, and Ahmad 2019:767). The numerous pharmacologic activities of moringa 
are still being evaluated for both preclinical and clinical trials, but their use as 
antihypertensive agents, as seen in this phase of the study, resonates with previous 
studies done elsewhere on moringa (Adefegha, Oboh, Iyoha, and Oyagbemi 2019:1; 
Gbankoto, Sindete, Adjagba, Sangare, Attakpa, and Awede 2019:1257; Vergara-
Jimenez, Almatrafi, and Fernandez 2019:2).  
 
4.15.1.9 Roselle (Hibiscus sabdariffa) [Malvaceae] 
 
Roselle, a popular beverage in Africa, Caribean, and Europe, has been indicated as a 
medicinal plant by the vendors. Roselle’s blood pressure-lowering activities have been 
extensively studied and reported both in humans and animals (Onyenekwe et al. 
1999:199; Herrera-Arellano et al. 2004:375, 2007:6; Mojiminiyi et al. 2007:292; Mozaffari-
Khosravi et al. 2009:48; Inuwa et al. 2012:563; Hopkins et al. 2013:84; Islam 2019:14). 
Consequently, different mechanisms for Roselle’s antihypertensive effect have been 
reported (Islam 2019:14). The vasorelaxant pathways of both VSMCs (Ali et al. 2005:369; 
Ajay et al. 2007:388) and endothelial cells (Ajay et al. 2007:388; Herrera-Arellano et al. 
2007:6) are primed by Roselle. Inhibition of Ca2+ channels (Ajay et al. 2007:388), the 
opening of KATP channels (Sarr et al. 2009:45), and increased production of NO (Ajay et 
al. 2007:388; Alarcon-Alonso et al. 2012:751) are various mediated pathways of Roselle’s 
relaxant effect. Roselle has also been reported to decrease heart rates in rats (Odigie et 
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al., 2003:181) and inhibit cardiac hypertrophy (Odigie et al. 2003:181; Inuwa et al. 
2012:563). Additionally, Roselle’s diuretic abilities (Onyenekwe et al. 1999:199; Ali et al. 
2005:369; Herrera-Arellano et al., 2007:6; Alarcon-Alonso et al. 2012:751; Jalalyazdi et 
al. 2019:107), its ability to lower uric acid concentration (Ali et al. 2005:365) and decrease 
in the blood sodium content of stage 1 and 2 hypertensive humans (Herrera-Arellano et 
al. 2007:6) have all been described. The flavonoid and phenolic compounds found in the 
roselle calyces, such as chlorogenic acids, anthocynins, quercetin, and kaempferol are 
mainly responsible for the hypotensive effect roselle (Okereke, Iroka, and Chukwuma 
2015:16).  
 
4.15.1.10 Lemongrass (Cymbopogon andropogoneae/citratus) [Poaceae] 
 
As noted earlier in this report, the vendors mentioned lemongrass for hypertension 
management. Interestingly, lemongrass has been reported to exhibit antihypertensive 
properties attributed to its active phytochemicals, especially citral (Devi et al. 2011:143, 
2012:539475; Unuigbe et al. 2019:1). The antihypertensive effects of lemongrass, its 
relaxant properties, and its effects in rats have previously been extensively described 
(Devi et al. 2011:143, 2012:539475; Bastos et al. 2010:331). Additionally, Dzeufiet, 
Mogueo, Bilanda, Aboubakar, Tédong, Dimo, and Kamtchouing (2014:507) evaluated the 
effect of fresh lemongrass extracts on ethanol - and sucrose-induced hypertension in rats. 
The results of their study showed a reduction in blood pressure in rats through the 
improvement of biochemical indices such as kidneys, vascular endothelium, and oxidative 
status signifying lemongrass therapeutic potentials for hypertension (Dzeufiet et al. 
(2014:507). In a recent human study, a significant increase in urine frequency, volume, 
and urinary electrolytes was also reported when lemongrass was administered to human 
participants compared to the control group indicating the diuretic properties of lemongrass 






4.15.1.11 Celery (Apium graveolens) [Umbellifers] 
 
The vendors also mentioned celery as a therapy for hypertension. Reported studies on 
celery showed an active ingredient called N-butylphthalide, which gives celery an 
aromatic odor and flavor and has been reported to lower blood pressure in animal models 
(Tsi and Tan, 1997:34; Dianat et al. 2015:12; Tashakori-Sabzevar et al. 2016:619). Aortic 
ring contractions caused by cumulative calcium increases in high potassium (60mM) due 
to blocking Ca2+ influx via calcium channels have also been shown to be a property of 
apigenin, which is a flavone isolate of A. graveolens (Ko, Huang, and Teng 1991:1). 
Additionally, this medicinal plant can reduce oxidative stress by its flavonoid content that 
potentiates antioxidant mechanisms (Popovic et al. 2006:1; Dianat et al. 2015:1; 
Tashakori-Sabzevar et al. 2016:619). 
 
4.15.1.12 Cerasee (Momordica charantia) [Cucurbitaceae] 
 
Cerasee (Momordica charantia) is another medicinal plant identified by indigenous 
therapy vendors to manage hypertension. The leaves and fruits of cerasee are rich in 
phytochemicals and have been reported in indigenous folk therapies for managing 
cancers, diabetes, high blood pressure, and various viral and bacterial infections (Polito, 
Bortolotti, Maiello, Battelli, and Bolognesi 2016a:1). Cerasee contains five major 
phytochemicals, which include terpenoids and saponins (cucurbitacines and 
cucurbitanes), heteropolysaccharides (such as mannose, rhamnose, glucose, galactose, 
and arabinose), phenols and flavonoids, peptides and proteins (such as mormorcharins 
and momordins), and other fatty acids, sterols, essential oils and amino acids 
(Dandawate, Subramaniam, Padhye, and Anant 2016:81). The pharmacological activity 
attributed to cerasee is its antioxidant and anti-inflammatory properties (Dandawate et al. 
2016:81). Currently, no sufficient data exist on the adverse effects of cerasee; however, 
Raman and Lau (1996:349) reported that ceracee should be avoided in an allergy to 
Cucurbitaceae families and individuals with glucose-6-phosphate dehydrogenase 
deficiency because of the risk of developing favism. Other adverse effects include 
reduced fertility (Stepka, Wilson, and Madge 1974:645), pregnancy (Basch, Gabardi, and 
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Ulbricht 2003:356), risk of kidney toxicity (Mardani, Nasri, Hajian, Ahmadi, Kazemi, and 
Rafieian-Kopaei 2014:35), and possible acute intestinal nephritis (Beniwal, Gaur, Singh, 
Raveendran, and Malhotra 2017:456). 
 
4.15.1.13 Neem (Azadirachta indica) [Meliaceae] 
 
Neem’s mention by the vendors has some historical and indigenous significance in that 
neem trees have been reported to be used to manage many illnesses. For instance, 
Alzohairy (2016:1) reported that the activities of neem include but are not limited to 
antidiabetic, antimalarial, antifungal, antioxidant, and antinephrotoxicity, anticancer, 
antiviral, and anti-inflammatory activities. The most important active ingredient found in 
need is azadirachtin. Others include salannin, nimbidol, nimbolinin, nimbin, gedunin, 
nimbidin, ascorbic acid, nimbiol, quertin, nimbanene, 7-desacetyl-7-benzoylgedunin, n-
hexacosanol, 6-desacetylnimbinene, nimbolide, 17-hydroxyazadiradione, polyphenolic 
flavonoids, β-sitosterol, and sodium nimbinate (Djibril, Mamadou, Gérard, Geuye, Oumar, 
and Rigal 2015:52; Alzohairy 2016:1). Possible mechanisms of action for hypertension 
have been reported to antioxidant activity due to scavenging free radicals (Alzohairy 
2016:1), and a combination of Ca2+, NO-inhibition, and a possible negative inotropic 
activity of the heart (Shah, Gilani, Hanif, Ahmad, Khalid, and Bukhari 2014:418). 
 
4.15.1.14 Pineapple (Ananas comosus) [Bromeliaceae] 
 
Pineapple skin (peel) is one of the recommended therapies that vendors gave their clients 
to manage hypertension. Bromelain is the name of the pineapple fruit extract and is found 
in high concentrations in the pineapple stem. Bromelain contains carbohydrates, 
cellulases, phosphatases, glycoproteins, thiol endopeptidases, and some protease 
inhibitors (Pavan, Jain, Shraddha, and Kumar 2012:1). Furthermore, bromelain has been 
reported to have some therapeutic effects, including improving angina pectoris, reversing 
platelet aggregation inhibition, thrombophlebitis, and enhancing the absorption of many 
drugs (Pavan et al. 2012:1). The pharmacologic benefits of bromelain in hypertension are 
234 
 
not very clear but are thought to breakdown cholesterol, thereby improving arterial and 
general cardiovascular function (Pavan et al., 2012).  
 
4.15.1.15 Boldo (Peumus Molina) [Monimiaceae] 
 
The vendors also identified boldo as one of the medicinal plants used for the management 
of hypertension. Lau, Ling, Murugan, and Mustafa (2015:522), in a recent review, 
reported that Boldine [(S)-2,9-dihydroxy-1,10-dimethoxy-aporphine] is a potent 
antioxidant that contains aporphine alkaloids and exhibits some health benefits such as 
antitumor, cytoprotective, anti-inflammatory, and antidiabetic activities. This review 
further describes the attributed mechanism of boldine action to its ability to reduce 
oxidative stress due to its antioxidant properties. Additionally, the phenolic compounds 
found in boldine have been reported to have potential in controlling the pathogenesis of 
chronic diseases that result from oxidative stress, maintain physiological homeostasis, 
and scavenge oxygen and nitrogen reactive species (Forni, Braglia, Mulinacci, Urbani, 
Ronci, Gismondi, Tabolacci, Provenzano, Lentini, and Beninati 2014:1255; Impei, 
Gismondi, Canuti, and Canini 2015:1526; Gómez and Velarde 2018:3). Low toxicity with 
boldine has also been reported (Lau et al. 2015:522). 
 
4.15.1.16 Annatto (Bixa orellana) [Bixaceae] 
 
The vendors identified annatto leaf extracts as one of the medicinal plants recommended 
for hypertension. The crude pigment extract of Bixa orellana L. is called Annatto, contains 
norbixin, bixin, and carotenoids (Raddatz-Mota, Pérez-Flores, Carrari, Mendoza-
Espinoza, de León-Sánchez, Pinzón-López, Godoy-Hernández, and Rivera-Cabrera 
2017:1729). The presence of salicylic acid, tomentosic acid, bixaghanene, phenylalanine, 
crocetin, ellagic acid, saponins, flavonoid bisulfates, bixol, isobixin, bixein, threonine, 
sterols, tryptophan, and tannins have been revealed from phytochemical studies of Bixa 
Orellana leaves (Venugopalan, Giridhar, and Ravishankar 2011:9). The antioxidant 
properties of boldine are attributed to stereoisomers of vitamin E, tocotrienols, and 
tocopherols (Patacsil, Tran, Cho, Suy, Saenz, Malyukova, Ressom, Collins, Clarke, and 
Kumar 2012:93). Boiled extracts of boldine leaves have been reported for use in 
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managing hypertension, obesity, vomiting, prostate disorders, heartburn, urinary 
disorders, hypercholesterolemia, nausea, diuretic, renal insufficiency, and as a laxative 
(Raddatz-Mota et al. 2017:1729). 
 
4.15.1.17 Trumpet tree (Cecropia peltata) [Cecropiaceae] 
 
The widespread use of trumpet tree for treating hypertension and type 2 diabetes mellitus 
has been reported (Salas, Brenes, and Morales 1987:127; Andrade-Cetto, Cárdenas, and 
Ramírez-Reyes 2007:203). The therapeutic effects of trumpet tree have been associated 
with triterpernoids, phenolic acids, chlorogenic acids, and flavone C-glycoside, such as 
isovitexin, isoorientin, orientin and vitexin (Costa, Schenkel, and Reginatto 2011:913; 
Ortmann, Réus, Ignácio, Abelaira, Titus, de Carvalho, Arent, Dos Santos, Matias, Martins, 
de Campos, Petronilho, Teixeira, Morais, Streck, Quevedo, and Reginatto 2016:469; 
Rivera-Mondragon, Bijttebier, Tuenter, Custers, Ortíz, Pieters, Caballero-George, Apers, 
and Foubert 2019:1). The medicinal befits of leaf extracts of the trumpet tree have been 
reported to include treatment of respiratory diseases, inflammation, hypertension, 
malaria, and diabetes mellitus type 2 (Rivera-Mondragon, Ortíz, Bijttebier, Vlietinck, 
Apers, Pieters, and Caballero-George 2017:1500).  
 
4.15.1.18 Cat's Claw – [Uña de Gato] (Uncaria tomentosa) [Rubiaceae] 
 
The phytochemicals found in Uncaria tomentosa include alkaloids, polyphenols, quinovic 
acid glycosides, and the plant has been used as an anti-gastric ulcer, anti-inflammatory, 
antiviral, anti-arthritic, and to reduce the adverse effects of chemotherapy (Araujo, 
Feitosa, Murata, Furigo, Teixeira, Lucena, and Carvalho 2018:1). Reduced lipid 
concentration and insulin sensitivity improvement have been reported in rats with U. 
tomentosa (Araujo et al. 2018:1). The phytochemicals reported in U. tomentosa include 
sterols, flavonoids, oxindole alkaloids (such as mitraphylline, isopteropodine, 
isomitraphylline, pteropodine, and uncarine F.), polyphenols, polyhydroxylated 
triterpenes, catechin tannins, and quinovic acid glycosides (Kemper, 1999:4). U. 
tomentosa’s antihypertensive activities were reported to be associated with its antioxidant 
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activity. Blockage of voltage-gated calcium channels, and negative inotropic activity on 
the heart, hypolipidemic, and vasodilation due to inhibition of the sympathetic nervous 
system have been reported (Kemper 1999:5). Although no updated scientific information 
was found on U. tomentosa’s toxicity, Kemper (1999:9) earlier in a review reported clinical 
data to show hypotension, sedation, slight diarrhea, and possible renal failure. The 
medicinal plant is traditionally contraindicated in children less than three years, 
pregnancy, and lactation (Kemper 1999:4). 
 
4.15.1.19 Breadfruit (Artocarpus altilis) [Moraceae] 
 
Artocarpus altilis has been used in folk medicine to manage high blood pressure and has 
been reported to contain phytochemicals such as essential oils, valine, phenylalanine, 
isoleucine, and leucine (Liu, Ragone, and Murch 2015:847). Many identified compounds 
of A. altilis demonstrate antifungal activity, antitumor properties, inhibition of platelet 
aggregation, and antibacterial activity (Mukesh, Boey, Kumutha, Bavani, Ling, and Kaveti 
2014:091). Breadfruit extracts have also been reported to lower mean arterial blood 
pressure in mice by enhanced nitric oxide production and reduced angiotensin-mediated 
mean arterial blood pressure (Christian, Jackson, and Mukhopadhyaya 2019:4). 
Similarly, Nwokocha et al. (2012:1096) reported hypotensive effects of A. altilis due to 
negative chronotropic activity, antagonism of Ca2+ channels, and alpha peripheral 
sympathetic activity.  
 
4.15.1.20 Ginger (Zingiber officinale) [Zingiberaceae] 
 
Ginger has been reported to reduce blood pressure mainly from its bioactive constituents, 
namely (6)-gingerol and (6)-shogoal (Khan, Ullah, and Azhar 2019:125). Liu and Huang 
(2016:1) reported (6)-gingerol as a potent angiotensin II type 1 receptor blocker. Inhibition 
of angiotensin-converting enzyme (ACE) and lipid peroxidation in hearts of rats has been 
demonstrated (Akinyemi et al. 2013:641). Potent scavenging of oxidant molecules like 
peroxynitrite has been reported with zingerone, another active compound found in ginger 
(Shin et al. 2005:7617; Khan et al. 2019:4). Akinyemi et al. (2014:317) recently reported 
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ginger inhibition of ACE-1 activity while reducing LDL levels, total cholesterol, vLDL, and 
triglycerides.  
 
4.15.1.21 Garlic (Allium sativum) [Amaryllidaceae] 
 
Garlic has been reported for its anti-inflammatory, hypocholesterolemic, anti-cancer, 
antibacterial, hypotensive and antioxidant properties, and its healing abilities have been 
reported in various cultures and societies for over a thousand years (Chan et al. 2020:3). 
The significant bioactive organo-sulfur substances reported in garlic are diallyl disulfides 
(DADS), methyl thiosulfonate, S-allyl cysteine (SAC), diallyl trisulfides (DATS) and Allicin 
(Qidwai and Ashfaq 2013:12), produce its unique mechanisms of action. Various garlic 
types have been reported to lower systolic, diastolic, or both blood pressure in extensive 
reviews (Banerjee et al. 2002:4; Chan et al. 2020:3). In the same vein, garlic was reported 
(Qidwai and Ashfaq 2013:12 Chan et al. 2020:3) to have an efficacy of almost 80% as an 
anti-hypertensive herb. Additionally, inhibition of vascular smooth muscle cell 
proliferation, reduction in angiotensin II-induced vasoconstrictor responses, abrogating 
activation of NF-κB, and inhibition of endothelin-1 induced vasoconstriction have all been 
reported with garlic (Banerjee et al. 2002:4; Castro et al. 2010:552; Pan et al. 2013: 
627375). 
 
4.15.1.22 Bukut (Cassia grandis) [Leguminosae] 
 
The phytochemical studies of C. grandis revealed the medicinal plant to have potent 
purgative and laxative properties due to anthranoides (Lodha, Joshi, Vyas, Upadhye, 
Kirve, Salunke, Kadu, and Rogye 2010:330). The therapeutic effect of C. grandis was 
further reported by Lodha et al. (2010:330) to possess antidiabetic properties due to its 
effect on triglycerides, cholesterol, and glucose in rats. Although most of the scientific 
studies reviewed on C. gradins are in relation to its antidiabetic effects, its antioxidant 
properties may be a great potential in the management of hypertension (Prada, Keita, de 
Souza, Lima, Acho, da Silva, Carvalho, and Amado 2019:191; Sakharkar and Chauhan, 
2017:295). The presence of flavonoid and phenolic compounds in C. grandis have been 
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associated with its antioxidant and free radical scavenging properties (Umamaheswari 
and Chatterjee, 2007:61). Other reported therapeutic potentials of C. grandis include 
fever, indigestion, jaundice, bronchitis, gonorrhea, burns, nausea, and syphilis 
(Wasantwisut and Viriyapanich, 2003:60).  
4.16 CONCLUSION 
 
This study’s qualitative phase revealed different medicinal plants used by both 
hypertensive patients and vendors of indigenous therapies interviewed. The various 
reasons for indigenous therapy use were connected to culture, availability, affordability, 
and perceived efficacy and safety of the indigenous therapies. The medicinal plants 
mentioned were carefully reviewed and compared with current scientific studies. Most of 
the claims made on the medicinal plants have verifiable scientific backing. Medicinal 
plants secondary metabolites were the basis for the pharmacological activity seen with 
many reported medicinal plants.  
 
Secondary metabolites found in medicinal plants are the major therapeutic effects for 
hypertension and other diseases produced by the medicinal plants (Teixeira, dos Santos, 
and Citadini-Zanette, 2017:4). These secondary metabolite compounds synthesized and 
stored by the plants, which are major determinants of their bioactive and pharmacologic 
activities, were represented in this study phase. In a recent review, Teixeira et al. (2017:4) 
reported various pharmacological mechanisms of lowering hypertension by medicinal 
plants. These include weak diuretic effect and direct vasodilation activity (Eugenia uniflora 
L.), inhibition of calcium influx leading to decreased vascular resistance (Cymbopogan 
citratus), vasodilation through nitric oxide mediation and calcium channel blockade 
(Panax ginseng), diuresis and vasodilatory activity (Allium sativum), angiotensin-
converting enzyme inhibition (Crataegus laevigata), and a combination of vasodilation, 
inhibition of calcium channels and diuresis.  
 
A few vendors in this study also reported concurrent indigenous and western therapies 
usage and medicinal plants’ combination. Also, even though a lack of standardization and 
quality control was noted with the medicinal preparations, dosage, and shelf-life, many of 
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the reported medicinal plants did not present significant side-effects. The common side-
effects reported were mild hypotension, heartburn, acid reflux, abdominal swelling, and 
flatulence, which resonates with the previous study of medicinal plants’ side effects (Al 















































In chapter four, data were obtained and analyzed both quantitatively and qualitatively. In 
the quantitative phase, a total of 422 participants were surveyed on indigenous-western 
therapies use from hypertensive patients in Belize utilizing a well-structured and verified 
questionnaire. Information collected from participants was grouped into demographic, 
Western medication, and indigenous therapy usage. Collected data were analyzed using 
SPSS version 22.0 software. Results are presented in frequency tables, graphs, and 
charts. 
 
Furthermore, chapter four describes the detailed research analysis and results of the 
qualitative phase of the study. In the study’s qualitative phase, two data sets were 
collected on indigenous-western therapies for treating hypertension using face-to-face 
interviews. Data set were collected from 24 patients diagnosed with hypertension using 
indigenous therapies or combined therapies to manage hypertension and 19 vendors of 
indigenous therapies in Belize. The themes and sub-themes categories that emerged 
from the analysis of interviews are described in detail in chapter four. Summaries of the 
analyses for both hypertensive patients and vendors are presented below. 
 
5.2 MAIN FINDINGS OF QUANTITATIVE PHASE  
 
Detailed results of the analysis of hypertensive patients were described in chapter four, 
and the summaries of the results are presented here. The data analyzed revealed the 
various medicinal plants used by indigenous people in the management of hypertension. 
Long before colonization, the indigenous people had ways of caring for the sick in a 
holistic manner, which involved the individual, family, community, and the environment 
(Mans et al. 2017a:1; 2017b).   
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Even though these holistic indigenous healthcare approaches were disrupted and not 
recognized by the colonial masters, the practice still exists and is widely accepted among 
indigenous people in Belize and many parts of the world (Mans et al., 2017a:1). Christian 
religious traditions and scientific knowledge have been widely attributed to the disruptions 
of indigenous knowledge systems. Despite these disruptions, indigenous practices are 
still mainstream healthcare in many communities with proven effectiveness (Mphuthi 
2015:150). The summary of the main findings from the study’s quantitative phase is 
presented in the following paragraphs.  
 
The following main findings were derived from the quantitative data collected from 
diagnosed hypertensive patients in Belize. The quantitative data revealed that the 
indigenous hypertensive Belizeans have a wealth of knowledge on indigenous therapies 
used in managing hypertension that has been used by the communities long before 
colonization (Mans et al., 2017a:1).  
 
5.2.1 Hypertension diagnosis and medication use 
 
High blood pressure or hypertension is often called the “silent killer” because it frequently 
has no apparent symptoms. Metabolic disease has been reported to increase the risk of 
heart diseases such as heart attack, stroke, and other untoward conditions (Hypertension 
2020:1). The majority of the respondents reported being diagnosed with hypertension 
within the last ten years. About 39.6% (n=167) were diagnosed in the last 1 to 5 years 
and had the highest reported hypertension diagnoses, while 27.7% (n=116) were 
diagnosed in the last 6 - 10 years. In order to prevent organ damage in patients diagnosed 
with hypertension, effective management of hypertension requires the timely clinical 
provision of balanced nonpharmacological and pharmacologic interventions (Rivera et al., 
2019:97). The majority (n=173; 41.0%) of the participants reported being on westerns 
medications for 1-5 years, while 25.5% (n=107) reported using Western medications for 
6 – 10years. The majority (n=335; 33.7%) of the respondents reported being on 
hydrochlorothiazide, with 12.3% (n=122) using captopril. 
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Regarding Western medication adherence, approximately 39.3% (n=166) of the 
respondents did not stop their medications, even when they felt their blood pressure was 
under control. The compliance with Western medication seen among respondents could 
be attributed to the single-dose regimen reported by the majority (83.6%; n=353) of the 
respondents. In addition, adherence to the medication regimen could be due to effective 
patient counseling by the pharmacist. Minimal adverse effects have been reported to 
improve Western medication adherence (Burnier & Egan, 2019:1124). Therefore, this 
study results indicate that most hypertensive participants adhered to their prescribed 
Western antihypertensive medications. 
 
5.2.2 Use of indigenous therapies  
 
Ever before the emergence of modern medicines, people used indigenous therapies to 
treat their diseases. Presently, over a hundred active compounds have been scientifically 
identified as drugs from plants alone (Helmenstine 2019:1). An increasing amount of 
literature exists on medicinal plants and herbs used for the management of hypertension. 
Some of the herbal therapies have gone through extensive studies with many reported 
discoveries about their bioactive metabolites, while others are still being studied, and new 
information on their pharmacology and toxicities has been revealed (Helmenstine 
2019:1). In this study’s quantitative phase, questions on indigenous therapies used to 
manage hypertension, and how they were prepared were asked the respondents. Data 
analyzed showed that respondents reported over 30 medicinal plants as available 
indigenous therapies used to manage hypertension. Beetroot (n=56; 13.3%), garlic (n=45; 
10.7%), and aloe vera (n=27; 6.4%) were among the highest reported indigenous 
therapies used by the public for the management of hypertension. Respondents also 
reported Garlic (Allium sativum) [n=225; 70.9%], Lime (Citrus aurantiifolia) [n=105; 
32.8%], and Aloe vera (Aloe barbadensis miller) [24.4% n=78] as the most common 
indigenous therapies used for the management of their hypertension. Furthermore, the 
primary sources of indigenous therapies reported by respondents were 
yard/family/friends (n=94; 22.3%) and indigenous therapy vendors/markets (n=69; 
16.3%).   
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A combination of leaves, roots, seeds or bark (n=161; 38.2%) and leaves (n=64; 15.2%) 
were majorly reported as the parts used for hypertension therapy (Figure 5:1 below). In 
this phase of the study, medicinal plants were the only indigenous therapies reported by 
the participants for managing hypertension, with approximately 55% (n=232) of 
respondents using medicinal plant therapies to manage their hypertension. 
Approximately 20.1% (n=85) reported having consumed indigenous therapy for their 
hypertension more than five times in 12 months. 13.5% (n=57) reported consuming the 
therapies more than five times per week, while 10.2% (n=43) reported taking indigenous 
therapies for their hypertension every day in the past 12months. 
 
Numerous factors have led to a substantial global increase in medicinal herb usage. 
Foremost among them is that herbal remedies are inexpensive compared to conventional 
drugs and have fewer adverse effects. The World Health Organization (2019:4) reported 
that this increase in patronizing herbal remedies is not necessarily dependent on the 
country, region or economic status or the individuals since complementary and alternative 
medicines are now used by over 70% of people in developed countries for the prevention 
or treatment of various ailments and diseases. The trend is not any less in developing 
countries where a more pronounced usage of alternative medicines is being recorded 
(WHO 2019:4; Ekor 2014:117). 
 
5.2.3 Indigenous therapies with western medications. 
 
Regarding concomitant medication use, a common practice with indigenous therapy is 
polypharmacy. Polypharmacy uses more than one drug or substance for therapy (Burt et 
al. 2018:2). This practice is monitored in the clinical setting using carefully designed 
paper-based or computer software. Although it is much easier to monitor the possibilities 
of drug-drug interactions in the clinical setting, monitoring for indigenous-western drug 
interactions is difficult because these interactions have not been scientifically extensively 
studied. There are many uncharacterized compounds in medicinal plants that present 




These drug-herb or herb–herb interactions can precipitate toxic effects or, in some 
instances, render the therapeutic effect of a conventional drug or the more promising 
herbal preparation (Mans et al., 2017a:1). 
 
The respondents in this study reported a combination of indigenous therapies used to 
manage hypertension with prescribed western antihypertensive medications. About 
29.4% (n=124) of the respondents reported combining indigenous therapies with 
prescribed Western antihypertensive medications to manage their hypertension. The 
major reason for combining indigenous therapies with western medications was that the 
combination was more effective in managing hypertension (28.3%; n=119) and lower 
blood pressure faster (38.8%; n=164).  
 
Furthermore, the majority (n=149; 35.3%) of respondents reported not informing their 
medical practitioners about using indigenous therapy to manage their hypertension, and 
21.3% (n=90) did not give a reason for not informing their medical practitioners about 
indigenous therapy consumption for the management of their hypertension. 
 
Religion, cultural beliefs, the cost of those herbs, and the perceived efficacy of indigenous 
therapies informs the patient’s choice to use indigenous medicines (Ekor 2014:177). 
These herbs are readily available and cheap, making them the first line of treatment in 
many communities. 
 
5.3 MAIN POINTS OF THE QUALITATIVE PHASE (PART ONE, MEDICINAL 
PLANTS USERS). 
 
Although the use of medicinal therapies in many communities is rising and gaining wide 
acceptance globally, many countries are yet to embrace the benefits derived from them. 
Rigorous regulative obligations make it challenging and difficult for herbal medications to 
be registered. Therefore, the stringent regulatory requirements in such countries limit the 
opportunity for the use of medicinal therapies.  
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For instance, herbal medicines in the United Kingdom have been viewed with reservation 
and seen suspiciously as therapies that are likely to cause peculiar health challenges to 
the public’s generality of health. Because of this perception, many consultations between 
indigenous medicine practitioners and physicians are being conducted to ensure public 
safety while being careful not to deny the benefits derived from such therapies (Walker, 
2015:1; Boyle et al., 2011:951). In this qualitative section, summaries of analyzed data 
and discussed results on medicinal plants, prescription, dosage, and administration 
routes from hypertensive patients in the qualitative phase are presented.  
 
The hypertensive patients who participated in this phase of the study primarily reported 
medicinal plants as the indigenous therapies used to manage their hypertension. The 
plants reported were soursop (n=9), moringa (n=6), garlic (n=5), lime (n=3), ginger (n=2), 
lemongrass (n=2), breadfruit (n=2), Cat’s claw seed (n=1), pineapple (n=1), annatto 
(n=1), bukut (n=1), Serosi (n=1), trumpet leaves (n=1), and cinnamon (n=1). Some 
reported a single medicinal plant, while others reported a combination of medicinal plants 
they used to manage their hypertension (Figure 5:1 below). 
 
Most of the participants indicated that the knowledge of indigenous therapies was passed 
down from generation to generation. Similarly, the participants reported their knowledge 
about the medicinal plant to come from family members, community, practitioners, or 
other sources. Furthermore, most of the participant’s duration of medicinal plant use for 
managing hypertension was mostly dependent on the number of years diagnosed with 
hypertension. Whereas some of the participants did not specify the duration of usage, 
most participants reported short-term, medium-term, and long-term use of medicinal 
plants to manage their condition (hypertension).  
 
Furthermore, most participants reported leaves as a common part of the medicinal plant 
used to manage their hypertension. In addition to leaves, fruits, roots, seeds, stems, and 
whole herbs have been reported by a few participants as parts of plants used to manage 
their hypertension. Although participants reported no standardized method, medicinal 
plant parts’ boiling was the commonly reported method of preparation reported by 
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hypertensive participants. Furthermore, most participants in this study reported the oral 
route as the primary route for medicinal plant administration. Participants take medicinal 
preparations as decoctions, teas, juices, mixtures of boiled plant parts, or herbs to 
manage their hypertension. In addition, respondents reported taking between half a glass 
to full glass of medicinal plant therapies are taken either once or twice per day, as reported 
by most participants. Some participants reported taking medicinal plant therapy anytime 
and for the entire day. 
 
Although some of the participants were not able to provide insight into the biological 
activity of the medicinal plant they used for their hypertension, the majority of them 
reported a lowering of their blood pressure, as evidenced by the fact that some of them 
go to the hospital to regularly check their blood pressure just to verify the effectiveness of 
indigenous therapy. Additionally, participants reported various durations of medicinal 
plant use and indicated that they had been drinking preparations from medicinal plants 
for different lengths of time. Some participants mentioned that they have been drinking 
the therapies for three months to ten years. Although a few participants reported 
dizziness, stomach upset and heartburn, bad feeling, drop in blood pressure and sugar, 
most participants reported not experiencing side effects with the medicinal plants they 
were taking for their hypertension. In essence, this experience can infer that medicinal 
plants’ use is safer in side effects. 
 
Finally, hypertensive participants in this phase of the study reported that most of the 
medicinal plants they use to manage their hypertension are found within the community, 
while a few will buy some of the ingredients in the market for the preparation of therapy. 
Most participants reported that they did not spend any funds to purchase the therapies 
because they either grew them at home or were found within the community. Friends and 
family members also supplied medicinal plants to their relatives at no cost. Some 
participants reported that when they did not have a supply, they buy from the market, and 
the cost is reported to be less than 50 Belizean dollars in a month. The concurrent use of 
indigenous and western therapies was reported by a few participants in this phase of the 
study. These participants believed that combining medicinal plants and prescribed 
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Western medications will help manage their blood pressure better. The concurrent use of 
Western medications and indigenous therapies reported in this phase of the study could 
lead to drug-herb interactions. The interactions could result in better hypertension 
management or pronounced adverse. Few adverse effects were reported by the 
participants designating indigenous therapies safe for public health. Further research is 
envisaged in this field. 
 
5.4 MAIN POINTS OF QUALITATIVE ANALYSIS WITH VENDORS (PART TWO) 
 
The importance and usefulness of indigenous therapies cannot be overemphasized. The 
practice has been recognized, approved, and encouraged by the World Health 
Organization (WHO 2019:11). The WHO’s recognition of indigenous medicine could only 
span from the therapy’s effectiveness, and historically, long before the WHO’s 
declarations, many indigenous populations have used indigenous therapies to treat their 
ailments. Participants in this study gave examples of how their recommended therapies 
improved the health conditions of their clients. 
 
In this section, summaries of analyzed and discussed results from vendors of 
hypertensive therapies are presented. The main themes and sub-themes that addressed 
this phase of the study’s major objectives are also discussed and described below. A total 
of nine (47.4%) vendors were males, while 10 (52.6%) were females. Most participants 
reported practicing as an indigenous therapist for a minimum of nine years, with the 
maximum years of practice being 66. Most of the vendors reported medicinal plants as 
the indigenous therapies used to manage hypertension, and most of them learned about 
indigenous therapies from their ancestors, such as grandparents, parents, or older people 
in the community.  
 
A few vendors reported learning about indigenous therapies from traditional healers and 
herbal books. Only one vendor took college courses on indigenous medicines. A vast 
majority of the vendors either cultivate the medicinal plants, obtain them from the forest 
or purchase from the local market. The plant parts reported by the vendors for use in the 
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preparation of therapy for hypertension were leaves, fruits, seeds, bark, and the calyx of 
flowers. Leaves were the commonly used plant part by most vendors, the same as 
reported by the users. Furthermore, $100 was reported by vendors as the highest cost of 
indigenous antihypertensive therapies when buying them from the market. Some vendors 
only accept donations for their services, while some reported charging a minimal fee to 
cover the therapy’s cost of ingredients. Some vendors charged a small fee of between $4 
- $15 Belize dollars. 
 
The therapies used by the vendors for hypertension included roots (carrots, turmeric, 
garlic, ginger, and Talawala), seeds (cats claw, flaxseed, and sesame seeds), fruits (lime, 
grape, pineapple, and noni), and leaves (bukut, John Elema, Hammonds, soursop, 
lemongrass, moringa, breadfruit tree leaves, celery, orange tree leaves, Annatto, Boldo, 
samento, serosi, rosemary, neem, lime tree leaves, sage, dandelion, and senna), and 
flowers (sorrel calyx) [Fig. 5.1 below]. Also, honey was mentioned as a sweetener by one 
vendor and coconut water as a ‘cooling agent.’ Seven vendors mentioned soursop leaves 
as a therapy for hypertension, making soursop leaves the common therapy reported by 
the vendors. Additionally, therapies mentioned more than once by the vendors included 
garlic (4), ginger (3), serosi (3), Boldo (2), Annato (2), Hammonds (2), Bukut (2), and 
Tumeric (2). All other therapies were mentioned just once by the vendors. The vendors 
recommended a single medicinal plant or a combination of two or more plants to manage 
hypertension. In regards to medicinal plant preparation, two levels of preparation were 
documented by the researcher. Two vendors indicated that they would first prepare or 
clean out the patients before the actual hypertensive therapy commencement, while other 
vendors simply gave the therapy without patient preparation. In addition, most of the 
vendors prepared their antihypertensive therapies by decoction or infusion of the 
medicinal plant.  
 
Similarly, differences in preparation methods were also observed among vendors. 
Additionally, the indigenous therapy vendors’ report showed diversity in water quantity 




Regarding medicinal plants’ packaging, most of the vendors have a ready-made 
packaged therapy for hypertension to sell or provide to their clients. The treatment is 
made up of either single or a combination of medicinal plants. Most vendors indicated ¼ 
cup to full cup of the treatment once, twice, or three times in a day. A few recommended 
the treatment to be taken before bedtime. The lack of standard indigenous therapies for 
treating diseases was seen in this phase of the study. 
 
A few vendors responded to the question on concomitant use of medicinal plants with 
prescribed western antihypertensive medications. The few vendors that responded had 
conflicting recommendations for their clients. Some vendors recommend medicinal plants 
to be taken with western medications, while other vendors did not. In this phase of the 
study, most indigenous therapy vendors reported alleged efficacies in their 
antihypertensive therapies to lower, control, or even out-rightly cure hypertension. Some 
vendors claim their therapies cure hypertension, contrary to available scientific evidence 
and medical practice. Such claims call for additional research in exploring the bioactive 
ingredients and mechanism by which they cure hypertension. Finally, few mechanisms of 
action for recommended medicinal plants were proposed by the vendors. These 
mechanisms of action included antioxidant activity, antidiuretic, hypolipidemic, and 
immunomodulation activity. Generally, mechanisms of actions attributed to many 
medicinal plants used in managing hypertension have been reported and discussed in 
chapter four. Guidelines on indigenous therapies are discussed in this chapter based on 






Fig. 5.1 List of medicinal plants for the management of hypertension mentioned by participants in both ph
Medicinal plants used by the public to manage hypertesnion as suggested by quantitative respondents
Beetroots, Garlic, Aloe Vera, Moringa leaves, Soursop leaves, Eggplant, Mango leaves, Neem leaves, 
Almonds leaves, Bay leaves, Avocado leaves, Noni leaves, Tumpet leaves, Seracee leaves, Pine tree bark, Flax 
seed, Xshcanan, Tamarind leaves, Marijuana, Susumba leaves, Papaya leaves, Calabash fruit, Jackass bitters, 
Lime, Celery, Cinnamon, and Ginger.
Medicinal plants used by quantitative respondents to manage hypertension
Beetroot, Garlic, Aloe Vera, Moringa, Soursop, Eggplant, Mango leaves, Neem leaves, Almonds, Bay 
leaves, Avocado leaves, Noni Juice, Trumpet leaves, Searcee, Pine tree bark, Tamarind, Susumba, 
Papaya tree leaves, Calabash fruit, Jackass bitters, Lime, Celery, Sorrel, Cat's claw seed, Breadfruit, 
Lemmongrass, Lettuce, Choko, Guava tree leaves, Periwinkle, Scoggineal, Cascarilla, and Chestnut. 
Medicinal Plants used by hypertensive patients in qualitative (n=24)
Garlic, Moringa tree leaves, Soursop tree leaves, Trumpet tree leaves, Seracee leaves, Lime, Cinnamon, 
Ginger, Garlic, Cat's claw seed, Breadfruit tree leaves, Lemongrass, Bukut, Pineapple skin, and Annatto 
Medicinal Plants used for the management of hypertension as recommended by Vendors (n=19)
Garlic, Moringa Tree leaves, Soursop tree leaves, Neem tree leaves, Trumpet tree leaves, Ceracee leaves, 
Celery, Ginger, Garlic, Sorrel, Cat's claw seed, Breadfruit tree leaves, Lemongrass, Bukut, Oineapple skin, 




5.5 INTEGRATION OF THE FINDINGS FROM THIS RESEARCH 
 
The mixed-methods methodology research with the multiphase design described by 
Cresswell (2015:67) was followed to provide a baseline level data in the use of 
indigenous-western antihypertensive therapies in the country of Belize. Data generated 
from both quantitative and qualitative phases were mixed to provide detailed guidelines 
on the use of indigenous-western therapies as reported by both hypertensive patients 
and vendors of indigenous therapies. The data collection procedure followed an 
explanatory sequential mixed method design. The triangulation principle was used to 
combine the quantitative and qualitative data that aided in developing the guidelines.  
 
Creswell & Plano-Clark (2018:54) described an explanatory sequential mixed method 
design consisting of first collecting quantitative data and then collecting qualitative data 
to explain or elaborate on the quantitative results. This approach’s rationale was that the 
quantitative data provided a general overview of the research problem, while the 
qualitative data collection was needed to refine, extend, or explain the general picture. In 
this method, Creswell (2015:542) further classified three ways how the data from an 
explanatory sequential method can be mixed.  
 
First, the quantitative data (QUAN) collection and analysis were given by introducing it 
first in the study and representing a significant data collection aspect. A small qualitative 
(QUAL) component typically followed in the second phase of the research. Second, 
quantitative data was collected in the sequence followed by the secondary qualitative 
data collection. This approach was presented in two phases, with each phase identified 
in headings on the report. Third, the qualitative data was used to refine the results from 
the quantitative data. This refinement results in exploring a few typical cases, probing a 
key result in more detail, or following up with an outline.  
 
The merging or mixing of the data was done by triangulation. Creswell (2015:542) 
described triangulation “as a means that investigators could improve their inquiries by 
collecting and integrating different kinds of data bearing on the same phenomenon.” The 
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three points to the triangle are the two sources of the data and the phenomenon. This 
improvement in inquiries would come from blending the strengths of one type of method 
and neutralizing the weaknesses of the other. This study adapted the triangulation 
principles to combine the quantitative data with the qualitative data to produce the 
guidelines on indigenous – western antihypertensive therapies in Belize. Such guidelines 
included parts of the plants used for hypertensive management, how to process the 
indigenous therapy, the recommended dosage, how the remedy should be taken, and 
reported adverse effects or interactions when used with western medicines. 
 
Finally, the WHO Handbook for guidelines development was followed in ensuring 
standardization in the development of the guidelines (WHO 2019:6). The WHO handbook 
provided detailed help for a transparent decision-making process and a high-quality 
methodology for using systematic strategies in developing guidelines (WHO 2019:2). The 
minimum reporting standards were also provided, inclusive of information dissemination 
of developed guidelines. The handbook recommendations were followed in the 
development of indigenous-western therapies guidelines.  
 
The WHO consolidated type guideline was chosen for the development of indigenous-
western therapies guidelines. The consolidated guidelines are also referred to as a 
compilation of guidelines. It provided the flexibility to form guidelines in line with previous 
guidelines that are already in existence. However, such guidelines are expected to be 
complex because the updated information and recommendations are required. However, 
since this is the first attempt to document and provide guidelines for indigenous-western 
hypertensives, it is only proper to consider the consolidated guidelines. Standard 
guidelines are usually applied to clinical or policy areas, while interim guidelines are only 
produced when WHO is asked to provide such guidelines based on data completion and 
availability. Since indigenous-western hypertensive guidelines were not in response to an 
emergency or rapid response, WHO guidelines will be inappropriate and not suited for 




However, in following the WHO guidelines, first, the PICO (Population, Intervention [or 
exposure], Comparison and Outcomes) model was applied and modified for this study as 
a framework that provided the effectiveness of the indigenous intervention as compared 
with western therapies (WHO 2014:79). 
 
P (Population) Hypertensive patients and indigenous medicines vendors 
I (intervention) The concurrent use of both indigenous-western therapies 
for hypertension  
C (comparison) How many people are using these therapies as single or 
combination 
O (outcome of 
interest) 
Reduced or lowered blood pressure and guidelines for 
indigenous therapy use for hypertension.  
 
Table 5.1: PICO table used to describe the development of guidelines (Source: WHO 
2014:8) 
 
5.5.1 Population – Taylor (2020:1) described the population as the participants of a 
particular study. He further explained that everyone or everything included as the subject 
of a statistical observation could be considered the population. In this study, the 
population comprises diagnosed hypertensive patients and vendors of indigenous 
therapies in Belize. Trends, patterns, and behaviors are observed from a statistical 
population as individuals interact with clearly defined interventions used to draw 
conclusions (Taylor 2020:1). The detailed sampling technique, sample, and sampling size 
for quantitative and qualitative populations were described in chapter three.  
 
5.5.2 Intervention – An active (e.g., drugs) or non-active (e.g., placebo) but specified 
treatment applied to a population is referred to as intervention (Glen 2019:1). Additionally, 
intervention has been defined as the action or process to address an issue to find 
outcomes (Creswell 2015:73; WHO 2014:80). In the present study, the use of indigenous- 
western therapies for managing hypertension by the Belizean populace was considered 
the intervention.  
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5.5.3 Comparison – Comparison is used when two or more items or people are evaluated 
to determine similar and relevant characteristics (Merriam-Webster’s Collegiate 
Dictionary, 1999). In this study, the number of people using indigenous–western therapies 
was evaluated. The study further assessed whether the participants use single or 
combination of both indigenous–western therapies to manage hypertension. The 
outcomes of the comparison for both indigenous and western therapies were used to 
develop guidelines as described by WHO (WHO, 2014:180).  
 
5.5.4 Outcomes – An outcome is described as any possible result seen in a trial or an 
experiment (Home statistics libreTexts 2019:1). The outcomes for the study were reduced 
blood pressure from either single or combinatorial indigenous–western therapies. These 
outcomes were used to develop the guidelines in line with WHO protocols (WHO 
2014:81).  
 
5.6 GUIDELINES ON THE USE OF INDIGENOUS-WESTERN 
ANTIHYPERTENSIVE THERAPIES 
 
Guidelines on the use of indigenous-western anti-hypertensive therapies developed are 
presented here based on the data collected and literature reviewed. In line with the WHO 
guidelines on acceptable herbal processing practices for herbal medicines and 
documentation of all procedures that depict the safety and quality of indigenous 
medicines, especially herbal therapies, were made (WHO 2019:102). The guidelines 
provided in the current study are in line with the WHO recommendations to document 
indigenous therapies studied here to manage hypertension. Furthermore, the World 
Health Organization recommended the inclusion of the information below as part of the 
documentation process (WHO 2019:102). The information on medicinal plants reported 
here was also compared with reported research and WHO monographs on medicinal 
plants (WHO 2011:1). The guidelines were summarized and presented in tabular form for 
comprehension, as shown in Table 5.2 below. Reported doses and routes are from the 
research participants, while other information such as active ingredients found in 
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*Reported doses and routes are from the participants, while the other information like active ingredients, presumed 




5.7 RESEARCH OBJECTIVES, QUESTIONS, AND HYPOTHESIS 
 
A numerical statement of a specific relationship about unknown parameters to the 
researcher is termed hypothesis (Rodrigues, Lima, and Barbosa et al. 2017:619). The 
hypothesis needs to be tested after collecting data that could be used to accept or reject 
the hypothesis. In this research, the hypothesis is tested from the percentages generated 
during the quantitative phase and used to draw inferences with the qualitative data 
(Creamer, 2018:145).  
 
5.7.1 Research objectives  
 
The objectives of this study, as described in chapter one, were as follows: 
 
5.7.1.1 Phase 1: Quantitative phase 
 
● To determine the indigenous therapies used by hypertensive patients in Belize to 
treat hypertensive conditions. 
● To identify the common western therapies used in the treatment of hypertension 
in Belize.  
● To identify concomitant usage of indigenous-western therapies among 
hypertensive patients in Belize.  
 
In order to achieve the above set objectives, data were collected quantitatively utilizing a 
questionnaire. A total of 422 participants were surveyed using a well-structured and 
verified questionnaire. Information collected from participants was grouped into 
demographic, western medication, and indigenous therapy usage. Collected were was 
analyzed using SPSS version 21.0 software. Results are presented in frequency tables, 
graphs, and charts. The most common Western antihypertensive medicines reported by 
the respondents were hydrochlorothiazide and captopril. The majority (n=335; 33.7%) of 
the respondents reported being on hydrochlorothiazide, while 12.3% (n=122) were on 
captopril. Respondents reported over 30 different medicinal plants used for indigenous 
therapies in the management of hypertension in Belize. Beetroot (n=56; 13.3%), garlic 
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(n=45; 10.7%), and aloe vera (n=27; 6.4%) were among the highest reported indigenous 
therapies used for the management of hypertension. The majority (48.3%) of the 
respondents indicated they do not take indigenous therapies to manage hypertension. 
Approximately 29.4% combine indigenous-western therapies in the management of their 
hypertension.  
 
5.7.1.2 Phase 2 Qualitative phase 
 
● To explore and describe the preparation, storage, and usage of indigenous 
therapies by hypertensive patients in Belize. 
● To understand the concomitant use of indigenous-western therapies by 
hypertensive patients in Belize. 
 
The above objectives were achieved using qualitative analysis. Two sets of data were 
collected on indigenous-western therapies for treating hypertension. The first set of data 
was collected from patients diagnosed with hypertension who used either or both 
indigenous and western therapies to manage hypertension, while the second set of data 
was collected from vendors of indigenous therapies. Face-to-face interviews were used 
for data collection from both hypertensive patients and the vendors of indigenous 
therapies. Data were analyzed using thematic analyses and results presented. Data 
collected qualitatively from hypertensive patients and vendors of hypertensive therapies 
provided a more in-depth understanding of the use of indigenous therapies among 
Belize’s population and helped achieve set objectives for the research. Plants were the 
most common indigenous therapies reported by both hypertensive patients and the 
vendors of indigenous therapies. The participants also reported leaves as the most used 
part of the plants, while boiling was the most used preparation method. The most-reported 
administration route was oral, while ½ to 1 glass of the plant extracts are usually 
administered twice or trice per day. Most participants reported taking either indigenous 




A few participants combined the therapies, while most respondents reported not 
experiencing side effects with indigenous therapies. Indigenous therapy vendors reported 
that their therapies are effective in controlling blood pressure. Some of their claims were 
verified by Western science, as noted in Table 5.2. 
 
5.7.1.3 Phase 3 Guideline development 
 
● To develop guidelines on the use of indigenous-western therapies for the 
management of hypertension in Belize.  
Data generated from both quantitative and qualitative phases were mixed to provide 
detailed guidelines on the use of indigenous-western therapies as reported by both 
hypertensive patients and vendors of indigenous therapies. The data collection procedure 
followed an explanatory sequential mixed method design. The principle of triangulation 
was used to combine the quantitative and qualitative data that aided in developing the 
guidelines. The guidelines included parts of the plants used for hypertensive 
management, how to process the indigenous therapy, the recommended dosage, how 
the remedy should be taken, and reported adverse effects or interactions when used with 
western medicines. 
 
5.7.2 Research questions  
 
The research questions for this study were as follows. 
 
5.7.2.1 Phase I 
 
● What are the common indigenous therapies used by patients to treat hypertension 
in Belize? 
● What are the common western therapies used by hypertensive patients in Belize? 
● Do Belizean hypertensive patients combine indigenous-western therapies in the 
management of their hypertension? 
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As reported by the research participants, the common indigenous therapies used in 
managing hypertension were from plant sources. The most common Western 
antihypertensive medicines reported by the respondents were hydrochlorothiazide and 
captopril. The majority (n=335; 33.7%) of the respondents reported being on 
hydrochlorothiazide, while 12.3% (n=122) were on captopril. Respondents reported over 
30 different medicinal plants used for indigenous therapies in the management of 
hypertension in Belize. Beetroot (n=56; 13.3%), garlic (n=45; 10.7%), and aloe vera 
(n=27; 6.4%) were among the highest reported indigenous therapies used for the 
management of hypertension. The majority (48.3%) of the respondents indicated they do 
not take indigenous therapies to manage hypertension. Approximately 29.4% combine 
indigenous-western therapies in the management of their hypertension.  
 
5.7.2.2 Phase II 
 
● How are indigenous therapies prepared, stored, and used by hypertensive patients 
in Belize? 
● Why do hypertensive patients in Belize use indigenous therapies? 
 
Although no standardized method was reported by participants, boiling of medicinal plant 
parts was the commonly reported method of preparation reported by hypertensive 
participants. Furthermore, most participants in this study reported the oral route as the 
primary route for medicinal plant administration. Participants take medicinal preparations 
as decoctions, teas, juices, mixtures of boiled plant parts, or herbs to manage their 
hypertension. In addition, respondents reported taking between half a glass to full glass 
of medicinal plant therapies are taken either once or twice per day, as reported by most 
participants. Some participants reported taking medicinal plant therapy anytime and for 
the entire day. 
 
5.7.2.3 Phase III 
● What guidelines should hypertensive patients in Belize use in the management of 
their hypertension using indigenous-western therapies?  
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Detailed guidelines on using indigenous-western therapies were presented in Table 5.2 
based on the outcomes obtained from the studies’ qualitative and quantitative phases. 
The guidelines included parts of the plants used for hypertensive management, how to 
process the indigenous therapy, the recommended dosage, how the remedy should be 
taken, and reported adverse effects or interactions when used with Western medicines. 
In addition, few mechanisms of action for recommended medicinal plants were proposed 
by the vendors. These mechanisms of action included antioxidant activity, antidiuretic, 
hypolipidemic, and immunomodulation activity. Generally, mechanisms of actions 
attributed to many medicinal plants used in managing hypertension have been reported 
and discussed in chapter four. 
 
5.7.3 Research hypothesis  
 
The hypothesis statements made from the beginning of the study were: 
● H0. The use of indigenous-western antihypertensive therapies does not control 
high blood pressure than a single therapy approach among the Belizean 
population. 
 
Based on the results in chapter four of the quantitative phase, the above hypothesis is 
accepted (P<0.0001). This means that individuals diagnosed with hypertension either use 
indigenous therapies or western medicines to manage their hypertension. According to 
both quantitative and qualitative results obtained in this study, most of the respondents 
during the qualitative study did not combine indigenous and western therapies to manage 
their high blood pressure. In addition, most hypertensive patients who participated in the 
qualitative study indicated taking indigenous therapy as the sole method for managing 
hypertension, or they used Western medications but not a combination of both.  
 
The alternate hypothesis, as described in chapter one, is stated below: 
●  H1.The use of indigenous-western antihypertensive therapies controls high blood 
pressure than single therapy among the Belizean population. 
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The above hypothesis is rejected based on the findings in chapter four of the quantitative 
phase. Therefore, to have good control of high blood pressure, both respondents in phase 
I of the study and the participants in phase II use or recommended either therapies but 
not a combination of both. In addition, few of the respondents in this study reported 
combining indigenous therapies used for the management of hypertension with 
prescribed western antihypertensive medications. About 29.4% (n=124) of the 
respondents reported combining indigenous therapies with prescribed Western 
antihypertensive medications to manage their hypertension. The major reason for 
combining indigenous therapies with Western medications was that the combination is 
more effective (28.3%; n=119) and helps lower blood pressure faster (38.8%; n=164).  
 
Respondents (29.4%) who indicated combining indigenous-western therapies is low 
compared to those who do not use indigenous therapies (47.9%). Also, the respondents 
(28.3%) indicated that the indigenous-western combination to be effective compared to 
those who do not take indigenous therapies (48.3%) is also low. Therefore, the z-score 
test for two population proportions was used to test the level of significance for two 
populations (McLeod 2019:1). The level of significance was set at p < 0.05. The value 
of z was -5.5143, while the value of p was < .00001. The result is, therefore, significant 
at p < .05. Based on the statistically significant p<value (0.0001), it is indicative that a 
combination of indigenous-western antihypertensive therapy does not control blood 
pressure than a single therapy approach.  
 
The participants for both the users of indigenous therapies and the vendors of indigenous 
therapies in the qualitative phase of the study laid credence to the efficacy of indigenous 
therapies in managing hypertension. With the qualitative study, both users and vendors 
reported a low level of concomitant use of indigenous and western therapies for 
hypertensive management. The singular use of indigenous therapy was reported to be 
efficacious by both users and vendors alike. In addition, some of the medicinal plants 
identified were also confirmed by science to have bioactive compounds that can lower 
blood pressure.  
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5.7.4 Research design and method 
 
The mixed-methods methodology research with the multiphase design described by 
Creswell (2015:67) was followed to provide baseline level data in the use of indigenous-
western antihypertensive therapies in Belize. Data generated from both quantitative and 
qualitative phases were mixed to provide detailed guidelines on the use of indigenous-
western therapies as reported by both hypertensive patients and vendors of indigenous 
therapies. The data collection procedure followed an explanatory sequential mixed 
method design. The principle of triangulation was used to combine the quantitative and 
qualitative data that aided in developing the guidelines. Methods of triangulation in this 
study involved having quantitative and qualitative data elucidated complementary aspects 
of the study, where the diverged data provided greater insights than a single data 
collection method. 
 
The different research methodologies employed using quantitative and qualitative 
approaches have helped provide greater authenticity and value in the quality of the data 
collected, analyzed, and reported in this study. First, priority on quantitative data (QUAN) 
collection and analysis were given. This was done by introducing it first in the study and 
representing a significant aspect of data collection. A small qualitative (qual) component 
typically followed in the second phase of the research. Second, quantitative data was first 
collected in the sequence, followed by the secondary qualitative data collection. This was 
presented in two phases, with each phase clearly identified in headings on the report. 
Third, the qualitative data was used to refine the results from the quantitative data. The 
refinement of the results led to exploring a few typical cases, probing a key result in more 
detail, and following up with an outline.  
 
In addition, a robust literature was reviewed that provided rich and current information on 
indigenous and Western therapies used in hypertension management. The reviewed 
literature assisted in the design of the questionnaire that was used for quantitative data 
collection. The data collection questionnaire was well designed and questions pre-tested 
for their relevancy, preciseness, and clarity.   
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Part of the items included in the questionnaire was adopted and modified from previous 
studies. Experts in the field, including the research supervisor, provided useful input to 
ensure the research tool’s validity. The researcher personally administered the 
questionnaire and offered useful guidance to respondents that needed help with language 
translation. The reliability of the research tool was assured by using statistical methods, 
as described in chapter three. Finally, the WHO Handbook for guidelines development 
was followed in ensuring standardization in the development of the guidelines (WHO 
2014:6). 
 
The findings obtained from this research adequately answered research questions while 
achieving set objectives. The robust data collected, analyzed, and presented has helped 
achieve all research objectives.  
 




Elo et al. (2014:1) described validity as the research instrument’s ability to measure 
ideally what is supposed to be measure. The data collection questionnaire was well 
designed and questions pre-tested for their relevancy, preciseness, and clarity. Part of 
the items included in the questionnaire was adopted and modified from previous studies. 
Furthermore, reviewed literature, experts in the field, including the research supervisor, 
provided useful input to ensure the research tool’s validity. The researcher personally 
administered the questionnaire and offered useful guidance to respondents that needed 
help with language translation. 
 
5.8.2 Reliability  
 
The primary role of reliability in research is to minimize biases and errors encountered in 
the study. In addition, reliability refers to the extent to which a given study is consistent 
and stable when the same techniques are applied in a repeated number of ways or the 
scores from an instrument are stable and consistent (Creswell 2015:159). The use of 
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statistical methods assured the reliability of the research tool. Reliability testing of the 
questionnaire showed a Cronbach’s alpha value of 0.779. The exploratory factor analysis 
(EFA) using principle component analysis extraction and direct oblimin rotation with 
Kaiser Normalization was also employed, which extracted five components. The Kaiser 
Mayer Olkin (KMO) measure of sampling adequacy and Bartlett’s test for sphericity was 





In order to establish asperity in the qualitative phase of the study, triangulation, peer 
briefing, and member checks credibility strategies were adopted in this phase of the study. 
The confidence that can be placed in the truth of qualitative research findings is defined 
as its credibility (Anney 2014:276). Methods of triangulation in this study involved having 
quantitative and qualitative data elucidated complementary aspects of the study, where 
the diverged data provided greater insights than a single data collection method. A few 
colleagues at the University of Belize were subjected to peer briefing on some of the data 
to ensure the study’s credibility. At different times the study’s findings were crosschecked 
with participants to confirm the report’s accuracy, making the data more credible. In 
addition, to ensure trustworthiness in the qualitative phase, a detailed description of 
inquiry was kept from the beginning to the end of the study. Finally, some of the research 
participants were given the opportunity to evaluate the research’s findings, interpretation, 
and recommendations to ensure consistency and agreement. During the entire process, 
the researcher maintained neutrality through a reflexive journal and confirmability through 
triangulation.  
 
5.9 SUMMARY  
 
This chapter presents the convergence of findings from both phases I and II of this study. 
The converged data provided information for the formulation of guidelines on the use of 




A total of 47 medicinal plants used in managing hypertension in Belize were reported by 
the research participants in qualitative and quantitative studies. The medicinal plants were 
organized and presented based on the family they belong to, their phytochemicals, 
presumed pharmacological action, toxicity, interactions with western medications, 
common methods of preparation, and administration routes. Identified medicinal plants in 
the study, information on preparation methods, routes of administration, and frequency of 
administration were obtained from study participants. The mechanisms of action, 
phytochemical properties, toxicities, and medicinal plants’ interactions were obtained 
from the reviewed literature. Based on the guidelines above (Table 5.2), it can be 
suggested that both approaches of treating hypertension with indigenous and Western 
therapies can co-exist as long as the safety precautions are practiced. It can also be 
proposed that no approach should be given preference over the other based on what the 
participants in this study said about these approaches. It is important to note that 
indigenous and Western health practitioners in Belize acquire an understanding of how 
each system works. These findings will make it easy for patients to have freedom of 
choice for their health and help the community. These guidelines serve as the basis for 
more guidelines to be developed by other researchers to treat other conditions for which 





CONCLUSIONS AND RECOMMENDATIONS 
 
6.1 INTRODUCTION  
 
Indigenous therapies have been with humans since ancient times and are still relevant, 
effective, and trusted by many indigenous communities (Mphuthi 2015:201). In addition, 
indigenous therapies have been the source of many Western therapies, and new 
medicines are still being discovered today from indigenous knowledge. Scientific 
evidence from clinical trials and accumulating literature from epidemiological research 
makes indigenous therapies slowly embedded into evidence-based Western medical 
practice (Al Disi et al. 2016). With all the progress being made with indigenous therapies, 
many Western medical practitioners, Belize included, have disconnected themselves 
from collaborating with indigenous therapy knowledge holders to provide a holistic 
healthcare approach to public health. However, the World Health Organization and many 
countries have taken a bold step to recognize and promote indigenous therapies and their 
use in managing many diseases (WHO 2019:8). 
 
The previous chapter discusses the convergence of data findings from quantitative and 
qualitative (hypertensive patients and vendors of indigenous therapies) phases. The 
chapter also presented suggested guidelines for indigenous therapies to manage 
hypertension and concomitant use with Western therapies.  
 
This chapter presents the gap between indigenous therapies and Western health 
practices, conclusions of the study, relationship statements between Belizean indigenous 
knowledge holders and Western therapy sciences recommendations, and insights gained 






6.2 THE GAP BETWEEN INDIGENOUS THERAPIES AND WESTERN HEALTH 
PRACTICES  
 
Carrie, Mackey, and Laird (2016:129) reported the United Nations Declarations’ adoption 
on the Rights of Indigenous People (UNDRIP), where global recognition was accorded to 
more than 370 million people representing 5000 divergent groups globally in 2007. 
Previously, indigenous knowledge was not recognized, creating gaps between 
indigenous and Western healing systems with given rise to myths that continually 
discredited indigenous healing methods. Indigenous medicines, health practices, and 
social and health practices rights of the indigenous people were affirmed in the UNDRIP. 
Furthermore, the World Health Organization (WHO) took bold steps to close the 
knowledge gap between indigenous (traditional, alternative, and complementary) 
therapies with Western healing systems by producing the WHO global report on 
traditional and complementary medicine documents. The WHO report highlighted the 
need for collaboration between indigenous and Western healers to manage diseases 
while documenting the various indigenous and complementary medicines from different 
member nations (WHO 2019:4). In addition, the collaboration between indigenous and 
Western healers was aimed at complementing a good understanding of holistic patient 
care and research. 
 
Despite these international efforts to encourage collaboration between indigenous and 
Western healers and the long ancestral history of indigenous therapies usage in Belize, 
indigenous therapy is not recognized by Western healers and grossly marginalized in 
Belize. This marginalization of the indigenous therapy approach has also been reported 
in most countries (Mphuthi 2015:218). Presently, there is no policy regarding indigenous 
therapies in Belize, even though the practice existed before pre-colonial times. Even 
today, Belizeans use indigenous therapies as mainstream therapy before consulting 
Western healers. Finally, Belize is yet to respond to the call to collaborate in recognizing 
indigenous therapy practice as part of a holistic approach to healthcare.  
 
Therefore, based on the above, this study provides insights into indigenous knowledge 
systems in managing hypertension in Belize. In addition, the results of this study further 
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revealed the need for Western healers to collaborate with indigenous therapies rather 
than marginalizing them. The collaboration will facilitate a holistic approach in healthcare 
and create a more in-depth understanding between trained Western practitioners and 
indigenous therapies. Mphuthi (2015:213) reported that indigenous healthcare systems 
and Western practices are usually a part of a broader knowledge regarding health, illness, 
and the relationship between nature and humans. A complex relational kinship exists 
between the people, animals, and the environment in a natural community. This 
complexity requires a holistic approach for harmony to be sustained in the community.  
 
In contextualizing the statement above, the study participants indicated concomitant use 
of indigenous and Western therapies to which the trained Western healers were unaware. 
Additionally, participants alluded to not using their antihypertensive medications, even 
though they went to visit the doctors to refill the drugs and validate the effectiveness of 
the indigenous therapies they are using to manage their hypertension. It was evident that 
the lack of interest in indigenous therapies by trained Western healers has created a 
disconnection between them and the patients they treat and, by extension, the 
communities they serve.  
 
6.3 RELATIONSHIP STATEMENTS BETWEEN BELIZEAN INDIGENOUS 
SCIENCES AND WESTERN SCIENCES  
 
Mphuthi (2015:213) reported a relationship between the widely known scientific 
knowledge and indigenous knowledge since they both generate knowledge. These 
relationships have been reported by a few authors (Mphuthi 2015:213; Marsh, Coholic, 
Cote-Meek, and Najavits 2015:14; Carrie et al. 2016:129). Some of the highlights 
statements are listed below.  
● Western science has enjoyed and is still enjoying the global status while 
indigenous science enjoys the local status. 
● Both indigenous and Western scientific knowledge have identical foundations and 
are built on the same philosophies. Since Western science was given full and 
unreserved acceptance, indigenous science should be accorded the exact status 
of unreserved acceptance. 
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● The direct comparable nature of Western and indigenous science can benefit the 
community appropriately and provide a holistic approach appropriate for the 
intended use. 
● Much Western science is narrowly defined in terms of testing, adopting, or rejecting 
external advice. Indigenous science may validate Western science, while in the 
same vein, Western science may support and corroborate indigenous knowledge, 
especially in ethno-scientific research (Mphuthi 2015:216). This study showed that 
several Western scientific claims were validated by indigenous science and not 
necessarily through a discovery. 
● Both indigenous and Western sciences need to be open to learning from each 
other because both have unique ideas that can benefit the community. In this 
study, results showed that some claims made by indigenous people on the efficacy 
of medicinal plants to lower blood pressure could not be scientifically validated. To 
continue with such claims and practices could be detrimental to the community and 
public health. 
● In a few scenarios, these authors allude that sometimes Western science gets it 
wrong, the indigenous science most often gets it right. The community needs to 
respect both sciences. 
● In order to gain a wider acceptance for both indigenous and Western sciences, 
there has to be a point of agreement and compromise on the part of both sciences. 
For instance, this study showed that indigenous therapists administered most 
medicinal plants orally long before the advent of Western science. Also, the parts 
of the plants used by Western science as a source of medicines were the same 
plant parts used by indigenous science. It clearly shows that agreement between 
the two sciences exists as previously reported in the hybrid approach (Mphuthi 
2015:218). 
 
● The outcome of this research showed that indigenous people have good 
experiences in medicinal plants for the management of their hypertension. Also, 
the vendors had success stories in the management of hypertension and other 
diseases using indigenous therapies. Reviewed literature verified and confirmed 
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some of these therapies, making both Western sciences have similar approaches 
and outcomes in managing hypertension. Results of this study, therefore, provide 
Western scientific support to indigenous therapy practices in Belize.  
 
6.4 CONCLUSIONS FROM THE LITERATURE AND STUDY FINDINGS  
 
A total of 47 medicinal plants allegedly used in the management of hypertension in Belize 
were mentioned by all the participants in both qualitative and quantitative studies. The 
medicinal plants were organized and presented based on their family, phytochemicals, 
presumed pharmacological action, toxicity, interactions with Western medications, 
common preparation methods, and administration routes. The medicinal plants in this 
study, information on preparation methods, routes of administration, and frequency of 
administration were obtained from study participants, while the mechanisms of action, 
phytochemical properties, toxicities, and interactions of medicinal plants were obtained 
from reviewed literature. The medicinal plants reported in this study belonged to 34 
families made up of Amaryllidaceae, Anacardiaceae, Annonaceae, Apiaceae (2), 
Apocynaceae, Asphodelaceae, Asteraceae (3), Bixaceae, Bromeliaceae, Cactaceae, 
Cannabaceae, Caricaceae, Cecropiaceae, Chenopodiaceae, Cucurbitaceae (3), 
Euphorbiaceae, Fabaceae (2), Lamiaceae, Lauraceae (3), Leguminosae, Linaceae, 
Malvaceae (2), Meliaceae, Monimiaceae, Moraceae, Moringaceae, Myrtaceae, 
Pinaceae, Poaceae, Rosaceae, Rubiaceae (2), Rutaceae (2), Solanaceae (2), and 
Zingiberaceae (2), as shown in Table 5.1 above. The medicinal plants with the highest 
mention belonged to the Asteraceae (3), Cucurbitaceae (3), and Lauraceae (3) families. 
The phytochemicals found in most plants produced their mechanism of action through 
antioxidant activity (Shaik et al. 2020:1008).   
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The generation of reactive nitrogen species (RNS) and reactive oxygen species (ROS) 
by the human body due to normal biochemical activities, dietary chemicals, and the 
environment leads to oxidative stress and pathological conditions. Antioxidants found in 
medicinal plants have been reported to be effective because of their ability to donate 
hydrogen atoms (Nimse and Pal 2015:27986). The antioxidant activities of medicinal 
plants are mainly due to flavonoids (kaempferol, quercetin, naringenin, and catechin), 
phenolic acids (rosmarinic acids, gallic, caffeic, and protocatechuic), volatile oils (menthol, 
eugenol, thymol, and carvacrol), and phenolic diterpenes such as rosmadial, carnosol, 
rosmanol and carnosic acid (Nimse and Pal 2015:27986). Additionally, resveratrol, 
catechins, proanthocyanidins, phenolic acids, and epicatechins antioxidant activity can 
be seen in extracts of grape skins, seeds, and teas. Anthocyanidin and anthocyanin have 
also been reported to donate hydrogen atoms to oxygen radicals and chelate metals in 
slowing the oxidation reactions (Nimse and Pal 2015:27986).  
 
Information regarding the possibilities of interactions between medicinal plants and 
Western medications is also presented in chapter five (Table 5.2). There is a public 
perception that most medicinal plants are safe because they come directly from the earth 
with no change, scientifically proven to be true (Mphuthi 2015:213). A paucity of 
information was seen regarding toxicities and interactions with Western medications for 
some medicinal plants presented. Most of the information identified on toxicities and 
interactions in research was based on cellular assays, hypothetical, inferred from other 
indirect means, or based on inference from animal studies (Asher, Corbett, and Hawke 
2017:1). Mphuthi (2015:213) conducted a mini-trial with rats testing the two commonly 
used medicinal plants’ toxicity. This study showed no kidney or liver toxicity, and the study 
utilized crude plant extracts to test toxicity. The limitation was that the sample was small, 
but this study gave the baseline information about indigenous therapy use. 
 
Meaningful, well-designed clinical studies evaluating medicinal plant toxicities and 
interactions are mostly inconclusive and very limited (Shaik et al. 2020:1008). In the use 
of indigenous therapies with Western medications such as digoxin, chemotherapeutic 
agents, and warfarin, care must be taken to such drugs because of their narrow 
312 
 
therapeutic index (Asher et al., 2017:1). The potential for herb-drug interactions has been 
extensively reviewed and presented in some studies (Shaikh et al. 2020:1008; Kahraman 
et al. 2020). For instance, the oral bioavailability of various drugs, including calcium 
channel blockers, have been reported with grapefruit juice. In addition, the oral 
bioavailability of drugs like simvastatin, midazolam, and terfenadine was also seen in 





Based on this research’s outcomes, the following paragraphs discuss recommendations 
to policymakers, healthcare practitioners, indigenous therapy vendors, indigenous 
therapy users, and research and learning.  
 
6.5.1 Recommendations to policymakers 
 
The following recommendations to policymakers are aimed at encouraging policymakers 
to promulgate policies that will promote the use of indigenous therapies and collaboration 
between indigenous therapists and Western healers: 
● Policies have to be made to incorporate indigenous therapies as part of a holistic 
approach to healthcare since, from the results of this study and reviewed literature, 
such incorporation provides corroboration between indigenous and Western 
sciences.  
● There is a need for an awareness campaign by the Ministry of Health on the need 
for hypertensive patients to exercise caution with medicinal plants to manage 
hypertension. Since presently not many medicinal plants have gone through 
thorough scientific investigations, including pre and post clinical trials, the 
possibilities of harmful toxicities cannot be overlooked.  
● Plants that have shown remarkable efficacies with proven pre and post clinical 
studies should be approved for supplemental usage by hypertensive patients in 
Belize. Presently, there is no clear policy from the Ministry of Health on medicinal 
plants and alternative medicines to manage diseases, especially metabolic 
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disorders in Belize. Developing such policies will help regulate the use of medicinal 
plants. 
● As a country, presently, Belize is not a member of the WHO’s efforts on indigenous, 
complementary, and alternative medicines. Membership accords a global 
partnership to member states to regularly share strategies for the safety, quality, 
and efficacy of indigenous and alternative therapies. Being a member will also help 
the country formulate policies on indigenous and alternative therapies based on 
WHO guidelines and research findings. 
● Indigenous therapy vendors should be recognized, and their knowledge 
incorporated into holistic care discussions at all healthcare system levels, including 
the university curriculums.  
● Policy regarding the harvesting and preservation of medicinal plants in the country 
be made to ensure the passing of information to the next generation.  
6.5.2 Recommendations to healthcare practitioners 
 
The following recommendations are aimed at encouraging healthcare practitioners to 
discuss the use of indigenous therapies with their patients in order to provide a holistic 
approach to hypertension management:  
● Healthcare personnel should be encouraged to discuss the use of medicinal plants 
during consultations with hypertensive patients. The majority of the participants 
indicated that their doctors did not ask them about indigenous therapies. 
Discussing with the patients during consultations will guide the healthcare team to 
design appropriate interventions for the patients and minimize herb-drug 
interactions. 
● Healthcare personnel should update their knowledge of recent information 
regarding indigenous therapies to help their patients. 
● The nurses have to be well informed about medicinal plants’ use to connect the 




6.5.3 Recommendations to vendors of indigenous therapies 
 
The following recommendations to vendors to encourage the vendors to harmonize their 
therapies and develop a cross-referral system: 
● There is an urgent need for indigenous therapists to harmonize their therapies in 
terms of dosage, duration, and medicinal plant intake frequency.  
● Indigenous therapy vendors should make an effort to document detailed 
formulations of their therapies for standardization and pass on such knowledge to 
the generations behind them.  
● Indigenous therapy vendors should update their knowledge of medicinal plants’ 
abilities to heal and interactions with Western medications. 
● Both indigenous vendors and Western-trained doctors need to discuss the 
approach used by each system; this will provide respect and have a cross-referral 
system.  
6.5.4 Recommendations for users of indigenous therapies 
 
The following recommendations to indigenous therapy users will encourage users to have 
current knowledge of both indigenous and Western therapies used for the management 
of hypertension: 
● This study’s findings strongly suggest that indigenous therapies have been used 
successfully in the management of hypertension. The confidence of the users, 
vendors, and available scientific data advocates indigenous therapies alongside 
Western therapies. Therefore this study recommends the practice to be identified 
and incorporated as part of a holistic approach to managing hypertension.  
● There is a need to create patient awareness to maintain consistency in taking their 
prescribed Western medications to avoid resistant hypertension, rebound 
hypertension, interactions, and toxicities. 
● Users of indigenous therapies should also be educated on the dangers of herb-
drug interactions. A well-spaced time between the use of indigenous and Western 
therapies should be encouraged to avoid interactions.  
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● Indigenous therapy users should be encouraged to share with their doctor’s 
information on medicinal plants they are using for any purpose.  
● The users should present a near standardized prescription when asked about 
indigenous therapies for their condition. 
6.5.5 Recommendations regarding teaching and learning 
 
These recommendations are made regarding teaching and learning at the teaching 
institutions based on this study’s findings on the medicinal plants and their uses. 
● Necessary identification and compilation of all plant species native to Belize need 
to be conducted and regularly updated. The compilation should include medicinal 
use, phytochemistry, toxicology, and interactions. Presently, there is a paucity of 
updated information on the medicinal plants endogenous to Belize, especially 
those used in managing hypertension. 
● Acute and chronic toxicological studies by the University of Belize and other 
research institutions in the country need to be urgently conducted to identify 
toxicities of medicinal plants unique to plant species endogenous to Belize, 
especially those used in the management of hypertension.  
● Collaborative discussions and research should be conducted between indigenous 
therapy vendors and university faculty to identify and document bioactive 
compounds found in Belize’s medicinal plants. The efficacy of medicinal plants in 
managing and treating many disease conditions should continually be 
investigated, documented, and made public. 
● Conferences, workshops, seminars, and congresses should be jointly held 
between faculty, indigenous vendors, and health practitioners as a means of 
healthy interaction and sharing of knowledge.  
● Collaborative research with national and international researchers needs to be 
adopted to research the effectiveness, biological effects, and pharmacological 
usefulness of medicinal plants. With the variety of medicinal plants in Belize, this 




● A postgraduate diploma or certificate course should be designed at the university 
to help preserve indigenous knowledge and help indigenous therapy vendors with 
certification (Jacobs 2015:50). 
● Curriculum for nurses and doctors should incorporate indigenous knowledge 
systems to have health practitioners who are well informed about both care 
systems. 
6.5.6 Recommendations for the public 
 
The following are the recommendations to the general public in Belize based on the 
findings of this study. 
● Since indigenous therapy has been in existence before Western medicines and 
has effectively been used to treat various diseases with proven efficacy, 
indigenous therapy and Western therapies can co-exist to provide holistic 
healthcare to the Belizean population.  
● Western therapy’s approach is not a consultation approach in most cases, rather 
a system that tells the patient what to do. The approach needs to change to a 
consultative approach between the community and the Western medicine 
practitioners. 
● The public needs to be adequately informed on indigenous therapies, especially 
related to such therapies being combined with Western therapies. Information on 
dosing, frequency of intake, and possible interactions should be verified before 
consuming indigenous therapies. Safety considerations should always be taken 
into account with any therapy.  
 
6.5.7 Recommendations for research 
 
The following recommendations are made for future research, and they are based on the 
findings of this study. 
● More research on indigenous knowledge systems should be conducted by faculty 
to help unravel novel approaches to therapy and disease management and to 
document such knowledge. 
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● Research to standardize and harmonize indigenous therapies should help patients 
and vendors as they utilize indigenous therapies. 
● The ethical and legal rights of indigenous vendors must be made known to the 
public and adequately respected. Their intellectual property rights and the right to 
voluntarily participate in research must be respected. 
● A memorandum of understanding or contract must be entered between 
researchers and indigenous therapist.  
● Researchers need to acknowledge that they will be taught by the public when 
undertaking this form of research. The reason is that indigenous knowledge is 
based and generated in the community.  
● Researchers have to be aware that most of this knowledge is not documented and 
passed from generation to generation orally. 
● It is also recommended that the researchers show respect to the community by not 
only taking their knowledge just for research purposes with no benefits. 
● When undertaking the research, the community’s morals and values have to 
supersede the research ethics as the community cannot be forced to do what they 
are not free to do. 
● The community should not be forced to communicate things that they regard as 
sacred and secrets of their knowledge and practice.  
 
6.6 CONTRIBUTORY STATEMENTS AND INSIGHTS DERIVED FROM THIS 
RESEARCH 
 
The following contributory statements spawned from the research objectives and 
research questions: 
● A respectful interaction between the researcher and the research participants 
(especially the vendors) was observed. For instance, some vendors did not reveal 
some of the detailed recipes used to prepare their therapies. The researcher 
respected the decisions of the vendors. 
● The researcher did not approach the indigenous community with pride from 
Western knowledge; instead, with humility, the researcher showed respect to the 
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indigenous community and learned without interference. Being at an equal level 
with the indigenous community opens the door for mutual respect and learning.  
● The hypertensive participants and the indigenous therapy vendors used various 
medicinal plants to manage hypertension, unknowingly validated as useful by 
trained Western healers. Due to prolonged use and proven experience, the 
indigenous community has also trusted their remedies as useful. The quantitative 
and qualitative baseline data collection methods used in this study and the 
reviewed literature on preclinical and clinical studies prove that these medicinal 
plants heal many diseases. To further undermine the community by anyone in the 
Western health care practice is a disservice to indigenous knowledge systems 
that have been proven to be safe and efficacious even by science. 
● Despite concerns over medicinal plants’ safety, the indigenous community 
reported medicinal therapies to be relatively safe in this study. In addition to safety, 
medicinal plants were also reported to be available as most of the plants are 
cultivated by the communities or found in the wild. The plants were also reported 
to be affordable to those who do not cultivate them. 
● The indigenous community reported very minimal toxicities in the use of 
indigenous medicinal plants to manage hypertension, even though the community 
reported no standardization. Therefore, it is logical to assume that if the 
indigenous community is trained with knowledge in measurements and dosing, 
the few toxicities reported could be eliminated or made insignificant.  
● Based on reviewed literature and the fact that many drugs were historically 
discovered from medicinal plants, it is imperative to acknowledge that indigenous 
people’s medicinal plants can also be investigated in the Western laboratory to 
discover active ingredients useful for the cure of diseases. 
● The reviewed literature and the results seen in this research showed that not many 
differences exist between indigenous knowledge systems and Western scientific 
outcomes. Indigenous communities have their science and methods that need to 




6.7 FINAL REMARKS  
 
The proposed execution of this study was discussed in chapters one and three. The final 
remarks took into consideration of the outlined execution plan of the research. A mixed-
method exploratory research approach was utilized for data collection, as described by 
Creswell (2015:35). The final remarks for each phase are presented below. 
 
6.7.1 Phase 1 (Quantitative) 
 
Data was collected quantitatively from the hypertensive patients in Belize. The 
respondents identified valuable medicinal plants used in the management of hypertension 
in Belize. The respondents also identified common Western therapies for hypertension. 
Most respondents used either indigenous therapies or Western therapies for the 
management of their hypertension. A few of the respondents indicated combining both 
therapies for the management of their hypertension.  
 
This phase saw the hypothesis accepted that the combination of indigenous-western 
therapies does not lower blood pressure than a single therapy based on the findings of 
this phase’s results, summarized above.  
 
6.7.2 Phase 2a (Qualitative – hypertensive patients) 
 
Qualitative data was obtained through interviews with hypertensive patients. 
Hypertensive participants in the study identified plant sources for the management of 
hypertension. Leaves were the common plant part used by hypertensive patients, and the 
common process of preparation is boiling. The oral route was identified as the most 
common route of administering medicinal therapies by the hypertensive participants. Most 
respondents do not combine indigenous and Western therapies and generally reported 
that effective blood pressure management is seen with the combination. The participants 
reported fewer side effects, and most of them considered the indigenous therapies safer, 




6.7.3 Phase 2b (Qualitative – vendors of indigenous therapies) 
 
Vendors of indigenous therapies for the management of hypertension contributed 
immensely to the study by providing valuable information on medicinal plants used in the 
management of hypertension, part of the plant, method of preparation, dosing, routes of 
administration, recognized efficacy, and presumed mechanisms of action of some of the 
medicinal plants. Some of the information obtained from the vendors’ corroborated 
Western scientific data found literature. Phase two (A&B) concentrated on the research 
questions, which were answered adequately based on the study’s findings summarized 
above. 
 
6.7.4 Phase 3 Development of guidelines for indigenous therapies  
 
The guidelines generated from this study contributed in no small measure to create 
awareness and provide the scientific knowledge needed by hypertensive patients on how 
to use medicinal plants, especially when used alongside Western therapies. Reported 
doses and administration routes are from the research participants, while other 
information such as active ingredients found in medicinal plants, mechanisms of action, 
interactions, and toxicities were from literature. Based on the findings of the study’s 
phases and the use of the WHO guidelines, the use of indigenous-western medication to 
treat hypertension in Belize was developed. 
 
6.7.5 Contribution of this study 
 
Despite the paucity of literature in Belize regarding the use of medicinal plants individually 
or in combination with Western therapy, this study is groundbreaking in Belize as it forms 
the baseline knowledge creation. The findings will be disseminated to the ministry of 
health in Belize to encourage the country to be a World Health Organization member. The 
country will benefit from developing policies that will regulate the use of indigenous 
therapies and preserve indigenous plants. The baseline information from this study can 




In conclusion, this study will ensure the trust between the two health-seeking behaviors 
of the Belizean community. 
 
6.8 LIMITATIONS TO THE STUDY 
 
The researcher recognizes some limitations in conducting this study.  
● Both quantitative and qualitative data collection methods were used in conducting 
this study. The results generated, therefore, provided a significantly rich but large 
amount of data. Although transparency, honesty, and rigorous data analysis were 
made, not all the data were discussed in detail. Some aspects of the data were 
briefly discussed, hoping that more will be discussed during a follow-up study, and 
during publications, a more detailed explanation may be pursued. 
● Information on medicinal plants’ interactions and toxicities was found to be in 
paucity or nonexistent for many of the plants discussed. This paucity of information 
did not allow for a full presentation on the medicinal plants’ guidelines, which was 
deemed a limitation. 
● In the researcher’s opinion, the broad objectives of the study were achieved. 
However, further research on animal studies, pre and post clinic studies on 
medicinal plants used for managing hypertension needs to be conducted. This 
approach will address scientific evidence-based information needed for 
supplemental approval of such medicinal plants.  
● During the interview sessions for the qualitative phase, few indigenous therapists 
had some “secret recipes” for managing hypertension that they did to share. 
Although he provided information on the available therapies, he did not reveal the 
secret recipe. Such recipes could not be documented as such, a limitation.  
● Finally, because the research was not funded, financial constraints played a bit of 
limitation where the researcher would have preferred to bring together the 
indigenous therapists for a focused group discussion rather than individual 
interviews. To do this will require funds for transportation, refreshments, and 
honorarium. This was however addressed by the researcher traveling to the 
individual indigenous therapists. 
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● Despite these limitations, since the study’s overall goal was to generate data from 
indigenous people and provide guidelines for the use of indigenous-western 
medications for managing hypertension, the researcher believes the goal was 
achieved and hence the strength of the study.  
 
6.9 CONCLUDING REMARKS  
 
The use of indigenous-western therapies for managing hypertension in Belize was 
quantitatively and qualitatively investigated in this study. The study identified the 
medicinal plants used in managing hypertension, how they are prepared, their 
recommended dosages, shelf-lives, presumed pharmacology, toxicities, and interactions. 
From the information gathered, a guideline was provided for medicinal plants used to 
manage hypertension in Belize. Based on the study results, recommendations have been 
made for practical actions on the use of medicinal plants in Belize. Indigenous knowledge 
systems in healthcare in Belize have long been ignored and neglected by the Western 
healers even though the practice has been in existence from the pre-colonial era. The 
need for collaboration and mutual respect between indigenous and Western science 
should be encouraged since both could learn from each other. Indigenous knowledge 
systems are heavily dependent on indigenous people, and such knowledge is fast 
disappearing because of a lack of adequate documentation. The present study results 
significantly serve as documentation for both present and future generations on medicinal 
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Annexure B: Participant information letter 
 
Project Title: Guidelines on the use of indigenous-western antihypertensive 
therapies in Belize. 
 
Please read this consent agreement carefully before you decide to participate in 
the study. 
 
Purpose of the research study: The study will look at the types of indigenous-western 
anti-hypertensive therapies used in the management of hypertension in Belize. The study 
will also find out why, when and how such therapies are used. The study will further 
develop guidelines for western-indigenous antihypertensive therapies in Belize to 
promote coexistence of western-indigenous practices.  
 
What you will do in the study: The study will be divided into two phases. You are 
required to answer the questions as truthful as you can. Any information you provide will 
be handled with uttermost confidentiality.  
 
Phase one: Please do not write your name or contact address on the questionnaires that 
will be provided for this phase. 
 
Phase two: This phase you will be requested to be interviewed. The interview will last 
about 30 minutes.  
 
Risks: There is no known risks associated with this study.  
 
Benefits: There are no direct benefits to you for participating in this research study. The 
study may help us understand the indigenous – western remedies practices in the 
management of hypertension. At the end of the study, guidelines for the use of such 
therapies shall be provided to help the public to improve the quality of life in regards to 




The information that you give in the study will be handled confidentially. Your data will be 
anonymous which means that your name will not be collected or linked to the data.  
Voluntary participation: Your participation in the study is completely voluntary.  
Right to withdraw from the study: You have the right to withdraw from the study at any 
time without penalty.  




I, (full name and surname) ………………………………………………….. the undersigned, 
have received adequate information and given a chance to ask questions about the 
nature of research study. My questions have been answered such that I feel comfortable 
in participating and signing this form. I have read and understand that the following 
principles: 
1) That participation is completely voluntary and there is no pressure 
2) That I am free to withdraw from the assignment at anytime without stating reasons 
3) That I may not benefit personally from my participation in the assignment although 
knowledge gained by means of assignment may benefit others or communities. 
 
Participant signature:       Date:  
 
Witness: Name and Surname:  
 
Signature:        Date: 
 
Researcher: Name and Surname: 
 
Signature:        Date: 
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Annexure C: Information Letter to Participants  
 
Title of Project: Guidelines on the use of indigenous-western antihypertensive 
therapies in Belize. 
 
Principal Researcher: Danladi Chiroma Husaini 
                    Department of Health Sciences; UNISA 
                  61113271@mylife.unisa.ac.za; +501 622-6176 
 
Supervisor:         D. D. Mphuthi (Professor) 
                   Senior Lecturer– Health Studies; College of Human Sciences 
  Muckleneuk Campus, TvW 7 – 163; Tel: 012 429 2058;    
        mphutdd@unisa.ac.za  
 
You are invited to participate in a study that seeks to provide detailed guidelines on the 
use of indigenous-western anti-hypertensives therapies in Belize. The study will look at 
the types of indigenous-western anti-hypertensive therapies used in the management of 
hypertension in Belize. The provision of the guidelines for western-indigenous 
antihypertensive usage among hypertensive patients in Belize is an intervention designed 
to curb public health concerns for western-indigenous practices. 
As a participant in this study, you will be asked to complete a questionnaire that is divided 
into 3 sections. Section one is demographics; section 2 use of antihypertensive 
medications and section 3 the use of indigenous remedies. For each section you will be 
required to answer the questions truthfully and to the best of your knowledge.  
Participation in this study is voluntary, and will take approximately 30 minutes of your 
time. By volunteering for this study, you will be helping to provide a national data on 
indigenous -western therapies used for the management of hypertension in Belize. There 
are no personal benefits to participation. You may decline to answer any questions 
presented during the study if you so wish. Furthermore, you may decide to withdraw from 
this study at any time by advising the researcher, and may do so without any penalty. All 
information you provide is considered completely confidential; your name will not be 
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included or in any other way associated, with the data collected in the study. Furthermore, 
because the interest of this study is in the average responses of the entire group of 
participants, you will not be identified individually in any way in any written reports of this 
research. Data collected during this study will be retained in a locked office and locked 
filing cabinet to which only researchers associated with this study have access. Data shall 
be destroyed in line with approved protocols of the ethics committee. There are no known 
or anticipated risks associated to participation in this study. 
Although this study has been reviewed and approved by the Research Ethics Review 
Board at UNISA, the final decision about participation is yours. If you have any comments 
or concerns resulting from your participation in this study, please contact me on +501 
622-6176. 
 




Annexure D: Phase 1 - Quantitative data collection questionnaire  
 
COLLECTION TOOL 
Phase 1: Quantitative data collection questionnaire  
Dear Respondent, 
This survey on the Guidelines on the use of indigenous-western therapies in the treatment 
of hypertension in Belize is conducted with a view to assess the practice of indigenous-
western therapies use in treating hypertension in Belize. Your participation in this survey 
will help to provide a national data in this area and contribute to the development of a 
national guideline on indigenous-western therapies use in the management of 
hypertension. Your participation is voluntary and at any point you may wish to withdraw 
from completing this survey. 
Thank you. 
Section 1: Demographics 
 
1. Your age in years  
□ 18 – 30yrs   
□ 31 – 40 yrs. 
□ 41 – 50 yrs. 
□ 51- 60 yrs.   
□ 58 – 62 yrs.  
 
2. Gender 
□ Male □ Female 
   
3. Marriage status 
□ Married    
□ Separated   
□ Divorced    




4. Religious affiliation 
□ Catholic  
□ Evangelicals (Baptist, Methodist, SDA etc.)   
□ Pentecostals  
□ Rastafarian  
□ Traditional     
□ Other (specify) __________________   
 
5. Education 
□ No formal education    
□ Primary  
□ Secondary  
□ Tertiary (undergraduate) 
□ Postgraduate (Masters, PhD) 
 
6. Employment 
□ Self employed      
□ Public service    
□ Private sector     
□Not employed    
□ Retired  
 
7. District 
□ Belize     
□ Cayo    
□ Corozal  
□ Orange Walk    
□ Stan Creek      
□ Toledo 
 




□ Creole  
□ Hispanic  
□ Garinagu  
□ Mestizo  
□ Maya       
□ European/North American  
□ Other (specify) __________________________ 
 
9. Monthly income (Belizean Dollars) 
□Less than $200     
□$201 – 500    
□$501 – 1000   
□$1001 - 2000    
□$2001 and above 
 
Section 2: Hypertension history/adherence 
 
1. How long since you became aware that you have high blood pressure? 
□ 1- 5 years   
□ 6 – 10 years  
□ 11 – 15 year   
□ 16 – 20 years  
□ 21 years and above   
 
2. How long have you been taking drugs to treat your blood pressure? 
□ 1- 5 years   
□ 6 – 10 years  
□ 11 – 15 year   
□ 16 – 20 years  
□ 21 years and above 
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3. How often do you take your prescribed drugs/medicines for high blood pressure? 
□ Once daily  
□ Twice daily   
□ Thrice daily  
□ Four times daily 
  
4. What blood pressure medicines (pressure pill) are you currently taking? (check all 
that   applies)  
□ Hydroclorothiazide (Water pill)  
□ Atenolol (Tenormin)   
□ Metoprolol (Toprol) 
□ Amlodipine (Norvasc)  
□ Lorsartan (Cozaar) 
□ Lisinopril (Prinivil) 
  □ Others (please specify) __________________________   
 
5. When you feel like your blood pressure is under control, do you sometimes stop 
taking your drugs/medicine?  
□ Yes  
□ No   
 
6. How often did you stop taking your blood pressure medicines in the PAST 30 
DAYS? 
 □ Just once (in the past 30 days) 
 □ More than 5 times (in the past 30 days) 
  □ More than 5 times a month (in the past 30 days) 
 □ More than 5 times a week (in the past 30 days) 
 □ Every day (in the past 30 days) 





7. Do you sometimes forget to take your blood pressure medicines?  
□ Yes   
□ No   
 
8. When you travel or leave home, do you sometimes forget to take along your blood 
pressure medicines?  
□ Yes  
□ No   
 
9. Have you ever cut back or stopped taking your antihypertensive medicines without 
telling your doctor because you felt worse when you took it?  
□ Yes    
□ No    
 
10. Taking medicines every day is a real inconvenience for some people. Do you ever 
feel hassled (stressed) about sticking to your treatment plan?  
□ Yes    
□ No   
 
Section 3: Herbal/bush-drug prevalence and usage  
 
11. Do you know anyone who uses herbal/bush remedies to treat their disease?  
□ Yes  
□ No   
 
12. Do you know of any herbal/bush remedies used to treat high blood pressure in 
Belize?  
□ Yes   
□ No   
 
if No, skip to 15  
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14. What are (or do you know) some of the reasons why people take herbal/bush 
remedies in Belize? 
 □ It’s safer   
□ It is cheaper   
□ It is readily available  
□ Religious reasons 
 □ It is natural   
15. Do you take herbal/bush remedies to treat diseases other than hypertension? 
□ Yes  
□ No   
 
16. Do you take herbal/bush remedies to treat your high blood pressure? 
□ Yes   
□ No   
 
If no skip to 32. 
 









18. How often have you used herbal/bush remedies in the PAST 12 MONTHS to treat 
your high blood pressure? 
  □ Just once (in the past 12 months) 
  □ More than 5 times (in the past 12 months) 
  □ More than 5 times a month (in the past 12 months) 
  □ More than 5 times a week (in the past 12 months) 
  □ Every day (in the past 12 months) 
 
19. Do you take herbal remedies alone or together with your prescribed blood pressure 
medications? 
□ Herbal/bush remedies alone (no drugs) 
□ Herb/bush remedies with drugs together (concomitant) 
□ Sometimes herbal alone and sometimes in combination 
□ I do not combine herbs with drugs. Medications alone without herbs 
   
 If no combination skip to 26 
 
20. Why do you take herbal/bush remedies together with your blood pressure drugs? 
□ They work well together  
□ Pharmaceutical drug alone not good  
□ Too many side effects with pharmaceutical drug  
□ Pharmaceutical drug expensive  
□ No harm in taking both together  
□ Not taking pharmaceutical drug for same condition 
 
21. Do you think combining herbal/bush remedies with your prescribed blood pressure 
drugs can help lower your pressure more quickly than drugs alone? 





22. Are you aware of possible interactions that might occur between herbal/bush 
remedies and prescribed medications when taken together?  
□ Yes   
□ No   
 
23. Did your medical practitioner/doctor ask if you use herbal/bush remedies together 
with your anti-hypertensive drugs? 
□ Yes   
□ No     
 
24. Did you inform your medical practitioner/doctor that you use herbal/bush remedies 
together with your prescribed antihypertensive medications?  
□ Yes  
□ No   
 
If yes skip to 26 
25. Why didn’t you inform your medical practitioner that you are taking herbal/bush 
remedies together with your prescribed medication? 
□ Didn’t think it was important 
□ He/she didn’t ask me 
□ I wasn’t aware that I should inform him/her 
□ Doctors don’t like herbal/bush remedies 
□ I didn’t want doctor to stop me from taking them 
 
26. What is the source of your herbal/bush remedies? 
□ Grocery stores/super market   
□ Bush doctor   
□ My yard 
□ Herbal shop/store/market   




Please provide information on how you prepare your herbal/bush remedies for 
hypertension (if you don’t buy ready made). 
 





□ Combination of all 
 
 28. How do you prepare the herbal medication for use? 
  □ Boiling them and drinking the tea 
  □ Infusion after pooling 
  □ Chewing  
  □ Sniffing  




31. Why do you prefer herbs to pharmaceutical medications? 
□ Pharmaceutical medications are expensive 
□ Hospitals waste too much time 
□ Herbs are natural  
□ Herbs are readily available  
□ Herbs are safe and cause no harm 
□ I don’t like health workers (doctors/nurses) 
32. Why don't you take herbal preparations for the management of your hypertension? 
 
Thank you for your time. 
 
Danladi Husaini (Researcher) 
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Annexure E: Phase II Interview guide for hypertensive patients 
 
Phase II Interview guide for hypertensive patients 
 
INTRODUCTION: 
• Introduction and welcome. 
• Informs the participants about the use of the audio-tape during the discussion.  
• Participants are informed about the confidentiality as well as the no name use during 
the interview and their names will not be reflected in the transcribed text. 
• Consent forms discussed and signed by participants. 
 
INTERVIEW SESSION 
Good day and welcome to this session. Thank you for taking time to come and join me in 
this interview. The information will be used for research purposes only. There are no 
wrong answers to the questions therefore feel free to express your views. Feel free to 
share with me your experiences and knowledge regarding the use of herbal remedies for 
the treatment of hypertension. No names will be written in the research transcripts as 
well as report. You are assured of complete confidentiality.  
 
RESEARCH QUESTIONS: 
“Can you please tell me which indigenous therapies you use to treat your high blood 




1. How long have you been taking indigenous therapies? 
2. Why do you take herbal remedies for your hypertension? [Reasons for use] 
3. How did you learn about the use of indigenous therapies in the treatment of 
hypertension? 




5. Does your therapy cure hypertension or just controls it? 
6. How long the therapy should be taken for cure to take place or for the pressure to 
be under control? 
7. Do you combine your indigenous therapy with Western medicines? If yes why? 
And if no why? 
8. Have you experienced any sort of side effects while taking herbs for your 
hypertension? 
9. How much do you spend on such remedies for your hypertension? 
Closing the interview: 
Is there anything else that you would like to add that you think may help me to understand 
the reasons for the usage of indigenous remedies? 




Annexure F: Phase II Interview guide for vendors of indigenous therapies 
 
INTRODUCTION: 
• Introduction and welcome. 
• Informs the participants about the use of the audio-tape during the discussion.  
• Participants are informed about the confidentiality as well as the no name use during 
the interview and their names will not be reflected in the transcribed text. 
• Consent forms discussed and signed by participants. 
 
INTERVIEW SESSION 
Good day and welcome to this session. Thank you for taking time to come and join me in 
this interview. The information will be used for research purposes only. There are no 
wrong answers to the questions therefore feel free to express your views. Feel free to 
share with me your experiences and knowledge regarding the use of herbal remedies for 
the treatment of hypertension. No names will be written in the research transcripts as 
well as report. You are assured of complete confidentiality.  
 
RESEARCH QUESTIONS: 
“Can you please tell me which indigenous therapies you recommend to treat the high 
blood pressure and how it should be prepared by the persons taking them?” 
 
Probing questions 
1. For how long have you been selling indigenous therapies? 
2. How did you learn the use of indigenous therapies? 
3. What indigenous therapies do you recommend for the treatment of hypertension? 
4. How do you get the indigenous therapies for hypertension? 
5. What part of the indigenous therapy (example plant) do you use or recommend 
for hypertension? 
6. How is the preparation to be taken for the management of hypertension? 
7. How long should the preparation stay after preparation? (shelf life) 
8. Does the herb cure hypertension or just lower the pressure?  
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9. What is the average cost of a regimen for hypertension? 
 
Closing the interview: 
Is there anything else that you would like to add that you think may help me to understand 
the reasons for the usage of herbal remedies? 
 




Annexure G: Phase III guidelines development 
 
Information to be included in the guidelines for the use of indigenous-western 
therapies for hypertension in Belize. 
 
• Scientific name of plant/herb. 
• Local name (s) of plant/herb. 
• Part of plant used for hypertensive management. 
• Picture of herb/plant. 
• Habitat/how herb can be found or purchased. 
• How herb is prepared and taken. 
• Indication (s) for therapy. 
• Proposed mechanism of action. 
• Efficacy of herb. 
• Side effects of herb. 
• Possible interactions with western remedies. 
• Possible contraindications. 
• Any warning. 
• Any other useful information. 
 
 
 
 
 
 
 
